GeneSymbol	GeneId	PrimaryPubMed	EvidenceCode	IsNegative	Comments	Score	Strength	ScoreType	ExternalDatabase	DatabaseLink	Phenotypes
PBX1		23319801	TAS		Disease/Trait: Breast cancer (prognosis); Initial Sample Size: 536 early-onset cases; Replication Sample Size: 1,516 early-onset cases; Strongest SNP-Risk Allele: rs1387389-?; SNPs: rs1387389; Context: intron; Risk Allele Frequency: 0.36; p-Value: 4E-6; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [487,496]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
SYT6		23319801	TAS		Disease/Trait: Breast cancer (prognosis); Initial Sample Size: 536 early-onset cases; Replication Sample Size: 1,516 early-onset cases; Strongest SNP-Risk Allele: rs2774307-?; SNPs: rs2774307; Context: intron; Risk Allele Frequency: 0.26; p-Value: 8E-6; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [487,496]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
NTN1		23319801	TAS		Disease/Trait: Breast cancer (prognosis); Initial Sample Size: 536 early-onset cases; Replication Sample Size: 1,516 early-onset cases; Strongest SNP-Risk Allele: rs3785982-?; SNPs: rs3785982; Context: intron; Risk Allele Frequency: 0.12; p-Value: 8E-6; OR or beta:    1.40; Platform [SNPs passing QC]: Illumina [487,496]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
C6orf10		23321320	TAS		Disease/Trait: Hepatitis C induced liver cirrhosis; Initial Sample Size: 682 Japanese ancestry cases, 1,045 Japanese ancestry controls; Replication Sample Size: 936 Japanese ancestry cases, 3,809 Japanese ancestry controls; Strongest SNP-Risk Allele: rs910049-A; SNPs: rs910049; Context: intron; Risk Allele Frequency: 0.142; p-Value: 9E-11; OR or beta:    1.46; Platform [SNPs passing QC]: Illumina [431,618]	0.00000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C;liver cirrhosis
BTNL2		23321320	TAS		Disease/Trait: Hepatitis C induced liver cirrhosis; Initial Sample Size: 682 Japanese ancestry cases, 1,045 Japanese ancestry controls; Replication Sample Size: 936 Japanese ancestry cases, 3,809 Japanese ancestry controls; Strongest SNP-Risk Allele: rs3817963-A; SNPs: rs3817963; Context: intron; Risk Allele Frequency: 0.315; p-Value: 1E-8; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [431,618]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C;liver cirrhosis
TCF7L2		23300278	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 842 Punjabi Sikh cases, 774 Punjabi Sikh controls; Replication Sample Size: up to 2,512 Punjabi Sikh cases and 3,201 Punjabi Sikh controls; up to 2,569 non-Sikh Punjabi cases and 3,024 non-Sikh Punjabi controls; up to 13,559 other South Asian cases and 20,822 other South Asian controls; up to 16,746 East Asian ancestry cases and 16,961 East Asian ancestry controls; up to 8,130 European ancestry cases and 38,987 European ancestry controls; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.3; p-Value: 2E-38; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [1,232,008] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
IGF2BP2		23300278	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 842 Punjabi Sikh cases, 774 Punjabi Sikh controls; Replication Sample Size: up to 2,512 Punjabi Sikh cases and 3,201 Punjabi Sikh controls; up to 2,569 non-Sikh Punjabi cases and 3,024 non-Sikh Punjabi controls; up to 13,559 other South Asian cases and 20,822 other South Asian controls; up to 16,746 East Asian ancestry cases and 16,961 East Asian ancestry controls; up to 8,130 European ancestry cases and 38,987 European ancestry controls; Strongest SNP-Risk Allele: rs1470579-C; SNPs: rs1470579; Context: intron; Risk Allele Frequency: 0.45; p-Value: 2E-13; OR or beta:    1.06; Platform [SNPs passing QC]: Illumina [1,232,008] (imputed)	0.0000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		23300278	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 842 Punjabi Sikh cases, 774 Punjabi Sikh controls; Replication Sample Size: up to 2,512 Punjabi Sikh cases and 3,201 Punjabi Sikh controls; up to 2,569 non-Sikh Punjabi cases and 3,024 non-Sikh Punjabi controls; up to 13,559 other South Asian cases and 20,822 other South Asian controls; up to 16,746 East Asian ancestry cases and 16,961 East Asian ancestry controls; up to 8,130 European ancestry cases and 38,987 European ancestry controls; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.5; p-Value: 9E-75; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [1,232,008] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
IGF2BP2		23300278	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 842 Punjabi Sikh cases, 774 Punjabi Sikh controls; Replication Sample Size: up to 2,512 Punjabi Sikh cases and 3,201 Punjabi Sikh controls; up to 2,569 non-Sikh Punjabi cases and 3,024 non-Sikh Punjabi controls; up to 13,559 other South Asian cases and 20,822 other South Asian controls; up to 16,746 East Asian ancestry cases and 16,961 East Asian ancestry controls; up to 8,130 European ancestry cases and 38,987 European ancestry controls; Strongest SNP-Risk Allele: rs1470579-C; SNPs: rs1470579; Context: intron; Risk Allele Frequency: 0.5; p-Value: 2E-19; OR or beta:    1.08; Platform [SNPs passing QC]: Illumina [1,232,008] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
IGF2BP2		23300278	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 842 Punjabi Sikh cases, 774 Punjabi Sikh controls; Replication Sample Size: up to 2,512 Punjabi Sikh cases and 3,201 Punjabi Sikh controls; up to 2,569 non-Sikh Punjabi cases and 3,024 non-Sikh Punjabi controls; up to 13,559 other South Asian cases and 20,822 other South Asian controls; up to 16,746 East Asian ancestry cases and 16,961 East Asian ancestry controls; up to 8,130 European ancestry cases and 38,987 European ancestry controls; Strongest SNP-Risk Allele: rs1470579-C; SNPs: rs1470579; Context: intron; Risk Allele Frequency: 0.45; p-Value: 4E-9; OR or beta:    1.06; Platform [SNPs passing QC]: Illumina [1,232,008] (imputed)	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		23300278	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 842 Punjabi Sikh cases, 774 Punjabi Sikh controls; Replication Sample Size: up to 2,512 Punjabi Sikh cases and 3,201 Punjabi Sikh controls; up to 2,569 non-Sikh Punjabi cases and 3,024 non-Sikh Punjabi controls; up to 13,559 other South Asian cases and 20,822 other South Asian controls; up to 16,746 East Asian ancestry cases and 16,961 East Asian ancestry controls; up to 8,130 European ancestry cases and 38,987 European ancestry controls; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.3; p-Value: 3E-35; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [1,232,008] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		23300278	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 842 Punjabi Sikh cases, 774 Punjabi Sikh controls; Replication Sample Size: up to 2,512 Punjabi Sikh cases and 3,201 Punjabi Sikh controls; up to 2,569 non-Sikh Punjabi cases and 3,024 non-Sikh Punjabi controls; up to 13,559 other South Asian cases and 20,822 other South Asian controls; up to 16,746 East Asian ancestry cases and 16,961 East Asian ancestry controls; up to 8,130 European ancestry cases and 38,987 European ancestry controls; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.31; p-Value: 3E-19; OR or beta:    1.44; Platform [SNPs passing QC]: Illumina [1,232,008] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
RHOU		23300278	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 842 Punjabi Sikh cases, 774 Punjabi Sikh controls; Replication Sample Size: up to 2,512 Punjabi Sikh cases and 3,201 Punjabi Sikh controls; up to 2,569 non-Sikh Punjabi cases and 3,024 non-Sikh Punjabi controls; up to 13,559 other South Asian cases and 20,822 other South Asian controls; up to 16,746 East Asian ancestry cases and 16,961 East Asian ancestry controls; up to 8,130 European ancestry cases and 38,987 European ancestry controls; Strongest SNP-Risk Allele: rs6426514-A; SNPs: rs6426514; Context: ncRNA; Risk Allele Frequency: 0.06; p-Value: 2E-6; OR or beta:    1.51; Platform [SNPs passing QC]: Illumina [1,232,008] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
IGF2BP2		23300278	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 842 Punjabi Sikh cases, 774 Punjabi Sikh controls; Replication Sample Size: up to 2,512 Punjabi Sikh cases and 3,201 Punjabi Sikh controls; up to 2,569 non-Sikh Punjabi cases and 3,024 non-Sikh Punjabi controls; up to 13,559 other South Asian cases and 20,822 other South Asian controls; up to 16,746 East Asian ancestry cases and 16,961 East Asian ancestry controls; up to 8,130 European ancestry cases and 38,987 European ancestry controls; Strongest SNP-Risk Allele: rs1470579-C; SNPs: rs1470579; Context: intron; Risk Allele Frequency: 0.41; p-Value: 5E-6; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [1,232,008] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		23300278	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 842 Punjabi Sikh cases, 774 Punjabi Sikh controls; Replication Sample Size: up to 2,512 Punjabi Sikh cases and 3,201 Punjabi Sikh controls; up to 2,569 non-Sikh Punjabi cases and 3,024 non-Sikh Punjabi controls; up to 13,559 other South Asian cases and 20,822 other South Asian controls; up to 16,746 East Asian ancestry cases and 16,961 East Asian ancestry controls; up to 8,130 European ancestry cases and 38,987 European ancestry controls; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.31; p-Value: 6E-22; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [1,232,008] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
IGF2BP2		23300278	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 842 Punjabi Sikh cases, 774 Punjabi Sikh controls; Replication Sample Size: up to 2,512 Punjabi Sikh cases and 3,201 Punjabi Sikh controls; up to 2,569 non-Sikh Punjabi cases and 3,024 non-Sikh Punjabi controls; up to 13,559 other South Asian cases and 20,822 other South Asian controls; up to 16,746 East Asian ancestry cases and 16,961 East Asian ancestry controls; up to 8,130 European ancestry cases and 38,987 European ancestry controls; Strongest SNP-Risk Allele: rs1470579-C; SNPs: rs1470579; Context: intron; Risk Allele Frequency: 0.41; p-Value: 4E-7; OR or beta:     .88; Platform [SNPs passing QC]: Illumina [1,232,008] (imputed)	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
ERAP1		23291587	TAS		Disease/Trait: Behcet's disease; Initial Sample Size: 435 Turkish cases with uveitis, 780 Turkish cases without uveitis, 1,278 Turkish controls; Replication Sample Size: 355 Turkish cases with uveitis, 483 Turkish cases without uveitis, 601 Turkish controls, up to 612 Japanese ancestry cases, up to 740 Japanese ancestry controls; Strongest SNP-Risk Allele: rs17482078-T; SNPs: rs17482078; Context: missense; Risk Allele Frequency: 0.02; p-Value: 4E-8; OR or beta:    3.08; Platform [SNPs passing QC]: Illumina [779,465] (imputed)	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Behcet's disease
ERAP1		23291587	TAS		Disease/Trait: Behcet's disease; Initial Sample Size: 435 Turkish cases with uveitis, 780 Turkish cases without uveitis, 1,278 Turkish controls; Replication Sample Size: 355 Turkish cases with uveitis, 483 Turkish cases without uveitis, 601 Turkish controls, up to 612 Japanese ancestry cases, up to 740 Japanese ancestry controls; Strongest SNP-Risk Allele: rs17482078-T; SNPs: rs17482078; Context: missense; Risk Allele Frequency: 0.02; p-Value: 5E-11; OR or beta:    4.56; Platform [SNPs passing QC]: Illumina [779,465] (imputed)	0.00000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Behcet's disease
STAT4		23291587	TAS		Disease/Trait: Behcet's disease; Initial Sample Size: 435 Turkish cases with uveitis, 780 Turkish cases without uveitis, 1,278 Turkish controls; Replication Sample Size: 355 Turkish cases with uveitis, 483 Turkish cases without uveitis, 601 Turkish controls, up to 612 Japanese ancestry cases, up to 740 Japanese ancestry controls; Strongest SNP-Risk Allele: rs7574070-A; SNPs: rs7574070; Context: intron; Risk Allele Frequency: 0.421; p-Value: 1E-9; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [779,465] (imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Behcet's disease
TNFAIP3		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs2230926-G; SNPs: rs2230926; Context: missense; Risk Allele Frequency: 0.02; p-Value: 1E-13; OR or beta:    2.71; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.0000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
WDFY4		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs877819-A; SNPs: rs877819; Context: intron; Risk Allele Frequency: 0.18; p-Value: 8E-9; OR or beta:    1.46; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
SLC15A4		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs1385374-A; SNPs: rs1385374; Context: intron; Risk Allele Frequency: 0.17; p-Value: 8E-8; OR or beta:    1.41; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
ELF1		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs7329174-G; SNPs: rs7329174; Context: intron; Risk Allele Frequency: 0.21; p-Value: 6E-6; OR or beta:    1.45; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
RASGRP3		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs13385731-A; SNPs: rs13385731; Context: intron; Risk Allele Frequency: 0.83; p-Value: 4E-6; OR or beta:    1.39; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
TNIP1		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs10036748-T; SNPs: rs10036748; Context: intron; Risk Allele Frequency: 0.74; p-Value: 3E-6; OR or beta:    1.25; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
UBE2L3		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs5754217-T; SNPs: rs5754217; Context: intron; Risk Allele Frequency: 0.56; p-Value: 5E-6; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
UHRF1BP1		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs3734266-G; SNPs: rs3734266; Context: intron; Risk Allele Frequency: 0.13; p-Value: 1E-12; OR or beta:    1.56; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
CLEC16A		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs12599402-A; SNPs: rs12599402; Context: intron; Risk Allele Frequency: 0.56; p-Value: 5E-7; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
ITGAM		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs9937837-G; SNPs: rs9937837; Context: intron; Risk Allele Frequency: 0.02; p-Value: 7E-6; OR or beta:    1.86; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
CD80		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs6804441-A; SNPs: rs6804441; Context: intron; Risk Allele Frequency: 0.61; p-Value: 3E-16; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
CREBL2		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs12822507-A; SNPs: rs12822507; Context: ; Risk Allele Frequency: 0.57; p-Value: 2E-8; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
GPR19		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs10845606-C; SNPs: rs10845606; Context: ; Risk Allele Frequency: 0.71; p-Value: 4E-17; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
CDKN1B		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs34330-C; SNPs: rs34330; Context: UTR-5; Risk Allele Frequency: 0.52; p-Value: 5E-12; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
SLC29A3		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs2252996-A; SNPs: rs2252996; Context: missense; Risk Allele Frequency: 0.68; p-Value: 3E-6; OR or beta:    1.22; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
SEZ6L2		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs12917712-T; SNPs: rs12917712; Context: UTR-3; Risk Allele Frequency: 0.29; p-Value: 7E-6; OR or beta:    1.07; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
DDA1		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs2303745-A; SNPs: rs2303745; Context: nearGene-5; Risk Allele Frequency: 0.39; p-Value: 1E-6; OR or beta:    1.07; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
BANK1		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs4522865-A; SNPs: rs4522865; Context: intron; Risk Allele Frequency: 0.54; p-Value: 5E-6; OR or beta:    1.35; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
STAT4		23273568	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,656 Han Chinese cases, 3,394 Han Chinese controls; Replication Sample Size: 3,256 Han Chinese cases, 5,667 Han Chinese controls, 453 Thai ancestry cases, 963 Thai ancestry controls; Strongest SNP-Risk Allele: rs7574865-T; SNPs: rs7574865; Context: intron; Risk Allele Frequency: 0.34; p-Value: 1E-21; OR or beta:    1.63; Platform [SNPs passing QC]: Illumina [2,100,739] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
HSPA12A		23263487	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 2,098 East Asian ancestry cases, 5,749 East Asian ancestry controls; Replication Sample Size: 5,358 East Asian ancestry cases, 5,922 East Asian ancestry controls, 26,060 European ancestry individuals; Strongest SNP-Risk Allele: rs1665650-T; SNPs: rs1665650; Context: intron; Risk Allele Frequency: 0.315; p-Value: 9E-7; OR or beta:    1.13; Platform [SNPs passing QC]: Illumina & Affymetrix (1,636,380) imputed	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
ABCG2		23263486	TAS		Disease/Trait: Gout; Initial Sample Size: 2,115 European ancestry cases, 67,259 European ancestry controls; Replication Sample Size: 1,036 European ancestry cases; Strongest SNP-Risk Allele: rs1481012-A; SNPs: rs1481012; Context: intron; Risk Allele Frequency: 0.8903; p-Value: 2E-32; OR or beta:     .55; Platform [SNPs passing QC]: Affymetrix, Illumina [2,538,056] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	gout
SLC2A9		23263486	TAS		Disease/Trait: Gout; Initial Sample Size: 2,115 European ancestry cases, 67,259 European ancestry controls; Replication Sample Size: 1,036 European ancestry cases; Strongest SNP-Risk Allele: rs4475146-A; SNPs: rs4475146; Context: intron; Risk Allele Frequency: 0.2237; p-Value: 4E-26; OR or beta:     .47; Platform [SNPs passing QC]: Affymetrix, Illumina [2,538,056] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	gout
TBX3		23266556	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 12,696 European ancestry colorectal tumor cases, and 15,113 European ancestry controls; Replication Sample Size: 958 European ancestry colorectal tumor cases, up to 2,098 East Asian ancestry colorectal tumor cases, 909 European ancestry controls, up to 5,749 East Asian ancestry controls; Strongest SNP-Risk Allele: rs59336-T; SNPs: rs59336; Context: intron; Risk Allele Frequency: 0.48; p-Value: 4E-7; OR or beta:    1.09; Platform [SNPs passing QC]: Illumina & Affymetrix [2,708,280] imputed	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
CCND2		23266556	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 12,696 European ancestry colorectal tumor cases, and 15,113 European ancestry controls; Replication Sample Size: 958 European ancestry colorectal tumor cases, up to 2,098 East Asian ancestry colorectal tumor cases, 909 European ancestry controls, up to 5,749 East Asian ancestry controls; Strongest SNP-Risk Allele: rs3217901-G; SNPs: rs3217901; Context: intron; Risk Allele Frequency: 0.41; p-Value: 3E-7; OR or beta:    1.10; Platform [SNPs passing QC]: Illumina & Affymetrix [2,708,280] imputed	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
CCND2		23266556	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 12,696 European ancestry colorectal tumor cases, and 15,113 European ancestry controls; Replication Sample Size: 958 European ancestry colorectal tumor cases, up to 2,098 East Asian ancestry colorectal tumor cases, 909 European ancestry controls, up to 5,749 East Asian ancestry controls; Strongest SNP-Risk Allele: rs3217810-T; SNPs: rs3217810; Context: intron; Risk Allele Frequency: 0.16; p-Value: 6E-8; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina & Affymetrix [2,708,280] imputed	0.00000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
LAMC1		23266556	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 12,696 European ancestry colorectal tumor cases, and 15,113 European ancestry controls; Replication Sample Size: 958 European ancestry colorectal tumor cases, up to 2,098 East Asian ancestry colorectal tumor cases, 909 European ancestry controls, up to 5,749 East Asian ancestry controls; Strongest SNP-Risk Allele: rs10911251-A; SNPs: rs10911251; Context: intron; Risk Allele Frequency: 0.57; p-Value: 9E-8; OR or beta:    1.09; Platform [SNPs passing QC]: Illumina & Affymetrix [2,708,280] imputed	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
SMAD7		23266556	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 12,696 European ancestry colorectal tumor cases, and 15,113 European ancestry controls; Replication Sample Size: 958 European ancestry colorectal tumor cases, up to 2,098 East Asian ancestry colorectal tumor cases, 909 European ancestry controls, up to 5,749 East Asian ancestry controls; Strongest SNP-Risk Allele: rs4939827-?; SNPs: rs4939827; Context: intron; Risk Allele Frequency: 0.52; p-Value: 2E-10; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina & Affymetrix [2,708,280] imputed	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
ABCB5		23259602	TAS		Disease/Trait: Dental caries; Initial Sample Size: 1,483 comparatively younger European ancestry individuals, 5,960 comparatively older European ancestry individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs2108258-?; SNPs: rs2108258; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina and Affymetrix [~ 1.4 Million] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
ADAMTS3		23259602	TAS		Disease/Trait: Dental caries; Initial Sample Size: 1,483 comparatively younger European ancestry individuals, 5,960 comparatively older European ancestry individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs1383934-?; SNPs: rs1383934; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina and Affymetrix [~ 1.4 Million] (imputed)	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
CHST9		23259602	TAS		Disease/Trait: Dental caries; Initial Sample Size: 1,483 comparatively younger European ancestry individuals, 5,960 comparatively older European ancestry individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs9961915-?; SNPs: rs9961915; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina and Affymetrix [~ 1.4 Million] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
RPS6KA2		23259602	TAS		Disease/Trait: Dental caries; Initial Sample Size: 1,483 comparatively younger European ancestry individuals, 5,960 comparatively older European ancestry individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs635808-?; SNPs: rs635808; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina and Affymetrix [~ 1.4 Million] (imputed)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
APBB2		23259602	TAS		Disease/Trait: Dental caries; Initial Sample Size: 1,483 comparatively younger European ancestry individuals, 5,960 comparatively older European ancestry individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs4466078-?; SNPs: rs4466078; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina and Affymetrix [~ 1.4 Million] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
SIDT1		23259602	TAS		Disease/Trait: Dental caries; Initial Sample Size: 1,483 comparatively younger European ancestry individuals, 5,960 comparatively older European ancestry individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs13092825-?; SNPs: rs13092825; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina and Affymetrix [~ 1.4 Million] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
BOC		23259602	TAS		Disease/Trait: Dental caries; Initial Sample Size: 1,483 comparatively younger European ancestry individuals, 5,960 comparatively older European ancestry individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs775227-?; SNPs: rs775227; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina and Affymetrix [~ 1.4 Million] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
SCN9A		23259602	TAS		Disease/Trait: Dental caries; Initial Sample Size: 1,483 comparatively younger European ancestry individuals, 5,960 comparatively older European ancestry individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs4438497-?; SNPs: rs4438497; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina and Affymetrix [~ 1.4 Million] (imputed)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
SLC25A10		23259602	TAS		Disease/Trait: Dental caries; Initial Sample Size: 1,483 comparatively younger European ancestry individuals, 5,960 comparatively older European ancestry individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs3204270-?; SNPs: rs3204270; Context: cds-synon; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina and Affymetrix [~ 1.4 Million] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
ADAMTS3		23259602	TAS		Disease/Trait: Dental caries; Initial Sample Size: 1,483 comparatively younger European ancestry individuals, 5,960 comparatively older European ancestry individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs1383934-?; SNPs: rs1383934; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina and Affymetrix [~ 1.4 Million] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
PSORS1C3		23266558	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 372 Japanese ancestry cases and 3,389 Japanese ancestry controls; Replication Sample Size: Up to 1,151 Japanese ancestry cases and up to 15,800 Japanese ancestry controls; Strongest SNP-Risk Allele: rs3094188-C; SNPs: rs3094188; Context: intron; Risk Allele Frequency: 0.280; p-Value: 7E-7; OR or beta:    1.61; Platform [SNPs passing QC]: Illumina [4,929,034] (imputed)	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
JAK2		23266558	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 372 Japanese ancestry cases and 3,389 Japanese ancestry controls; Replication Sample Size: Up to 1,151 Japanese ancestry cases and up to 15,800 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2274471-A; SNPs: rs2274471; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [4,929,034] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
STAT3		23266558	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 372 Japanese ancestry cases and 3,389 Japanese ancestry controls; Replication Sample Size: Up to 1,151 Japanese ancestry cases and up to 15,800 Japanese ancestry controls; Strongest SNP-Risk Allele: rs9891119-A; SNPs: rs9891119; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-15; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [4,929,034] (imputed)	0.000000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
RUNX3		23266558	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 372 Japanese ancestry cases and 3,389 Japanese ancestry controls; Replication Sample Size: Up to 1,151 Japanese ancestry cases and up to 15,800 Japanese ancestry controls; Strongest SNP-Risk Allele: rs7551188-T; SNPs: rs7551188; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-6; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina [4,929,034] (imputed)	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
STAT4		23242368	TAS		Disease/Trait: Hepatocellular carcinoma (hepatitis B virus related); Initial Sample Size: 1,161 Chinese ancestry cases, 1,353 Chinese ancestry controls; Replication Sample Size: 4,319 Chinese ancestry cases, 4,966 Chinese ancestry controls; Strongest SNP-Risk Allele: rs7574865-G; SNPs: rs7574865; Context: intron; Risk Allele Frequency: 0.67; p-Value: 2E-10; OR or beta:    1.21; Platform [SNPs passing QC]: Illumina (1,672,517) imputed	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatocellular carcinoma
TFCP2L1		23001997	TAS		Disease/Trait: Behcet's disease; Initial Sample Size: 147 Han Chinese cases, 951 Han Chinese controls; Replication Sample Size: 554 Han Chinese cases, 1,159 Han Chinese controls; Strongest SNP-Risk Allele: rs17006292-?; SNPs: rs17006292; Context: intron; Risk Allele Frequency: 0.925; p-Value: 5E-9; OR or beta:    4.17; Platform [SNPs passing QC]: Affyemtrix [661,736]	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Behcet's disease
STAT4		23001997	TAS		Disease/Trait: Behcet's disease; Initial Sample Size: 147 Han Chinese cases, 951 Han Chinese controls; Replication Sample Size: 554 Han Chinese cases, 1,159 Han Chinese controls; Strongest SNP-Risk Allele: rs897200-A; SNPs: rs897200; Context: nearGene-5; Risk Allele Frequency: 0.529; p-Value: 6E-9; OR or beta:    1.45; Platform [SNPs passing QC]: Affyemtrix [661,736]	0.000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Behcet's disease
PSORS1C1		23001997	TAS		Disease/Trait: Behcet's disease; Initial Sample Size: 147 Han Chinese cases, 951 Han Chinese controls; Replication Sample Size: 554 Han Chinese cases, 1,159 Han Chinese controls; Strongest SNP-Risk Allele: rs4959053-?; SNPs: rs4959053; Context: intron; Risk Allele Frequency: .11; p-Value: 2E-20; OR or beta:    4.38; Platform [SNPs passing QC]: Affyemtrix [661,736]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Behcet's disease
LCP1		23213074	TAS		Disease/Trait: Non-alcoholic fatty liver disease histology (other); Initial Sample Size: 126 European ancestry adolescent cases, 802 European ancestry adolescent controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7324845-A; SNPs: rs7324845; Context: intron; Risk Allele Frequency: 0.096; p-Value: 3E-6; OR or beta:    3.29; Platform [SNPs passing QC]: Illumina [2,078,805] (imputed)	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
TOMM40		23207651	TAS		Disease/Trait: Cognitive decline; Initial Sample Size: 3,280 European ancestry individuals; Replication Sample Size: 1,367 European ancestry individuals; Strongest SNP-Risk Allele: rs2075650-G; SNPs: rs2075650; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta:     .20; Platform [SNPs passing QC]: Illumina (549,692)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Mental deterioration
HLA-DQA1		23181788	TAS		Disease/Trait: Asthma; Initial Sample Size: Up to 1,238 European ancestry cases, up to 2,617 European ancestry controls ; Replication Sample Size: Up to European 1,837 ancestry cases, up to 3,803 European ancestry controls, up to 2,806 cases, up to 2,150 controls, up to 603 Costa Rican cases and their parents; Strongest SNP-Risk Allele: rs9272346-?; SNPs: rs9272346; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix (455,089)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
FTO		23209189	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,101 Indo-European ancestry cases, 1,027 Indo-European ancestry controls; Replication Sample Size: 3,607 Indo-European ancestry cases, 2,924 Indo-European ancestry controls, 1,184 Dravidian ancestry cases, 1,061 Dravidian ancestry controls, 11,285 European ancestry cases, 11,285 European ancestry controls; Strongest SNP-Risk Allele: rs8050136-A; SNPs: rs8050136; Context: intron; Risk Allele Frequency: 0.34; p-Value: 6E-6; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [536,420]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		23209189	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,101 Indo-European ancestry cases, 1,027 Indo-European ancestry controls; Replication Sample Size: 3,607 Indo-European ancestry cases, 2,924 Indo-European ancestry controls, 1,184 Dravidian ancestry cases, 1,061 Dravidian ancestry controls, 11,285 European ancestry cases, 11,285 European ancestry controls; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.30; p-Value: 1E-35; OR or beta:    1.51; Platform [SNPs passing QC]: Illumina [536,420]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TGFBR3		23209189	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,101 Indo-European ancestry cases, 1,027 Indo-European ancestry controls; Replication Sample Size: 3,607 Indo-European ancestry cases, 2,924 Indo-European ancestry controls, 1,184 Dravidian ancestry cases, 1,061 Dravidian ancestry controls, 11,285 European ancestry cases, 11,285 European ancestry controls; Strongest SNP-Risk Allele: rs11165354-A; SNPs: rs11165354; Context: intron; Risk Allele Frequency: 0.78; p-Value: 4E-6; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina [536,420]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
ZFYVE28		23212062	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 2,454 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs959770-?; SNPs: rs959770; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-6; OR or beta:     .12; Platform [SNPs passing QC]: Affymetrix [696,491]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
RORA		23212062	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 2,454 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7172342-?; SNPs: rs7172342; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:     .08; Platform [SNPs passing QC]: Affymetrix [696,491]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
KIF26B		23212062	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 2,454 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10924245-?; SNPs: rs10924245; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta:     .17; Platform [SNPs passing QC]: Affymetrix [696,491]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
PDZD2		23184150	TAS		Disease/Trait: Renal cell carcinoma; Initial Sample Size: 2,215 European ancestry cases, 8,566 European ancestry controls; Replication Sample Size: 3,739 European ancestry cases, 8,786 European ancestry controls; Strongest SNP-Risk Allele: rs10054504-?; SNPs: rs10054504; Context: intron; Risk Allele Frequency: 0.11; p-Value: 8E-7; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [284,377]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	renal cell carcinoma
ZEB2		23184150	TAS		Disease/Trait: Renal cell carcinoma; Initial Sample Size: 2,215 European ancestry cases, 8,566 European ancestry controls; Replication Sample Size: 3,739 European ancestry cases, 8,786 European ancestry controls; Strongest SNP-Risk Allele: rs12105918-?; SNPs: rs12105918; Context: intron; Risk Allele Frequency: 0.056; p-Value: 2E-8; OR or beta:    1.45; Platform [SNPs passing QC]: Illumina [284,377]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	renal cell carcinoma
SBF2		23180869	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 642 European ancestry cases; Replication Sample Size: 363 Chinese ancestry cases; Strongest SNP-Risk Allele: rs10500715-T; SNPs: rs10500715; Context: intron; Risk Allele Frequency: 0.63; p-Value: 2E-7; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [2,731,086] (imputed)	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
GTF2H1		23180869	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 642 European ancestry cases; Replication Sample Size: 363 Chinese ancestry cases; Strongest SNP-Risk Allele: rs9783347-A; SNPs: rs9783347; Context: intron; Risk Allele Frequency: 0.30; p-Value: 9E-6; OR or beta:    1.36; Platform [SNPs passing QC]: Illumina [2,731,086] (imputed)	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
GRID1		23180869	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 642 European ancestry cases; Replication Sample Size: 363 Chinese ancestry cases; Strongest SNP-Risk Allele: rs10788473-T; SNPs: rs10788473; Context: intron; Risk Allele Frequency: 0.38; p-Value: 3E-6; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [2,731,086] (imputed)	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
BBS9		23160099	TAS		Disease/Trait: Sagittal craniosynostosis; Initial Sample Size: 130 European ancestry trios; Replication Sample Size: 172 cases, 548 controls; Strongest SNP-Risk Allele: rs10262453-A; SNPs: rs10262453; Context: intron; Risk Allele Frequency: 0.69; p-Value: 6E-20; OR or beta:    4.17; Platform [SNPs passing QC]: Illumina [915,307]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	craniosynostosis
TP63		23143601	TAS		Disease/Trait: Lung cancer; Initial Sample Size: 5,510 East Asian ancestry cases, 4,544 East Asian ancestry controls; Replication Sample Size: 1,099 East Asian ancestry cases, 2,913 East Asian ancestry controls; Strongest SNP-Risk Allele: rs4488809-C; SNPs: rs4488809; Context: intron; Risk Allele Frequency: 0.42; p-Value: 4E-9; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [596,032]	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer
VTI1A		23143601	TAS		Disease/Trait: Lung cancer; Initial Sample Size: 5,510 East Asian ancestry cases, 4,544 East Asian ancestry controls; Replication Sample Size: 1,099 East Asian ancestry cases, 2,913 East Asian ancestry controls; Strongest SNP-Risk Allele: rs7086803-A; SNPs: rs7086803; Context: intron; Risk Allele Frequency: 0.27; p-Value: 4E-18; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [596,032]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer
BPTF		23143601	TAS		Disease/Trait: Lung cancer; Initial Sample Size: 5,510 East Asian ancestry cases, 4,544 East Asian ancestry controls; Replication Sample Size: 1,099 East Asian ancestry cases, 2,913 East Asian ancestry controls; Strongest SNP-Risk Allele: rs7216064-A; SNPs: rs7216064; Context: intron; Risk Allele Frequency: 0.63; p-Value: 7E-6; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [596,032]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer
ASRGL1		23144326	TAS		Disease/Trait: Chronic obstructive pulmonary disease-related biomarkers; Initial Sample Size: Up to 1,951 European ancestry smokers; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2463822-T; SNPs: rs2463822; Context: nearGene-5; Risk Allele Frequency: 0.12; p-Value: 1E-10; OR or beta: NR; Platform [SNPs passing QC]: Illumina (588,352)	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
HLA-C		23144326	TAS		Disease/Trait: Chronic obstructive pulmonary disease-related biomarkers; Initial Sample Size: Up to 1,951 European ancestry smokers; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2074488-T; SNPs: rs2074488; Context: nearGene-5; Risk Allele Frequency: 0.13; p-Value: 2E-10; OR or beta: NR; Platform [SNPs passing QC]: Illumina (588,352)	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
SFTPD		23144326	TAS		Disease/Trait: Chronic obstructive pulmonary disease-related biomarkers; Initial Sample Size: Up to 1,951 European ancestry smokers; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7078012-T; SNPs: rs7078012; Context: intron; Risk Allele Frequency: 0.13; p-Value: 5E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina (588,352)	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
JAKMIP3		23144326	TAS		Disease/Trait: Chronic obstructive pulmonary disease-related biomarkers; Initial Sample Size: Up to 1,951 European ancestry smokers; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs954820-C; SNPs: rs954820; Context: intron; Risk Allele Frequency: 0.44; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina (588,352)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
P2RX7		23144326	TAS		Disease/Trait: Chronic obstructive pulmonary disease-related biomarkers; Initial Sample Size: Up to 1,951 European ancestry smokers; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3751143-C; SNPs: rs3751143; Context: missense; Risk Allele Frequency: 0.18; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina (588,352)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
SCGB1A1		23144326	TAS		Disease/Trait: Chronic obstructive pulmonary disease-related biomarkers; Initial Sample Size: Up to 1,951 European ancestry smokers; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3741240-A; SNPs: rs3741240; Context: UTR-5; Risk Allele Frequency: 0.36; p-Value: 1E-26; OR or beta: NR; Platform [SNPs passing QC]: Illumina (588,352)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
ATP2C2		23144326	TAS		Disease/Trait: Chronic obstructive pulmonary disease-related biomarkers; Initial Sample Size: Up to 1,951 European ancestry smokers; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs8048576-A; SNPs: rs8048576; Context: intron; Risk Allele Frequency: 0.12; p-Value: 9E-13; OR or beta: NR; Platform [SNPs passing QC]: Illumina (588,352)	0.0000000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
ANXA11		23144326	TAS		Disease/Trait: Chronic obstructive pulmonary disease-related biomarkers; Initial Sample Size: Up to 1,951 European ancestry smokers; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6585424-G; SNPs: rs6585424; Context: intron; Risk Allele Frequency: 0.13; p-Value: 1E-10; OR or beta: NR; Platform [SNPs passing QC]: Illumina (588,352)	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
PSORS1C1		23144326	TAS		Disease/Trait: Chronic obstructive pulmonary disease-related biomarkers; Initial Sample Size: Up to 1,951 European ancestry smokers; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3130559-T; SNPs: rs3130559; Context: intron; Risk Allele Frequency: 0.2; p-Value: 8E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina (588,352)	0.000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
EYA1		23144326	TAS		Disease/Trait: Chronic obstructive pulmonary disease-related biomarkers; Initial Sample Size: Up to 1,951 European ancestry smokers; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7006821-C; SNPs: rs7006821; Context: intron; Risk Allele Frequency: 0.07; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina (588,352)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
RNF150		23144326	TAS		Disease/Trait: Chronic obstructive pulmonary disease-related biomarkers; Initial Sample Size: Up to 1,951 European ancestry smokers; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10007052-A; SNPs: rs10007052; Context: intron; Risk Allele Frequency: 0.23; p-Value: 1E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina (588,352)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
CCDC102A		23137000	TAS		Disease/Trait: Cataracts in type 2 diabetes; Initial Sample Size: 109 Han Chinese cases, 649 Han Chinese controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs8052123-C; SNPs: rs8052123; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [517,401]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus;diabetic cataract
NALCN		23144319	TAS		Disease/Trait: Non-small cell lung cancer; Initial Sample Size: 348 Korean ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9557635-A; SNPs: rs9557635; Context: intron; Risk Allele Frequency: 0.146; p-Value: 9E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [271,817]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	non-small cell lung carcinoma
SLC35D2		23144319	TAS		Disease/Trait: Non-small cell lung cancer; Initial Sample Size: 348 Korean ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6479272-T; SNPs: rs6479272; Context: intron; Risk Allele Frequency: 0.086; p-Value: 9E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [271,817]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	non-small cell lung carcinoma
CDH8		23144319	TAS		Disease/Trait: Non-small cell lung cancer; Initial Sample Size: 348 Korean ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs8048207-T; SNPs: rs8048207; Context: intron; Risk Allele Frequency: 0.121; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [271,817]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	non-small cell lung carcinoma
NCOA2		23144319	TAS		Disease/Trait: Non-small cell lung cancer; Initial Sample Size: 348 Korean ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2926702-T; SNPs: rs2926702; Context: intron; Risk Allele Frequency: 0.572; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [271,817]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	non-small cell lung carcinoma
THSD7B		23144319	TAS		Disease/Trait: Non-small cell lung cancer; Initial Sample Size: 348 Korean ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13405020-?; SNPs: rs13405020; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [271,817]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	non-small cell lung carcinoma
DLST		23144319	TAS		Disease/Trait: Non-small cell lung cancer; Initial Sample Size: 348 Korean ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs732765-G; SNPs: rs732765; Context: intron; Risk Allele Frequency: 0.257; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [271,817]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	non-small cell lung carcinoma
ANKS1A		23144319	TAS		Disease/Trait: Non-small cell lung cancer; Initial Sample Size: 348 Korean ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs847845-?; SNPs: rs847845; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [271,817]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	non-small cell lung carcinoma
FAM154A		23144319	TAS		Disease/Trait: Non-small cell lung cancer; Initial Sample Size: 348 Korean ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1571228-?; SNPs: rs1571228; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [271,817]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	non-small cell lung carcinoma
HHAT		23142968	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 188 European ancestry cases, 376 European ancestry controls; Replication Sample Size: 99 European ancestry cases, 328 European ancestry controls; Strongest SNP-Risk Allele: rs7527939-C; SNPs: rs7527939; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-9; OR or beta:    2.63; Platform [SNPs passing QC]: Illumina [495,089]	0.000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
SP140		23128233	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: Up to 12,924 European ancestry cases, up to 21,442 European ancestry controls ; Replication Sample Size: Up to 25,683 European ancestry cases, up to 17,015 European ancestry controls ; Strongest SNP-Risk Allele: rs6716753-C; SNPs: rs6716753; Context: intron; Risk Allele Frequency: 0.196; p-Value: 1E-16; OR or beta:    1.13; Platform [SNPs passing QC]: Affyemtrix & Illumina [1.23 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
CPEB4		23128233	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: Up to 12,924 European ancestry cases, up to 21,442 European ancestry controls ; Replication Sample Size: Up to 25,683 European ancestry cases, up to 17,015 European ancestry controls ; Strongest SNP-Risk Allele: rs17695092-T; SNPs: rs17695092; Context: intron; Risk Allele Frequency: 0.703; p-Value: 5E-9; OR or beta:    1.10; Platform [SNPs passing QC]: Affyemtrix & Illumina [1.23 million] (imputed)	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
LACC1		23128233	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: Up to 12,924 European ancestry cases, up to 21,442 European ancestry controls ; Replication Sample Size: Up to 25,683 European ancestry cases, up to 17,015 European ancestry controls ; Strongest SNP-Risk Allele: rs3764147-G; SNPs: rs3764147; Context: missense; Risk Allele Frequency: 0.248; p-Value: 2E-21; OR or beta:    1.16; Platform [SNPs passing QC]: Affyemtrix & Illumina [1.23 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
MAP3K8		23128233	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 12,924 European ancestry cases, 21,442 European ancestry controls; Replication Sample Size: 25,683 European ancestry cases, 17,015 European ancestry controls; Strongest SNP-Risk Allele: rs1042058-C; SNPs: rs1042058; Context: cds-synon; Risk Allele Frequency: 0.592; p-Value: 6E-11; OR or beta:    1.08; Platform [SNPs passing QC]: Affymetrix & Illumina [1.23 million](imputed)	0.00000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
ADCY3		23128233	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 12,924 European ancestry cases, 21,442 European ancestry controls; Replication Sample Size: 25,683 European ancestry cases, 17,015 European ancestry controls; Strongest SNP-Risk Allele: rs6545800-T; SNPs: rs6545800; Context: intron; Risk Allele Frequency: 0.445; p-Value: 6E-16; OR or beta:    1.11; Platform [SNPs passing QC]: Affymetrix & Illumina [1.23 million](imputed)	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
CXCR5		23128233	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 12,924 European ancestry cases, 21,442 European ancestry controls; Replication Sample Size: 25,683 European ancestry cases, 17,015 European ancestry controls; Strongest SNP-Risk Allele: rs630923-C; SNPs: rs630923; Context: nearGene-5; Risk Allele Frequency: 0.846; p-Value: 7E-9; OR or beta:    1.07; Platform [SNPs passing QC]: Affymetrix & Illumina [1.23 million](imputed)	0.000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
SMAD3		23128233	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 12,924 European ancestry cases, 21,442 European ancestry controls; Replication Sample Size: 25,683 European ancestry cases, 17,015 European ancestry controls; Strongest SNP-Risk Allele: rs17293632-T; SNPs: rs17293632; Context: intron; Risk Allele Frequency: 0.235; p-Value: 6E-16; OR or beta:    1.07; Platform [SNPs passing QC]: Affymetrix & Illumina [1.23 million](imputed)	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
CRTC3		23128233	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 12,924 European ancestry cases, 21,442 European ancestry controls; Replication Sample Size: 25,683 European ancestry cases, 17,015 European ancestry controls; Strongest SNP-Risk Allele: rs7495132-C; SNPs: rs7495132; Context: intron; Risk Allele Frequency: 0.891; p-Value: 9E-11; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix & Illumina [1.23 million](imputed)	0.00000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
PRKCB		23128233	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 12,924 European ancestry cases, 21,442 European ancestry controls; Replication Sample Size: 25,683 European ancestry cases, 17,015 European ancestry controls; Strongest SNP-Risk Allele: rs7404095-C; SNPs: rs7404095; Context: intron; Risk Allele Frequency: 0.572; p-Value: 1E-9; OR or beta:    1.06; Platform [SNPs passing QC]: Affymetrix & Illumina [1.23 million](imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
GPR35		23128233	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 12,924 European ancestry cases, 21,442 European ancestry controls; Replication Sample Size: 25,683 European ancestry cases, 17,015 European ancestry controls; Strongest SNP-Risk Allele: rs3749171-T; SNPs: rs3749171; Context: missense; Risk Allele Frequency: 0.167; p-Value: 3E-21; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix & Illumina [1.23 million](imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
RORC		23128233	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 12,924 European ancestry cases, 21,442 European ancestry controls; Replication Sample Size: 25,683 European ancestry cases, 17,015 European ancestry controls; Strongest SNP-Risk Allele: rs4845604-G; SNPs: rs4845604; Context: intron; Risk Allele Frequency: 0.857; p-Value: 4E-16; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix & Illumina [1.23 million](imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
CD226		23128233	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 12,924 European ancestry cases, 21,442 European ancestry controls; Replication Sample Size: 25,683 European ancestry cases, 17,015 European ancestry controls; Strongest SNP-Risk Allele: rs727088-G; SNPs: rs727088; Context: ; Risk Allele Frequency: 0.484; p-Value: 5E-9; OR or beta:    1.08; Platform [SNPs passing QC]: Affymetrix & Illumina [1.23 million](imputed)	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
DNMT3B		23128233	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 12,924 European ancestry cases, 21,442 European ancestry controls; Replication Sample Size: 25,683 European ancestry cases, 17,015 European ancestry controls; Strongest SNP-Risk Allele: rs4911259-G; SNPs: rs4911259; Context: intron; Risk Allele Frequency: 0.383; p-Value: 1E-9; OR or beta:    1.08; Platform [SNPs passing QC]: Affymetrix & Illumina [1.23 million](imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
DAP		23128233	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 12,924 European ancestry cases, 21,442 European ancestry controls; Replication Sample Size: 25,683 European ancestry cases, 17,015 European ancestry controls; Strongest SNP-Risk Allele: rs2930047-C; SNPs: rs2930047; Context: intron; Risk Allele Frequency: 0.382; p-Value: 1E-8; OR or beta:    1.07; Platform [SNPs passing QC]: Affymetrix & Illumina [1.23 million](imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
ITGAL		23128233	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: Up to 12,924 European ancestry cases, up to 21,442 European ancestry controls; Replication Sample Size: Up to 25,683 European ancestry cases, up to 17,015 European ancestry controls; Strongest SNP-Risk Allele: rs11150589-T; SNPs: rs11150589; Context: nearGene-5; Risk Allele Frequency: 0.463; p-Value: 6E-10; OR or beta:    1.09; Platform [SNPs passing QC]: Affymetrix & Illumina [1.23 million] (imputed)	0.0000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
ZFP90		23128233	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: Up to 12,924 European ancestry cases, up to 21,442 European ancestry controls; Replication Sample Size: Up to 25,683 European ancestry cases, up to 17,015 European ancestry controls; Strongest SNP-Risk Allele: rs1728785-C; SNPs: rs1728785; Context: intron; Risk Allele Frequency: 0.767; p-Value: 4E-8; OR or beta:    1.08; Platform [SNPs passing QC]: Affymetrix & Illumina [1.23 million] (imputed)	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
PHACTR2		23108145	TAS		Disease/Trait: Lung Cancer (DNA repair capacity); Initial Sample Size: 914 European ancestry non-small cell lung cancer cases, 860 European ancestry controls; Replication Sample Size: 679 European ancestry ancestry non-small cell lung cancer cases, 695 European ancestry controls; Strongest SNP-Risk Allele: rs9390123-A; SNPs: rs9390123; Context: intron; Risk Allele Frequency: 0.3957; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [303,669]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer
GREB1		23104006	TAS		Disease/Trait: Endometriosis; Initial Sample Size: 3,181 European ancestry cases, 8,075 European ancestry controls, 1,423 Japanese ancestry cases, 1,318 Japanese ancestry controls; Replication Sample Size: 1,044 Japanese ancestry, 4,017 Japanese ancestry controls; Strongest SNP-Risk Allele: rs13394619-G; SNPs: rs13394619; Context: splice-3; Risk Allele Frequency: 0.521; p-Value: 6E-9; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [407,632]	0.000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	endometriosis
LRFN2		23103227	TAS		Disease/Trait: Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma); Initial Sample Size: 2,331 Han Chinese lung cancer cases, 1,006 Han Chinese non-cardia gastric cancer cases, 2,031 Han Chinese esophageal squamous-cell carcinoma cases, 4,006 Han Chinese controls; Replication Sample Size: 2,665 Han Chinese lung cancer cases, 3,330 Han Chinese non-cardia gastric cancer cases, 3,006 Han Chinese esophageal squamous-cell carcinoma cases, 11,436 Han Chinese controls; Strongest SNP-Risk Allele: rs2494938-A; SNPs: rs2494938; Context: intron; Risk Allele Frequency: 0.23; p-Value: 1E-12; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix [NR]	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer;stomach cancer;squamous cell carcinoma
LRFN2		23103227	TAS		Disease/Trait: Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma); Initial Sample Size: 2,331 Han Chinese lung cancer cases, 1,006 Han Chinese non-cardia gastric cancer cases, 2,031 Han Chinese esophageal squamous-cell carcinoma cases, 4,006 Han Chinese controls; Replication Sample Size: 2,665 Han Chinese lung cancer cases, 3,330 Han Chinese non-cardia gastric cancer cases, 3,006 Han Chinese esophageal squamous-cell carcinoma cases, 11,436 Han Chinese controls; Strongest SNP-Risk Allele: rs2494938-A; SNPs: rs2494938; Context: intron; Risk Allele Frequency: 0.23; p-Value: 5E-9; OR or beta:    1.18; Platform [SNPs passing QC]: Affymetrix [NR]	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer;stomach cancer;squamous cell carcinoma
LRFN2		23103227	TAS		Disease/Trait: Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma); Initial Sample Size: 2,331 Han Chinese lung cancer cases, 1,006 Han Chinese non-cardia gastric cancer cases, 2,031 Han Chinese esophageal squamous-cell carcinoma cases, 4,006 Han Chinese controls; Replication Sample Size: 2,665 Han Chinese lung cancer cases, 3,330 Han Chinese non-cardia gastric cancer cases, 3,006 Han Chinese esophageal squamous-cell carcinoma cases, 11,436 Han Chinese controls; Strongest SNP-Risk Allele: rs2494938-A; SNPs: rs2494938; Context: intron; Risk Allele Frequency: 0.23; p-Value: 2E-6; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix [NR]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer;stomach cancer;squamous cell carcinoma
KIF5B		23092984	TAS		Disease/Trait: Bipolar disorder (mood-incongruent); Initial Sample Size: 2,196 cases, 8,148 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1775715-G; SNPs: rs1775715; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.18; Platform [SNPs passing QC]: Affymetrix & Illumina [NR] (~2.5 Million)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
MYOM3		23092984	TAS		Disease/Trait: Bipolar disorder (mood-incongruent); Initial Sample Size: 2,196 cases, 8,148 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3934861-?; SNPs: rs3934861; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix & Illumina [NR] (~2.5 Million)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
INPP4A		23092984	TAS		Disease/Trait: Bipolar disorder (mood-incongruent); Initial Sample Size: 2,196 cases, 8,148 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12617721-C; SNPs: rs12617721; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix & Illumina [NR] (~2.5 Million)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
NUMB		23092984	TAS		Disease/Trait: Bipolar disorder (mood-incongruent); Initial Sample Size: 2,196 cases, 8,148 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2333194-?; SNPs: rs2333194; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-7; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix & Illumina [NR] (~2.5 Million)	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
EXOC2		23064961	TAS		Disease/Trait: Dental caries; Initial Sample Size: 920 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2476842-?; SNPs: rs2476842; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [518,997]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
CTNNA3		23064961	TAS		Disease/Trait: Dental caries; Initial Sample Size: 920 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2441755-?; SNPs: rs2441755; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [518,997]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
MYO16		23064961	TAS		Disease/Trait: Dental caries; Initial Sample Size: 920 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17485138-?; SNPs: rs17485138; Context: ; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [518,997]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
LYZL2		23064961	TAS		Disease/Trait: Dental caries; Initial Sample Size: 920 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs399593-?; SNPs: rs399593; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina [518,997]	0.000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
ATXN7L1		23064961	TAS		Disease/Trait: Dental caries; Initial Sample Size: 920 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10242311-?; SNPs: rs10242311; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [518,997]	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
PCDH9		23064961	TAS		Disease/Trait: Dental caries; Initial Sample Size: 920 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2875517-?; SNPs: rs2875517; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [518,997]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
NT5DC1		23064961	TAS		Disease/Trait: Dental caries; Initial Sample Size: 920 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1204798-?; SNPs: rs1204798; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [518,997]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
PROM1		23064961	TAS		Disease/Trait: Dental caries; Initial Sample Size: 920 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2531154-?; SNPs: rs2531154; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [518,997]	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
ZNF536		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs3786800-?; SNPs: rs3786800; Context: intron; Risk Allele Frequency: .803; p-Value: 3E-12; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
TACC2		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs17103138-?; SNPs: rs17103138; Context: intron; Risk Allele Frequency: 0.086; p-Value: 2E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
SRPK2		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs6968355-?; SNPs: rs6968355; Context: UTR-3; Risk Allele Frequency: 0.174; p-Value: 2E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
PTPRN2		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs10274279-?; SNPs: rs10274279; Context: intron; Risk Allele Frequency: 0.123; p-Value: 4E-11; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.00000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
GATA4		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs804280-?; SNPs: rs804280; Context: intron; Risk Allele Frequency: 0.406; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
PTPRD		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs7849581-?; SNPs: rs7849581; Context: intron; Risk Allele Frequency: 0.012; p-Value: 9E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
ABCA1		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs4149311-?; SNPs: rs4149311; Context: intron; Risk Allele Frequency: 0.134; p-Value: 9E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
CNTN5		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs12803066-?; SNPs: rs12803066; Context: intron; Risk Allele Frequency: .518; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
FLI1		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs665440-?; SNPs: rs665440; Context: intron; Risk Allele Frequency: 0.073; p-Value: 2E-8; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
CHD4		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs1057510-?; SNPs: rs1057510; Context: intron; Risk Allele Frequency: 0.154; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
DHX15		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs6841898-?; SNPs: rs6841898; Context: cds-synon; Risk Allele Frequency: 0.021; p-Value: 3E-26; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
LOC100129620		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs10747502-?; SNPs: rs10747502; Context: intron; Risk Allele Frequency: 0.08; p-Value: 1E-9; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
CAPN9		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs12038826-?; SNPs: rs12038826; Context: intron; Risk Allele Frequency: 0.071; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
BMP6		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs9505270-?; SNPs: rs9505270; Context: intron; Risk Allele Frequency: 0.261; p-Value: 4E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
FHIT		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs931317-?; SNPs: rs931317; Context: intron; Risk Allele Frequency: 0.786; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
CLSTN2		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs4683505-?; SNPs: rs4683505; Context: intron; Risk Allele Frequency: 0.033; p-Value: 4E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
PML		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs8039584-?; SNPs: rs8039584; Context: intron; Risk Allele Frequency: 0.044; p-Value: 5E-8; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
ASPA		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs923375-?; SNPs: rs923375; Context: intron; Risk Allele Frequency: 0.188; p-Value: 4E-16; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
DNAH9		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs4792192-?; SNPs: rs4792192; Context: intron; Risk Allele Frequency: 0.115; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
LOC646021		23049088	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 187 European ancestry cases, 1064 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs17826255-?; SNPs: rs17826255; Context: intron; Risk Allele Frequency: 0.067; p-Value: 8E-9; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [152,234]	0.000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
LOC100505634		23042114	TAS		Disease/Trait: Atopic dermatitis; Initial Sample Size: 1,472 Japanese ancestry cases, 7,971 Japanese ancestry controls; Replication Sample Size: 1,856 Japanese ancestry cases, 7,021 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2271404-G; SNPs: rs2271404; Context: intron; Risk Allele Frequency: 0.238; p-Value: 3E-7; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina [606,164]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atopic dermatitis
CLEC16A		23042114	TAS		Disease/Trait: Atopic dermatitis; Initial Sample Size: 1,472 Japanese ancestry cases, 7,971 Japanese ancestry controls; Replication Sample Size: 1,856 Japanese ancestry cases, 7,021 Japanese ancestry controls; Strongest SNP-Risk Allele: rs9923856-A; SNPs: rs9923856; Context: intron; Risk Allele Frequency: 0.781; p-Value: 6E-6; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina [606,164]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atopic dermatitis
C6orf10		23042114	TAS		Disease/Trait: Atopic dermatitis; Initial Sample Size: 1,472 Japanese ancestry cases, 7,971 Japanese ancestry controls; Replication Sample Size: 1,856 Japanese ancestry cases, 7,021 Japanese ancestry controls; Strongest SNP-Risk Allele: rs9469099-G; SNPs: rs9469099; Context: intron; Risk Allele Frequency: 0.909; p-Value: 5E-19; OR or beta:    1.61; Platform [SNPs passing QC]: Illumina [606,164]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atopic dermatitis
GLB1		23042114	TAS		Disease/Trait: Atopic dermatitis; Initial Sample Size: 1,472 Japanese ancestry cases, 7,971 Japanese ancestry controls; Replication Sample Size: 1,856 Japanese ancestry cases, 7,021 Japanese ancestry controls; Strongest SNP-Risk Allele: rs7613051-A; SNPs: rs7613051; Context: intron; Risk Allele Frequency: 0.453; p-Value: 6E-21; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [606,164]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atopic dermatitis
ZNF365		23042114	TAS		Disease/Trait: Atopic dermatitis; Initial Sample Size: 1,472 Japanese ancestry cases, 7,971 Japanese ancestry controls; Replication Sample Size: 1,856 Japanese ancestry cases, 7,021 Japanese ancestry controls; Strongest SNP-Risk Allele: rs10995251-C; SNPs: rs10995251; Context: intron; Risk Allele Frequency: 0.511; p-Value: 6E-20; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [606,164]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atopic dermatitis
TNPO3		23053960	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,527 European ancestry cases, 3,421 European ancestry controls, ; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12531711-A; SNPs: rs12531711; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-13; OR or beta:    1.59; Platform [SNPs passing QC]: Illumina [737,984]	0.0000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
STAT4		23053960	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,527 European ancestry cases, 3,421 European ancestry controls, ; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7574865-T; SNPs: rs7574865; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-14; OR or beta:    1.48; Platform [SNPs passing QC]: Illumina [737,984]	0.00000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
ZFHX3		23041239	TAS		Disease/Trait: Stroke (ischemic); Initial Sample Size: 12,389 European ancestry cases, 62,004 European ancestry controls; Replication Sample Size: 1,322 Pakistani ancestry cases, 1,143 Pakistani ancestry controls, 12,025 European ancestry cases, 27,940 European ancestry controls; Strongest SNP-Risk Allele: rs879324-A; SNPs: rs879324; Context: intron; Risk Allele Frequency: 0.19; p-Value: 2E-8; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix & Illumina [NR] (imputed)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Ischemic stroke;cerebrovascular accident
SPSB4		23041239	TAS		Disease/Trait: Stroke (ischemic); Initial Sample Size: 12,389 European ancestry cases, 62,004 European ancestry controls; Replication Sample Size: 1,322 Pakistani ancestry cases, 1,143 Pakistani ancestry controls, 12,025 European ancestry cases, 27,940 European ancestry controls; Strongest SNP-Risk Allele: rs16851055-G; SNPs: rs16851055; Context: ; Risk Allele Frequency: 0.81; p-Value: 6E-7; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix & Illumina [NR] (imputed)	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Ischemic stroke;cerebrovascular accident
ALDH2		23041239	TAS		Disease/Trait: Stroke (ischemic); Initial Sample Size: 12,389 European ancestry cases, 62,004 European ancestry controls; Replication Sample Size: 1,322 Pakistani ancestry cases, 1,143 Pakistani ancestry controls, 12,025 European ancestry cases, 27,940 European ancestry controls; Strongest SNP-Risk Allele: rs2238151-T; SNPs: rs2238151; Context: intron; Risk Allele Frequency: 0.66; p-Value: 1E-6; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix & Illumina [NR] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Ischemic stroke;cerebrovascular accident
PYGL		23007406	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 1,268 cases; Replication Sample Size: 1,267 cases; Strongest SNP-Risk Allele: rs7142143-C; SNPs: rs7142143; Context: intron; Risk Allele Frequency: 0.01; p-Value: 7E-9; OR or beta:    3.61; Platform [SNPs passing QC]: Affymetrix [444,044]	0.000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
NPFFR1		23007406	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 1,268 cases; Replication Sample Size: 1,267 cases; Strongest SNP-Risk Allele: rs41322152-C; SNPs: rs41322152; Context: intron; Risk Allele Frequency: 0.012; p-Value: 8E-6; OR or beta:    2.52; Platform [SNPs passing QC]: Affymetrix [444,044]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
PDE4B		23007406	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 1,268 cases; Replication Sample Size: 1,267 cases; Strongest SNP-Risk Allele: rs6683977-C; SNPs: rs6683977; Context: intron; Risk Allele Frequency: 0.449; p-Value: 5E-6; OR or beta:    1.41; Platform [SNPs passing QC]: Affymetrix [444,044]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
TBXAS1		23007406	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 1,268 cases; Replication Sample Size: 1,267 cases; Strongest SNP-Risk Allele: rs17837497-A; SNPs: rs17837497; Context: intron; Risk Allele Frequency: 0.016; p-Value: 2E-6; OR or beta:    2.34; Platform [SNPs passing QC]: Affymetrix [444,044]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
PDE4B		23007406	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 1,268 cases; Replication Sample Size: 1,267 cases; Strongest SNP-Risk Allele: rs546784-A; SNPs: rs546784; Context: intron; Risk Allele Frequency: 0.457; p-Value: 9E-6; OR or beta:    1.40; Platform [SNPs passing QC]: Affymetrix [444,044]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
RIT2		23007406	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 1,268 cases; Replication Sample Size: 1,267 cases; Strongest SNP-Risk Allele: rs9958208-A; SNPs: rs9958208; Context: intron; Risk Allele Frequency: 0.099; p-Value: 5E-6; OR or beta:    1.62; Platform [SNPs passing QC]: Affymetrix [444,044]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
MAGI2		23007406	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 1,268 cases; Replication Sample Size: 1,267 cases; Strongest SNP-Risk Allele: rs1496766-C; SNPs: rs1496766; Context: intron; Risk Allele Frequency: 0.014; p-Value: 5E-6; OR or beta:    2.84; Platform [SNPs passing QC]: Affymetrix [444,044]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
ADAMTS12		22990015	TAS		Disease/Trait: Stroke (pediatric); Initial Sample Size: 270 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1364044-A; SNPs: rs1364044; Context: intron; Risk Allele Frequency: .296; p-Value: 3E-6; OR or beta:    1.91; Platform [SNPs passing QC]: Illumina [334,581]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cerebrovascular accident
ADAMTS2		22990015	TAS		Disease/Trait: Stroke (pediatric); Initial Sample Size: 270 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs469568-T; SNPs: rs469568; Context: intron; Risk Allele Frequency: 0.483; p-Value: 8E-6; OR or beta:    1.77; Platform [SNPs passing QC]: Illumina [334,581]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cerebrovascular accident
AFF3		23028342	TAS		Disease/Trait: Type 1 diabetes nephropathy; Initial Sample Size: Up to 2,916 European ancestry Type 1 Diabetes cases with nephropathy, 3,315 European ancestry Type 1 Diabetes cases without nephropathy; Replication Sample Size: Up to 1,493 European ancestry Type 1 Diabetes cases with nephropathy, 3,191 European ancestry Type 1 Diabetes cases without nephropathy; Strongest SNP-Risk Allele: rs7583877-C; SNPs: rs7583877; Context: intron; Risk Allele Frequency: 0.29; p-Value: 1E-8; OR or beta:    1.29; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 Million] (imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus;Nephropathy
ERBB4		23028342	TAS		Disease/Trait: Type 1 diabetes nephropathy; Initial Sample Size: Up to 2,916 European ancestry Type 1 Diabetes cases with nephropathy, 3,315 European ancestry Type 1 Diabetes cases without nephropathy; Replication Sample Size: Up to 1,493 European ancestry Type 1 Diabetes cases with nephropathy, 3,191 European ancestry Type 1 Diabetes cases without nephropathy; Strongest SNP-Risk Allele: rs7588550-A; SNPs: rs7588550; Context: intron; Risk Allele Frequency: 0.95; p-Value: 2E-7; OR or beta:    1.52; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 Million] (imputed)	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus;Nephropathy
AFF3		23028342	TAS		Disease/Trait: Type 1 diabetes nephropathy; Initial Sample Size: Up to 2,916 European ancestry Type 1 Diabetes cases with nephropathy, 3,315 European ancestry Type 1 Diabetes cases without nephropathy; Replication Sample Size: Up to 1,493 European ancestry Type 1 Diabetes cases with nephropathy, 3,191 European ancestry Type 1 Diabetes cases without nephropathy; Strongest SNP-Risk Allele: rs7583877-C; SNPs: rs7583877; Context: intron; Risk Allele Frequency: 0.30; p-Value: 3E-7; OR or beta:    1.29; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 Million] (imputed)	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus;Nephropathy
TNFSF15		23000144	TAS		Disease/Trait: Primary biliary cirrhosis; Initial Sample Size: 487 Japanese ancestry cases, 476 Japanese ancestry controls; Replication Sample Size: 787 Japanese ancestry cases, 615 Japanese ancestry controls; Strongest SNP-Risk Allele: rs4979462-T; SNPs: rs4979462; Context: intron; Risk Allele Frequency: 0.46; p-Value: 3E-14; OR or beta:    1.56; Platform [SNPs passing QC]: Affymetrix [421,245]	0.00000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary biliary cirrhosis
STAT4		23000144	TAS		Disease/Trait: Primary biliary cirrhosis; Initial Sample Size: 487 Japanese ancestry cases, 476 Japanese ancestry controls; Replication Sample Size: 787 Japanese ancestry cases, 615 Japanese ancestry controls; Strongest SNP-Risk Allele: rs7574865-T; SNPs: rs7574865; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.35; Platform [SNPs passing QC]: Affymetrix [421,245]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary biliary cirrhosis
RTKN2		23028356	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 2,303 Japanese ancestry cases, 3,380 Japanese ancestry controls; Replication Sample Size: 5,604 Japanese ancestry cases, 31,982 Japanese ancestry controls; Strongest SNP-Risk Allele: rs3125734-T; SNPs: rs3125734; Context: missense; Risk Allele Frequency: 0.108; p-Value: 5E-9; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [NR]	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
NFKBIE		23028356	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 2,303 Japanese ancestry cases, 3,380 Japanese ancestry controls; Replication Sample Size: 5,604 Japanese ancestry cases, 31,982 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2233434-G; SNPs: rs2233434; Context: missense; Risk Allele Frequency: 0.215; p-Value: 1E-15; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [NR]	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
ADH1B		22960999	TAS		Disease/Trait: Esophageal cancer  (alcohol interaction); Initial Sample Size: 2,031 Han Chinese cases, 2,044 Han Chinese controls; Replication Sample Size: 8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls; Strongest SNP-Risk Allele: rs1042026-?; SNPs: rs1042026; Context: UTR-3; Risk Allele Frequency: 0.22; p-Value: 3E-7; OR or beta:    1.27; Platform [SNPs passing QC]: NR	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	esophageal cancer;alcohol abuse
ST6GAL1		22960999	TAS		Disease/Trait: Esophageal cancer (squamous cell); Initial Sample Size: 2,031 Han Chinese cases, 2,044 Han Chinese controls; Replication Sample Size: 8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls; Strongest SNP-Risk Allele: rs2239612-T; SNPs: rs2239612; Context: intron; Risk Allele Frequency: 0.19; p-Value: 6E-14; OR or beta:    1.21; Platform [SNPs passing QC]: NR	0.00000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	esophagus squamous cell carcinoma
SMG6		22960999	TAS		Disease/Trait: Esophageal cancer (squamous cell); Initial Sample Size: 2,031 Han Chinese cases, 2,044 Han Chinese controls; Replication Sample Size: 8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls; Strongest SNP-Risk Allele: rs17761864-A; SNPs: rs17761864; Context: intron; Risk Allele Frequency: 0.14; p-Value: 2E-11; OR or beta:    1.21; Platform [SNPs passing QC]: NR	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	esophagus squamous cell carcinoma
PTPN2		22960999	TAS		Disease/Trait: Esophageal cancer (squamous cell); Initial Sample Size: 2,031 Han Chinese cases, 2,044 Han Chinese controls; Replication Sample Size: 8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls; Strongest SNP-Risk Allele: rs2847281-C; SNPs: rs2847281; Context: intron; Risk Allele Frequency: 0.16; p-Value: 2E-11; OR or beta:    1.20; Platform [SNPs passing QC]: NR	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	esophagus squamous cell carcinoma
CHEK2		22960999	TAS		Disease/Trait: Esophageal cancer (squamous cell); Initial Sample Size: 2,031 Han Chinese cases, 2,044 Han Chinese controls; Replication Sample Size: 8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls; Strongest SNP-Risk Allele: rs4822983-T; SNPs: rs4822983; Context: intron; Risk Allele Frequency: 0.20; p-Value: 2E-22; OR or beta:    1.27; Platform [SNPs passing QC]: NR	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	esophagus squamous cell carcinoma
XBP1		22960999	TAS		Disease/Trait: Esophageal cancer (squamous cell); Initial Sample Size: 2,031 Han Chinese cases, 2,044 Han Chinese controls; Replication Sample Size: 8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls; Strongest SNP-Risk Allele: rs2239815-T; SNPs: rs2239815; Context: intron; Risk Allele Frequency: 0.37; p-Value: 4E-15; OR or beta:    1.18; Platform [SNPs passing QC]: NR	0.000000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	esophagus squamous cell carcinoma
HEATR3		22960999	TAS		Disease/Trait: Esophageal cancer (squamous cell); Initial Sample Size: 2,031 Han Chinese cases, 2,044 Han Chinese controls; Replication Sample Size: 8,092 Chinese ancestry cases, 8,620 Chinese ancestry controls; Strongest SNP-Risk Allele: rs4785204-T; SNPs: rs4785204; Context: intron; Risk Allele Frequency: 0.26; p-Value: 2E-20; OR or beta:    1.24; Platform [SNPs passing QC]: NR	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	esophagus squamous cell carcinoma
FGFR2		22951594	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 1,086 Japanese ancestry cases, 1,816 Japanese ancestry controls; Replication Sample Size: 1,653 Japanese ancestry cases, 2,797 Japanese ancestry controls; Strongest SNP-Risk Allele: rs3750817-T; SNPs: rs3750817; Context: intron; Risk Allele Frequency: 0.49; p-Value: 8E-8; OR or beta:    1.22; Platform [SNPs passing QC]: Illumina [453,627]	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
SIAH2		22951594	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 1,086 Japanese ancestry cases, 1,816 Japanese ancestry controls; Replication Sample Size: 1,653 Japanese ancestry cases, 2,797 Japanese ancestry controls; Strongest SNP-Risk Allele: rs6788895-G; SNPs: rs6788895; Context: intron; Risk Allele Frequency: 0.65; p-Value: 9E-8; OR or beta:    1.22; Platform [SNPs passing QC]: Illumina [453,627]	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
CDKN2B-AS1		22961961	TAS		Disease/Trait: Intracranial aneurysm; Initial Sample Size: 1,483 European ancestry cases, 1,683 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6475606-T; SNPs: rs6475606; Context: intron; Risk Allele Frequency: 0.48; p-Value: 4E-8; OR or beta:    1.35; Platform [SNPs passing QC]: Axiom & Affymetrix [451,088]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	intracranial aneurysm
HNF1B		22961080	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,839 Han Chinese cases, 1,873 Han Chinese controls; Replication Sample Size: 14,006 Han Chinese cases, 15,013 Han Chinese controls, 1,973 East Asian cases, 4,347 East Asian ancestry controls, 794 Singaporean Malay cases, 1,240 Singaporean Malay controls, 159 South Asian ancestry cases, 1,624 South Asian ancestry controls; Strongest SNP-Risk Allele: rs4430796-G; SNPs: rs4430796; Context: intron; Risk Allele Frequency: 0.276; p-Value: 2E-11; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [2,234,194] (imputed)	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
FAM58A		22961080	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,839 Han Chinese cases, 1,873 Han Chinese controls; Replication Sample Size: 14,006 Han Chinese cases, 15,013 Han Chinese controls, 1,973 East Asian cases, 4,347 East Asian ancestry controls, 794 Singaporean Malay cases, 1,240 Singaporean Malay controls, 159 South Asian ancestry cases, 1,624 South Asian ancestry controls; Strongest SNP-Risk Allele: rs12010175-G; SNPs: rs12010175; Context: intron; Risk Allele Frequency: 0.786; p-Value: 2E-9; OR or beta:    1.21; Platform [SNPs passing QC]: Illumina [2,234,194] (imputed)	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CDKAL1		22961080	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,839 Han Chinese cases, 1,873 Han Chinese controls; Replication Sample Size: 14,006 Han Chinese cases, 15,013 Han Chinese controls, 1,973 East Asian cases, 4,347 East Asian ancestry controls, 794 Singaporean Malay cases, 1,240 Singaporean Malay controls, 159 South Asian ancestry cases, 1,624 South Asian ancestry controls; Strongest SNP-Risk Allele: rs7754840-C; SNPs: rs7754840; Context: intron; Risk Allele Frequency: 0.411; p-Value: 7E-10; OR or beta:    1.35; Platform [SNPs passing QC]: Illumina [2,234,194] (imputed)	0.0000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
KCNQ1		22961080	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,839 Han Chinese cases, 1,873 Han Chinese controls; Replication Sample Size: 14,006 Han Chinese cases, 15,013 Han Chinese controls, 1,973 East Asian cases, 4,347 East Asian ancestry controls, 794 Singaporean Malay cases, 1,240 Singaporean Malay controls, 159 South Asian ancestry cases, 1,624 South Asian ancestry controls; Strongest SNP-Risk Allele: rs2237892-C; SNPs: rs2237892; Context: intron; Risk Allele Frequency: 0.657; p-Value: 1E-7; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [2,234,194] (imputed)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
GLIS3		22961080	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,839 Han Chinese cases, 1,873 Han Chinese controls; Replication Sample Size: 14,006 Han Chinese cases, 15,013 Han Chinese controls, 1,973 East Asian cases, 4,347 East Asian ancestry controls, 794 Singaporean Malay cases, 1,240 Singaporean Malay controls, 159 South Asian ancestry cases, 1,624 South Asian ancestry controls; Strongest SNP-Risk Allele: rs10814916-C; SNPs: rs10814916; Context: intron; Risk Allele Frequency: 0.439; p-Value: 6E-12; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina [2,234,194] (imputed)	0.000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
GRK5		22961080	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,839 Han Chinese cases, 1,873 Han Chinese controls; Replication Sample Size: 14,006 Han Chinese cases, 15,013 Han Chinese controls, 1,973 East Asian cases, 4,347 East Asian ancestry controls, 794 Singaporean Malay cases, 1,240 Singaporean Malay controls, 159 South Asian ancestry cases, 1,624 South Asian ancestry controls; Strongest SNP-Risk Allele: rs10886471-C; SNPs: rs10886471; Context: intron; Risk Allele Frequency: 0.778; p-Value: 7E-9; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [2,234,194] (imputed)	0.000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
RASGRP1		22961080	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,839 Han Chinese cases, 1,873 Han Chinese controls; Replication Sample Size: 14,006 Han Chinese cases, 15,013 Han Chinese controls, 1,973 East Asian cases, 4,347 East Asian ancestry controls, 794 Singaporean Malay cases, 1,240 Singaporean Malay controls, 159 South Asian ancestry cases, 1,624 South Asian ancestry controls; Strongest SNP-Risk Allele: rs7403531-T; SNPs: rs7403531; Context: intron; Risk Allele Frequency: 0.346; p-Value: 4E-9; OR or beta:    1.10; Platform [SNPs passing QC]: Illumina [2,234,194] (imputed)	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
LPP		22951725	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 1,117 Han Chinese cases, 1,701 Han Chinese controls; Replication Sample Size: 5,740 Han Chinese cases, 10,324 Han Chinese controls; Strongest SNP-Risk Allele: rs9851967-?; SNPs: rs9851967; Context: intron; Risk Allele Frequency: 0.28; p-Value: 9E-8; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [493,909]	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
KIAA0513		22959728	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 4,243 European ancestry cases, 5,112 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs8056742-C; SNPs: rs8056742; Context: intron; Risk Allele Frequency: 0.11; p-Value: 5E-7; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [254,145]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
UNC13A		22959728	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 4,243 European ancestry cases, 5,112 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12608932-C; SNPs: rs12608932; Context: intron; Risk Allele Frequency: 0.34; p-Value: 5E-8; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [254,145]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
LAMA3		22959728	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 4,243 European ancestry cases, 5,112 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11082762-A; SNPs: rs11082762; Context: intron; Risk Allele Frequency: 0.36; p-Value: 7E-7; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [254,145]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
CPNE4		22959728	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 4,243 European ancestry cases, 5,112 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1320900-?; SNPs: rs1320900; Context: intron; Risk Allele Frequency: 0.34; p-Value: 7E-6; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [254,145]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
ST3GAL3		22959728	TAS		Disease/Trait: Amyotrophic lateral sclerosis (age of onset); Initial Sample Size: 4,243 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3011225-G; SNPs: rs3011225; Context: intron; Risk Allele Frequency: 0.22; p-Value: 7E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [254,145]	0.00000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
NRXN3		22959728	TAS		Disease/Trait: Amyotrophic lateral sclerosis (age of onset); Initial Sample Size: 4,243 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7147705-T; SNPs: rs7147705; Context: intron; Risk Allele Frequency: 0.29; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [254,145]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
CNOT2		22959728	TAS		Disease/Trait: Amyotrophic lateral sclerosis (age of onset); Initial Sample Size: 4,243 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2904524-T; SNPs: rs2904524; Context: intron; Risk Allele Frequency: 0.13; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [254,145]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
ARAP2		22959728	TAS		Disease/Trait: Amyotrophic lateral sclerosis (age of onset); Initial Sample Size: 4,243 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12651329-C; SNPs: rs12651329; Context: intron; Risk Allele Frequency: 0.39; p-Value: 5E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [254,145]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
PTPRF		22959728	TAS		Disease/Trait: Amyotrophic lateral sclerosis (age of onset); Initial Sample Size: 4,243 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2819332-A; SNPs: rs2819332; Context: intron; Risk Allele Frequency: 0.23; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [254,145]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
ARHGEF2		22959728	TAS		Disease/Trait: Amyotrophic lateral sclerosis (age of onset); Initial Sample Size: 4,243 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2364403-A; SNPs: rs2364403; Context: intron; Risk Allele Frequency: 0.2; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [254,145]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
ANKS1B		22959728	TAS		Disease/Trait: Amyotrophic lateral sclerosis (age of onset); Initial Sample Size: 4,243 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2036225-T; SNPs: rs2036225; Context: intron; Risk Allele Frequency: 0.41; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [254,145]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
PCSK5		22959728	TAS		Disease/Trait: Amyotrophic lateral sclerosis (age of onset); Initial Sample Size: 4,243 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7047865-G; SNPs: rs7047865; Context: intron; Risk Allele Frequency: 0.41; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [254,145]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
IFRD1		22959728	TAS		Disease/Trait: Amyotrophic lateral sclerosis (age of onset); Initial Sample Size: 4,243 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6956741-G; SNPs: rs6956741; Context: intron; Risk Allele Frequency: 0.06; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [254,145]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
SCN1A		22949513	TAS		Disease/Trait: Epilepsy (generalized); Initial Sample Size: 702 European ancestry GAE cases, 586 European ancestry JME cases, 239 European ancestry other GGE cases, 2,461 European ancestry controls; Replication Sample Size: 347 European ancestry GAE parent-child trios, 166 European ancestry JME parent-child trios, 91 European ancestry other GGE parent-child trios, 385 European ancestry GAE cases, 382 European ancestry JME cases, 122 European ancestry other GGE cases, up to 889 European ancestry controls; Strongest SNP-Risk Allele: rs11890028-T; SNPs: rs11890028; Context: ; Risk Allele Frequency: 0.688; p-Value: 4E-6; OR or beta:    1.18; Platform [SNPs passing QC]: Affymetrix [4.56 million] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	epilepsy syndrome
PLA2G4A		22949513	TAS		Disease/Trait: Epilepsy (generalized); Initial Sample Size: 702 European ancestry GAE cases, 586 European ancestry JME cases, 239 European ancestry other GGE cases, 2,461 European ancestry controls; Replication Sample Size: 347 European ancestry GAE parent-child trios, 166 European ancestry JME parent-child trios, 91 European ancestry other GGE parent-child trios, 385 European ancestry GAE cases, 382 European ancestry JME cases, 122 European ancestry other GGE cases, up to 889 European ancestry controls; Strongest SNP-Risk Allele: rs12720541-T; SNPs: rs12720541; Context: intron; Risk Allele Frequency: 0.264; p-Value: 9E-6; OR or beta:    1.21; Platform [SNPs passing QC]: Affymetrix [4.56 million] (imputed)	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	epilepsy syndrome
CHRM3		22949513	TAS		Disease/Trait: Epilepsy (generalized); Initial Sample Size: 702 European ancestry GAE cases, 586 European ancestry JME cases, 239 European ancestry other GGE cases, 2,461 European ancestry controls; Replication Sample Size: 347 European ancestry GAE parent-child trios, 166 European ancestry JME parent-child trios, 91 European ancestry other GGE parent-child trios, 385 European ancestry GAE cases, 382 European ancestry JME cases, 122 European ancestry other GGE cases, up to 889 European ancestry controls; Strongest SNP-Risk Allele: rs12059546-G; SNPs: rs12059546; Context: intron; Risk Allele Frequency: .172; p-Value: 4E-8; OR or beta:    1.42; Platform [SNPs passing QC]: Affymetrix [4.56 million] (imputed)	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	epilepsy syndrome
MAST4		22949513	TAS		Disease/Trait: Epilepsy (generalized); Initial Sample Size: 702 European ancestry GAE cases, 586 European ancestry JME cases, 239 European ancestry other GGE cases, 2,461 European ancestry controls; Replication Sample Size: 347 European ancestry GAE parent-child trios, 166 European ancestry JME parent-child trios, 91 European ancestry other GGE parent-child trios, 385 European ancestry GAE cases, 382 European ancestry JME cases, 122 European ancestry other GGE cases, up to 889 European ancestry controls; Strongest SNP-Risk Allele: rs39861-C; SNPs: rs39861; Context: intron; Risk Allele Frequency: .235; p-Value: 3E-7; OR or beta:    1.26; Platform [SNPs passing QC]: Affymetrix [4.56 million] (imputed)	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	epilepsy syndrome
BARD1		22941191	TAS		Disease/Trait: Neuroblastoma; Initial Sample Size: 2,101 European ancestry cases, 4,202 European ancestry controls; Replication Sample Size: 351 Italian cases, 780 Italian controls, 365 African American cases, 2,491 African American controls; Strongest SNP-Risk Allele: rs7587476-T; SNPs: rs7587476; Context: intron; Risk Allele Frequency: 0.246; p-Value: 4E-14; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [426,697]	0.00000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	neuroblastoma
LMO1		22941191	TAS		Disease/Trait: Neuroblastoma; Initial Sample Size: 2,101 European ancestry cases, 4,202 European ancestry controls; Replication Sample Size: 351 Italian cases, 780 Italian controls, 365 African American cases, 2,491 African American controls; Strongest SNP-Risk Allele: rs110419-A; SNPs: rs110419; Context: intron; Risk Allele Frequency: 0.489; p-Value: 1E-13; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [426,697]	0.0000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	neuroblastoma
LIN28B		22941191	TAS		Disease/Trait: Neuroblastoma; Initial Sample Size: 2,101 European ancestry cases, 4,202 European ancestry controls; Replication Sample Size: 351 Italian cases, 780 Italian controls, 365 African American cases, 2,491 African American controls; Strongest SNP-Risk Allele: rs17065417-A; SNPs: rs17065417; Context: intron; Risk Allele Frequency: 0.89; p-Value: 1E-8; OR or beta:    1.38; Platform [SNPs passing QC]: Illumina [426,697]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	neuroblastoma
HSD17B12		22941191	TAS		Disease/Trait: Neuroblastoma; Initial Sample Size: 2,101 European ancestry cases, 4,202 European ancestry controls; Replication Sample Size: 351 Italian cases, 780 Italian controls, 365 African American cases, 2,491 African American controls; Strongest SNP-Risk Allele: rs11037575-C; SNPs: rs11037575; Context: intron; Risk Allele Frequency: 0.407; p-Value: 5E-8; OR or beta:    1.23; Platform [SNPs passing QC]: Illumina [426,697]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	neuroblastoma
HACE1		22941191	TAS		Disease/Trait: Neuroblastoma; Initial Sample Size: 2,101 European ancestry cases, 4,202 European ancestry controls; Replication Sample Size: 351 Italian cases, 780 Italian controls, 365 African American cases, 2,491 African American controls; Strongest SNP-Risk Allele: rs4336470-C; SNPs: rs4336470; Context: intron; Risk Allele Frequency: 0.65; p-Value: 3E-11; OR or beta:    1.26; Platform [SNPs passing QC]: Illumina [426,697]	0.00000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	neuroblastoma
MPZL1		22881374	TAS		Disease/Trait: Alzheimer's disease (late onset); Initial Sample Size: 109 Amish cases, 689 Amish controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4145462-T; SNPs: rs4145462; Context: intron; Risk Allele Frequency: 0.05; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [614,963]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
ATXN7L1		22881374	TAS		Disease/Trait: Alzheimer's disease (late onset); Initial Sample Size: 109 Amish cases, 689 Amish controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11983798-T; SNPs: rs11983798; Context: intron; Risk Allele Frequency: 0.08; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [614,963]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
LUZP2		22881374	TAS		Disease/Trait: Alzheimer's disease (late onset); Initial Sample Size: 109 Amish cases, 689 Amish controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12361953-C; SNPs: rs12361953; Context: intron; Risk Allele Frequency: 0.15; p-Value: 8E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [614,963]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
CDON		22881374	TAS		Disease/Trait: Alzheimer's disease (late onset); Initial Sample Size: 109 Amish cases, 689 Amish controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs472926-C; SNPs: rs472926; Context: intron; Risk Allele Frequency: 0.15; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [614,963]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
PCNX		22881374	TAS		Disease/Trait: Alzheimer's disease (late onset); Initial Sample Size: 109 Amish cases, 689 Amish controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11848070-C; SNPs: rs11848070; Context: intron; Risk Allele Frequency: 0.25; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [614,963]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
CNTNAP5		22885689	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 1,218 European ancestry cases, 990 European ancestry controls, 139 cases, 114 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1170612-?; SNPs: rs1170612; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-6; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [up to 531,195]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
PPFIA2		22885689	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 1,218 European ancestry cases, 990 European ancestry controls, 139 cases, 114 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12426725-?; SNPs: rs12426725; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [up to 531,195]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
CNTNAP5		22885689	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 1,218 European ancestry cases, 990 European ancestry controls, 139 cases, 114 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1170612-?; SNPs: rs1170612; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta:    1.40; Platform [SNPs passing QC]: Illumina [up to 531,195]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
TMTC1		22885689	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 1,218 European ancestry cases, 990 European ancestry controls, 139 cases, 114 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs16934812-?; SNPs: rs16934812; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta:    1.34; Platform [SNPs passing QC]: Illumina [up to 531,195]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
BTNL2		22936702	TAS		Disease/Trait: Sarcoidosis; Initial Sample Size: 637 European ancestry cases, 1,233 European ancestry controls; Replication Sample Size: 3,121 European ancestry cases, 4,284 European ancestry controls; Strongest SNP-Risk Allele: rs2076530-?; SNPs: rs2076530; Context: missense; Risk Allele Frequency: NR; p-Value: 3E-11; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [677,619]	0.00000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	sarcoidosis
IFNGR2		22936669	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 1,277 European ancestry cases, 1,488 European ancestry controls; Replication Sample Size: 1,365 European ancestry cases, 1,396 European ancestry controls; Strongest SNP-Risk Allele: rs2834215-?; SNPs: rs2834215; Context: intron; Risk Allele Frequency: 0.58; p-Value: 3E-7; OR or beta:    1.22; Platform [SNPs passing QC]: Illumina [508,934]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
NOD2		22936669	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 1,277 European ancestry cases, 1,488 European ancestry controls; Replication Sample Size: 1,365 European ancestry cases, 1,396 European ancestry controls; Strongest SNP-Risk Allele: rs2076756-G; SNPs: rs2076756; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-10; OR or beta:    1.46; Platform [SNPs passing QC]: Illumina [508,934]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
IL23R		22936669	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 1,277 European ancestry cases, 1,488 European ancestry controls; Replication Sample Size: 1,365 European ancestry cases, 1,396 European ancestry controls; Strongest SNP-Risk Allele: rs11209026-G; SNPs: rs11209026; Context: missense; Risk Allele Frequency: NR; p-Value: 4E-14; OR or beta:    2.84; Platform [SNPs passing QC]: Illumina [508,934]	0.00000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
COL11A1		22922875	TAS		Disease/Trait: Glaucoma (primary open-angle); Initial Sample Size: 984 Singaporean Chinese cases, 943 Singaporean Chinese controls, 297 Han Chinese cases, 1,044 Han Chinese controls, 573 South Asian ancestry cases, 3,065 Singaporean Malay controls, 2,538 Singaporean Asian Indian controls, 2,018 Vietnamese ancestry controls.; Replication Sample Size: 309 Singaporean Chinese cases, 1,479 Singaporean Chinese controls, 1,236 Chinese ancestry cases, 2,277 Chinese ancestry controls, 165 Saudi Arabian ancestry cases, 175 Saudi Arabian controls, 127 European ancestry cases, 4,703 European ancestry controls, 80 Indian ancestry cases, 309 Indian ancestry controls; Strongest SNP-Risk Allele: rs3753841-G; SNPs: rs3753841; Context: missense; Risk Allele Frequency: NR; p-Value: 9E-10; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [493,501] 	0.0000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary open angle glaucoma
TXNRD2		22922875	TAS		Disease/Trait: Glaucoma (primary open-angle); Initial Sample Size: 984 Singaporean Chinese cases, 943 Singaporean Chinese controls, 297 Han Chinese cases, 1,044 Han Chinese controls, 573 South Asian ancestry cases, 3,065 Singaporean Malay controls, 2,538 Singaporean Asian Indian controls, 2,018 Vietnamese ancestry controls.; Replication Sample Size: 309 Singaporean Chinese cases, 1,479 Singaporean Chinese controls, 1,236 Chinese ancestry cases, 2,277 Chinese ancestry controls, 165 Saudi Arabian ancestry cases, 175 Saudi Arabian controls, 127 European ancestry cases, 4,703 European ancestry controls, 80 Indian ancestry cases, 309 Indian ancestry controls; Strongest SNP-Risk Allele: rs3788317-?; SNPs: rs3788317; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-7; OR or beta:    1.22; Platform [SNPs passing QC]: Illumina [493,501] 	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary open angle glaucoma
PLEKHA7		22922875	TAS		Disease/Trait: Glaucoma (primary open-angle); Initial Sample Size: 984 Singaporean Chinese cases, 943 Singaporean Chinese controls, 297 Han Chinese cases, 1,044 Han Chinese controls, 573 South Asian ancestry cases, 3,065 Singaporean Malay controls, 2,538 Singaporean Asian Indian controls, 2,018 Vietnamese ancestry controls.; Replication Sample Size: 309 Singaporean Chinese cases, 1,479 Singaporean Chinese controls, 1,236 Chinese ancestry cases, 2,277 Chinese ancestry controls, 165 Saudi Arabian ancestry cases, 175 Saudi Arabian controls, 127 European ancestry cases, 4,703 European ancestry controls, 80 Indian ancestry cases, 309 Indian ancestry controls; Strongest SNP-Risk Allele: rs11024102-G; SNPs: rs11024102; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-12; OR or beta:    1.22; Platform [SNPs passing QC]: Illumina [493,501] 	0.000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary open angle glaucoma
AUTS2		22925353	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 2,191 European ancestry cases, 1,434 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10237317-?; SNPs: rs10237317; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.78; Platform [SNPs passing QC]: Affymetrix [703,012]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
RUFY1		22911880	TAS		Disease/Trait: Eating disorders; Initial Sample Size: Up to 2,567 European ancestry individuals; Replication Sample Size: Up to 767 European ancestry cases, up to 486  European ancestry controls; Strongest SNP-Risk Allele: rs6894268-A; SNPs: rs6894268; Context: intron; Risk Allele Frequency: 0.354; p-Value: 3E-6; OR or beta:    1.44; Platform [SNPs passing QC]: Illumina [283,744]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	eating disorder
SEMA6D		22911880	TAS		Disease/Trait: Eating disorders; Initial Sample Size: Up to 2,567 European ancestry individuals; Replication Sample Size: Up to 767 European ancestry cases, up to 486  European ancestry controls; Strongest SNP-Risk Allele: rs1898111-A; SNPs: rs1898111; Context: intron; Risk Allele Frequency: 0.837; p-Value: 8E-6; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [283,744]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	eating disorder
SHC4		22911880	TAS		Disease/Trait: Eating disorders; Initial Sample Size: Up to 2,567 European ancestry individuals; Replication Sample Size: Up to 767 European ancestry cases, up to 486  European ancestry controls; Strongest SNP-Risk Allele: rs10519201-T; SNPs: rs10519201; Context: intron; Risk Allele Frequency: 0.132; p-Value: 6E-6; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [283,744]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	eating disorder
ATP2B4		22895189	TAS		Disease/Trait: Malaria; Initial Sample Size: 1,325 African ancestry, 828 African ancestry controls; Replication Sample Size: 2,229 African ancestry cases, 3,526 African ancestry controls; Strongest SNP-Risk Allele: rs10900585-T; SNPs: rs10900585; Context: intron; Risk Allele Frequency: 0.62; p-Value: 2E-10; OR or beta:    1.64; Platform [SNPs passing QC]: Affymetrix [4,205,739] (imputed)	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	malaria
ABO		22895189	TAS		Disease/Trait: Malaria; Initial Sample Size: 1,325 African ancestry, 828 African ancestry controls; Replication Sample Size: 2,229 African ancestry cases, 3,526 African ancestry controls; Strongest SNP-Risk Allele: rs8176719-G; SNPs: rs8176719; Context: ; Risk Allele Frequency: 0.37; p-Value: 4E-21; OR or beta:    1.48; Platform [SNPs passing QC]: Affymetrix [4,205,739] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	malaria
PHEX		22889924	TAS		Disease/Trait: Tourette syndrome; Initial Sample Size: 778 European ancestry cases, 4,414 European ancestry controls, 242 Ashkenazi Jewish cases, 354 Ashkenazi Jewish controls, 265 French Canadian cases, 196 French Canadian controls; Replication Sample Size: 211 Latin American ancestry cases, 285 Latin American ancestry controls; Strongest SNP-Risk Allele: rs5951698-G; SNPs: rs5951698; Context: intron; Risk Allele Frequency: 0.0032; p-Value: 6E-6; OR or beta:    5.65; Platform [SNPs passing QC]: Illumina [484,295]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Gilles de la Tourette syndrome
FSHR		22885925	TAS		Disease/Trait: Polycystic ovary syndrome; Initial Sample Size: 2,254 Han Chinese cases, 3,001 Han Chinese controls; Replication Sample Size: 8,226 Han Chinese cases, 7,578 Han Chinese controls; Strongest SNP-Risk Allele: rs2268361-C; SNPs: rs2268361; Context: intron; Risk Allele Frequency: 0.504; p-Value: 1E-12; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix [NR] (imputed)	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	polycystic ovary syndrome
C9orf3		22885925	TAS		Disease/Trait: Polycystic ovary syndrome; Initial Sample Size: 2,254 Han Chinese cases, 3,001 Han Chinese controls; Replication Sample Size: 8,226 Han Chinese cases, 7,578 Han Chinese controls; Strongest SNP-Risk Allele: rs3802457-G; SNPs: rs3802457; Context: intron; Risk Allele Frequency: 0.904; p-Value: 5E-14; OR or beta:    1.30; Platform [SNPs passing QC]: Affymetrix [NR] (imputed)	0.00000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	polycystic ovary syndrome
YAP1		22885925	TAS		Disease/Trait: Polycystic ovary syndrome; Initial Sample Size: 2,254 Han Chinese cases, 3,001 Han Chinese controls; Replication Sample Size: 8,226 Han Chinese cases, 7,578 Han Chinese controls; Strongest SNP-Risk Allele: rs1894116-G; SNPs: rs1894116; Context: intron; Risk Allele Frequency: 0.194; p-Value: 1E-22; OR or beta:    1.27; Platform [SNPs passing QC]: Affymetrix [NR] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	polycystic ovary syndrome
HMGA2		22885925	TAS		Disease/Trait: Polycystic ovary syndrome; Initial Sample Size: 2,254 Han Chinese cases, 3,001 Han Chinese controls; Replication Sample Size: 8,226 Han Chinese cases, 7,578 Han Chinese controls; Strongest SNP-Risk Allele: rs2272046-A; SNPs: rs2272046; Context: intron; Risk Allele Frequency: 0.907; p-Value: 2E-21; OR or beta:    1.43; Platform [SNPs passing QC]: Affymetrix [NR] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	polycystic ovary syndrome
INSR		22885925	TAS		Disease/Trait: Polycystic ovary syndrome; Initial Sample Size: 2,254 Han Chinese cases, 3,001 Han Chinese controls; Replication Sample Size: 8,226 Han Chinese cases, 7,578 Han Chinese controls; Strongest SNP-Risk Allele: rs2059807-G; SNPs: rs2059807; Context: intron; Risk Allele Frequency: 1.24; p-Value: 1E-8; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix [NR] (imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	polycystic ovary syndrome
TERT		22886559	TAS		Disease/Trait: Glioma; Initial Sample Size: 1,856 European ancestry cases, 4,955 European ancestry controls; Replication Sample Size: 5,015 European ancestry cases, 11,601 European ancestry controls; Strongest SNP-Risk Allele: rs2736100-G; SNPs: rs2736100; Context: intron; Risk Allele Frequency: 0.494; p-Value: 4E-9; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [559,977]	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	malignant glioma
IRF6		22863734	TAS		Disease/Trait: Orofacial clefts; Initial Sample Size: Up to 666 European ancestry trios, 399 European ancestry cases, 1,318 European ancestry controls; Replication Sample Size: up to 795 East and South Asian ancestry trios; Strongest SNP-Risk Allele: rs861020-A; SNPs: rs861020; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-12; OR or beta:    1.44; Platform [SNPs passing QC]: NR [497,084]	0.000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	orofacial cleft
PAX7		22863734	TAS		Disease/Trait: Orofacial clefts; Initial Sample Size: Up to 666 European ancestry trios, 399 European ancestry cases, 1,318 European ancestry controls; Replication Sample Size: up to 795 East and South Asian ancestry trios; Strongest SNP-Risk Allele: rs742071-T; SNPs: rs742071; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-9; OR or beta:    1.32; Platform [SNPs passing QC]: NR [497,084]	0.000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	orofacial cleft
THADA		22863734	TAS		Disease/Trait: Orofacial clefts; Initial Sample Size: Up to 666 European ancestry trios, 399 European ancestry cases, 1,318 European ancestry controls; Replication Sample Size: up to 795 East and South Asian ancestry trios; Strongest SNP-Risk Allele: rs7590268-G; SNPs: rs7590268; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta:    1.42; Platform [SNPs passing QC]: NR [497,084]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	orofacial cleft
TAF1C		22843504	TAS		Disease/Trait: Autism; Initial Sample Size: 1,419 European ancestry cases from 1416 families; Replication Sample Size: 1,314 European ancestry cases from 1301 families; Strongest SNP-Risk Allele: rs4150167-?; SNPs: rs4150167; Context: missense; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta:    1.96; Platform [SNPs passing QC]: Illumina [947,233]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	autistic disorder
PARD3B		22843504	TAS		Disease/Trait: Autism; Initial Sample Size: 1,419 European ancestry cases from 1416 families; Replication Sample Size: 1,314 European ancestry cases from 1301 families; Strongest SNP-Risk Allele: rs4675502-?; SNPs: rs4675502; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-7; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [947,233]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	autistic disorder
GLT8D2		22841784	TAS		Disease/Trait: Hepatitis C induced liver fibrosis; Initial Sample Size: 1,161 European ancestry HCV-infected individuals; Replication Sample Size: 1,181 European ancestry HCV-infected individuals; Strongest SNP-Risk Allele: rs2629751-G; SNPs: rs2629751; Context: intron; Risk Allele Frequency: 0.31; p-Value: 1E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [780,650] (imputed)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C
RNF7		22841784	TAS		Disease/Trait: Hepatitis C induced liver fibrosis; Initial Sample Size: 1,161 European ancestry HCV-infected individuals; Replication Sample Size: 1,181 European ancestry HCV-infected individuals; Strongest SNP-Risk Allele: rs16851720-C; SNPs: rs16851720; Context: intron; Risk Allele Frequency: 0.19; p-Value: 9E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina [780,650] (imputed)	0.000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C
MERTK		22841784	TAS		Disease/Trait: Hepatitis C induced liver fibrosis; Initial Sample Size: 1,161 European ancestry HCV-infected individuals; Replication Sample Size: 1,181 European ancestry HCV-infected individuals; Strongest SNP-Risk Allele: rs4374383-A; SNPs: rs4374383; Context: intron; Risk Allele Frequency: 0.42; p-Value: 1E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina [780,650] (imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C
TCF4		22821403	TAS		Disease/Trait: Sclerosing cholangitis and ulcerative colitis (combined); Initial Sample Size: Up to 389 European ancestry PSC cases, 987 European ancestry UC cases, 2,968 European ancestry controls; Replication Sample Size: 1,012 European ancestry PSC cases, 4,444 European ancestry UC cases, 11,659 European ancestry controls; Strongest SNP-Risk Allele: rs1452787-A; SNPs: rs1452787; Context: intron; Risk Allele Frequency: 0.72; p-Value: 3E-8; OR or beta:    1.33; Platform [SNPs passing QC]: Affymetrix [up to 1,279,891] (imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	sclerosing cholangitis;ulcerative colitis
GPR35		22821403	TAS		Disease/Trait: Sclerosing cholangitis and ulcerative colitis (combined); Initial Sample Size: Up to 389 European ancestry PSC cases, 987 European ancestry UC cases, 2,968 European ancestry controls; Replication Sample Size: 1,012 European ancestry PSC cases, 4,444 European ancestry UC cases, 11,659 European ancestry controls; Strongest SNP-Risk Allele: rs4676410-A; SNPs: rs4676410; Context: intron; Risk Allele Frequency: 0.20; p-Value: 2E-9; OR or beta:    1.38; Platform [SNPs passing QC]: Affymetrix [up to 1,279,891] (imputed)	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	sclerosing cholangitis;ulcerative colitis
F8		22808956	TAS		Disease/Trait: Antineutrophil cytoplasmic antibody-associated vasculitis ; Initial Sample Size: 914 European ancestry cases, 5,259 European ancestry controls; Replication Sample Size: 1,454 European ancestry cases, 1,666 European ancestry controls; Strongest SNP-Risk Allele: rs17281398-?; SNPs: rs17281398; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [NR]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vasculitis
ARHGAP18		22808956	TAS		Disease/Trait: Antineutrophil cytoplasmic antibody-associated vasculitis ; Initial Sample Size: 914 European ancestry cases, 5,259 European ancestry controls; Replication Sample Size: 1,454 European ancestry cases, 1,666 European ancestry controls; Strongest SNP-Risk Allele: rs17057678-?; SNPs: rs17057678; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 6E-7; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix [NR]	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vasculitis
TSC22D1		22808956	TAS		Disease/Trait: Antineutrophil cytoplasmic antibody-associated vasculitis ; Initial Sample Size: 914 European ancestry cases, 5,259 European ancestry controls; Replication Sample Size: 1,454 European ancestry cases, 1,666 European ancestry controls; Strongest SNP-Risk Allele: rs17065868-?; SNPs: rs17065868; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [NR]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vasculitis
WNT9B		22808956	TAS		Disease/Trait: Antineutrophil cytoplasmic antibody-associated vasculitis ; Initial Sample Size: 914 European ancestry cases, 5,259 European ancestry controls; Replication Sample Size: 1,454 European ancestry cases, 1,666 European ancestry controls; Strongest SNP-Risk Allele: rs11079740-?; SNPs: rs11079740; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-6; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix [NR]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vasculitis
BTNL2		22797724	TAS		Disease/Trait: Lung adenocarcinoma; Initial Sample Size: 1,695 Japanese ancestry cases, 5,333 Japanese ancestry controls; Replication Sample Size: 4,334 Japanese ancestry cases, 8,202 Japanese ancestry controls; Strongest SNP-Risk Allele: rs3817963-G; SNPs: rs3817963; Context: intron; Risk Allele Frequency: 0.318; p-Value: 3E-10; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina [538,166]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung adenocarcinoma
BPTF		22797724	TAS		Disease/Trait: Lung adenocarcinoma; Initial Sample Size: 1,695 Japanese ancestry cases, 5,333 Japanese ancestry controls; Replication Sample Size: 4,334 Japanese ancestry cases, 8,202 Japanese ancestry controls; Strongest SNP-Risk Allele: rs7216064-A; SNPs: rs7216064; Context: intron; Risk Allele Frequency: 0.707; p-Value: 7E-11; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [538,166]	0.00000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung adenocarcinoma
TP63		22797724	TAS		Disease/Trait: Lung adenocarcinoma; Initial Sample Size: 1,695 Japanese ancestry cases, 5,333 Japanese ancestry controls; Replication Sample Size: 4,334 Japanese ancestry cases, 8,202 Japanese ancestry controls; Strongest SNP-Risk Allele: rs10937405-C; SNPs: rs10937405; Context: intron; Risk Allele Frequency: 0.67; p-Value: 7E-17; OR or beta:    1.25; Platform [SNPs passing QC]: Illumina [538,166]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung adenocarcinoma
TERT		22797724	TAS		Disease/Trait: Lung adenocarcinoma; Initial Sample Size: 1,695 Japanese ancestry cases, 5,333 Japanese ancestry controls; Replication Sample Size: 4,334 Japanese ancestry cases, 8,202 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2853677-C; SNPs: rs2853677; Context: intron; Risk Allele Frequency: 0.30; p-Value: 3E-40; OR or beta:    1.41; Platform [SNPs passing QC]: Illumina [538,166]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung adenocarcinoma
GRIK1		22807686	TAS		Disease/Trait: Hepatocellular carcinoma; Initial Sample Size: 1,538 Han Chinese HBV-positive HCC cases, 1,465 Han Chinese chronic HBV carriers  ; Replication Sample Size: 4,431 Han Chinese HBV-positive HCC cases, 4,725 Han Chinese  chronic HBV carriers  ; Strongest SNP-Risk Allele: rs455804-C; SNPs: rs455804; Context: intron; Risk Allele Frequency: 0.66; p-Value: 5E-10; OR or beta:    1.19; Platform [SNPs passing QC]: NR [523,663]	0.0000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatocellular carcinoma
SLC1A2		22764253	TAS		Disease/Trait: Essential tremor; Initial Sample Size: 436 European ancestry cases, 928 European ancestry controls; Replication Sample Size: 554 European ancestry cases, 609 European ancestry controls; Strongest SNP-Risk Allele: rs3794087-?; SNPs: rs3794087; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta:    1.43; Platform [SNPs passing QC]: Affymetrix [620,077]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	essential tremor
FTO		22763110	TAS		Disease/Trait: Osteoarthritis; Initial Sample Size: 7,410 European ancestry cases, 11,009 European ancestry controls; Replication Sample Size: 7,473 European ancestry cases, 42,938 European ancestry controls; Strongest SNP-Risk Allele: rs8044769-C; SNPs: rs8044769; Context: intron; Risk Allele Frequency: 0.50; p-Value: 4E-6; OR or beta:    1.07; Platform [SNPs passing QC]: Illumina [485,491] 	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	osteoarthritis
MTUS2		22754043	TAS		Disease/Trait: Insomnia (caffeine-induced); Initial Sample Size: 2,402 individuals from 1,470 families; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2388082-?; SNPs: rs2388082; Context: intron; Risk Allele Frequency: 0.89; p-Value: 4E-6; OR or beta:    1.69; Platform [SNPs passing QC]: Illumina [2,380,486] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Insomnia
NEDD4L		22754043	TAS		Disease/Trait: Insomnia (caffeine-induced); Initial Sample Size: 2,402 individuals from 1,470 families; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs158856-?; SNPs: rs158856; Context: intron; Risk Allele Frequency: 0.66; p-Value: 7E-6; OR or beta:    1.41; Platform [SNPs passing QC]: Illumina [2,380,486] (imputed)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Insomnia
PRIMA1		22754043	TAS		Disease/Trait: Insomnia (caffeine-induced); Initial Sample Size: 2,402 individuals from 1,470 families; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6575353-?; SNPs: rs6575353; Context: intron; Risk Allele Frequency: 0.90; p-Value: 1E-6; OR or beta:    1.47; Platform [SNPs passing QC]: Illumina [2,380,486] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Insomnia
PHACTR1		22751097	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 1,515 Han Chinese cases, 5,019 Han Chinese controls; Replication Sample Size: 15,460 Han Chinese cases, 11,472 Han Chinese controls; Strongest SNP-Risk Allele: rs9349379-G; SNPs: rs9349379; Context: intron; Risk Allele Frequency: 0.74; p-Value: 2E-9; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix [~2.2 million] (imputed)	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
HLA-DPA1		22737229	TAS		Disease/Trait: Hepatitis B (viral clearance); Initial Sample Size: 181 East Asian ancestry HBV carriers, 184 East Asian ancestry controls, 185 East Asian ancestry spontaneously HBV-resolved individuals; Replication Sample Size: Up to 8,045 East Asian ancestry HBV carriers, up to 9,003 East Asian ancestry controls, and up to 3,995 East Asian ancestry spontaneously HBV-resolved individuals; Strongest SNP-Risk Allele: rs3077-C; SNPs: rs3077; Context: UTR-3; Risk Allele Frequency: 0.60; p-Value: 4E-45; OR or beta:    1.82; Platform [SNPs passing QC]: Affymetrix [597,789]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis B
HLA-DPB1		22737229	TAS		Disease/Trait: Hepatitis B (viral clearance); Initial Sample Size: 181 East Asian ancestry HBV carriers, 184 East Asian ancestry controls, 185 East Asian ancestry spontaneously HBV-resolved individuals; Replication Sample Size: Up to 8,045 East Asian ancestry HBV carriers, up to 9,003 East Asian ancestry controls, and up to 3,995 East Asian ancestry spontaneously HBV-resolved individuals; Strongest SNP-Risk Allele: rs9277535-G; SNPs: rs9277535; Context: UTR-3; Risk Allele Frequency: 0.57; p-Value: 2E-17; OR or beta:    1.52; Platform [SNPs passing QC]: Affymetrix [597,789]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis B
HLA-DPA1		22737229	TAS		Disease/Trait: Hepatitis B (viral clearance); Initial Sample Size: 181 East Asian ancestry HBV carriers, 184 East Asian ancestry controls, 185 East Asian ancestry spontaneously HBV-resolved individuals; Replication Sample Size: Up to 8,045 East Asian ancestry HBV carriers, up to 9,003 East Asian ancestry controls, and up to 3,995 East Asian ancestry spontaneously HBV-resolved individuals; Strongest SNP-Risk Allele: rs3077-C; SNPs: rs3077; Context: UTR-3; Risk Allele Frequency: 0.60; p-Value: 1E-9; OR or beta:    1.67; Platform [SNPs passing QC]: Affymetrix [597,789]	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis B
HLA-DPB1		22737229	TAS		Disease/Trait: Hepatitis B (viral clearance); Initial Sample Size: 181 East Asian ancestry HBV carriers, 184 East Asian ancestry controls, 185 East Asian ancestry spontaneously HBV-resolved individuals; Replication Sample Size: Up to 8,045 East Asian ancestry HBV carriers, up to 9,003 East Asian ancestry controls, and up to 3,995 East Asian ancestry spontaneously HBV-resolved individuals; Strongest SNP-Risk Allele: rs9277535-G; SNPs: rs9277535; Context: UTR-3; Risk Allele Frequency: 0.57; p-Value: 2E-21; OR or beta:    1.64; Platform [SNPs passing QC]: Affymetrix [597,789]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis B
PHACTR1		22745674	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 1,949 individuals of Middle Eastern ancestry; Replication Sample Size: 2,547 individuals of Middle Eastern ancestry; Strongest SNP-Risk Allele: rs9349379-G; SNPs: rs9349379; Context: intron; Risk Allele Frequency: 0.349; p-Value: 6E-12; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [513,079]	0.000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
PHACTR1		22745674	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 1,949 individuals of Middle Eastern ancestry; Replication Sample Size: 2,547 individuals of Middle Eastern ancestry; Strongest SNP-Risk Allele: rs9349379-G; SNPs: rs9349379; Context: intron; Risk Allele Frequency: 0.349; p-Value: 4E-7; OR or beta:    1.23; Platform [SNPs passing QC]: Illumina [513,079]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
PHACTR1		22745674	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 1,949 individuals of Middle Eastern ancestry; Replication Sample Size: 2,547 individuals of Middle Eastern ancestry; Strongest SNP-Risk Allele: rs9349379-G; SNPs: rs9349379; Context: intron; Risk Allele Frequency: 0.349; p-Value: 8E-10; OR or beta:    1.34; Platform [SNPs passing QC]: Illumina [513,079]	0.0000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
C3		22705344	TAS		Disease/Trait: Age-related macular degeneration (CNV); Initial Sample Size: 1,775 European ancestry CNV cases, 4,134 European ancestry controls; Replication Sample Size: 4,515 CNV cases, 15,240 controls; Strongest SNP-Risk Allele: rs2230199-C; SNPs: rs2230199; Context: missense; Risk Allele Frequency: 0.193; p-Value: 1E-12; OR or beta:    1.61; Platform [SNPs passing QC]: Affymetrix & Illumina [6,036,699] (imputed)	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
CFB		22705344	TAS		Disease/Trait: Age-related macular degeneration (CNV); Initial Sample Size: 1,775 European ancestry CNV cases, 4,134 European ancestry controls; Replication Sample Size: 4,515 CNV cases, 15,240 controls; Strongest SNP-Risk Allele: rs641153-?; SNPs: rs641153; Context: missense; Risk Allele Frequency: 0.899; p-Value: 1E-17; OR or beta:    2.22; Platform [SNPs passing QC]: Affymetrix & Illumina [6,036,699] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
CFH		22705344	TAS		Disease/Trait: Age-related macular degeneration (CNV); Initial Sample Size: 1,775 European ancestry CNV cases, 4,134 European ancestry controls; Replication Sample Size: 4,515 CNV cases, 15,240 controls; Strongest SNP-Risk Allele: rs1061170-?; SNPs: rs1061170; Context: missense; Risk Allele Frequency: 0.371; p-Value: 1E-108; OR or beta:    2.78; Platform [SNPs passing QC]: Affymetrix & Illumina [6,036,699] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
C2		22705344	TAS		Disease/Trait: Age-related macular degeneration (CNV); Initial Sample Size: 1,775 European ancestry CNV cases, 4,134 European ancestry controls; Replication Sample Size: 4,515 CNV cases, 15,240 controls; Strongest SNP-Risk Allele: rs9332739-?; SNPs: rs9332739; Context: missense; Risk Allele Frequency: 0.955; p-Value: 2E-8; OR or beta:    2.08; Platform [SNPs passing QC]: Affymetrix & Illumina [6,036,699] (imputed)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
C3		22705344	TAS		Disease/Trait: Age-related macular degeneration (GA); Initial Sample Size: 819 European ancestry GA cases, 4,134 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs2230199-C; SNPs: rs2230199; Context: missense; Risk Allele Frequency: .19; p-Value: 5E-13; OR or beta:    1.83; Platform [SNPs passing QC]: Affymetrix & Illumina [6,036,699] (imputed)	0.0000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
CFH		22705344	TAS		Disease/Trait: Age-related macular degeneration (GA); Initial Sample Size: 819 European ancestry GA cases, 4,134 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs1061170-?; SNPs: rs1061170; Context: missense; Risk Allele Frequency: 0.371; p-Value: 5E-67; OR or beta:    2.78; Platform [SNPs passing QC]: Affymetrix & Illumina [6,036,699] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
C2		22705344	TAS		Disease/Trait: Age-related macular degeneration (GA); Initial Sample Size: 819 European ancestry GA cases, 4,134 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs9332739-?; SNPs: rs9332739; Context: missense; Risk Allele Frequency: 0.955; p-Value: 1E-6; OR or beta:    2.63; Platform [SNPs passing QC]: Affymetrix & Illumina [6,036,699] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
CFB		22705344	TAS		Disease/Trait: Age-related macular degeneration (GA); Initial Sample Size: 819 European ancestry GA cases, 4,134 European ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs641153-?; SNPs: rs641153; Context: missense; Risk Allele Frequency: 0.899; p-Value: 2E-9; OR or beta:    2.13; Platform [SNPs passing QC]: Affymetrix & Illumina [6,036,699] (imputed)	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
SAMM50		22719876	TAS		Disease/Trait: Nonalcoholic fatty liver disease; Initial Sample Size: 529 Japanese ancestry cases, 932 Japanese ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2143571-A; SNPs: rs2143571; Context: intron; Risk Allele Frequency: 0.458; p-Value: 6E-7; OR or beta:    1.47; Platform [SNPs passing QC]: Illumina [484,751]	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
YIPF1		22719876	TAS		Disease/Trait: Nonalcoholic fatty liver disease; Initial Sample Size: 529 Japanese ancestry cases, 932 Japanese ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11206226-A; SNPs: rs11206226; Context: intron; Risk Allele Frequency: 0.848; p-Value: 5E-6; OR or beta:    1.72; Platform [SNPs passing QC]: Illumina [484,751]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
PARVB		22719876	TAS		Disease/Trait: Nonalcoholic fatty liver disease; Initial Sample Size: 529 Japanese ancestry cases, 932 Japanese ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2073080-T; SNPs: rs2073080; Context: nearGene-5; Risk Allele Frequency: 0.458; p-Value: 8E-7; OR or beta:    1.47; Platform [SNPs passing QC]: Illumina [484,751]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
PNPLA3		22719876	TAS		Disease/Trait: Nonalcoholic fatty liver disease; Initial Sample Size: 529 Japanese ancestry cases, 932 Japanese ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs738409-G; SNPs: rs738409; Context: missense; Risk Allele Frequency: 0.484; p-Value: 1E-10; OR or beta:    1.66; Platform [SNPs passing QC]: Illumina [484,751]	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
CFH		22694956	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 893 European ancestry cases, 2,199 European ancestry controls; Replication Sample Size: 1,411 European ancestry cases, 1,431 European ancestry controls; Strongest SNP-Risk Allele: rs10801555-A; SNPs: rs10801555; Context: intron; Risk Allele Frequency: 0.40; p-Value: 2E-47; OR or beta:    2.33; Platform [SNPs passing QC]: Illumina [2,272,849] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
TNXB		22694956	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 893 European ancestry cases, 2,199 European ancestry controls; Replication Sample Size: 1,411 European ancestry cases, 1,431 European ancestry controls; Strongest SNP-Risk Allele: rs12153855-C; SNPs: rs12153855; Context: intron; Risk Allele Frequency: 0.011; p-Value: 1E-9; OR or beta:    1.44; Platform [SNPs passing QC]: Illumina [2,272,849] (imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
NOTCH4		22694956	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 893 European ancestry cases, 2,199 European ancestry controls; Replication Sample Size: 1,411 European ancestry cases, 1,431 European ancestry controls; Strongest SNP-Risk Allele: rs2071277-C; SNPs: rs2071277; Context: intron; Risk Allele Frequency: 0.219; p-Value: 2E-11; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [2,272,849] (imputed)	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
CFB		22694956	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 893 European ancestry cases, 2,199 European ancestry controls; Replication Sample Size: 1,411 European ancestry cases, 1,431 European ancestry controls; Strongest SNP-Risk Allele: rs541862-T; SNPs: rs541862; Context: intron; Risk Allele Frequency: 0.99; p-Value: 9E-17; OR or beta:    1.89; Platform [SNPs passing QC]: Illumina [2,272,849] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
TOMM40		22694956	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 893 European ancestry cases, 2,199 European ancestry controls; Replication Sample Size: 1,411 European ancestry cases, 1,431 European ancestry controls; Strongest SNP-Risk Allele: rs2075650-A; SNPs: rs2075650; Context: intron; Risk Allele Frequency: 0.851; p-Value: 8E-8; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [2,272,849] (imputed)	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
PHACTR2		22704111	TAS		Disease/Trait: Erectile dysfunction; Initial Sample Size: 125 European ancestry Erectile dysfunction cases with Type 1 Diabetes, 403 European ancestry non Erectile dysfunction controls with Type 1 Diabetes ; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6931865-A; SNPs: rs6931865; Context: intron; Risk Allele Frequency: 0.336; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [840,354]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	impotence 
F13B		22704111	TAS		Disease/Trait: Erectile dysfunction; Initial Sample Size: 125 European ancestry Erectile dysfunction cases with Type 1 Diabetes, 403 European ancestry non Erectile dysfunction controls with Type 1 Diabetes ; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2990510-G; SNPs: rs2990510; Context: intron; Risk Allele Frequency: 0.305; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [840,354]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	impotence 
BAK1		22700719	TAS		Disease/Trait: Chronic lymphocytic leukemia; Initial Sample Size: 1,121 European ancestry cases, 3,745 European ancestry controls; Replication Sample Size: 861 European ancestry cases, 2,033 European ancestry controls; Strongest SNP-Risk Allele: rs210142-C; SNPs: rs210142; Context: intron; Risk Allele Frequency: 0.70; p-Value: 9E-16; OR or beta:    1.40; Platform [SNPs passing QC]: Affymetrix & Illumina [~1,500,000] (imputed)	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic lymphocytic leukemia
DLC1		22688191	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 836 European ancestry bipolar disorder cases, 2,535 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs289585-?; SNPs: rs289585; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.45; Platform [SNPs passing QC]: Affymetrix [745,006]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
COMMD10		22688191	TAS		Disease/Trait: Bipolar disorder and schizophrenia; Initial Sample Size: 2,111 European ancestry schizophrenia cases, 836 European ancestry bipolar disorder cases, 2,535 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs253959-T; SNPs: rs253959; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.21; Platform [SNPs passing QC]: Affymetrix [745,006]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder;schizophrenia
MSRA		22688191	TAS		Disease/Trait: Bipolar disorder and schizophrenia; Initial Sample Size: 2,111 European ancestry schizophrenia cases, 836 European ancestry bipolar disorder cases, 2,535 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1484642-C; SNPs: rs1484642; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta:    1.43; Platform [SNPs passing QC]: Affymetrix [745,006]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder;schizophrenia
NLRC5		22688191	TAS		Disease/Trait: Bipolar disorder and schizophrenia; Initial Sample Size: 2,111 European ancestry schizophrenia cases, 836 European ancestry bipolar disorder cases, 2,535 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs821470-A; SNPs: rs821470; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix [745,006]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder;schizophrenia
KCNMB2		22688191	TAS		Disease/Trait: Bipolar disorder and schizophrenia; Initial Sample Size: 2,111 European ancestry schizophrenia cases, 836 European ancestry bipolar disorder cases, 2,535 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2054399-?; SNPs: rs2054399; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.22; Platform [SNPs passing QC]: Affymetrix [745,006]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder;schizophrenia
CACNA1C		22688191	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 2,111 European ancestry schizophrenia cases, 2,535 European ancestry controls; Replication Sample Size: 11,271 schizophrenia cases, 14,601 controls; Strongest SNP-Risk Allele: rs4765905-?; SNPs: rs4765905; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-7; OR or beta:    1.11; Platform [SNPs passing QC]: Affymetrix [745,006]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
CSMD1		22688191	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 2,111 European ancestry schizophrenia cases, 2,535 European ancestry controls; Replication Sample Size: 11,271 schizophrenia cases, 14,601 controls; Strongest SNP-Risk Allele: rs10503256-?; SNPs: rs10503256; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-7; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix [745,006]	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
MEF2D		22683712	TAS		Disease/Trait: Migraine; Initial Sample Size: 2,326 European ancestry cases, 4,580 European ancestry controls; Replication Sample Size: 2,508 European ancestry cases, 2,652 European ancestry controls; Strongest SNP-Risk Allele: rs3790455-C; SNPs: rs3790455; Context: intron; Risk Allele Frequency: 0.34; p-Value: 7E-11; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [1,246,388] (imputed)	0.00000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	migraine
PHACTR1		22683712	TAS		Disease/Trait: Migraine; Initial Sample Size: 2,326 European ancestry cases, 4,580 European ancestry controls; Replication Sample Size: 2,508 European ancestry cases, 2,652 European ancestry controls; Strongest SNP-Risk Allele: rs9349379-?; SNPs: rs9349379; Context: intron; Risk Allele Frequency: 0.62; p-Value: 3E-8; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [1,246,388] (imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	migraine
TRPM8		22683712	TAS		Disease/Trait: Migraine; Initial Sample Size: 2,326 European ancestry cases, 4,580 European ancestry controls; Replication Sample Size: 2,508 European ancestry cases, 2,652 European ancestry controls; Strongest SNP-Risk Allele: rs10166942-?; SNPs: rs10166942; Context: nearGene-5; Risk Allele Frequency: 0.82; p-Value: 1E-12; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [1,246,388] (imputed)	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	migraine
MMP17		22683712	TAS		Disease/Trait: Migraine; Initial Sample Size: 2,326 European ancestry cases, 4,580 European ancestry controls; Replication Sample Size: 2,508 European ancestry cases, 2,652 European ancestry controls; Strongest SNP-Risk Allele: rs6598163-G; SNPs: rs6598163; Context: missense; Risk Allele Frequency: 0.48; p-Value: 5E-7; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [1,246,388] (imputed)	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	migraine
ASTN2		22683712	TAS		Disease/Trait: Migraine; Initial Sample Size: 2,326 European ancestry cases, 4,580 European ancestry controls; Replication Sample Size: 2,508 European ancestry cases, 2,652 European ancestry controls; Strongest SNP-Risk Allele: rs6478241-A; SNPs: rs6478241; Context: intron; Risk Allele Frequency: 0.38; p-Value: 4E-8; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [1,246,388] (imputed)	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	migraine
MARCH4		22683712	TAS		Disease/Trait: Migraine; Initial Sample Size: 2,326 European ancestry cases, 4,580 European ancestry controls; Replication Sample Size: 2,508 European ancestry cases, 2,652 European ancestry controls; Strongest SNP-Risk Allele: rs6756590-?; SNPs: rs6756590; Context: intron; Risk Allele Frequency: 0.56; p-Value: 1E-6; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [1,246,388] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	migraine
LRP1		22683712	TAS		Disease/Trait: Migraine; Initial Sample Size: 2,326 European ancestry cases, 4,580 European ancestry controls; Replication Sample Size: 2,508 European ancestry cases, 2,652 European ancestry controls; Strongest SNP-Risk Allele: rs11172113-?; SNPs: rs11172113; Context: intron; Risk Allele Frequency: 0.60; p-Value: 3E-8; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [1,246,388] (imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	migraine
SPTBN1		22685421	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 2,789 Singaporean Chinese ancestry individuals, 2,155 Singaporean Malay ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4557020-T; SNPs: rs4557020; Context: intron; Risk Allele Frequency: 0.37; p-Value: 3E-7; OR or beta:     .12; Platform [SNPs passing QC]: Illumina [456,634]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
PARP8		22685421	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 2,789 Singaporean Chinese ancestry individuals, 2,155 Singaporean Malay ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs282544-C; SNPs: rs282544; Context: intron; Risk Allele Frequency: 0.35; p-Value: 4E-6; OR or beta:     .10; Platform [SNPs passing QC]: Illumina [456,634]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
C8orf34		22664479	TAS		Disease/Trait: Response to irinotecan in non-small-cell lung cancer; Initial Sample Size: 101 non-small-cell lung cancer cases; Replication Sample Size: 146 non-small-cell lung cancer cases; Strongest SNP-Risk Allele: rs1517114-C; SNPs: rs1517114; Context: intron; Risk Allele Frequency: 0.12; p-Value: 9E-6; OR or beta:    4.10; Platform [SNPs passing QC]: Affyemtrix [312,230]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	non-small cell lung carcinoma
PLCB1		22664479	TAS		Disease/Trait: Response to irinotecan in non-small-cell lung cancer; Initial Sample Size: 101 non-small-cell lung cancer cases; Replication Sample Size: 146 non-small-cell lung cancer cases; Strongest SNP-Risk Allele: rs2745761-C; SNPs: rs2745761; Context: intron; Risk Allele Frequency: 0.072; p-Value: 6E-6; OR or beta:    4.80; Platform [SNPs passing QC]: Affyemtrix [312,230]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	non-small cell lung carcinoma
NME7		22672568	TAS		Disease/Trait: Venous thromboembolism; Initial Sample Size: 1,503 European and other ancestry cases, 1,459 European and other ancestry controls; Replication Sample Size: 1,407 cases, 1,418 controls; Strongest SNP-Risk Allele: rs16861990-C; SNPs: rs16861990; Context: intron; Risk Allele Frequency: 0.099; p-Value: 2E-12; OR or beta:    2.02; Platform [SNPs passing QC]: Illumina [~2.5 million] (imputed)	0.000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Thromboembolism
ABO		22672568	TAS		Disease/Trait: Venous thromboembolism; Initial Sample Size: 1,503 European and other ancestry cases, 1,459 European and other ancestry controls; Replication Sample Size: 1,407 cases, 1,418 controls; Strongest SNP-Risk Allele: rs2519093-A; SNPs: rs2519093; Context: intron; Risk Allele Frequency: 0.243; p-Value: 8E-16; OR or beta:    1.69; Platform [SNPs passing QC]: Illumina [~2.5 million] (imputed)	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Thromboembolism
F5		22672568	TAS		Disease/Trait: Venous thromboembolism; Initial Sample Size: 1,503 European and other ancestry cases, 1,459 European and other ancestry controls; Replication Sample Size: 1,407 cases, 1,418 controls; Strongest SNP-Risk Allele: rs6025-T; SNPs: rs6025; Context: ; Risk Allele Frequency: 0.063; p-Value: 2E-22; OR or beta:    3.57; Platform [SNPs passing QC]: Illumina [~2.5 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Thromboembolism
ABO		22672568	TAS		Disease/Trait: Venous thromboembolism; Initial Sample Size: 1,503 European and other ancestry cases, 1,459 European and other ancestry controls; Replication Sample Size: 1,407 cases, 1,418 controls; Strongest SNP-Risk Allele: rs8176719-G; SNPs: rs8176719; Context: ; Risk Allele Frequency: 0.419; p-Value: 6E-12; OR or beta:    1.47; Platform [SNPs passing QC]: Illumina [~2.5 million] (imputed)	0.000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Thromboembolism
HDAC9		22693459	TAS		Disease/Trait: Male-pattern baldness; Initial Sample Size: 3,891 European ancestry cases, 8,915 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2073963-G; SNPs: rs2073963; Context: intron; Risk Allele Frequency: 0.530; p-Value: 1E-12; OR or beta:    1.29; Platform [SNPs passing QC]: Affymetrix & Illumina [2,391,230] (imputed)	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Frontal balding
HMG20A		22693455	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,112 lean type 2 diabetes cases, 4,123 obese type 2 diabetes cases, 54,412 controls; Replication Sample Size: 2,881 lean type 2 diabetes cases, 8,702 obese type 2 diabetes cases, 18,957 controls; Strongest SNP-Risk Allele: rs7178572-G; SNPs: rs7178572; Context: ; Risk Allele Frequency: 0.70; p-Value: 1E-8; OR or beta:    1.11; Platform [SNPs passing QC]: NR	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
LAMA1		22693455	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,112 lean type 2 diabetes cases, 4,123 obese type 2 diabetes cases, 54,412 controls; Replication Sample Size: 2,881 lean type 2 diabetes cases, 8,702 obese type 2 diabetes cases, 18,957 controls; Strongest SNP-Risk Allele: rs8090011-G; SNPs: rs8090011; Context: intron; Risk Allele Frequency: 0.38; p-Value: 8E-9; OR or beta:    1.13; Platform [SNPs passing QC]: NR	0.000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		22693455	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,112 lean type 2 diabetes cases, 4,123 obese type 2 diabetes cases, 54,412 controls; Replication Sample Size: 2,881 lean type 2 diabetes cases, 8,702 obese type 2 diabetes cases, 18,957 controls; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.29; p-Value: 2E-40; OR or beta:    1.58; Platform [SNPs passing QC]: NR	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CDKAL1		22693455	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,112 lean type 2 diabetes cases, 4,123 obese type 2 diabetes cases, 54,412 controls; Replication Sample Size: 2,881 lean type 2 diabetes cases, 8,702 obese type 2 diabetes cases, 18,957 controls; Strongest SNP-Risk Allele: rs7766070-A; SNPs: rs7766070; Context: intron; Risk Allele Frequency: 0.27; p-Value: 7E-10; OR or beta:    1.26; Platform [SNPs passing QC]: NR	0.0000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CDKAL1		22693455	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,112 lean type 2 diabetes cases, 4,123 obese type 2 diabetes cases, 54,412 controls; Replication Sample Size: 2,881 lean type 2 diabetes cases, 8,702 obese type 2 diabetes cases, 18,957 controls; Strongest SNP-Risk Allele: rs7766070-A; SNPs: rs7766070; Context: intron; Risk Allele Frequency: 0.27; p-Value: 6E-11; OR or beta:    1.21; Platform [SNPs passing QC]: NR	0.00000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
SLC30A8		22693455	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,112 lean type 2 diabetes cases, 4,123 obese type 2 diabetes cases, 54,412 controls; Replication Sample Size: 2,881 lean type 2 diabetes cases, 8,702 obese type 2 diabetes cases, 18,957 controls; Strongest SNP-Risk Allele: rs3802177-G; SNPs: rs3802177; Context: UTR-3; Risk Allele Frequency: 0.68; p-Value: 4E-8; OR or beta:    1.23; Platform [SNPs passing QC]: NR	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
ADCY5		22693455	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,112 lean type 2 diabetes cases, 4,123 obese type 2 diabetes cases, 54,412 controls; Replication Sample Size: 2,881 lean type 2 diabetes cases, 8,702 obese type 2 diabetes cases, 18,957 controls; Strongest SNP-Risk Allele: rs11708067-A; SNPs: rs11708067; Context: intron; Risk Allele Frequency: 0.78; p-Value: 6E-8; OR or beta:    1.25; Platform [SNPs passing QC]: NR	0.00000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		22693455	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,112 lean type 2 diabetes cases, 4,123 obese type 2 diabetes cases, 54,412 controls; Replication Sample Size: 2,881 lean type 2 diabetes cases, 8,702 obese type 2 diabetes cases, 18,957 controls; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.29; p-Value: 4E-21; OR or beta:    1.26; Platform [SNPs passing QC]: NR	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
FTO		22693455	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,112 lean type 2 diabetes cases, 4,123 obese type 2 diabetes cases, 54,412 controls; Replication Sample Size: 2,881 lean type 2 diabetes cases, 8,702 obese type 2 diabetes cases, 18,957 controls; Strongest SNP-Risk Allele: rs9939609-A; SNPs: rs9939609; Context: intron; Risk Allele Frequency: 0.40; p-Value: 1E-20; OR or beta:    1.25; Platform [SNPs passing QC]: NR	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
C4orf26		22658654	TAS		Disease/Trait: Parkinson's disease (motor and cognition); Initial Sample Size: 443 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17000647-?; SNPs: rs17000647; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    5.58; Platform [SNPs passing QC]: NR [198,345]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
CLRN3		22658654	TAS		Disease/Trait: Parkinson's disease (motor and cognition); Initial Sample Size: 443 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6482992-?; SNPs: rs6482992; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    2.03; Platform [SNPs passing QC]: NR [198,345]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
POLD3		22634755	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 8,323 European ancestry cases, 9,457 European ancestry controls; Replication Sample Size: 19,513 European ancestry cases, 17,657 European ancestry controls, 1,583 Japanese ancestry cases, 1,898 Japanese ancestry controls; Strongest SNP-Risk Allele: rs3824999-?; SNPs: rs3824999; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-10; OR or beta:    1.08; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.0000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
DIP2C		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17221323-G; SNPs: rs17221323; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
CYMP		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4839431-A; SNPs: rs4839431; Context: ncRNA; Risk Allele Frequency: NR; p-Value: 2E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
ATP8A1		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10517025-A; SNPs: rs10517025; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
SGK1		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9493873-G; SNPs: rs9493873; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
DAPK1		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3095748-G; SNPs: rs3095748; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
PTCHD1		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs5925760-A; SNPs: rs5925760; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
LPP		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13067593-G; SNPs: rs13067593; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
LTBP1		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs542631-A; SNPs: rs542631; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
UBE2D2		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs261532-A; SNPs: rs261532; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
RAB14		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9408928-G; SNPs: rs9408928; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
COL4A4		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2272205-G; SNPs: rs2272205; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
TIMELESS		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11171846-A; SNPs: rs11171846; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-10; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
MNAT1		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6573333-A; SNPs: rs6573333; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-10; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
ZNF827		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2048161-A; SNPs: rs2048161; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-12; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
WDR92		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4078978-A; SNPs: rs4078978; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-18; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
PHEX		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1540283-G; SNPs: rs1540283; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
KCND3		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12044963-A; SNPs: rs12044963; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-10; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
MAMLD1		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IFN-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17252936-G; SNPs: rs17252936; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-10; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
DNAH3		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-10); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs16970881-A; SNPs: rs16970881; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
DAB1		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-10); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6679454-G; SNPs: rs6679454; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
DYNC1I1		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-10); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13231718-C; SNPs: rs13231718; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
BCO2		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-12p40); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7105056-A; SNPs: rs7105056; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
ARHGAP10		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-12p40); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7658486-A; SNPs: rs7658486; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
GFRA3		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-12p40); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11242417-C; SNPs: rs11242417; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
PRR16		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-12p40); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1584468-A; SNPs: rs1584468; Context: ; Risk Allele Frequency: NR; p-Value: 9E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
COL1A2		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-12p40); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3736638-A; SNPs: rs3736638; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
DCHS2		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-1beta); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs902464-A; SNPs: rs902464; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
XKR4		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-1beta); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12542677-A; SNPs: rs12542677; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
RAB6B		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-1beta); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9835973-A; SNPs: rs9835973; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
MTHFD2L		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-1beta); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs16850864-A; SNPs: rs16850864; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
COL28A1		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-1beta); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17168526-G; SNPs: rs17168526; Context: cds-synon; Risk Allele Frequency: NR; p-Value: 6E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
SLC15A1		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-1beta); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9582259-C; SNPs: rs9582259; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
GRIN2B		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-2); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2268118-A; SNPs: rs2268118; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
RFT1		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-2); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13088281-A; SNPs: rs13088281; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-11; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
DAGLA		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-2); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4963243-A; SNPs: rs4963243; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
BCAS3		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-2); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7224438-G; SNPs: rs7224438; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
CNTN5		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted IL-2); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11223581-G; SNPs: rs11223581; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
SLC6A20		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted TNF-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs758386-A; SNPs: rs758386; Context: cds-synon; Risk Allele Frequency: NR; p-Value: 2E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
SLC4A5		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted TNF-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13006863-A; SNPs: rs13006863; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
CAMKMT		22610502	TAS		Disease/Trait: Immune reponse to smallpox (secreted TNF-alpha); Initial Sample Size: Up to 512 European ancestry individuals, up to 199 African American individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13414205-A; SNPs: rs13414205; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
PDE4D		22610502	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: Up to 512 European ancestry individuals, 199 African American individuals; Replication Sample Size: Nr; Strongest SNP-Risk Allele: rs17444059-G; SNPs: rs17444059; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
MEX3C		22610502	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: Up to 512 European ancestry individuals, 199 African American individuals; Replication Sample Size: Nr; Strongest SNP-Risk Allele: rs8096445-A; SNPs: rs8096445; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
BLK		22610502	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: Up to 512 European ancestry individuals, 199 African American individuals; Replication Sample Size: Nr; Strongest SNP-Risk Allele: rs2255327-A; SNPs: rs2255327; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
PICALM		22832961	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 1,291 European ancestry cases, 938 European ancestry controls; Replication Sample Size: 2,727 cases, 3,336 controls; Strongest SNP-Risk Allele: rs17817600-?; SNPs: rs17817600; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta:    1.33; Platform [SNPs passing QC]: Illumina [2,543,888] (imputed)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
PPP1R3B		22832961	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 1,291 European ancestry cases, 938 European ancestry controls; Replication Sample Size: 2,727 cases, 3,336 controls; Strongest SNP-Risk Allele: rs3748140-?; SNPs: rs3748140; Context: missense; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta:    2.43; Platform [SNPs passing QC]: Illumina [2,543,888] (imputed)	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
DOT1L		22566624	TAS		Disease/Trait: Osteoarthritis; Initial Sample Size: 6,523 individuals; Replication Sample Size: 4,442 individuals; Strongest SNP-Risk Allele: rs12982744-G; SNPs: rs12982744; Context: intron; Risk Allele Frequency: 0.39; p-Value: 1E-11; OR or beta:     .09; Platform [SNPs passing QC]: Illumina [2,455,290] (imputed)	0.00000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	osteoarthritis
TICAM1		22561518	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 418 European ancestry cases, 2,810 European ancestry controls        ; Replication Sample Size: 1,377 European ancestry cases, 1,284 European ancestry controls; Strongest SNP-Risk Allele: rs6510827-T; SNPs: rs6510827; Context: intron; Risk Allele Frequency: 0.41; p-Value: 9E-8; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [495,821]	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
BACH2		22561518	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 418 European ancestry cases, 2,810 European ancestry controls        ; Replication Sample Size: 1,377 European ancestry cases, 1,284 European ancestry controls; Strongest SNP-Risk Allele: rs3757247-A; SNPs: rs3757247; Context: intron; Risk Allele Frequency: 0.47; p-Value: 3E-8; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [495,821]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
CASP7		22561518	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 418 European ancestry cases, 2,810 European ancestry controls        ; Replication Sample Size: 1,377 European ancestry cases, 1,284 European ancestry controls; Strongest SNP-Risk Allele: rs3814231-G; SNPs: rs3814231; Context: intron; Risk Allele Frequency: 0.75; p-Value: 4E-8; OR or beta:    1.23; Platform [SNPs passing QC]: Illumina [495,821]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
IKZF4		22561518	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 418 European ancestry cases, 2,810 European ancestry controls        ; Replication Sample Size: 1,377 European ancestry cases, 1,284 European ancestry controls; Strongest SNP-Risk Allele: rs2456973-C; SNPs: rs2456973; Context: intron; Risk Allele Frequency: 0.35; p-Value: 3E-14; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [495,821]	0.00000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
ALPL		22569225	TAS		Disease/Trait: Response to TNF-alpha inhibitors in rheumatoid arthritis; Initial Sample Size: 196 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs885814-?; SNPs: rs885814; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [486,450]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
SLCO1C1		22569225	TAS		Disease/Trait: Response to TNF-alpha inhibitors in rheumatoid arthritis; Initial Sample Size: 196 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3794271-?; SNPs: rs3794271; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    3.20; Platform [SNPs passing QC]: Illumina [486,450]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
C5orf56		22561531	TAS		Disease/Trait: Asthma; Initial Sample Size: 933 European ancestry cases, 3,346 European ancestry controls; Replication Sample Size: 231 European ancestry cases, 1,345 European ancestry controls; Strongest SNP-Risk Allele: rs11745587-?; SNPs: rs11745587; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    1.26; Platform [SNPs passing QC]: Illumina [6,103,628] (Imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
ZNF665		22561531	TAS		Disease/Trait: Asthma; Initial Sample Size: 933 European ancestry cases, 3,346 European ancestry controls; Replication Sample Size: 231 European ancestry cases, 1,345 European ancestry controls; Strongest SNP-Risk Allele: rs16984547-?; SNPs: rs16984547; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.43; Platform [SNPs passing QC]: Illumina [6,103,628] (Imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
ACO1		22561531	TAS		Disease/Trait: Asthma; Initial Sample Size: 933 European ancestry cases, 3,346 European ancestry controls; Replication Sample Size: 231 European ancestry cases, 1,345 European ancestry controls; Strongest SNP-Risk Allele: rs10970976-?; SNPs: rs10970976; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [6,103,628] (Imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
FAM65B		22554406	TAS		Disease/Trait: Electroencephalographic traits in alcoholism; Initial Sample Size: 1,560 European ancestry individuals from 117 families; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4256430-A; SNPs: rs4256430; Context: intron; Risk Allele Frequency: 0.465; p-Value: 8E-6; OR or beta:     .10; Platform [SNPs passing QC]: Illumina [634,583]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
C11orf84		22554406	TAS		Disease/Trait: Electroencephalographic traits in alcoholism; Initial Sample Size: 1,560 European ancestry individuals from 117 families; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10897449-T; SNPs: rs10897449; Context: intron; Risk Allele Frequency: 0.453; p-Value: 7E-6; OR or beta:     .10; Platform [SNPs passing QC]: Illumina [634,583]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
KCNJ6		22554406	TAS		Disease/Trait: Electroencephalographic traits in alcoholism; Initial Sample Size: 1,560 European ancestry individuals from 117 families; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2835872-G; SNPs: rs2835872; Context: intron; Risk Allele Frequency: 0.681; p-Value: 5E-10; OR or beta:     .15; Platform [SNPs passing QC]: Illumina [634,583]	0.0000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
SYNE2		22544366	TAS		Disease/Trait: Atrial fibrillation; Initial Sample Size: 6,707 European ancestry cases, 52,426 European ancestry controls; Replication Sample Size: 5,381 European ancestry casses, 10,030 European ancestry  controls; Strongest SNP-Risk Allele: rs1152591-A; SNPs: rs1152591; Context: intron; Risk Allele Frequency: 0.48; p-Value: 6E-13; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.0000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	familial atrial fibrillation
C9orf3		22544366	TAS		Disease/Trait: Atrial fibrillation; Initial Sample Size: 6,707 European ancestry cases, 52,426 European ancestry controls; Replication Sample Size: 5,381 European ancestry casses, 10,030 European ancestry  controls; Strongest SNP-Risk Allele: rs10821415-A; SNPs: rs10821415; Context: intron; Risk Allele Frequency: 0.42; p-Value: 4E-11; OR or beta:    1.11; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.00000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	familial atrial fibrillation
CAV1		22544366	TAS		Disease/Trait: Atrial fibrillation; Initial Sample Size: 6,707 European ancestry cases, 52,426 European ancestry controls; Replication Sample Size: 5,381 European ancestry casses, 10,030 European ancestry  controls; Strongest SNP-Risk Allele: rs3807989-G; SNPs: rs3807989; Context: intron; Risk Allele Frequency: 0.60; p-Value: 4E-12; OR or beta:    1.11; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	familial atrial fibrillation
WNT8A		22544366	TAS		Disease/Trait: Atrial fibrillation; Initial Sample Size: 6,707 European ancestry cases, 52,426 European ancestry controls; Replication Sample Size: 5,381 European ancestry casses, 10,030 European ancestry  controls; Strongest SNP-Risk Allele: rs2040862-T; SNPs: rs2040862; Context: intron; Risk Allele Frequency: 0.18; p-Value: 3E-7; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	familial atrial fibrillation
HCN4		22544366	TAS		Disease/Trait: Atrial fibrillation; Initial Sample Size: 6,707 European ancestry cases, 52,426 European ancestry controls; Replication Sample Size: 5,381 European ancestry casses, 10,030 European ancestry  controls; Strongest SNP-Risk Allele: rs7164883-G; SNPs: rs7164883; Context: intron; Risk Allele Frequency: 0.16; p-Value: 3E-17; OR or beta:    1.19; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	familial atrial fibrillation
ZFHX3		22544366	TAS		Disease/Trait: Atrial fibrillation; Initial Sample Size: 6,707 European ancestry cases, 52,426 European ancestry controls; Replication Sample Size: 5,381 European ancestry casses, 10,030 European ancestry  controls; Strongest SNP-Risk Allele: rs2106261-T; SNPs: rs2106261; Context: intron; Risk Allele Frequency: 0.176; p-Value: 3E-16; OR or beta:    1.24; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	familial atrial fibrillation
DLG2		22544364	TAS		Disease/Trait: Wilms tumor; Initial Sample Size: 757 European ancestry cases, 1,879 European ancestry controls; Replication Sample Size: 1,488 European ancestry cases, 3,851 European ancestry controls; Strongest SNP-Risk Allele: rs790356-G; SNPs: rs790356; Context: intron; Risk Allele Frequency: 0.5; p-Value: 4E-15; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [599,255]	0.000000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	nephroblastoma
HLA-DRA		22541561	TAS		Disease/Trait: Non-obstructive azoospermia; Initial Sample Size: 802 Han Chinese cases, 1,863 Han Chinese controls; Replication Sample Size: 1,424 Han Chinese cases, 2,713 Han Chinese controls; Strongest SNP-Risk Allele: rs7192-T; SNPs: rs7192; Context: missense; Risk Allele Frequency: 0.26; p-Value: 3E-6; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina & Affymetrix [912,924]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	azoospermia
IL5RA		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3804795-?; SNPs: rs3804795; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
FAM108C1		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12148329-?; SNPs: rs12148329; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
SPIRE1		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9959145-?; SNPs: rs9959145; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
GREM2		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10495471-?; SNPs: rs10495471; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
CSMD1		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17070309-?; SNPs: rs17070309; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
RUNX1		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2834655-?; SNPs: rs2834655; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
SPIRE1		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1940973-?; SNPs: rs1940973; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
MKX		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10508727-?; SNPs: rs10508727; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-10; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
RASAL2		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs316274-?; SNPs: rs316274; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
CACNA2D3		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4955826-?; SNPs: rs4955826; Context: ; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
RAB10		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13388915-?; SNPs: rs13388915; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
BCR		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9608102-?; SNPs: rs9608102; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
PRKCQ		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4748153-?; SNPs: rs4748153; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
CYP2C8		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1934953-?; SNPs: rs1934953; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
UNC13C		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2553218-?; SNPs: rs2553218; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
ZHX2		22542470	TAS		Disease/Trait: Immune response to smallpox vaccine (IL-6); Initial Sample Size: 217 African American ancestry individuals, 580 European ancestry individuals, 217 Hispanic ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10108684-?; SNPs: rs10108684; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	smallpox
EPC1		22509378	TAS		Disease/Trait: Sexual dysfunction (female); Initial Sample Size: 1,104 European ancestry twins; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2370759-G; SNPs: rs2370759; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:     .24; Platform [SNPs passing QC]: Illumina [2,287,762] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	sexual dysfunction
PVALB		22509378	TAS		Disease/Trait: Sexual dysfunction (female); Initial Sample Size: 1,104 European ancestry twins; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4820255-C; SNPs: rs4820255; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:     .37; Platform [SNPs passing QC]: Illumina [2,287,762] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	sexual dysfunction
ETFA		22491018	TAS		Disease/Trait: Response to tocilizumab in rheumatoid arthritis; Initial Sample Size: 1,157 European and other ancestry rheumatoid arthritis cases; Replication Sample Size: 526 European and other ancestry rheumatoid arthritis cases; Strongest SNP-Risk Allele: rs1914816-?; SNPs: rs1914816; Context: intron; Risk Allele Frequency: 0.3; p-Value: 7E-7; OR or beta:     .87; Platform [SNPs passing QC]: Illumina [534,053]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
ENOX1		22491018	TAS		Disease/Trait: Response to tocilizumab in rheumatoid arthritis; Initial Sample Size: 1,157 European and other ancestry rheumatoid arthritis cases; Replication Sample Size: 526 European and other ancestry rheumatoid arthritis cases; Strongest SNP-Risk Allele: rs4942242-?; SNPs: rs4942242; Context: intron; Risk Allele Frequency: 0.47; p-Value: 2E-7; OR or beta:     .13; Platform [SNPs passing QC]: Illumina [534,053]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
MDGA2		22491018	TAS		Disease/Trait: Response to tocilizumab in rheumatoid arthritis; Initial Sample Size: 1,157 European and other ancestry rheumatoid arthritis cases; Replication Sample Size: 526 European and other ancestry rheumatoid arthritis cases; Strongest SNP-Risk Allele: rs17118552-?; SNPs: rs17118552; Context: intron; Risk Allele Frequency: 0.014; p-Value: 2E-7; OR or beta:   17.19; Platform [SNPs passing QC]: Illumina [534,053]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
PSMA4		22491018	TAS		Disease/Trait: Response to tocilizumab in rheumatoid arthritis; Initial Sample Size: 1,157 European and other ancestry rheumatoid arthritis cases; Replication Sample Size: 526 European and other ancestry rheumatoid arthritis cases; Strongest SNP-Risk Allele: rs12901682-?; SNPs: rs12901682; Context: intron; Risk Allele Frequency: 0.017; p-Value: 4E-8; OR or beta:  135.02; Platform [SNPs passing QC]: Illumina [534,053]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
RCHY1		22491018	TAS		Disease/Trait: Response to tocilizumab in rheumatoid arthritis; Initial Sample Size: 1,157 European and other ancestry rheumatoid arthritis cases; Replication Sample Size: 526 European and other ancestry rheumatoid arthritis cases; Strongest SNP-Risk Allele: rs13137105-?; SNPs: rs13137105; Context: intron; Risk Allele Frequency: 0.38; p-Value: 9E-7; OR or beta:    6.39; Platform [SNPs passing QC]: Illumina [534,053]	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
SPSB1		22491018	TAS		Disease/Trait: Response to tocilizumab in rheumatoid arthritis; Initial Sample Size: 1,157 European and other ancestry rheumatoid arthritis cases; Replication Sample Size: 526 European and other ancestry rheumatoid arthritis cases; Strongest SNP-Risk Allele: rs11121380-?; SNPs: rs11121380; Context: intron; Risk Allele Frequency: 0.07; p-Value: 5E-8; OR or beta:   11.11; Platform [SNPs passing QC]: Illumina [534,053]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
SLC6A11		22491018	TAS		Disease/Trait: Response to tocilizumab in rheumatoid arthritis; Initial Sample Size: 1,157 European and other ancestry rheumatoid arthritis cases; Replication Sample Size: 526 European and other ancestry rheumatoid arthritis cases; Strongest SNP-Risk Allele: rs1809529-?; SNPs: rs1809529; Context: intron; Risk Allele Frequency: 0.34; p-Value: 3E-7; OR or beta:     .28; Platform [SNPs passing QC]: Illumina [534,053]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
ALPK1		22484627	TAS		Disease/Trait: Obesity; Initial Sample Size: 5,530 European ancestry cases, 8,318 European ancestry controls; Replication Sample Size: 2,214 European ancestry cases, 2,674 European ancestry controls; Strongest SNP-Risk Allele: rs4833407-?; SNPs: rs4833407; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.11; Platform [SNPs passing QC]: Affymetrix & Illumina [2.7 million] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity
ZMIZ1		22482804	TAS		Disease/Trait: Crohn's disease and psoriasis; Initial Sample Size: 2,529 European ancestry psoriasis cases, 2,142 European ancestry Crohn's disease cases, 10,460 European ancestry controls; Replication Sample Size: Up to 3,187 European ancestry psoriasis cases, 4,073 European ancestry Crohn's disease cases, 10,100 European ancestry controls; Strongest SNP-Risk Allele: rs1250544-G; SNPs: rs1250544; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-14; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix, Illumina & Perlegen [1,116,213] (imputed)	0.00000000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease;psoriasis
ZDHHC23		22482804	TAS		Disease/Trait: Crohn's disease and psoriasis; Initial Sample Size: 2,529 European ancestry psoriasis cases, 2,142 European ancestry Crohn's disease cases, 10,460 European ancestry controls; Replication Sample Size: Up to 3,187 European ancestry psoriasis cases, 4,073 European ancestry Crohn's disease cases, 10,100 European ancestry controls; Strongest SNP-Risk Allele: rs1386478-A; SNPs: rs1386478; Context: UTR-3; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix, Illumina & Perlegen [1,116,213] (imputed)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease;psoriasis
CAPZB		22482804	TAS		Disease/Trait: Crohn's disease and psoriasis; Initial Sample Size: 2,529 European ancestry psoriasis cases, 2,142 European ancestry Crohn's disease cases, 10,460 European ancestry controls; Replication Sample Size: Up to 3,187 European ancestry psoriasis cases, 4,073 European ancestry Crohn's disease cases, 10,100 European ancestry controls; Strongest SNP-Risk Allele: rs7667-?; SNPs: rs7667; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.11; Platform [SNPs passing QC]: Affymetrix, Illumina & Perlegen [1,116,213] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease;psoriasis
SOCS1		22482804	TAS		Disease/Trait: Crohn's disease and psoriasis; Initial Sample Size: 2,529 European ancestry psoriasis cases, 2,142 European ancestry Crohn's disease cases, 10,460 European ancestry controls; Replication Sample Size: Up to 3,187 European ancestry psoriasis cases, 4,073 European ancestry Crohn's disease cases, 10,100 European ancestry controls; Strongest SNP-Risk Allele: rs4780355-T; SNPs: rs4780355; Context: nearGene-3; Risk Allele Frequency: NR; p-Value: 1E-13; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix, Illumina & Perlegen [1,116,213] (imputed)	0.0000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease;psoriasis
MTF1		22493691	TAS		Disease/Trait: Hypothyroidism; Initial Sample Size: 3,736 European ancestry cases, 35,546 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3748682-T; SNPs: rs3748682; Context: UTR-3; Risk Allele Frequency: 0.749; p-Value: 9E-6; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [870,065]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypothyroidism
PDE8B		22493691	TAS		Disease/Trait: Hypothyroidism; Initial Sample Size: 3,736 European ancestry cases, 35,546 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4704397-A; SNPs: rs4704397; Context: intron; Risk Allele Frequency: 0.391; p-Value: 2E-6; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina [870,065]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypothyroidism
CTLA4		22493691	TAS		Disease/Trait: Hypothyroidism; Initial Sample Size: 3,736 European ancestry cases, 35,546 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs231779-T; SNPs: rs231779; Context: intron; Risk Allele Frequency: 0.365; p-Value: 7E-6; OR or beta:    1.13; Platform [SNPs passing QC]: Illumina [870,065]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypothyroidism
VAV3		22493691	TAS		Disease/Trait: Hypothyroidism; Initial Sample Size: 3,736 European ancestry cases, 35,546 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4915077-C; SNPs: rs4915077; Context: intron; Risk Allele Frequency: 0.084; p-Value: 8E-10; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [870,065]	0.0000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypothyroidism
LOC100130480		22493691	TAS		Disease/Trait: Hypothyroidism; Initial Sample Size: 3,736 European ancestry cases, 35,546 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs948426-A; SNPs: rs948426; Context: intron; Risk Allele Frequency: 0.602; p-Value: 1E-6; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [870,065]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypothyroidism
C1QTNF6		22493691	TAS		Disease/Trait: Hypothyroidism; Initial Sample Size: 3,736 European ancestry cases, 35,546 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs229526-C; SNPs: rs229526; Context: missense; Risk Allele Frequency: 0.221; p-Value: 9E-6; OR or beta:    1.22; Platform [SNPs passing QC]: Illumina [870,065]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypothyroidism
PLEKHG1		22488850	TAS		Disease/Trait: Alcohol and nictotine co-dependence; Initial Sample Size: 818 European ancestry cases, 1,396 European ancestry controls, 449 African American cases, 480 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17427389-?; SNPs: rs17427389; Context: UTR-3; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [805,814]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	substance dependence
LOC339568		22488850	TAS		Disease/Trait: Alcohol and nictotine co-dependence; Initial Sample Size: 818 European ancestry cases, 1,396 European ancestry controls, 449 African American cases, 480 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6028335-?; SNPs: rs6028335; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [805,814]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	substance dependence
PKNOX2		22488850	TAS		Disease/Trait: Alcohol and nictotine co-dependence; Initial Sample Size: 818 European ancestry cases, 1,396 European ancestry controls, 449 African American cases, 480 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1426153-?; SNPs: rs1426153; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [805,814]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	substance dependence
KCND2		22488850	TAS		Disease/Trait: Alcohol and nictotine co-dependence; Initial Sample Size: 818 European ancestry cases, 1,396 European ancestry controls, 449 African American cases, 480 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs728115-?; SNPs: rs728115; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [805,814]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	substance dependence
HIVEP1		22488850	TAS		Disease/Trait: Alcohol and nictotine co-dependence; Initial Sample Size: 818 European ancestry cases, 1,396 European ancestry controls, 449 African American cases, 480 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1570989-?; SNPs: rs1570989; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [805,814]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	substance dependence
TRPS1		22472876	TAS		Disease/Trait: Major depressive disorder; Initial Sample Size: 9,240 European ancestry cases, 9,519 European ancestry controls; Replication Sample Size: 6,783 European ancestry cases, 50,695 European ancestry controls; Strongest SNP-Risk Allele: rs2721937-?; SNPs: rs2721937; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix, Illumina & Perlegen [~1.2 million](imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	major depressive disorder
SSBP2		22472174	TAS		Disease/Trait: Glioblastoma; Initial Sample Size: 315 European ancestry cases; Replication Sample Size: 434 European ancestry cases; Strongest SNP-Risk Allele: rs7732320-T; SNPs: rs7732320; Context: intron; Risk Allele Frequency: 0.11; p-Value: 1E-6; OR or beta:    1.64; Platform [SNPs passing QC]: Illumina [314,635]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	glioblastoma
SYK		22456796	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 4,470 Japanese ancestry cases, 3,071 Japanese ancestry controls; Replication Sample Size: 7,605 Japanese ancestry cases, 3,534 Japanese ancestry controls; Strongest SNP-Risk Allele: rs10993738-?; SNPs: rs10993738; Context: intron; Risk Allele Frequency: 0.152; p-Value: 5E-6; OR or beta:    1.16; Platform [SNPs passing QC]: NR [2,229,890] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
C6orf10		22457343	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 197 European ancestry cases, 234 European ancestry controls; Replication Sample Size: 379 European ancestry cases, 398 European ancestry controls; Strongest SNP-Risk Allele: rs3129934-T; SNPs: rs3129934; Context: intron; Risk Allele Frequency: 0.10; p-Value: 7E-16; OR or beta:    2.34; Platform [SNPs passing QC]: Affymetrix [277,866]	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
ERBB4		22452962	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 2,273 Korean ancestry cases, 2,052 Korean ancestry controls; Replication Sample Size: 4,049 Korean ancestry cases, 3,845 Korean ancestry controls ; Strongest SNP-Risk Allele: rs13393577-T; SNPs: rs13393577; Context: intron; Risk Allele Frequency: 0.051; p-Value: 9E-14; OR or beta:    1.53; Platform [SNPs passing QC]: Affymetrix [555,525]	0.00000000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
NFKB1		22479419	TAS		Disease/Trait: Schizophrenia (treatment refractory) ; Initial Sample Size: 522 Han Chinese cases, 806 Han Chinese controls; Replication Sample Size: 273 Han Chinese cases; Strongest SNP-Risk Allele: rs230529-T; SNPs: rs230529; Context: intron; Risk Allele Frequency: 0.47; p-Value: 2E-7; OR or beta:    1.45; Platform [SNPs passing QC]: Affymetrix [694,436]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
MED30		22446961	TAS		Disease/Trait: Kawasaki disease; Initial Sample Size: 622 Taiwanese Han Chinese cases, 1,107 Taiwanese Han Chinese controls; Replication Sample Size: 261 Taiwanese Han Chinese cases, 550 Taiwanese Han Chinese controls; Strongest SNP-Risk Allele: rs17667932-G; SNPs: rs17667932; Context: intron; Risk Allele Frequency: 0.019; p-Value: 5E-7; OR or beta:    2.37; Platform [SNPs passing QC]: Affymetrix [716,935]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Kawasaki disease
PPM1L		22446961	TAS		Disease/Trait: Kawasaki disease; Initial Sample Size: 622 Taiwanese Han Chinese cases, 1,107 Taiwanese Han Chinese controls; Replication Sample Size: 261 Taiwanese Han Chinese cases, 550 Taiwanese Han Chinese controls; Strongest SNP-Risk Allele: rs9290065-G; SNPs: rs9290065; Context: intron; Risk Allele Frequency: 0.020; p-Value: 9E-6; OR or beta:    2.12; Platform [SNPs passing QC]: Affymetrix [716,935]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Kawasaki disease
ARID5B		22446963	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 4,074 Japanese ancestry cases, 16,891 Japanese ancestry controls; Replication Sample Size: 5,277 Japanese ancestry cases, 21,684 Japanese ancestry controls; Strongest SNP-Risk Allele: rs10821944-G; SNPs: rs10821944; Context: intron; Risk Allele Frequency: 0.36; p-Value: 6E-18; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix & Illumina [1,948,139] 	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
PRKCH		22446963	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 4,074 Japanese ancestry cases, 16,891 Japanese ancestry controls; Replication Sample Size: 5,277 Japanese ancestry cases, 21,684 Japanese ancestry controls; Strongest SNP-Risk Allele: rs1957895-G; SNPs: rs1957895; Context: intron; Risk Allele Frequency: 0.39; p-Value: 4E-7; OR or beta:    1.09; Platform [SNPs passing QC]: Affymetrix & Illumina [1,948,139] 	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
PTPN2		22446963	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 4,074 Japanese ancestry cases, 16,891 Japanese ancestry controls; Replication Sample Size: 5,277 Japanese ancestry cases, 21,684 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2847297-G; SNPs: rs2847297; Context: intron; Risk Allele Frequency: 0.33; p-Value: 2E-8; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix & Illumina [1,948,139] 	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
PLD4		22446963	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 4,074 Japanese ancestry cases, 16,891 Japanese ancestry controls; Replication Sample Size: 5,277 Japanese ancestry cases, 21,684 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2841277-T; SNPs: rs2841277; Context: nearGene-5; Risk Allele Frequency: 0.69; p-Value: 2E-14; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix & Illumina [1,948,139] 	0.00000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
GCH1		22446963	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 4,074 Japanese ancestry cases, 16,891 Japanese ancestry controls; Replication Sample Size: 5,277 Japanese ancestry cases, 21,684 Japanese ancestry controls; Strongest SNP-Risk Allele: rs3783637-C; SNPs: rs3783637; Context: intron; Risk Allele Frequency: 0.74; p-Value: 2E-6; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix & Illumina [1,948,139] 	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
NFKBIE		22446963	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 4,074 Japanese ancestry cases, 16,891 Japanese ancestry controls; Replication Sample Size: 5,277 Japanese ancestry cases, 21,684 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2233434-G; SNPs: rs2233434; Context: missense; Risk Allele Frequency: 0.21; p-Value: 6E-19; OR or beta:    1.19; Platform [SNPs passing QC]: Affymetrix & Illumina [1,948,139] 	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
ANXA3		22446963	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 4,074 Japanese ancestry cases, 16,891 Japanese ancestry controls; Replication Sample Size: 5,277 Japanese ancestry cases, 21,684 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2867461-A; SNPs: rs2867461; Context: intron; Risk Allele Frequency: 0.44; p-Value: 1E-12; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix & Illumina [1,948,139] 	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
MLF1IP		22446962	TAS		Disease/Trait: Kawasaki disease; Initial Sample Size: 428 Japanese ancestry cases, 3,379 Japanese ancestry controls; Replication Sample Size: 754 Japanese ancestry cases, 947 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2130392-A; SNPs: rs2130392; Context: intron; Risk Allele Frequency: 0.358; p-Value: 3E-8; OR or beta:    1.42; Platform [SNPs passing QC]: Illumina [463,793]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Kawasaki disease
MDGA2		22445761	TAS		Disease/Trait: Sexual dysfunction (SSRI/SNRI-related); Initial Sample Size: 201 Japanese ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1160351-T; SNPs: rs1160351; Context: intron; Risk Allele Frequency: 0.381; p-Value: 3E-7; OR or beta:    2.92; Platform [SNPs passing QC]: Affymetrix [186,320]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	sexual dysfunction
ADAMTS19		22445761	TAS		Disease/Trait: Sexual dysfunction (SSRI/SNRI-related); Initial Sample Size: 201 Japanese ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13436218-C; SNPs: rs13436218; Context: intron; Risk Allele Frequency: 0.012; p-Value: 1E-6; OR or beta:    5.92; Platform [SNPs passing QC]: Affymetrix [186,320]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	sexual dysfunction
LRRK2		22438815	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 2,197 cases, 2,061 controls; Replication Sample Size: Up to 98,080 individuals of European and Asian ancestry; Strongest SNP-Risk Allele: rs34778348-?; SNPs: rs34778348; Context: missense; Risk Allele Frequency: 0.04; p-Value: 3E-21; OR or beta:    2.23; Platform [SNPs passing QC]: Illumina and Perlegen [7,123,920] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
LRRK2		22438815	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 2,197 cases, 2,061 controls; Replication Sample Size: Up to 98,080 individuals of European and Asian ancestry; Strongest SNP-Risk Allele: rs1491942-?; SNPs: rs1491942; Context: intron; Risk Allele Frequency: 0.21; p-Value: 6E-15; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina and Perlegen [7,123,920] (imputed)	0.000000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
GRM7		22419666	TAS		Disease/Trait: Orofacial clefts; Initial Sample Size: 1,094 European ancestry triads, 1,277 Asian ancestry triads and 87 other ancestry triads; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1450100-?; SNPs: rs1450100; Context: intron; Risk Allele Frequency: 0.65; p-Value: 8E-6; OR or beta:    1.54; Platform [SNPs passing QC]: Illumina [NR]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	orofacial cleft
FHIT		22419666	TAS		Disease/Trait: Orofacial clefts; Initial Sample Size: 1,094 European ancestry triads, 1,277 Asian ancestry triads and 87 other ancestry triads; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs212016-?; SNPs: rs212016; Context: intron; Risk Allele Frequency: 0.69; p-Value: 7E-6; OR or beta:    1.54; Platform [SNPs passing QC]: Illumina [NR]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	orofacial cleft
RASGRF2		22419666	TAS		Disease/Trait: Orofacial clefts; Initial Sample Size: 1,094 European ancestry triads, 1,277 Asian ancestry triads and 87 other ancestry triads; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4703822-?; SNPs: rs4703822; Context: intron; Risk Allele Frequency: 0.72; p-Value: 4E-6; OR or beta:    1.59; Platform [SNPs passing QC]: Illumina [NR]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	orofacial cleft
BMP6		22419666	TAS		Disease/Trait: Orofacial clefts; Initial Sample Size: 1,094 European ancestry triads, 1,277 Asian ancestry triads and 87 other ancestry triads; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2068361-?; SNPs: rs2068361; Context: intron; Risk Allele Frequency: 0.23; p-Value: 5E-6; OR or beta:    1.64; Platform [SNPs passing QC]: Illumina [NR]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	orofacial cleft
TXNDC16		22419666	TAS		Disease/Trait: Orofacial clefts; Initial Sample Size: 1,094 European ancestry triads, 1,277 Asian ancestry triads and 87 other ancestry triads; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs745080-?; SNPs: rs745080; Context: intron; Risk Allele Frequency: 0.55; p-Value: 8E-7; OR or beta:    1.59; Platform [SNPs passing QC]: Illumina [NR]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	orofacial cleft
ATXN3		22419666	TAS		Disease/Trait: Orofacial clefts; Initial Sample Size: 1,094 European ancestry triads, 1,277 Asian ancestry triads and 87 other ancestry triads; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17807815-?; SNPs: rs17807815; Context: intron; Risk Allele Frequency: 0.07; p-Value: 6E-6; OR or beta:    2.38; Platform [SNPs passing QC]: Illumina [NR]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	orofacial cleft
SH3BP4		22419666	TAS		Disease/Trait: Orofacial clefts; Initial Sample Size: 1,094 European ancestry triads, 1,277 Asian ancestry triads and 87 other ancestry triads; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10174126-?; SNPs: rs10174126; Context: intron; Risk Allele Frequency: 0.43; p-Value: 7E-7; OR or beta:    1.59; Platform [SNPs passing QC]: Illumina [NR]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	orofacial cleft
CDKN2B-AS1		22428042	TAS		Disease/Trait: Glaucoma (primary open-angle); Initial Sample Size: 833 Japanese ancestry cases, 686 Japanese ancestry controls; Replication Sample Size: 411 Japanese ancestry cases, 289 Japanese ancestry controls; Strongest SNP-Risk Allele: rs7865618-A; SNPs: rs7865618; Context: intron; Risk Allele Frequency: 0.82; p-Value: 9E-11; OR or beta:    1.78; Platform [SNPs passing QC]: Affymetrix [653,519]	0.00000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary open angle glaucoma
PSMB10		22412388	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 737 Ashkenazi Jewish cases, 2,257  Ashkenazi Jewish controls; Replication Sample Size: 971 Ashkenazi Jewish cases, 2,124 Ashkenazi Jewish controls; Strongest SNP-Risk Allele: rs11574514-A; SNPs: rs11574514; Context: nearGene-5; Risk Allele Frequency: 0.045; p-Value: 2E-7; OR or beta:    1.44; Platform [SNPs passing QC]: Affyemtrix & Illumina [1,060,934] (imputed)	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
CAMK2B		22399527	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,637 European ancestry cases, 7,927 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1127065-G; SNPs: rs1127065; Context: cds-synon; Risk Allele Frequency: 0.49; p-Value: 9E-11; OR or beta:     .08; Platform [SNPs passing QC]: Illumina [1,257,079] (imputed)	0.00000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
GALNT2		22399527	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,637 European ancestry cases, 7,927 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4846922-T; SNPs: rs4846922; Context: intron; Risk Allele Frequency: 0.39; p-Value: 4E-8; OR or beta:     .08; Platform [SNPs passing QC]: Illumina [1,257,079] (imputed)	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
APOB		22399527	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,637 European ancestry cases, 7,927 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs673548-G; SNPs: rs673548; Context: intron; Risk Allele Frequency: 0.73; p-Value: 1E-10; OR or beta:     .11; Platform [SNPs passing QC]: Illumina [1,257,079] (imputed)	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
LPL		22399527	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,637 European ancestry cases, 7,927 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs268-G; SNPs: rs268; Context: missense; Risk Allele Frequency: 0.02; p-Value: 2E-12; OR or beta:     .38; Platform [SNPs passing QC]: Illumina [1,257,079] (imputed)	0.000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
ABCA1		22399527	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,637 European ancestry cases, 7,927 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1883025-T; SNPs: rs1883025; Context: intron; Risk Allele Frequency: 0.19; p-Value: 6E-10; OR or beta:     .10; Platform [SNPs passing QC]: Illumina [1,257,079] (imputed)	0.0000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
NR1H3		22399527	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,637 European ancestry cases, 7,927 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10838681-G; SNPs: rs10838681; Context: intron; Risk Allele Frequency: 0.64; p-Value: 1E-9; OR or beta:     .08; Platform [SNPs passing QC]: Illumina [1,257,079] (imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
EDC4		22399527	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,637 European ancestry cases, 7,927 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs8060686-T; SNPs: rs8060686; Context: cds-synon; Risk Allele Frequency: 0.81; p-Value: 2E-10; OR or beta:     .11; Platform [SNPs passing QC]: Illumina [1,257,079] (imputed)	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
SMEK2		22399527	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,637 European ancestry cases, 7,927 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs782590-T; SNPs: rs782590; Context: intron; Risk Allele Frequency: 0.56; p-Value: 4E-8; OR or beta:     .09; Platform [SNPs passing QC]: Illumina [1,257,079] (imputed)	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
GCKR		22399527	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,637 European ancestry cases, 7,927 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs780094-A; SNPs: rs780094; Context: intron; Risk Allele Frequency: 0.36; p-Value: 6E-20; OR or beta:     .13; Platform [SNPs passing QC]: Illumina [1,257,079] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
MLXIPL		22399527	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,637 European ancestry cases, 7,927 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13226650-A; SNPs: rs13226650; Context: intron; Risk Allele Frequency: 0.83; p-Value: 2E-11; OR or beta:     .12; Platform [SNPs passing QC]: Illumina [1,257,079] (imputed)	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
ZNF259		22399527	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,637 European ancestry cases, 7,927 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs964184-G; SNPs: rs964184; Context: nearGene-3; Risk Allele Frequency: 0.15; p-Value: 3E-31; OR or beta:     .23; Platform [SNPs passing QC]: Illumina [1,257,079] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
FTO		22399527	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,637 European ancestry cases, 7,927 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9940128-A; SNPs: rs9940128; Context: intron; Risk Allele Frequency: 0.42; p-Value: 2E-9; OR or beta:     .09; Platform [SNPs passing QC]: Illumina [1,257,079] (imputed)	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
G6PC2		22399527	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,637 European ancestry cases, 7,927 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs560887-G; SNPs: rs560887; Context: intron; Risk Allele Frequency: 0.69; p-Value: 5E-26; OR or beta:     .15; Platform [SNPs passing QC]: Illumina [1,257,079] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
ABO		22387998	TAS		Disease/Trait: Duodenal ulcer ; Initial Sample Size: 1,043 Japanese ancestry cases, 21,694 Japanese ancestry controls; Replication Sample Size: 5,992 Japanese ancestry cases, 3,629 Japanese ancestry controls; Strongest SNP-Risk Allele: rs505922-T; SNPs: rs505922; Context: intron; Risk Allele Frequency: 0.54; p-Value: 1E-10; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [480,327]	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	duodenal ulcer
PSCA		22387998	TAS		Disease/Trait: Duodenal ulcer ; Initial Sample Size: 1,043 Japanese ancestry cases, 21,694 Japanese ancestry controls; Replication Sample Size: 5,992 Japanese ancestry cases, 3,629 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2294008-C; SNPs: rs2294008; Context: intron; Risk Allele Frequency: 0.37; p-Value: 2E-33; OR or beta:    1.41; Platform [SNPs passing QC]: Illumina [480,327]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	duodenal ulcer
PRDM15		22451204	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 4,238 European ancestry cases, 4,239 European ancestry controls; Replication Sample Size: 3,738 European ancestry cases, 2,111 European ancestry controls; Strongest SNP-Risk Allele: rs2839398-?; SNPs: rs2839398; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.23; Platform [SNPs passing QC]: Illumina [2.5 million] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
RIT2		22451204	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 4,238 European ancestry cases, 4,239 European ancestry controls; Replication Sample Size: 3,738 European ancestry cases, 2,111 European ancestry controls; Strongest SNP-Risk Allele: rs12456492-?; SNPs: rs12456492; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-10; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [2.5 million] (imputed)	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
WNT3		22451204	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 4,238 European ancestry cases, 4,239 European ancestry controls; Replication Sample Size: 3,738 European ancestry cases, 2,111 European ancestry controls; Strongest SNP-Risk Allele: rs199515-?; SNPs: rs199515; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-17; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [2.5 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
SLC2A13		22451204	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 4,238 European ancestry cases, 4,239 European ancestry controls; Replication Sample Size: 3,738 European ancestry cases, 2,111 European ancestry controls; Strongest SNP-Risk Allele: rs10877840-?; SNPs: rs10877840; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [2.5 million] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
SH3GL2		22451204	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 4,238 European ancestry cases, 4,239 European ancestry controls; Replication Sample Size: 3,738 European ancestry cases, 2,111 European ancestry controls; Strongest SNP-Risk Allele: rs1536076-?; SNPs: rs1536076; Context: ; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [2.5 million] (imputed)	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
DGKQ		22451204	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 4,238 European ancestry cases, 4,239 European ancestry controls; Replication Sample Size: 3,738 European ancestry cases, 2,111 European ancestry controls; Strongest SNP-Risk Allele: rs11248060-?; SNPs: rs11248060; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-9; OR or beta:    1.26; Platform [SNPs passing QC]: Illumina [2.5 million] (imputed)	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
CNKSR3		22451204	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 4,238 European ancestry cases, 4,239 European ancestry controls; Replication Sample Size: 3,738 European ancestry cases, 2,111 European ancestry controls; Strongest SNP-Risk Allele: rs2275336-?; SNPs: rs2275336; Context: UTR-3; Risk Allele Frequency: NR; p-Value: 9E-7; OR or beta:    1.36; Platform [SNPs passing QC]: Illumina [2.5 million] (imputed)	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
DGKH		22396660	TAS		Disease/Trait: Nephrolithiasis; Initial Sample Size: 904 Japanese ancestry cases, 7,471 Japanese ancestry controls; Replication Sample Size: 4,892 Japanese ancestry cases, 9,873 Japanese ancestry controls; Strongest SNP-Risk Allele: rs4142110-?; SNPs: rs4142110; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-9; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [556,249]	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	nephrolithiasis
ESR1		22383897	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 2,918 Chinese ancestry cases, 2,324 Chinese ancestry controls; Replication Sample Size: Up to 6,838 Chinese ancestry cases, up to 6,888 Chinese ancestry controls, up to 1,297 Han Chinese cases, up to 1,585 Han Chinese controls, up to 1,066 Taiwan Chinese cases, up to 1,065 Taiwan Chinese controls, up to 5,038 Korean ancestry cases, up to 6,869 Korean ancestry controls, up to 1,934 Japanese ancestry cases, up to 1,875 Japanese ancestry controls; Strongest SNP-Risk Allele: rs9383951-G; SNPs: rs9383951; Context: intron; Risk Allele Frequency: 0.90; p-Value: 2E-6; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix [690,947]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
INTS7		22365631	TAS		Disease/Trait: Temperament (bipolar disorder); Initial Sample Size: 1,263 European ancestry cases and 1,434 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17018311-?; SNPs: rs17018311; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta:    4.21; Platform [SNPs passing QC]: Affymetrix [703,012]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
GPM6A		22365631	TAS		Disease/Trait: Temperament (bipolar disorder); Initial Sample Size: 1,263 European ancestry cases and 1,434 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17599018-?; SNPs: rs17599018; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:     .98; Platform [SNPs passing QC]: Affymetrix [703,012]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
BRWD1		22365631	TAS		Disease/Trait: Temperament (bipolar disorder); Initial Sample Size: 1,263 European ancestry cases and 1,434 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2150410-?; SNPs: rs2150410; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.69; Platform [SNPs passing QC]: Affymetrix [703,012]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
WSCD2		22365631	TAS		Disease/Trait: Temperament (bipolar disorder); Initial Sample Size: 1,263 European ancestry cases and 1,434 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7313402-?; SNPs: rs7313402; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix [703,012]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
FBLN1		22365631	TAS		Disease/Trait: Temperament (bipolar disorder); Initial Sample Size: 1,263 European ancestry cases and 1,434 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1985671-?; SNPs: rs1985671; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta:    1.06; Platform [SNPs passing QC]: Affymetrix [703,012]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
JMJD1C		22354554	TAS		Disease/Trait: Arthritis (juvenile idiopathic); Initial Sample Size: 814 European ancestry cases, 658 European ancestry controls and 2,400 controls; Replication Sample Size: 1,744 European ancestry cases, 7,010 European ancestry controls; Strongest SNP-Risk Allele: rs6479891-T; SNPs: rs6479891; Context: intron; Risk Allele Frequency: 0.14; p-Value: 2E-7; OR or beta:    1.19; Platform [SNPs passing QC]: Affmyetrix [561,137]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	juvenile rheumatoid arthritis
REEP3		22354554	TAS		Disease/Trait: Arthritis (juvenile idiopathic); Initial Sample Size: 814 European ancestry cases, 658 European ancestry controls and 2,400 controls; Replication Sample Size: 1,744 European ancestry cases, 7,010 European ancestry controls; Strongest SNP-Risk Allele: rs12411988-C; SNPs: rs12411988; Context: intron; Risk Allele Frequency: 0.13; p-Value: 3E-7; OR or beta:    1.18; Platform [SNPs passing QC]: Affmyetrix [561,137]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	juvenile rheumatoid arthritis
DCC		22318345	TAS		Disease/Trait: Gallbladder cancer; Initial Sample Size: 41 Japanese ancestry cases, 866 Japanese ancestry controls; Replication Sample Size: 30 Japanese ancestry cases, 898 Japanese ancestry controls; Strongest SNP-Risk Allele: rs7504990-A; SNPs: rs7504990; Context: intron; Risk Allele Frequency: 0.21; p-Value: 7E-8; OR or beta:    6.95; Platform [SNPs passing QC]: Illumina [425,706] (imputed)	0.00000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	gallbladder cancer
LRRC7		22322875	TAS		Disease/Trait: Hypertension risk in short sleep duration; Initial Sample Size: 4,965 Korean ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2226284-?; SNPs: rs2226284; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-8; OR or beta:    5.91; Platform [SNPs passing QC]: Affymetrix [334,750]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertension
MYO1D		22322875	TAS		Disease/Trait: Hypertension risk in short sleep duration; Initial Sample Size: 4,965 Korean ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs225212-?; SNPs: rs225212; Context: ; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    5.08; Platform [SNPs passing QC]: Affymetrix [334,750]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertension
HDAC9		22306652	TAS		Disease/Trait: Stroke; Initial Sample Size: 3,548 European ancestry cases, 5,972 European ancestry controls; Replication Sample Size: 6,594 European ancestry cases, 34,864 European ancestry controls; Strongest SNP-Risk Allele: rs11984041-A; SNPs: rs11984041; Context: intron; Risk Allele Frequency: 0.09; p-Value: 2E-11; OR or beta:    1.42; Platform [SNPs passing QC]: Illumina [495,851]	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cerebrovascular accident
IL23R		22293688	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 16,179 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11209026-?; SNPs: rs11209026; Context: missense; Risk Allele Frequency: NR; p-Value: 4E-21; OR or beta:    3.18; Platform [SNPs passing QC]: NR [6,233,112] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
IL2RA		22293688	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 16,179 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs61839660-?; SNPs: rs61839660; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-9; OR or beta:    1.60; Platform [SNPs passing QC]: NR [6,233,112] (imputed)	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
CUX2		22293688	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 16,179 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1265564-?; SNPs: rs1265564; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-16; OR or beta:    1.45; Platform [SNPs passing QC]: NR [6,233,112] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
ABCA1		22286219	TAS		Disease/Trait: Lipid metabolism phenotypes; Initial Sample Size: 8,330 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2575876-?; SNPs: rs2575876; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-11; OR or beta:     .14; Platform [SNPs passing QC]: Illumina [~7.7 million] (imputed)	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lipid metabolism disorder
MLXIPL		22286219	TAS		Disease/Trait: Lipid metabolism phenotypes; Initial Sample Size: 8,330 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13247874-?; SNPs: rs13247874; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-14; OR or beta:     .16; Platform [SNPs passing QC]: Illumina [~7.7 million] (imputed)	0.00000000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lipid metabolism disorder
PLTP		22286219	TAS		Disease/Trait: Lipid metabolism phenotypes; Initial Sample Size: 8,330 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6065904-?; SNPs: rs6065904; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-31; OR or beta:     .22; Platform [SNPs passing QC]: Illumina [~7.7 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lipid metabolism disorder
CPT1A		22286219	TAS		Disease/Trait: Lipid metabolism phenotypes; Initial Sample Size: 8,330 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17610395-?; SNPs: rs17610395; Context: missense; Risk Allele Frequency: NR; p-Value: 8E-12; OR or beta:     .17; Platform [SNPs passing QC]: Illumina [~7.7 million] (imputed)	0.000000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lipid metabolism disorder
DAPK1		22293537	TAS		Disease/Trait: Response to gemcitabine in pancreatic cancer ; Initial Sample Size: 21 Japanese ancestry adverse reaction cases, 58 Japanese ancestry non-adverse reaction individuals; Replication Sample Size: 33 Japanese ancestry adverse reaction cases, 62 Japanese ancestry non-adverse reaction individuals; Strongest SNP-Risk Allele: rs11141915-T; SNPs: rs11141915; Context: intron; Risk Allele Frequency: 0.62; p-Value: 1E-6; OR or beta:    4.10; Platform [SNPs passing QC]: Illumina [470,064]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
ALDH2		22286173	TAS		Disease/Trait: Intracranial aneurysm; Initial Sample Size: 1,383 Japanese ancestry cases, 5,484 Japanese ancestry controls; Replication Sample Size: 1,048 Japanese ancestry cases, 7,212 Japanese ancestry controls; Strongest SNP-Risk Allele: rs671-C; SNPs: rs671; Context: missense; Risk Allele Frequency: 0.746; p-Value: 3E-6; OR or beta:    1.24; Platform [SNPs passing QC]: Illumina [565,149]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	intracranial aneurysm
BET1L		22286173	TAS		Disease/Trait: Intracranial aneurysm; Initial Sample Size: 1,383 Japanese ancestry cases, 5,484 Japanese ancestry controls; Replication Sample Size: 1,048 Japanese ancestry cases, 7,212 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2280543-T; SNPs: rs2280543; Context: UTR-3; Risk Allele Frequency: 0.124; p-Value: 3E-6; OR or beta:    1.25; Platform [SNPs passing QC]: Illumina [565,149]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	intracranial aneurysm
EDNRA		22286173	TAS		Disease/Trait: Intracranial aneurysm; Initial Sample Size: 1,383 Japanese ancestry cases, 5,484 Japanese ancestry controls; Replication Sample Size: 1,048 Japanese ancestry cases, 7,212 Japanese ancestry controls; Strongest SNP-Risk Allele: rs6842241-C; SNPs: rs6842241; Context: nearGene-5; Risk Allele Frequency: 0.694; p-Value: 1E-8; OR or beta:    1.25; Platform [SNPs passing QC]: Illumina [565,149]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	intracranial aneurysm
IL13		22286212	TAS		Disease/Trait: Hodgkin's lymphoma; Initial Sample Size: 1,200 European ancestry cases, 6,417 European ancestry controls; Replication Sample Size: 563 European ancestry cases, 613 European ancestry controls; Strongest SNP-Risk Allele: rs20541-?; SNPs: rs20541; Context: missense; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta:    1.47; Platform [SNPs passing QC]: Illumina [502,514]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Hodgkin's lymphoma
AFF1		22291604	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 891 Japanese ancestry cases, 3,384 Japanese ancestry controls; Replication Sample Size: 1,387 Japanese ancestry cases, 28,564 Japanese ancestry controls; Strongest SNP-Risk Allele: rs340630-A; SNPs: rs340630; Context: intron; Risk Allele Frequency: 0.52; p-Value: 8E-9; OR or beta:    1.21; Platform [SNPs passing QC]: Illumina [430,797]	0.000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
LEF1		22291604	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 891 Japanese ancestry cases, 3,384 Japanese ancestry controls; Replication Sample Size: 1,387 Japanese ancestry cases, 28,564 Japanese ancestry controls; Strongest SNP-Risk Allele: rs956237-A; SNPs: rs956237; Context: intron; Risk Allele Frequency: 0.33; p-Value: 2E-6; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina [430,797]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
DIRC3		22267200	TAS		Disease/Trait: Thyroid cancer; Initial Sample Size: 27,758 European ancestry individuals; Replication Sample Size: 1,156 European ancestry cases, up to 42,617 European ancestry controls; Strongest SNP-Risk Allele: rs966423-C; SNPs: rs966423; Context: intron; Risk Allele Frequency: 0.442; p-Value: 1E-9; OR or beta:    1.34; Platform [SNPs passing QC]: Illumina [~16 million] (Imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	thyroid cancer
NRG1		22267200	TAS		Disease/Trait: Thyroid cancer; Initial Sample Size: 27,758 European ancestry individuals; Replication Sample Size: 1,156 European ancestry cases, up to 42,617 European ancestry controls; Strongest SNP-Risk Allele: rs2439302-G; SNPs: rs2439302; Context: intron; Risk Allele Frequency: 0.351; p-Value: 2E-9; OR or beta:    1.36; Platform [SNPs passing QC]: Illumina [~16 million] (Imputed)	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	thyroid cancer
NTRK3		22388998	TAS		Disease/Trait: Gaucher disease severity; Initial Sample Size: 139 Ashkenazi Jewish cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9806762-?; SNPs: rs9806762; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [540,902]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Gaucher's disease
CDKAL1		22233651	TAS		Disease/Trait: Diabetes (gestational); Initial Sample Size: 468 cases of Korean ancestry, 1,242 controls of Korean ancestry; Replication Sample Size: 931 cases of Korean ancestry, 783 controls of Korean ancestry; Strongest SNP-Risk Allele: rs7754840-C; SNPs: rs7754840; Context: intron; Risk Allele Frequency: 0.445; p-Value: 7E-16; OR or beta:    1.52; Platform [SNPs passing QC]: Affymetrix [2,188,613](imputed)	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	gestational diabetes
IGF2BP2		22233651	TAS		Disease/Trait: Diabetes (gestational); Initial Sample Size: 468 cases of Korean ancestry, 1,242 controls of Korean ancestry; Replication Sample Size: 931 cases of Korean ancestry, 783 controls of Korean ancestry; Strongest SNP-Risk Allele: rs1470579-C; SNPs: rs1470579; Context: intron; Risk Allele Frequency: 0.293; p-Value: 2E-7; OR or beta:    1.33; Platform [SNPs passing QC]: Affymetrix [2,188,613](imputed)	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	gestational diabetes
ANK2		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7694725-?; SNPs: rs7694725; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    1.36; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
TSEN2		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6766510-?; SNPs: rs6766510; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    1.58; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
EVC		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs735172-?; SNPs: rs735172; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    1.31; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
UPF2		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10795917-?; SNPs: rs10795917; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-7; OR or beta:    1.24; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
DNAH12		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1916284-?; SNPs: rs1916284; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.27; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
BAIAP2L1		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9649213-?; SNPs: rs9649213; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.28; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
RNASE9		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1243647-?; SNPs: rs1243647; Context: missense; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.33; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
TNRC6B		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12628051-?; SNPs: rs12628051; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta:    1.30; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
ANXA13		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13258681-?; SNPs: rs13258681; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.32; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
KIF13A		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10456809-?; SNPs: rs10456809; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
SPATA16		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11720607-?; SNPs: rs11720607; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.37; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
ABLIM1		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10885582-?; SNPs: rs10885582; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.37; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
TMTC2		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12317459-?; SNPs: rs12317459; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    2.06; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
TNC		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7847271-?; SNPs: rs7847271; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.49; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
ZNF280B		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs5751168-?; SNPs: rs5751168; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.44; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
TNRC6B		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4821941-?; SNPs: rs4821941; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.30; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
ACOXL		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3789080-?; SNPs: rs3789080; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.41; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
EPHA10		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs731174-?; SNPs: rs731174; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.27; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
CEP152		22219177	TAS		Disease/Trait: Prostate cancer (gene x gene interaction); Initial Sample Size: 4,723 cases, 4,792 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs784411-?; SNPs: rs784411; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta:    1.42; Platform [SNPs passing QC]: Affymetrix & Illumina [1,117,531] (imputed)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
PRNP		22210626	TAS		Disease/Trait: Prion diseases; Initial Sample Size: 1,281 European ancestry cases, 6,015 European ancestry controls, 290 Papua New Guinea cases, 286 Papua New Guinea controls.; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1799990-?; SNPs: rs1799990; Context: missense; Risk Allele Frequency: NR; p-Value: 7E-7; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prion disease
LOC100289473		22197933	TAS		Disease/Trait: Non-obstructive azoospermia; Initial Sample Size: 981 Chinese ancestry cases, 1,657 Chinese ancestry controls.; Replication Sample Size: 1,946 Chinese ancestry cases, 4,077 Chinese ancestry controls.; Strongest SNP-Risk Allele: rs6080550-?; SNPs: rs6080550; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-9; OR or beta:    1.27; Platform [SNPs passing QC]: Affymetrix [587,347]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	azoospermia
SOX5		22197933	TAS		Disease/Trait: Non-obstructive azoospermia; Initial Sample Size: 981 Chinese ancestry cases, 1,657 Chinese ancestry controls.; Replication Sample Size: 1,946 Chinese ancestry cases, 4,077 Chinese ancestry controls.; Strongest SNP-Risk Allele: rs10842262-?; SNPs: rs10842262; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-9; OR or beta:    1.23; Platform [SNPs passing QC]: Affymetrix [587,347]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	azoospermia
KIF3A		22197932	TAS		Disease/Trait: Atopic dermatitis; Initial Sample Size: 5,606 European ancestry cases, 20,565 European ancestry controls; Replication Sample Size: 5,419 European ancestry cases, 19,833 European ancestry controls; Strongest SNP-Risk Allele: rs2897442-C; SNPs: rs2897442; Context: intron; Risk Allele Frequency: 0.29; p-Value: 4E-8; OR or beta:    1.11; Platform [SNPs passing QC]: Afftmetrix & Illumina [~2.5 million] (imputed)	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atopic dermatitis
NCF4		22197932	TAS		Disease/Trait: Atopic dermatitis; Initial Sample Size: 5,606 European ancestry cases, 20,565 European ancestry controls; Replication Sample Size: 5,419 European ancestry cases, 19,833 European ancestry controls; Strongest SNP-Risk Allele: rs4821544-C; SNPs: rs4821544; Context: intron; Risk Allele Frequency: 0.29; p-Value: 6E-6; OR or beta:    1.09; Platform [SNPs passing QC]: Afftmetrix & Illumina [~2.5 million] (imputed)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atopic dermatitis
ACOXL		22197929	TAS		Disease/Trait: IgA nephropathy; Initial Sample Size: 1,434 Chinese ancestry cases, 4,270 Chinese ancestry controls.; Replication Sample Size: 2,703 Chinese ancestry cases, 3,464 Chinese ancestry controls.; Strongest SNP-Risk Allele: rs4849121-G; SNPs: rs4849121; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-7; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [444,882]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	IgA glomerulonephritis
MTMR3		22197929	TAS		Disease/Trait: IgA nephropathy; Initial Sample Size: 1,434 Chinese ancestry cases, 4,270 Chinese ancestry controls.; Replication Sample Size: 2,703 Chinese ancestry cases, 3,464 Chinese ancestry controls.; Strongest SNP-Risk Allele: rs12537-C; SNPs: rs12537; Context: UTR-3; Risk Allele Frequency: 0.81; p-Value: 1E-11; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [444,882]	0.00000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	IgA glomerulonephritis
ANK3		22182935	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 5,568 European ancestry cases, 7,187 European ancestry controls, 1,000 Taiwanese cases, 1,000 Taiwanese controls; Replication Sample Size: 1,115 European ancestry cases, 2,728 European ancestry controls; Strongest SNP-Risk Allele: rs4948418-T; SNPs: rs4948418; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-10; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [748,555]	0.0000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
LMAN2L		22182935	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 5,568 European ancestry cases, 7,187 European ancestry controls, 1,000 Taiwanese cases, 1,000 Taiwanese controls; Replication Sample Size: 1,115 European ancestry cases, 2,728 European ancestry controls; Strongest SNP-Risk Allele: rs2271893-G; SNPs: rs2271893; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-10; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [748,555]	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
C10orf11		22180457	TAS		Disease/Trait: Response to tamoxifen in breast cancer; Initial Sample Size: 240 Japanese ancestry cases; Replication Sample Size: 222 Japanese ancestry cases; Strongest SNP-Risk Allele: rs10509373-C; SNPs: rs10509373; Context: intron; Risk Allele Frequency: 0.024; p-Value: 6E-8; OR or beta:    4.51; Platform [SNPs passing QC]: Illumina [470,796]	0.00000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
PC		22174851	TAS		Disease/Trait: HIV-1 susceptibility; Initial Sample Size: 798 African ancestry; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7122539-?; SNPs: rs7122539; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:     .00; Platform [SNPs passing QC]: Illumina [990,115]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
PRKG2		22174851	TAS		Disease/Trait: HIV-1 susceptibility; Initial Sample Size: 798 African ancestry; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3796804-?; SNPs: rs3796804; Context: nearGene-3; Risk Allele Frequency: NR; p-Value: 9E-6; OR or beta:     .00; Platform [SNPs passing QC]: Illumina [990,115]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
CYP7B1		22174851	TAS		Disease/Trait: HIV-1 susceptibility; Initial Sample Size: 798 African ancestry; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10808739-?; SNPs: rs10808739; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:     .00; Platform [SNPs passing QC]: Illumina [990,115]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
GLTSCR1		22174851	TAS		Disease/Trait: HIV-1 susceptibility; Initial Sample Size: 798 African ancestry; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3745760-?; SNPs: rs3745760; Context: UTR-3; Risk Allele Frequency: NR; p-Value: 8E-7; OR or beta:     .00; Platform [SNPs passing QC]: Illumina [990,115]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
ADAM18		22174851	TAS		Disease/Trait: HIV-1 susceptibility; Initial Sample Size: 798 African ancestry; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1349547-?; SNPs: rs1349547; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:     .00; Platform [SNPs passing QC]: Illumina [990,115]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
NEDD9		22174851	TAS		Disease/Trait: HIV-1 susceptibility; Initial Sample Size: 798 African ancestry; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4437462-?; SNPs: rs4437462; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:     .00; Platform [SNPs passing QC]: Illumina [990,115]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
GALNT14		22174851	TAS		Disease/Trait: HIV-1 viral setpoint; Initial Sample Size: 798 African ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1000916-?; SNPs: rs1000916; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [990,115]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
EPHA5		22174851	TAS		Disease/Trait: HIV-1 viral setpoint; Initial Sample Size: 798 African ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4404602-?; SNPs: rs4404602; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [990,115]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
CMTM8		22174851	TAS		Disease/Trait: HIV-1 viral setpoint; Initial Sample Size: 798 African ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6776297-?; SNPs: rs6776297; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [990,115]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
ZFP90		22174851	TAS		Disease/Trait: HIV-1 viral setpoint; Initial Sample Size: 798 African ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17689437-?; SNPs: rs17689437; Context: UTR-3; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [990,115]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
MAEA		22158537	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 4,026 Chinese ancestry cases, 1,042 Korean ancestry cases, 794 Malaysian ancestry cases, 931 Japanese ancestry cases, 159 Filipino ancestry cases, 4,654 Chinese ancestry controls, 2,943 Korean ancestry controls, 1,240 Malaysian ancestry controls, 1,404 Japanese ancestry controls, 1,624 Filipino ancestry controls.; Replication Sample Size: 9,723 Japanese ancestry cases, 1,815 Korean ancestry cases, 6,589 Chinese ancestry cases, 8,974 Japanese ancestry controls, 2,066 Korean ancestry controls, Chinese ancestry controls.; Strongest SNP-Risk Allele: rs6815464-C; SNPs: rs6815464; Context: intron; Risk Allele Frequency: 0.58; p-Value: 2E-20; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix & Illumina [2,626,356](imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
ZFAND3		22158537	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 4,026 Chinese ancestry cases, 1,042 Korean ancestry cases, 794 Malaysian ancestry cases, 931 Japanese ancestry cases, 159 Filipino ancestry cases, 4,654 Chinese ancestry controls, 2,943 Korean ancestry controls, 1,240 Malaysian ancestry controls, 1,404 Japanese ancestry controls, 1,624 Filipino ancestry controls.; Replication Sample Size: 9,723 Japanese ancestry cases, 1,815 Korean ancestry cases, 6,589 Chinese ancestry cases, 8,974 Japanese ancestry controls, 2,066 Korean ancestry controls, Chinese ancestry controls.; Strongest SNP-Risk Allele: rs9470794-C; SNPs: rs9470794; Context: intron; Risk Allele Frequency: 0.27; p-Value: 2E-10; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix & Illumina [2,626,356](imputed)	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
PEPD		22158537	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 4,026 Chinese ancestry cases, 1,042 Korean ancestry cases, 794 Malaysian ancestry cases, 931 Japanese ancestry cases, 159 Filipino ancestry cases, 4,654 Chinese ancestry controls, 2,943 Korean ancestry controls, 1,240 Malaysian ancestry controls, 1,404 Japanese ancestry controls, 1,624 Filipino ancestry controls.; Replication Sample Size: 9,723 Japanese ancestry cases, 1,815 Korean ancestry cases, 6,589 Chinese ancestry cases, 8,974 Japanese ancestry controls, 2,066 Korean ancestry controls, Chinese ancestry controls.; Strongest SNP-Risk Allele: rs3786897-A; SNPs: rs3786897; Context: intron; Risk Allele Frequency: 0.56; p-Value: 1E-8; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix & Illumina [2,626,356](imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
GLIS3		22158537	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 4,026 Chinese ancestry cases, 1,042 Korean ancestry cases, 794 Malaysian ancestry cases, 931 Japanese ancestry cases, 159 Filipino ancestry cases, 4,654 Chinese ancestry controls, 2,943 Korean ancestry controls, 1,240 Malaysian ancestry controls, 1,404 Japanese ancestry controls, 1,624 Filipino ancestry controls.; Replication Sample Size: 9,723 Japanese ancestry cases, 1,815 Korean ancestry cases, 6,589 Chinese ancestry cases, 8,974 Japanese ancestry controls, 2,066 Korean ancestry controls, Chinese ancestry controls.; Strongest SNP-Risk Allele: rs7041847-A; SNPs: rs7041847; Context: intron; Risk Allele Frequency: 0.41; p-Value: 2E-14; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix & Illumina [2,626,356](imputed)	0.00000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CMIP		22158537	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 4,026 Chinese ancestry cases, 1,042 Korean ancestry cases, 794 Malaysian ancestry cases, 931 Japanese ancestry cases, 159 Filipino ancestry cases, 4,654 Chinese ancestry controls, 2,943 Korean ancestry controls, 1,240 Malaysian ancestry controls, 1,404 Japanese ancestry controls, 1,624 Filipino ancestry controls.; Replication Sample Size: 9,723 Japanese ancestry cases, 1,815 Korean ancestry cases, 6,589 Chinese ancestry cases, 8,974 Japanese ancestry controls, 2,066 Korean ancestry controls, Chinese ancestry controls.; Strongest SNP-Risk Allele: rs16955379-C; SNPs: rs16955379; Context: intron; Risk Allele Frequency: 0.80; p-Value: 3E-7; OR or beta:    1.08; Platform [SNPs passing QC]: Affymetrix & Illumina [2,626,356](imputed)	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
FAM19A5		22158540	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 981 Chinese ancestry cases, 1,991 Chinese ancestry contorls.; Replication Sample Size: 2,603 Chinese ancestry cases, 2,877 Chinese ancestry controls.; Strongest SNP-Risk Allele: rs5768709-G; SNPs: rs5768709; Context: intron; Risk Allele Frequency: 0.23; p-Value: 1E-10; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix [666,141]	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
DAB2		22158540	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 981 Chinese ancestry cases, 1,991 Chinese ancestry contorls.; Replication Sample Size: 2,603 Chinese ancestry cases, 2,877 Chinese ancestry controls.; Strongest SNP-Risk Allele: rs2255280-T; SNPs: rs2255280; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-10; OR or beta:    1.23; Platform [SNPs passing QC]: Affymetrix [666,141]	0.0000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
BACH1		22158540	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 981 Chinese ancestry cases, 1,991 Chinese ancestry contorls.; Replication Sample Size: 2,603 Chinese ancestry cases, 2,877 Chinese ancestry controls.; Strongest SNP-Risk Allele: rs372883-T; SNPs: rs372883; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-13; OR or beta:    1.27; Platform [SNPs passing QC]: Affymetrix [666,141]	0.0000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
DCP1B		22142827	TAS		Disease/Trait: Response to gemcitabine in pancreatic cancer ; Initial Sample Size: 294 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11062040-A; SNPs: rs11062040; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.40; Platform [SNPs passing QC]: Illumina [330,690]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
IL17F		22142827	TAS		Disease/Trait: Response to gemcitabine in pancreatic cancer ; Initial Sample Size: 294 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs763780-G; SNPs: rs763780; Context: missense; Risk Allele Frequency: NR; p-Value: 3E-8; OR or beta:    3.30; Platform [SNPs passing QC]: Illumina [330,690]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
PRB2		22142827	TAS		Disease/Trait: Response to gemcitabine in pancreatic cancer ; Initial Sample Size: 294 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2900174-G; SNPs: rs2900174; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    3.30; Platform [SNPs passing QC]: Illumina [330,690]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
PHACTR1		22144573	TAS		Disease/Trait: Coronary artery calcification; Initial Sample Size: 9,961 European ancestry individuals; Replication Sample Size: 6,032 European ancestry individuals; Strongest SNP-Risk Allele: rs9349379-A; SNPs: rs9349379; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-22; OR or beta:     .20; Platform [SNPs passing QC]: Affyemtrix & Illumina [~2.5 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary arteriosclerosis
ANO6		22138694	TAS		Disease/Trait: Ankylosing spondylitis; Initial Sample Size: 1,837 Han Chinese cases, 4,231 Han Chinese controls; Replication Sample Size: 2,100 Han Chinese cases, 3,496 Han Chinese controls; Strongest SNP-Risk Allele: rs17095830-G; SNPs: rs17095830; Context: intron; Risk Allele Frequency: 0.10; p-Value: 2E-8; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [1,356,350] (imputed)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ankylosing spondylitis
PDGFRA		22144915	TAS		Disease/Trait: Corneal astigmatism; Initial Sample Size: 1,231 Chinese ancestry cases, 785 Chinese ancestry controls, 1,018 Malaysian ancestry cases, 1,220 Malaysian ancestry controls; Replication Sample Size: 825 Indian ancestry cases, 1,314 Indian ancestry controls, 760 Chinese ancestry cases, 169 Chinese ancestry controls, 1,191 Chinese ancestry individuals from 397 parent-trios; Strongest SNP-Risk Allele: rs7677751-T; SNPs: rs7677751; Context: intron; Risk Allele Frequency: 0.22; p-Value: 8E-9; OR or beta:    1.26; Platform [SNPs passing QC]: Illumina [460,528]	0.000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	astigmatism
SUCLG2		22144915	TAS		Disease/Trait: Corneal astigmatism; Initial Sample Size: 1,231 Chinese ancestry cases, 785 Chinese ancestry controls, 1,018 Malaysian ancestry cases, 1,220 Malaysian ancestry controls; Replication Sample Size: 825 Indian ancestry cases, 1,314 Indian ancestry controls, 760 Chinese ancestry cases, 169 Chinese ancestry controls, 1,191 Chinese ancestry individuals from 397 parent-trios; Strongest SNP-Risk Allele: rs6792584-G; SNPs: rs6792584; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.24; Platform [SNPs passing QC]: Illumina [460,528]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	astigmatism
KCNE3		22144915	TAS		Disease/Trait: Corneal astigmatism; Initial Sample Size: 1,231 Chinese ancestry cases, 785 Chinese ancestry controls, 1,018 Malaysian ancestry cases, 1,220 Malaysian ancestry controls; Replication Sample Size: 825 Indian ancestry cases, 1,314 Indian ancestry controls, 760 Chinese ancestry cases, 169 Chinese ancestry controls, 1,191 Chinese ancestry individuals from 397 parent-trios; Strongest SNP-Risk Allele: rs2270676-G; SNPs: rs2270676; Context: cds-synon; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [460,528]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	astigmatism
SLC4A1AP		22159054	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 513 African American ancestry cases, 496 African American ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs17006206-G; SNPs: rs17006206; Context: intron; Risk Allele Frequency: 0.10; p-Value: 2E-6; OR or beta:    2.05; Platform [SNPs passing QC]: Illumina [2,505,093] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
POLN		22159054	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 513 African American ancestry cases, 496 African American ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs1923775-T; SNPs: rs1923775; Context: intron; Risk Allele Frequency: 0.25; p-Value: 6E-6; OR or beta:    1.60; Platform [SNPs passing QC]: Illumina [2,505,093] (imputed)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
CNTNAP2		22159054	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 513 African American ancestry cases, 496 African American ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs10273775-G; SNPs: rs10273775; Context: intron; Risk Allele Frequency: 0.42; p-Value: 9E-6; OR or beta:    1.52; Platform [SNPs passing QC]: Illumina [2,505,093] (imputed)	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
STK24		22159054	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 513 African American ancestry cases, 496 African American ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs912330-?; SNPs: rs912330; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.85; Platform [SNPs passing QC]: Illumina [2,505,093] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
PVRL2		22159054	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 513 African American ancestry cases, 496 African American ancestry controls; Replication Sample Size: ; Strongest SNP-Risk Allele: rs6859-A; SNPs: rs6859; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta:    1.58; Platform [SNPs passing QC]: Illumina [2,505,093] (imputed)	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
ZMIZ1		22190364	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 5,545 European ancestry cases, 12,153 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1250542-A; SNPs: rs1250542; Context: intron; Risk Allele Frequency: 0.37; p-Value: 4E-7; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix & Illumina [2,529,394]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
TAGAP		22190364	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 5,545 European ancestry cases, 12,153 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1738074-C; SNPs: rs1738074; Context: UTR-5; Risk Allele Frequency: 0.58; p-Value: 4E-7; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix & Illumina [2,529,394]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
STAT3		22190364	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 5,545 European ancestry cases, 12,153 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2293152-C; SNPs: rs2293152; Context: intron; Risk Allele Frequency: 0.62; p-Value: 4E-8; OR or beta:    1.22; Platform [SNPs passing QC]: Affymetrix & Illumina [2,529,394]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
MLANA		22190364	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 5,545 European ancestry cases, 12,153 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2150702-G; SNPs: rs2150702; Context: intron; Risk Allele Frequency: 0.49; p-Value: 3E-8; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix & Illumina [2,529,394]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
EPS15L1		22190364	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 5,545 European ancestry cases, 12,153 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10411936-A; SNPs: rs10411936; Context: intron; Risk Allele Frequency: 0.30; p-Value: 2E-7; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix & Illumina [2,529,394]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
IL2RA		22190364	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 5,545 European ancestry cases, 12,153 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12722489-C; SNPs: rs12722489; Context: intron; Risk Allele Frequency: 0.85; p-Value: 4E-8; OR or beta:    1.23; Platform [SNPs passing QC]: Affymetrix & Illumina [2,529,394]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
PRNP		22137330	TAS		Disease/Trait: Creutzfeldt-Jakob disease (variant); Initial Sample Size: 93 European ancestry cases, 1,504 European ancestry controls; Replication Sample Size: 42 European ancestry cases; Strongest SNP-Risk Allele: rs6107516-?; SNPs: rs6107516; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-18; OR or beta: NR; Platform [SNPs passing QC]: Afymetrix [287,554]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Creutzfeldt-Jakob syndrome
MTMR7		22137330	TAS		Disease/Trait: Creutzfeldt-Jakob disease (variant); Initial Sample Size: 93 European ancestry cases, 1,504 European ancestry controls; Replication Sample Size: 42 European ancestry cases; Strongest SNP-Risk Allele: rs4921542-?; SNPs: rs4921542; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta:    3.25; Platform [SNPs passing QC]: Afymetrix [287,554]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Creutzfeldt-Jakob syndrome
DTNB		22120009	TAS		Disease/Trait: Multiple myeloma; Initial Sample Size: 1,675 European ancestry cases, 5,903 European ancestry controls; Replication Sample Size: 169 European ancestry cases, 927 European ancestry controls; Strongest SNP-Risk Allele: rs6746082-A; SNPs: rs6746082; Context: intron; Risk Allele Frequency: 0.79; p-Value: 4E-7; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [422,839]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple myeloma
ULK4		22120009	TAS		Disease/Trait: Multiple myeloma; Initial Sample Size: 1,675 European ancestry cases, 5,903 European ancestry controls; Replication Sample Size: 169 European ancestry cases, 927 European ancestry controls; Strongest SNP-Risk Allele: rs1052501-G; SNPs: rs1052501; Context: missense; Risk Allele Frequency: 0.16; p-Value: 2E-8; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [422,839]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple myeloma
DNAH11		22120009	TAS		Disease/Trait: Multiple myeloma; Initial Sample Size: 1,675 European ancestry cases, 5,903 European ancestry controls; Replication Sample Size: 169 European ancestry cases, 927 European ancestry controls; Strongest SNP-Risk Allele: rs4487645-C; SNPs: rs4487645; Context: intron; Risk Allele Frequency: 0.65; p-Value: 3E-14; OR or beta:    1.38; Platform [SNPs passing QC]: Illumina [422,839]	0.00000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple myeloma
TCF7L2		22101970	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,413 European ancestry cases, 810 African American cases, 2,392 European ancestry controls, 873 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.26 (EA+AA); p-Value: 2E-15; OR or beta:    1.46; Platform [SNPs passing QC]: Illumina [NR]	0.000000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
SLC22A3		22095909	TAS		Disease/Trait: Response to hepatitis C treatment; Initial Sample Size: 707 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2504916-T; SNPs: rs2504916; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:     .31; Platform [SNPs passing QC]: NR	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C
CWH43		22095909	TAS		Disease/Trait: Response to hepatitis C treatment; Initial Sample Size: 707 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11725957-G; SNPs: rs11725957; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:     .73; Platform [SNPs passing QC]: NR	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C
FCGR2A		22081228	TAS		Disease/Trait: Kawasaki disease; Initial Sample Size: 405 European ancestry cases, 6,252 European ancestry controls; Replication Sample Size: 1815 European ancestry individuals and 405 non-European ancestry individuals from 740 trios, 139 additional discordant European ancestry siblings, 1,028 East Asian ancestry cases, 1,512 East Asian ancestry controls; Strongest SNP-Risk Allele: rs1801274-A; SNPs: rs1801274; Context: missense; Risk Allele Frequency: 0.47; p-Value: 7E-11; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [494,236]	0.00000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Kawasaki disease
FAM13A		22080838	TAS		Disease/Trait: Chronic obstructive pulmonary disease; Initial Sample Size: 3,499 European ancestry cases, 1,922 European ancestry controls; Replication Sample Size: 983 probands, 1,876 siblings; Strongest SNP-Risk Allele: rs1964516-?; SNPs: rs1964516; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-9; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [797,983]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
SLCO3A1		22076464	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 419 European ancestry cases, 474 European ancestry controls; Replication Sample Size: Up to 1,277 European ancestry cases and 3,061 European ancestry controls; Strongest SNP-Risk Allele: rs207954-?; SNPs: rs207954; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [355,750]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
TP63		22076464	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 419 European ancestry cases, 474 European ancestry controls; Replication Sample Size: Up to 1,277 European ancestry cases and 3,061 European ancestry controls; Strongest SNP-Risk Allele: rs17505102-?; SNPs: rs17505102; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-9; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [355,750]	0.000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
PTPRJ		22076464	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 419 European ancestry cases, 474 European ancestry controls; Replication Sample Size: Up to 1,277 European ancestry cases and 3,061 European ancestry controls; Strongest SNP-Risk Allele: rs3942852-?; SNPs: rs3942852; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [355,750]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
TP63		22076464	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 419 European ancestry cases, 474 European ancestry controls; Replication Sample Size: Up to 1,277 European ancestry cases and 3,061 European ancestry controls; Strongest SNP-Risk Allele: rs17505102-?; SNPs: rs17505102; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta:    1.47; Platform [SNPs passing QC]: Affymetrix [355,750]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
OXTR		22064162	TAS		Disease/Trait: Depression and alcohol dependence; Initial Sample Size: 467 European ancestry cases, 407 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs237899-?; SNPs: rs237899; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    1.69; Platform [SNPs passing QC]: Illumina [876,476]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol dependence
FAF1		22064162	TAS		Disease/Trait: Depression and alcohol dependence; Initial Sample Size: 467 European ancestry cases, 407 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3827730-?; SNPs: rs3827730; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.72; Platform [SNPs passing QC]: Illumina [876,476]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol dependence
WDR7		22064162	TAS		Disease/Trait: Depression and alcohol dependence; Initial Sample Size: 467 European ancestry cases, 407 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17750015-?; SNPs: rs17750015; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.68; Platform [SNPs passing QC]: Illumina [876,476]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol dependence
EFHA2		22064162	TAS		Disease/Trait: Depression and alcohol dependence; Initial Sample Size: 467 European ancestry cases, 407 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10090288-?; SNPs: rs10090288; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    2.55; Platform [SNPs passing QC]: Illumina [876,476]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol dependence
OPA3		22064162	TAS		Disease/Trait: Depression and alcohol dependence; Initial Sample Size: 467 European ancestry cases, 407 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs8111589-?; SNPs: rs8111589; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.64; Platform [SNPs passing QC]: Illumina [876,476]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol dependence
LRP1		22055160	TAS		Disease/Trait: Abdominal aortic aneurysm; Initial Sample Size: 1,866 cases, 5,435 controls; Replication Sample Size: 4,362 cases, 43,747 controls; Strongest SNP-Risk Allele: rs1466535-C; SNPs: rs1466535; Context: intron; Risk Allele Frequency: 0.58; p-Value: 5E-10; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [535,296]	0.0000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	abdominal aortic aneurysm
ENTPD6		22036096	TAS		Disease/Trait: Allergic rhinitis; Initial Sample Size: 3,933 European ancestry cases, 8,965 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1044573-A; SNPs: rs1044573; Context: UTR-3; Risk Allele Frequency: 0.51; p-Value: 1E-6; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix & Illumina  [2,217,510] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	allergic rhinitis
GLI3		22036096	TAS		Disease/Trait: Allergic rhinitis; Initial Sample Size: 3,933 European ancestry cases, 8,965 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4724100-C; SNPs: rs4724100; Context: intron; Risk Allele Frequency: 0.45; p-Value: 2E-6; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix & Illumina  [2,217,510] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	allergic rhinitis
CLEC16A		22036096	TAS		Disease/Trait: Allergic rhinitis; Initial Sample Size: 3,933 European ancestry cases, 8,965 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs887864-A; SNPs: rs887864; Context: intron; Risk Allele Frequency: 0.63; p-Value: 1E-6; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix & Illumina  [2,217,510] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	allergic rhinitis
TSLP		22036096	TAS		Disease/Trait: Allergic rhinitis; Initial Sample Size: 3,933 European ancestry cases, 8,965 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1898671-T; SNPs: rs1898671; Context: intron; Risk Allele Frequency: 0.35; p-Value: 5E-6; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix & Illumina  [2,217,510] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	allergic rhinitis
DNAH5		22036096	TAS		Disease/Trait: IgE grass sensitization; Initial Sample Size: 2,315 Caucasian cases, 10,032 Caucasian controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6554809-C; SNPs: rs6554809; Context: intron; Risk Allele Frequency: 0.84; p-Value: 3E-6; OR or beta:    1.29; Platform [SNPs passing QC]: Affymetrix & Illumina [2,217,510] (imputed)	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypersensitivity reaction type I disease
EPS15		22036096	TAS		Disease/Trait: IgE grass sensitization; Initial Sample Size: 2,315 Caucasian cases, 10,032 Caucasian controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6673480-T; SNPs: rs6673480; Context: intron; Risk Allele Frequency: 0.07; p-Value: 2E-6; OR or beta:    1.35; Platform [SNPs passing QC]: Affymetrix & Illumina [2,217,510] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypersensitivity reaction type I disease
IL2		22036096	TAS		Disease/Trait: IgE grass sensitization; Initial Sample Size: 2,315 Caucasian cases, 10,032 Caucasian controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2069772-C; SNPs: rs2069772; Context: intron; Risk Allele Frequency: 0.30; p-Value: 1E-6; OR or beta:    1.19; Platform [SNPs passing QC]: Affymetrix & Illumina [2,217,510] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypersensitivity reaction type I disease
ABL2		22036096	TAS		Disease/Trait: IgE grass sensitization; Initial Sample Size: 2,315 Caucasian cases, 10,032 Caucasian controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1325195-A; SNPs: rs1325195; Context: UTR-3; Risk Allele Frequency: 0.59; p-Value: 5E-6; OR or beta:    1.17; Platform [SNPs passing QC]: Affymetrix & Illumina [2,217,510] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypersensitivity reaction type I disease
TERT		22037553	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 1,004 African ancestry cases, 2,745 African ancestry controls,1,718 European ancestry cases, 3,670 European ancestry controls; Replication Sample Size: 2,222 European ancestry cases, 16,363 European ancestry controls; Strongest SNP-Risk Allele: rs10069690-T ; SNPs: rs10069690; Context: intron; Risk Allele Frequency: 0.26; p-Value: 1E-10; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina [3,154,485] (imputed)	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
ZBTB20		22037551	TAS		Disease/Trait: Gastric cancer; Initial Sample Size: 1,006 Chinese ancestry cases, 2,273 Chinese ancestry controls; Replication Sample Size: 3,288 Chinese ancestry cases, 3,609 Chinese ancestry controls; Strongest SNP-Risk Allele: rs9841504-?; SNPs: rs9841504; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-9; OR or beta:    1.32; Platform [SNPs passing QC]: Affymetrix [555,896]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	stomach cancer
TSPAN18		22037552	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 746 Chinese ancestry cases, 1,599 Chinese ancestry controls; Replication Sample Size: 4,027 Chinese ancestry cases, 5,603 Chinese ancestry controls; Strongest SNP-Risk Allele: rs11038167-?; SNPs: rs11038167; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-11; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [493,203]	0.00000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
NKAPL		22037552	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 746 Chinese ancestry cases, 1,599 Chinese ancestry controls; Replication Sample Size: 4,027 Chinese ancestry cases, 5,603 Chinese ancestry controls; Strongest SNP-Risk Allele: rs1635-?; SNPs: rs1635; Context: missense; Risk Allele Frequency: NR; p-Value: 7E-12; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [493,203]	0.000000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
RPS6KA4		22019778	TAS		Disease/Trait: Leprosy; Initial Sample Size: 706 Chinese ancestry cases, 5,581 Chinese ancestry controls; Replication Sample Size: 3,301 Chinese ancestry cases, 5,299 Chinese ancestry controls; Strongest SNP-Risk Allele: rs538147-A; SNPs: rs538147; Context: intron; Risk Allele Frequency: 0.23; p-Value: 7E-6; OR or beta:    1.17; Platform [SNPs passing QC]: NR [1,701,673] (imputed)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	leprosy
GRM5		22012869	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 495 European ancestry child and adolescent cases, 1,300 European ancestry adult controls; Replication Sample Size: 1023 individuals (from 320 families with at least one affected child), 896 controls and 2455 cases (from 2064 trios); Strongest SNP-Risk Allele: rs5016282-A; SNPs: rs5016282; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [487,484]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
BCL11A		22012869	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 495 European ancestry child and adolescent cases, 1,300 European ancestry adult controls; Replication Sample Size: 1023 individuals (from 320 families with at least one affected child), 896 controls and 2455 cases (from 2064 trios); Strongest SNP-Risk Allele: rs2556378-T; SNPs: rs2556378; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [487,484]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
PAX5		22013104	TAS		Disease/Trait: Obesity and blood pressure; Initial Sample Size: 598 European ancestry adolescent individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs16933812-?; SNPs: rs16933812; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [530,011]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity;hypertension
PAX5		22013104	TAS		Disease/Trait: Obesity and blood pressure; Initial Sample Size: 598 European ancestry adolescent individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs16933812-?; SNPs: rs16933812; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina [530,011]	0.000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity;hypertension
VSNL1		22005930	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 1,299 European ancestry, African American ancestry and Native American ancestry cases with psychosis, 735 European ancestry, African American ancestry and Native American ancestry cases without psychosis, 5,659 European ancestry, African American ancestry and Native American ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4038131-?; SNPs: rs4038131; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-7; OR or beta:    1.54; Platform [SNPs passing QC]: Illumina [>1.8 million] (imputed)	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
BIN1		22005930	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 1,299 European ancestry, African American ancestry and Native American ancestry cases with psychosis, 735 European ancestry, African American ancestry and Native American ancestry cases without psychosis, 5,659 European ancestry, African American ancestry and Native American ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10207628-?; SNPs: rs10207628; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.41; Platform [SNPs passing QC]: Illumina [>1.8 million] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
MPP7		22005930	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 1,299 European ancestry, African American ancestry and Native American ancestry cases with psychosis, 735 European ancestry, African American ancestry and Native American ancestry cases without psychosis, 5,659 European ancestry, African American ancestry and Native American ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11006923-?; SNPs: rs11006923; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-6; OR or beta:    1.59; Platform [SNPs passing QC]: Illumina [>1.8 million] (imputed)	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
ZNF320		22005930	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 1,299 European ancestry, African American ancestry and Native American ancestry cases with psychosis, 735 European ancestry, African American ancestry and Native American ancestry cases without psychosis, 5,659 European ancestry, African American ancestry and Native American ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6509701-?; SNPs: rs6509701; Context: cds-synon; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.41; Platform [SNPs passing QC]: Illumina [>1.8 million] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
STK11		22005930	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 1,299 European ancestry, African American ancestry and Native American ancestry cases with psychosis, 735 European ancestry, African American ancestry and Native American ancestry cases without psychosis, 5,659 European ancestry, African American ancestry and Native American ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3764640-?; SNPs: rs3764640; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.47; Platform [SNPs passing QC]: Illumina [>1.8 million] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
DIP2C		22005930	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 1,299 European ancestry, African American ancestry and Native American ancestry cases with psychosis, 735 European ancestry, African American ancestry and Native American ancestry cases without psychosis, 5,659 European ancestry, African American ancestry and Native American ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11252926-?; SNPs: rs11252926; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.39; Platform [SNPs passing QC]: Illumina [>1.8 million] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
DCHS2		22005931	TAS		Disease/Trait: Alzheimer's disease (age of onset); Initial Sample Size: 2,222 cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1466662-?; SNPs: rs1466662; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [2,543,888] (imputed)	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
PVRL2		22005931	TAS		Disease/Trait: Alzheimer's disease (age of onset); Initial Sample Size: 2,222 cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6857-?; SNPs: rs6857; Context: UTR-3; Risk Allele Frequency: NR; p-Value: 2E-10; OR or beta: NR; Platform [SNPs passing QC]: Illumina [2,543,888] (imputed)	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
MICB		22001756	TAS		Disease/Trait: Dengue shock syndrome ; Initial Sample Size: 2,008 Vietnamese ancestry cases, 2,018 Vietnamese ancestry controls; Replication Sample Size: 1,737 Vietnamese ancestry cases, 2,934 Vietnamese ancestry controls; Strongest SNP-Risk Allele: rs3132468-?; SNPs: rs3132468; Context: intron; Risk Allele Frequency: 0.13; p-Value: 4E-11; OR or beta:    1.34; Platform [SNPs passing QC]: Illumina [481,342]	0.00000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dengue shock syndrome
PLCE1		22001756	TAS		Disease/Trait: Dengue shock syndrome ; Initial Sample Size: 2,008 Vietnamese ancestry cases, 2,018 Vietnamese ancestry controls; Replication Sample Size: 1,737 Vietnamese ancestry cases, 2,934 Vietnamese ancestry controls; Strongest SNP-Risk Allele: rs3765524-?; SNPs: rs3765524; Context: missense; Risk Allele Frequency: 0.70; p-Value: 3E-10; OR or beta:    1.25; Platform [SNPs passing QC]: Illumina [481,342]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dengue shock syndrome
MX2		21983787	TAS		Disease/Trait: Melanoma; Initial Sample Size: 2,804 European ancestry cases, 7,618 European ancestry controls; Replication Sample Size: 5,551 European ancestry cases, 7,449 European ancestry controls; Strongest SNP-Risk Allele: rs45430-?; SNPs: rs45430; Context: intron; Risk Allele Frequency: 0.61; p-Value: 3E-9; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [594,997]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	melanoma
SLC45A2		21983787	TAS		Disease/Trait: Melanoma; Initial Sample Size: 2,804 European ancestry cases, 7,618 European ancestry controls; Replication Sample Size: 5,551 European ancestry cases, 7,449 European ancestry controls; Strongest SNP-Risk Allele: rs35390-?; SNPs: rs35390; Context: intron; Risk Allele Frequency: 0.98; p-Value: 2E-7; OR or beta:    2.78; Platform [SNPs passing QC]: Illumina [594,997]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	melanoma
TYR		21983787	TAS		Disease/Trait: Melanoma; Initial Sample Size: 2,804 European ancestry cases, 7,618 European ancestry controls; Replication Sample Size: 5,551 European ancestry cases, 7,449 European ancestry controls; Strongest SNP-Risk Allele: rs1393350-A; SNPs: rs1393350; Context: intron; Risk Allele Frequency: 0.28; p-Value: 2E-13; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [594,997]	0.0000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	melanoma
PLA2G6		21983787	TAS		Disease/Trait: Melanoma; Initial Sample Size: 2,804 European ancestry cases, 7,618 European ancestry controls; Replication Sample Size: 5,551 European ancestry cases, 7,449 European ancestry controls; Strongest SNP-Risk Allele: rs6001027-?; SNPs: rs6001027; Context: intron; Risk Allele Frequency: 0.65; p-Value: 2E-6; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina [594,997]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	melanoma
ATM		21983787	TAS		Disease/Trait: Melanoma; Initial Sample Size: 2,804 European ancestry cases, 7,618 European ancestry controls; Replication Sample Size: 5,551 European ancestry cases, 7,449 European ancestry controls; Strongest SNP-Risk Allele: rs1801516-?; SNPs: rs1801516; Context: missense; Risk Allele Frequency: 0.87; p-Value: 3E-9; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [594,997]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	melanoma
PARP1		21983785	TAS		Disease/Trait: Melanoma; Initial Sample Size: 2,168 European ancestry cases, 4,387 European ancestry controls; Replication Sample Size: 5,193 European ancestry cases, 15,144 European ancestry controls; Strongest SNP-Risk Allele: rs3219090-C; SNPs: rs3219090; Context: intron; Risk Allele Frequency: 0.67; p-Value: 9E-8; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [5,480,804] (imputed)	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	melanoma
ALDH2		21971053	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 806 Japanese ancestry cases, 1,337 Japanese ancestry controls; Replication Sample Size: 3,593 Japanese ancestry cases, 6,335 Japanese ancestry controls; Strongest SNP-Risk Allele: rs671-A; SNPs: rs671; Context: missense; Risk Allele Frequency: 0.23; p-Value: 2E-34; OR or beta:    1.43; Platform [SNPs passing QC]: Illumina [451,382]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
GRIN2A		22004137	TAS		Disease/Trait: Hepatitis B; Initial Sample Size: 1944 Chinese ancestry cases, 854 Chinese ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11866328-G; SNPs: rs11866328; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta:    1.68; Platform [SNPs passing QC]: Affymetrix [NR] (pooled)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis B
LMO7		21980299	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 9,934 European ancestry cases, 16,956 European ancestry controls; Replication Sample Size: 1,120 European ancestry affected trios; Strongest SNP-Risk Allele: rs539514-?; SNPs: rs539514; Context: intron; Risk Allele Frequency: 0.50; p-Value: 6E-11; OR or beta:    1.43; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.54 million] (imputed)	0.00000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
PKNOX2		21956439	TAS		Disease/Trait: Alcohol dependence; Initial Sample Size: 1,409 European ancestry cases, 1,518 European ancestry controls, 681 African American cases, 508 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10893366-?; SNPs: rs10893366; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [805,814]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol dependence
F11		21980494	TAS		Disease/Trait: Venous thromboembolism; Initial Sample Size: 1,542 European ancestry cases, 1,110 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3756008-T; SNPs: rs3756008; Context: nearGene-5; Risk Allele Frequency: 0.44; p-Value: 6E-11; OR or beta:    1.40; Platform [SNPs passing QC]: Illumina [481,002]	0.00000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Thromboembolism
ABO		21980494	TAS		Disease/Trait: Venous thromboembolism; Initial Sample Size: 1,542 European ancestry cases, 1,110 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs505922-C; SNPs: rs505922; Context: intron; Risk Allele Frequency: 0.43; p-Value: 1E-34; OR or beta:    1.92; Platform [SNPs passing QC]: Illumina [481,002]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Thromboembolism
CELSR2		21943158	TAS		Disease/Trait: Cardiovascular disease risk factors; Initial Sample Size: 11,683 individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs660240-T; SNPs: rs660240; Context: UTR-3; Risk Allele Frequency: 0.22; p-Value: 2E-22; OR or beta:     .17; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cardiovascular system disease
OASL		21943158	TAS		Disease/Trait: Cardiovascular disease risk factors; Initial Sample Size: 11,683 individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3213545-A; SNPs: rs3213545; Context: cds-synon; Risk Allele Frequency: 0.30; p-Value: 4E-15; OR or beta:     .12; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.000000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cardiovascular system disease
TOMM40		21943158	TAS		Disease/Trait: Cardiovascular disease risk factors; Initial Sample Size: 11,683 individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2075650-G; SNPs: rs2075650; Context: intron; Risk Allele Frequency: 0.15; p-Value: 2E-14; OR or beta:     .15; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.00000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cardiovascular system disease
TOMM40		21943158	TAS		Disease/Trait: Cardiovascular disease risk factors; Initial Sample Size: 11,683 individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2075650-G; SNPs: rs2075650; Context: intron; Risk Allele Frequency: 0.15; p-Value: 4E-8; OR or beta:     .12; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cardiovascular system disease
GCKR		21943158	TAS		Disease/Trait: Cardiovascular disease risk factors; Initial Sample Size: 11,683 individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1260326-T; SNPs: rs1260326; Context: missense; Risk Allele Frequency: 0.40; p-Value: 2E-8; OR or beta:     .08; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cardiovascular system disease
SLC17A4		21943158	TAS		Disease/Trait: Cardiovascular disease risk factors; Initial Sample Size: 11,683 individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11754288-A; SNPs: rs11754288; Context: missense; Risk Allele Frequency: 0.43; p-Value: 4E-9; OR or beta:     .08; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cardiovascular system disease
HFE		21943158	TAS		Disease/Trait: Cardiovascular disease risk factors; Initial Sample Size: 11,683 individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1800562-A; SNPs: rs1800562; Context: missense; Risk Allele Frequency: 0.08; p-Value: 5E-12; OR or beta:     .18; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cardiovascular system disease
APOB		21943158	TAS		Disease/Trait: Cardiovascular disease risk factors; Initial Sample Size: 11,683 individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10199768-T; SNPs: rs10199768; Context: intron; Risk Allele Frequency: 0.47; p-Value: 8E-15; OR or beta:     .11; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.000000000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cardiovascular system disease
BCHE		21943158	TAS		Disease/Trait: Cardiovascular disease risk factors; Initial Sample Size: 11,683 individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1803274-T; SNPs: rs1803274; Context: missense; Risk Allele Frequency: 0.21; p-Value: 6E-92; OR or beta:     .37; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cardiovascular system disease
LDLR		21943158	TAS		Disease/Trait: Cardiovascular disease risk factors; Initial Sample Size: 11,683 individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6511720-T; SNPs: rs6511720; Context: intron; Risk Allele Frequency: 0.11; p-Value: 5E-11; OR or beta:     .15; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.00000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cardiovascular system disease
ANXA9		21926416	TAS		Disease/Trait: Melanoma; Initial Sample Size: 1,804 European ancestry cases, 1,026 European ancestry controls; Replication Sample Size: 6,483 European and Middle East/North African ancestry cases, 23,324 European and Middle East/North African ancestry controls; Strongest SNP-Risk Allele: rs1722784-?; SNPs: rs1722784; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [818,977]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	melanoma
MPPED2		21940522	TAS		Disease/Trait: Dental caries; Initial Sample Size: 1,305 European ancestry children; Replication Sample Size: 1,695 European ancestry children; Strongest SNP-Risk Allele: rs11031093-?; SNPs: rs11031093; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.36; Platform [SNPs passing QC]: Illumina [1,450,678] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dental caries
NT5C2		21926974	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 9,394 European ancestry cases, 12,462 European ancestry controls; Replication Sample Size: 8,442 European ancestry cases, 21,397 European ancestry controls; Strongest SNP-Risk Allele: rs11191580-T; SNPs: rs11191580; Context: intron; Risk Allele Frequency: 0.91; p-Value: 3E-8; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix & Illumina [1,252,901] (imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
TCF4		21926974	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 9,394 European ancestry cases, 12,462 European ancestry controls; Replication Sample Size: 8,442 European ancestry cases, 21,397 European ancestry controls; Strongest SNP-Risk Allele: rs17512836-C; SNPs: rs17512836; Context: intron; Risk Allele Frequency: 0.02; p-Value: 1E-6; OR or beta:    1.23; Platform [SNPs passing QC]: Affymetrix & Illumina [1,252,901] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
CNNM2		21926974	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 9,394 European ancestry cases, 12,462 European ancestry controls; Replication Sample Size: 8,442 European ancestry cases, 21,397 European ancestry controls; Strongest SNP-Risk Allele: rs7914558-G; SNPs: rs7914558; Context: intron; Risk Allele Frequency: 0.59; p-Value: 2E-8; OR or beta:    1.22; Platform [SNPs passing QC]: Affymetrix & Illumina [1,252,901] (imputed)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
CACNA1C		21926974	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 9,394 European ancestry cases, 12,462 European ancestry controls; Replication Sample Size: 8,442 European ancestry cases, 21,397 European ancestry controls; Strongest SNP-Risk Allele: rs4765905-?; SNPs: rs4765905; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    1.08; Platform [SNPs passing QC]: Affymetrix & Illumina [1,252,901] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
STT3A		21926974	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 9,394 European ancestry cases, 12,462 European ancestry controls; Replication Sample Size: 8,442 European ancestry cases, 21,397 European ancestry controls; Strongest SNP-Risk Allele: rs548181-G; SNPs: rs548181; Context: nearGene-5; Risk Allele Frequency: 0.88; p-Value: 1E-6; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix & Illumina [1,252,901] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
TRIM26		21926974	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 9,394 European ancestry cases, 12,462 European ancestry controls; Replication Sample Size: 8,442 European ancestry cases, 21,397 European ancestry controls; Strongest SNP-Risk Allele: rs2021722-C; SNPs: rs2021722; Context: intron; Risk Allele Frequency: 0.78; p-Value: 2E-12; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix & Illumina [1,252,901] (imputed)	0.000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
CSMD1		21926974	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 9,394 European ancestry cases, 12,462 European ancestry controls; Replication Sample Size: 8,442 European ancestry cases, 21,397 European ancestry controls; Strongest SNP-Risk Allele: rs10503253-A; SNPs: rs10503253; Context: intron; Risk Allele Frequency: 0.19; p-Value: 2E-8; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix & Illumina [1,252,901] (imputed)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
SYNE1		21926972	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 7,481 European ancestry cases, 9,250 European ancestry controls; Replication Sample Size: 4,496 European ancestry cases, 42,422 European ancestry controls; Strongest SNP-Risk Allele: rs9371601-T; SNPs: rs9371601; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-7; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix & Illumina [2,415,422] (imputed)	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
ANK3		21926972	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 7,481 European ancestry cases, 9,250 European ancestry controls; Replication Sample Size: 4,496 European ancestry cases, 42,422 European ancestry controls; Strongest SNP-Risk Allele: rs10994397-T; SNPs: rs10994397; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta:    1.22; Platform [SNPs passing QC]: Affymetrix & Illumina [2,415,422] (imputed)	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
MAD1L1		21926972	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 7,481 European ancestry cases, 9,250 European ancestry controls; Replication Sample Size: 4,496 European ancestry cases, 42,422 European ancestry controls; Strongest SNP-Risk Allele: rs4332037-T; SNPs: rs4332037; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta:    1.11; Platform [SNPs passing QC]: Affymetrix & Illumina [2,415,422] (imputed)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
RGS6		21935397	TAS		Disease/Trait: Obesity (extreme); Initial Sample Size: 2,633 European ancestry extremely obese adults, 2,740 European ancestry controls; Replication Sample Size: 29,181 European ancestry individuals; Strongest SNP-Risk Allele: rs699363-G; SNPs: rs699363; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [545,349]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	morbid obesity
SLC39A8		21909115	TAS		Disease/Trait: Hypertension; Initial Sample Size: 69,395 European ancestry individuals; Replication Sample Size: Up to 133,361 European ancestry individuals; Strongest SNP-Risk Allele: rs13107325-T; SNPs: rs13107325; Context: missense; Risk Allele Frequency: 0.05; p-Value: 5E-7; OR or beta:     .11; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertension
MOV10		21909115	TAS		Disease/Trait: Hypertension; Initial Sample Size: 69,395 European ancestry individuals; Replication Sample Size: Up to 133,361 European ancestry individuals; Strongest SNP-Risk Allele: rs2932538-G; SNPs: rs2932538; Context: nearGene-5; Risk Allele Frequency: 0.75; p-Value: 3E-7; OR or beta:     .05; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertension
PLCE1		21909115	TAS		Disease/Trait: Hypertension; Initial Sample Size: 69,395 European ancestry individuals; Replication Sample Size: Up to 133,361 European ancestry individuals; Strongest SNP-Risk Allele: rs932764-G; SNPs: rs932764; Context: intron; Risk Allele Frequency: 0.44; p-Value: 9E-9; OR or beta:     .06; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertension
HFE		21909115	TAS		Disease/Trait: Hypertension; Initial Sample Size: 69,395 European ancestry individuals; Replication Sample Size: Up to 133,361 European ancestry individuals; Strongest SNP-Risk Allele: rs1799945-G; SNPs: rs1799945; Context: missense; Risk Allele Frequency: 0.14; p-Value: 2E-10; OR or beta:     .10; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertension
PRKG1		21907864	TAS		Disease/Trait: Asthma; Initial Sample Size: 12,475 European ancestry cases, 19,967 European ancestry controls; Replication Sample Size: 3,322 European ancestry cases, 22,036 European ancestry controls; Strongest SNP-Risk Allele: rs7922491-A; SNPs: rs7922491; Context: intron; Risk Allele Frequency: 0.11; p-Value: 5E-7; OR or beta:    1.13; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
IL6R		21907864	TAS		Disease/Trait: Asthma; Initial Sample Size: 12,475 European ancestry cases, 19,967 European ancestry controls; Replication Sample Size: 3,322 European ancestry cases, 22,036 European ancestry controls; Strongest SNP-Risk Allele: rs4129267-T; SNPs: rs4129267; Context: intron; Risk Allele Frequency: 0.37; p-Value: 2E-8; OR or beta:    1.09; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
ZNF365		21908515	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 2,062 East Asian ancestry cases, 2,066 East Asian ancestry controls; Replication Sample Size: 15,091 East Asian ancestry cases, 14,877 East Asian ancestry controls; Strongest SNP-Risk Allele: rs10822013-T; SNPs: rs10822013; Context: intron; Risk Allele Frequency: 0.47; p-Value: 6E-9; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix [684,457]	0.000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
ST6GAL1		21874001	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 5,561 South Asian ancestry cases, 14,458 South Asian ancestry controls; Replication Sample Size: 13,170 South Asian ancestry cases, 25,398 South Asian ancestry controls; Strongest SNP-Risk Allele: rs16861329-G; SNPs: rs16861329; Context: intron; Risk Allele Frequency: 0.75; p-Value: 3E-8; OR or beta:    1.09; Platform [SNPs passing QC]: Illumina [568,976]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
HNF4A		21874001	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 5,561 South Asian ancestry cases, 14,458 South Asian ancestry controls; Replication Sample Size: 13,170 South Asian ancestry cases, 25,398 South Asian ancestry controls; Strongest SNP-Risk Allele: rs4812829-A; SNPs: rs4812829; Context: intron; Risk Allele Frequency: 0.29; p-Value: 3E-10; OR or beta:    1.09; Platform [SNPs passing QC]: Illumina [568,976]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
HMG20A		21874001	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 5,561 South Asian ancestry cases, 14,458 South Asian ancestry controls; Replication Sample Size: 13,170 South Asian ancestry cases, 25,398 South Asian ancestry controls; Strongest SNP-Risk Allele: rs7178572-G; SNPs: rs7178572; Context: ; Risk Allele Frequency: 0.52; p-Value: 7E-11; OR or beta:    1.09; Platform [SNPs passing QC]: Illumina [568,976]	0.00000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
VPS26A		21874001	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 5,561 South Asian ancestry cases, 14,458 South Asian ancestry controls; Replication Sample Size: 13,170 South Asian ancestry cases, 25,398 South Asian ancestry controls; Strongest SNP-Risk Allele: rs1802295-A; SNPs: rs1802295; Context: UTR-3; Risk Allele Frequency: 0.26; p-Value: 4E-8; OR or beta:    1.08; Platform [SNPs passing QC]: Illumina [568,976]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
MCF2L		21871595	TAS		Disease/Trait: Osteoarthritis; Initial Sample Size: 3,177 European ancestry cases, 4,894 European ancestry controls; Replication Sample Size: 15,864 European ancestry cases, 19,610 European ancestry controls; Strongest SNP-Risk Allele: rs11842874-A; SNPs: rs11842874; Context: intron; Risk Allele Frequency: 0.07; p-Value: 2E-8; OR or beta:    1.17; Platform [SNPs passing QC]: NR [7,258,070] (imputed)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	osteoarthritis
CSMD1		21901158	TAS		Disease/Trait: Insulin resistance/response; Initial Sample Size: 1,040 non-diabetic individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2407314-C; SNPs: rs2407314; Context: intron; Risk Allele Frequency: 0.47; p-Value: 8E-6; OR or beta:    9.00; Platform [SNPs passing QC]: Affymetrix [872,243]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Insulin resistance
CACNA1D		21901158	TAS		Disease/Trait: Insulin resistance/response; Initial Sample Size: 1,040 non-diabetic individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1401492-C; SNPs: rs1401492; Context: intron; Risk Allele Frequency: 0.07; p-Value: 3E-6; OR or beta:   15.00; Platform [SNPs passing QC]: Affymetrix [872,243]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Insulin resistance
SEZ6L		21901158	TAS		Disease/Trait: Insulin resistance/response; Initial Sample Size: 1,040 non-diabetic individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs591044-A; SNPs: rs591044; Context: intron; Risk Allele Frequency: 0.37; p-Value: 6E-6; OR or beta:    9.00; Platform [SNPs passing QC]: Affymetrix [872,243]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Insulin resistance
ZFAND3		21901158	TAS		Disease/Trait: Insulin resistance/response; Initial Sample Size: 1,040 non-diabetic individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17589516-C; SNPs: rs17589516; Context: intron; Risk Allele Frequency: 0.02; p-Value: 4E-6; OR or beta:   45.00; Platform [SNPs passing QC]: Affymetrix [872,243]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Insulin resistance
CACNA1D		21901158	TAS		Disease/Trait: Insulin resistance/response; Initial Sample Size: 1,040 non-diabetic individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1401492-C; SNPs: rs1401492; Context: intron; Risk Allele Frequency: 0.07; p-Value: 5E-6; OR or beta:   16.00; Platform [SNPs passing QC]: Affymetrix [872,243]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Insulin resistance
APOM		21844665	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 100 Korean ancestry cases, 600 Korean ancestry controls; Replication Sample Size: 578 Korean ancestry cases, 711 Korean ancestry controls; Strongest SNP-Risk Allele: rs805297-A; SNPs: rs805297; Context: intron; Risk Allele Frequency: 0.36; p-Value: 3E-10; OR or beta:    1.56; Platform [SNPs passing QC]: Affymetrix [300,909]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
TSHR		21841780	TAS		Disease/Trait: Graves' disease; Initial Sample Size: 1,468 Chinese ancestry cases, 1,490 Chinese ancestry controls; Replication Sample Size: 3,994 Chinese ancestry cases, 3,510 Chinese ancestry controls; Strongest SNP-Risk Allele: rs12101261-T; SNPs: rs12101261; Context: intron; Risk Allele Frequency: 0.64; p-Value: 7E-24; OR or beta:    1.35; Platform [SNPs passing QC]: Illumina [486,049]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Graves' disease
FCRL3		21841780	TAS		Disease/Trait: Graves' disease; Initial Sample Size: 1,468 Chinese ancestry cases, 1,490 Chinese ancestry controls; Replication Sample Size: 3,994 Chinese ancestry cases, 3,510 Chinese ancestry controls; Strongest SNP-Risk Allele: rs3761959-A; SNPs: rs3761959; Context: intron; Risk Allele Frequency: 0.40; p-Value: 2E-13; OR or beta:    1.23; Platform [SNPs passing QC]: Illumina [486,049]	0.0000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Graves' disease
ABO		21841780	TAS		Disease/Trait: Graves' disease; Initial Sample Size: 1,468 Chinese ancestry cases, 1,490 Chinese ancestry controls; Replication Sample Size: 3,994 Chinese ancestry cases, 3,510 Chinese ancestry controls; Strongest SNP-Risk Allele: rs505922-T; SNPs: rs505922; Context: intron; Risk Allele Frequency: 0.53; p-Value: 8E-6; OR or beta:    1.13; Platform [SNPs passing QC]: Illumina [486,049]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Graves' disease
CD58		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs1335532-A; SNPs: rs1335532; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-16; OR or beta:    1.22; Platform [SNPs passing QC]: Illumina [465,434]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
CD86		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs9282641-G; SNPs: rs9282641; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-11; OR or beta:    1.21; Platform [SNPs passing QC]: Illumina [465,434]	0.00000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
CHST12		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs6952809-A; SNPs: rs6952809; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.08; Platform [SNPs passing QC]: Illumina [465,434]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
CLEC16A		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs7200786-A; SNPs: rs7200786; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-17; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [465,434]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
CLECL1		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs10466829-A; SNPs: rs10466829; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta:    1.09; Platform [SNPs passing QC]: Illumina [465,434]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
CXCR5		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs630923-C; SNPs: rs630923; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [465,434]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
DKKL1		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs2303759-C; SNPs: rs2303759; Context: missense; Risk Allele Frequency: NR; p-Value: 5E-9; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina [465,434]	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
EVI5		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs11810217-A; SNPs: rs11810217; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-15; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [465,434]	0.000000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
IL7R		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs6897932-G; SNPs: rs6897932; Context: missense; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina [465,434]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
MALT1		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs7238078-A; SNPs: rs7238078; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-9; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [465,434]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
CYP24A1		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs2248359-G; SNPs: rs2248359; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 3E-11; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [465,434]	0.00000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
FCRL3		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs3761959-G; SNPs: rs3761959; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta:    1.08; Platform [SNPs passing QC]: Illumina [465,434]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
IL12A		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs2243123-G; SNPs: rs2243123; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta:    1.08; Platform [SNPs passing QC]: Illumina [465,434]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
MPV17L2		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs874628-A; SNPs: rs874628; Context: missense; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina [465,434]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
ZBTB46		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs6062314-A; SNPs: rs6062314; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [465,434]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
MAPK1		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs2283792-C; SNPs: rs2283792; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-9; OR or beta:    1.10; Platform [SNPs passing QC]: Illumina [465,434]	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
MERTK		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs17174870-G; SNPs: rs17174870; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina [465,434]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
NDFIP1		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs1062158-A; SNPs: rs1062158; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    1.08; Platform [SNPs passing QC]: Illumina [465,434]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
PLCL2		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs9821630-G; SNPs: rs9821630; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.08; Platform [SNPs passing QC]: Illumina [465,434]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
PVR		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs7255066-G; SNPs: rs7255066; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.09; Platform [SNPs passing QC]: Illumina [465,434]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
RGS14		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs4075958-A; SNPs: rs4075958; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta:    1.09; Platform [SNPs passing QC]: Illumina [465,434]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
RPS6KB1		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs180515-G; SNPs: rs180515; Context: UTR-3; Risk Allele Frequency: NR; p-Value: 9E-8; OR or beta:    1.09; Platform [SNPs passing QC]: Illumina [465,434]	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
RREB1		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs11755724-A; SNPs: rs11755724; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta:    1.08; Platform [SNPs passing QC]: Illumina [465,434]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
STAT3		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs9891119-C; SNPs: rs9891119; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-10; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina [465,434]	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
SYK		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs290986-A; SNPs: rs290986; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 9E-7; OR or beta:    1.10; Platform [SNPs passing QC]: Illumina [465,434]	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
TAGAP		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs1738074-G; SNPs: rs1738074; Context: UTR-5; Risk Allele Frequency: NR; p-Value: 7E-15; OR or beta:    1.13; Platform [SNPs passing QC]: Illumina [465,434]	0.000000000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
TNFRSF1A		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs1800693-G; SNPs: rs1800693; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-14; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [465,434]	0.00000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
TNFSF14		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs1077667-G; SNPs: rs1077667; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-14; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [465,434]	0.00000000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
ZFP36L1		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs4902647-G; SNPs: rs4902647; Context: nearGene-3; Risk Allele Frequency: NR; p-Value: 9E-12; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina [465,434]	0.000000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
ZMIZ1		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs1250550-A; SNPs: rs1250550; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-9; OR or beta:    1.10; Platform [SNPs passing QC]: Illumina [465,434]	0.000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
MYNN		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs10936599-G; SNPs: rs10936599; Context: cds-synon; Risk Allele Frequency: NR; p-Value: 7E-7; OR or beta:    1.10; Platform [SNPs passing QC]: Illumina [465,434]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
SAE1		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs307896-G; SNPs: rs307896; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta:    1.09; Platform [SNPs passing QC]: Illumina [465,434]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
SP140		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs10201872-A; SNPs: rs10201872; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-10; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [465,434]	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
CD86		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs4308217-C; SNPs: rs4308217; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-8; OR or beta:    1.10; Platform [SNPs passing QC]: Illumina [465,434]	0.00000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
IL2RA		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs3118470-G; SNPs: rs3118470; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-11; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [465,434]	0.00000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
AHI1		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs11154801-A; SNPs: rs11154801; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-13; OR or beta:    1.13; Platform [SNPs passing QC]: Illumina [465,434]	0.0000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
ALPK2		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs12456021-A; SNPs: rs12456021; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.10; Platform [SNPs passing QC]: Illumina [465,434]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
BACH2		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs12212193-G; SNPs: rs12212193; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-8; OR or beta:    1.09; Platform [SNPs passing QC]: Illumina [465,434]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
BATF		21833088	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 9,772 European ancestry cases, 16,849 European ancestry controls; Replication Sample Size: 4,218 European ancestry cases, 7,296 European ancestry controls; Strongest SNP-Risk Allele: rs2300603-A; SNPs: rs2300603; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina [465,434]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
TERT		21827660	TAS		Disease/Trait: Glioma; Initial Sample Size: 781 European ancestry cases, 3,992 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2736100-?; SNPs: rs2736100; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina [489,781]	0.000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	malignant glioma
SLC14A1		21824976	TAS		Disease/Trait: Bladder cancer; Initial Sample Size: 4,501 European ancestry cases, 6,076 European ancestry controls; Replication Sample Size: 1,382 European ancestry cases, 2,201 European ancestry controls; Strongest SNP-Risk Allele: rs7238033-?; SNPs: rs7238033; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-9; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [555,912]	0.000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	urinary bladder cancer
SH2B3		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs3184504-T; SNPs: rs3184504; Context: missense; Risk Allele Frequency: NR; p-Value: 2E-38; OR or beta:    1.30; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
TYK2		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs2304256-?; SNPs: rs2304256; Context: missense; Risk Allele Frequency: NR; p-Value: 1E-10; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
CD226		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs763361-C; SNPs: rs763361; Context: missense; Risk Allele Frequency: NR; p-Value: 1E-9; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
BACH2		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs11755527-G; SNPs: rs11755527; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-8; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
IL2		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs2069762-A; SNPs: rs2069762; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
CTLA4		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs3087243-A; SNPs: rs3087243; Context: nearGene-3; Risk Allele Frequency: NR; p-Value: 2E-17; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
FCRL3		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs7528684-T; SNPs: rs7528684; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 1E-11; OR or beta:    1.52; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0.00000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
PTPN22		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs2476601-A; SNPs: rs2476601; Context: ; Risk Allele Frequency: NR; p-Value: 2E-111; OR or beta:    2.00; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
UBASH3A		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs3788013-A; SNPs: rs3788013; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
CLEC16A		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs12708716-G; SNPs: rs12708716; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-14; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0.00000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
ERBB3		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs2292239-T; SNPs: rs2292239; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-27; OR or beta:    1.30; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
IL2RA		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs12722495-A; SNPs: rs12722495; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-38; OR or beta:    1.61; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
ADAD1		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs17388568-A; SNPs: rs17388568; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
IFIH1		21829393	TAS		Disease/Trait: Type 1 diabetes autoantibodies; Initial Sample Size: 12,501 European ancestry cases; Replication Sample Size: 3,598 affected siblings; Strongest SNP-Risk Allele: rs1990760-C; SNPs: rs1990760; Context: missense; Risk Allele Frequency: NR; p-Value: 2E-14; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix and Illumina [NR]	0.00000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
NSF		21812969	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 268 Ashkenazi Jewish ancestry cases, 178 Ashkenazi Jewish ancestry controls; Replication Sample Size: 923 cases, 798 controls; Strongest SNP-Risk Allele: rs183211-T; SNPs: rs183211; Context: intron; Risk Allele Frequency: 0.24; p-Value: 3E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [525,124]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
WNT3		21812969	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 268 Ashkenazi Jewish ancestry cases, 178 Ashkenazi Jewish ancestry controls; Replication Sample Size: 923 cases, 798 controls; Strongest SNP-Risk Allele: rs415430-T; SNPs: rs415430; Context: intron; Risk Allele Frequency: 0.786; p-Value: 7E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [525,124]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
UNC13B		21812969	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 268 Ashkenazi Jewish ancestry cases, 178 Ashkenazi Jewish ancestry controls; Replication Sample Size: 923 cases, 798 controls; Strongest SNP-Risk Allele: rs10121009-A; SNPs: rs10121009; Context: intron; Risk Allele Frequency: 0.21; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [525,124]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
POLR3G		21810746	TAS		Disease/Trait: Nevirapine-induced rash; Initial Sample Size: 72 Thai nevirapine-induced rash patients, 77 Thai nevirapine-tolerant rash patients; Replication Sample Size: 88 Thai nevirapine-induced rash patients, 145 nevirapine-tolerant patients; Strongest SNP-Risk Allele: rs2562519-A; SNPs: rs2562519; Context: intron; Risk Allele Frequency: 0.5; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [499,730]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	exanthem
CCHCR1		21810746	TAS		Disease/Trait: Nevirapine-induced rash; Initial Sample Size: 72 Thai nevirapine-induced rash patients, 77 Thai nevirapine-tolerant rash patients; Replication Sample Size: 88 Thai nevirapine-induced rash patients, 145 nevirapine-tolerant patients; Strongest SNP-Risk Allele: rs1265112-G; SNPs: rs1265112; Context: intron; Risk Allele Frequency: 0.06; p-Value: 1E-8; OR or beta:    4.36; Platform [SNPs passing QC]: Illumina [499,730]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	exanthem
PHACTR1		21846871	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,424 European ancestry cases, 6,996 South Asian cases, 15,062 controls; Replication Sample Size: 21,408 cases, 19,185 controls; Strongest SNP-Risk Allele: rs9349379-?; SNPs: rs9349379; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-26; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~575,00]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
PPAP2B		21846871	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,424 European ancestry cases, 6,996 South Asian cases, 15,062 controls; Replication Sample Size: 21,408 cases, 19,185 controls; Strongest SNP-Risk Allele: rs17114046-?; SNPs: rs17114046; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~575,00]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
MLLT10		21804547	TAS		Disease/Trait: Meningioma ; Initial Sample Size: 859 European ancestry cases, 704 European ancestry controls; Replication Sample Size: 774 European ancestry cases, 1,764 European ancestry controls; Strongest SNP-Risk Allele: rs11012732-A; SNPs: rs11012732; Context: intron; Risk Allele Frequency: 0.32; p-Value: 2E-14; OR or beta:    1.46; Platform [SNPs passing QC]: Illumina [270,875]	0.00000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	meningioma
PBX2		21804548	TAS		Disease/Trait: Asthma; Initial Sample Size: 1,532 Japanese ancestry cases, 3,304 Japanese ancestry controls; Replication Sample Size: 5,639 Japanese ancestry cases, 24,608 Japanese ancestry controls; Strongest SNP-Risk Allele: rs204993-A; SNPs: rs204993; Context: intron; Risk Allele Frequency: 0.58; p-Value: 2E-15; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina [458,847]	0.000000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
NOTCH4		21804548	TAS		Disease/Trait: Asthma; Initial Sample Size: 1,532 Japanese ancestry cases, 3,304 Japanese ancestry controls; Replication Sample Size: 5,639 Japanese ancestry cases, 24,608 Japanese ancestry controls; Strongest SNP-Risk Allele: rs404860-A; SNPs: rs404860; Context: intron; Risk Allele Frequency: 0.50; p-Value: 4E-23; OR or beta:    1.21; Platform [SNPs passing QC]: Illumina [458,847]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
C6orf10		21804548	TAS		Disease/Trait: Asthma; Initial Sample Size: 1,532 Japanese ancestry cases, 3,304 Japanese ancestry controls; Replication Sample Size: 5,639 Japanese ancestry cases, 24,608 Japanese ancestry controls; Strongest SNP-Risk Allele: rs3129943-T; SNPs: rs3129943; Context: intron; Risk Allele Frequency: 0.62; p-Value: 3E-15; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina [458,847]	0.000000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
GAB1		21804548	TAS		Disease/Trait: Asthma; Initial Sample Size: 1,532 Japanese ancestry cases, 3,304 Japanese ancestry controls; Replication Sample Size: 5,639 Japanese ancestry cases, 24,608 Japanese ancestry controls; Strongest SNP-Risk Allele: rs3805236-G; SNPs: rs3805236; Context: intron; Risk Allele Frequency: 0.25; p-Value: 7E-8; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [458,847]	0.00000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
CDK2		21804548	TAS		Disease/Trait: Asthma; Initial Sample Size: 1,532 Japanese ancestry cases, 3,304 Japanese ancestry controls; Replication Sample Size: 5,639 Japanese ancestry cases, 24,608 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2069408-C; SNPs: rs2069408; Context: intron; Risk Allele Frequency: 0.23; p-Value: 1E-10; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [458,847]	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
IL1RL1		21804549	TAS		Disease/Trait: Asthma; Initial Sample Size: 2,088 European American cases, 1,612 African American and African Caribbean cases, 1,688 Hispanic ancestry cases; Replication Sample Size: 2,727 European American cases, 2,147 African American and African Caribbean cases, 2,299 Hispanic ancestry cases; Strongest SNP-Risk Allele: rs3771180-?; SNPs: rs3771180; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-15; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [>2 million] (imputed)	0.000000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
GSDMB		21804549	TAS		Disease/Trait: Asthma; Initial Sample Size: 2,088 European American cases, 1,612 African American and African Caribbean cases, 1,688 Hispanic ancestry cases; Replication Sample Size: 2,727 European American cases, 2,147 African American and African Caribbean cases, 2,299 Hispanic ancestry cases; Strongest SNP-Risk Allele: rs11078927-?; SNPs: rs11078927; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-16; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [>2 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
PYHIN1		21804549	TAS		Disease/Trait: Asthma; Initial Sample Size: 2,088 European American cases, 1,612 African American and African Caribbean cases, 1,688 Hispanic ancestry cases; Replication Sample Size: 2,727 European American cases, 2,147 African American and African Caribbean cases, 2,299 Hispanic ancestry cases; Strongest SNP-Risk Allele: rs1101999-?; SNPs: rs1101999; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-9; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [>2 million] (imputed)	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
POU5F1		21801394	TAS		Disease/Trait: Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN); Initial Sample Size: 495 European ancestry cases, 1,881 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3130501-G; SNPs: rs3130501; Context: intron; Risk Allele Frequency: 0.74; p-Value: 2E-8; OR or beta:    1.74; Platform [SNPs passing QC]: Illumina [303,039]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Stevens-Johnson syndrome
PSORS1C1		21801394	TAS		Disease/Trait: Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN); Initial Sample Size: 495 European ancestry cases, 1,881 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3815087-A; SNPs: rs3815087; Context: UTR-5; Risk Allele Frequency: 0.21; p-Value: 3E-7; OR or beta:    1.53; Platform [SNPs passing QC]: Illumina [303,039]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Stevens-Johnson syndrome
ALPK1		21799462	TAS		Disease/Trait: Epirubicin-induced leukopenia ; Initial Sample Size: 67 Japanese ancestry cases, 203 Japanese ancestry controls; Replication Sample Size: 48 Japanese ancestry cases; Strongest SNP-Risk Allele: rs6838440-C; SNPs: rs6838440; Context: intron; Risk Allele Frequency: 0.51; p-Value: 3E-6; OR or beta:    2.10; Platform [SNPs passing QC]: Illumina [478,359]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	leukopenia
MCPH1		21799462	TAS		Disease/Trait: Epirubicin-induced leukopenia ; Initial Sample Size: 67 Japanese ancestry cases, 203 Japanese ancestry controls; Replication Sample Size: 48 Japanese ancestry cases; Strongest SNP-Risk Allele: rs2916733-C; SNPs: rs2916733; Context: intron; Risk Allele Frequency: 0.39; p-Value: 2E-9; OR or beta:    2.74; Platform [SNPs passing QC]: Illumina [478,359]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	leukopenia
KCNQ1		21799836	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 793 Han Chinese cases, 806 Han Chinese controls; Replication Sample Size: 4,445 Han Chinese cases, 4,458 Han Chinese controls; Strongest SNP-Risk Allele: rs163182-C; SNPs: rs163182; Context: intron; Risk Allele Frequency: 0.34; p-Value: 2E-17; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [474,515]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
SLC30A8		21814517	TAS		Disease/Trait: Asthma; Initial Sample Size: 938 Japanese ancestry cases, 2,376 Japanese ancestry controls; Replication Sample Size: 1653 East Asian cases, 1453 East Asian controls; Strongest SNP-Risk Allele: rs3019885-G; SNPs: rs3019885; Context: intron; Risk Allele Frequency: 0.31; p-Value: 5E-13; OR or beta:    1.34; Platform [SNPs passing QC]: Illumina [450,326]	0.0000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
GRIK5		21771265	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 188 Bulgarian cases, 376 Bulgarian controls; Replication Sample Size: 122 Bulgarian cases, 328 Bulgarian controls; Strongest SNP-Risk Allele: rs8099939-T; SNPs: rs8099939; Context: intron; Risk Allele Frequency: 0.39; p-Value: 2E-6; OR or beta:    1.95; Platform [SNPs passing QC]: Illumina [497,732]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
CTSH		21771265	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 188 Bulgarian cases, 376 Bulgarian controls; Replication Sample Size: 122 Bulgarian cases, 328 Bulgarian controls; Strongest SNP-Risk Allele: rs2289700-A; SNPs: rs2289700; Context: intron; Risk Allele Frequency: 0.07; p-Value: 9E-6; OR or beta:    2.13; Platform [SNPs passing QC]: Illumina [497,732]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
SMAD7		21761138	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 2,906 European descent cases, 3,416 European descent controls; Replication Sample Size: 8,161 European descent cases, 9,101 European descent controls; Strongest SNP-Risk Allele: rs4939827-?; SNPs: rs4939827; Context: intron; Risk Allele Frequency: 0.51; p-Value: 1E-7; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [378,739]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
HLA-DRA		21779181	TAS		Disease/Trait: Systemic sclerosis; Initial Sample Size: 2,296 European ancestry cases, 5,172 European ancestry controls; Replication Sample Size: 3,175 European ancestry cases, 4,210 European ancestry controls; Strongest SNP-Risk Allele: rs3129882-?; SNPs: rs3129882; Context: intron; Risk Allele Frequency: 0.44; p-Value: 2E-27; OR or beta:    2.17; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic scleroderma
GRB10		21779181	TAS		Disease/Trait: Systemic sclerosis; Initial Sample Size: 2,296 European ancestry cases, 5,172 European ancestry controls; Replication Sample Size: 3,175 European ancestry cases, 4,210 European ancestry controls; Strongest SNP-Risk Allele: rs12540874-?; SNPs: rs12540874; Context: intron; Risk Allele Frequency: 0.40; p-Value: 1E-6; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic scleroderma
SOX5		21779181	TAS		Disease/Trait: Systemic sclerosis; Initial Sample Size: 2,296 European ancestry cases, 5,172 European ancestry controls; Replication Sample Size: 3,175 European ancestry cases, 4,210 European ancestry controls; Strongest SNP-Risk Allele: rs11047102-?; SNPs: rs11047102; Context: intron; Risk Allele Frequency: 0.10; p-Value: 5E-6; OR or beta:    1.24; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic scleroderma
SOX5		21779181	TAS		Disease/Trait: Systemic sclerosis; Initial Sample Size: 2,296 European ancestry cases, 5,172 European ancestry controls; Replication Sample Size: 3,175 European ancestry cases, 4,210 European ancestry controls; Strongest SNP-Risk Allele: rs11047102-?; SNPs: rs11047102; Context: intron; Risk Allele Frequency: 0.10; p-Value: 1E-7; OR or beta:    1.36; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic scleroderma
NOTCH4		21779181	TAS		Disease/Trait: Systemic sclerosis; Initial Sample Size: 2,296 European ancestry cases, 5,172 European ancestry controls; Replication Sample Size: 3,175 European ancestry cases, 4,210 European ancestry controls; Strongest SNP-Risk Allele: rs443198-?; SNPs: rs443198; Context: cds-synon; Risk Allele Frequency: 0.63; p-Value: 9E-21; OR or beta:    1.82; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic scleroderma
CD247		21779181	TAS		Disease/Trait: Systemic sclerosis; Initial Sample Size: 2,296 European ancestry cases, 5,172 European ancestry controls; Replication Sample Size: 3,175 European ancestry cases, 4,210 European ancestry controls; Strongest SNP-Risk Allele: rs2056626-?; SNPs: rs2056626; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta:    1.23; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic scleroderma
STAT4		21779181	TAS		Disease/Trait: Systemic sclerosis; Initial Sample Size: 2,296 European ancestry cases, 5,172 European ancestry controls; Replication Sample Size: 3,175 European ancestry cases, 4,210 European ancestry controls; Strongest SNP-Risk Allele: rs3821236-?; SNPs: rs3821236; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-8; OR or beta:    1.31; Platform [SNPs passing QC]: Illumina [NR] (imputed)	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic scleroderma
MEPE		21779381	TAS		Disease/Trait: Cardiovascular disease risk factors; Initial Sample Size: 5,122 European ancestry women migraineurs; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7698623-?; SNPs: rs7698623; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta:    6.37; Platform [SNPs passing QC]: Illumina [339,596]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cardiovascular system disease
IRX4		21779381	TAS		Disease/Trait: Cardiovascular disease risk factors; Initial Sample Size: 5,122 European ancestry women migraineurs; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4975709-?; SNPs: rs4975709; Context: nearGene-3; Risk Allele Frequency: NR; p-Value: 8E-7; OR or beta:    5.06; Platform [SNPs passing QC]: Illumina [339,596]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cardiovascular system disease
BTBD9		21779176	TAS		Disease/Trait: Restless legs syndrome; Initial Sample Size: 922 European ancestry cases, 1,526 European ancestry controls; Replication Sample Size: 3,935 European ancestry cases, 5,754 European ancestry controls; Strongest SNP-Risk Allele: rs9357271-T; SNPs: rs9357271; Context: intron; Risk Allele Frequency: 0.76; p-Value: 8E-22; OR or beta:    1.47; Platform [SNPs passing QC]: Affymetrix [301,406]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	restless legs syndrome
PTPRD		21779176	TAS		Disease/Trait: Restless legs syndrome; Initial Sample Size: 922 European ancestry cases, 1,526 European ancestry controls; Replication Sample Size: 3,935 European ancestry cases, 5,754 European ancestry controls; Strongest SNP-Risk Allele: rs1975197-A; SNPs: rs1975197; Context: intron; Risk Allele Frequency: 0.16; p-Value: 3E-10; OR or beta:    1.29; Platform [SNPs passing QC]: Affymetrix [301,406]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	restless legs syndrome
MEIS1		21779176	TAS		Disease/Trait: Restless legs syndrome; Initial Sample Size: 922 European ancestry cases, 1,526 European ancestry controls; Replication Sample Size: 3,935 European ancestry cases, 5,754 European ancestry controls; Strongest SNP-Risk Allele: rs2300478-G; SNPs: rs2300478; Context: intron; Risk Allele Frequency: 0.24; p-Value: 3E-49; OR or beta:    1.68; Platform [SNPs passing QC]: Affymetrix [301,406]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	restless legs syndrome
LRRC7		21784300	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 341 ADHD offspring from 339 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12037173-?; SNPs: rs12037173; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [835,136]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
SEMA3A		21784300	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 341 ADHD offspring from 339 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs797820-?; SNPs: rs797820; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [835,136]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
FERMT3		21784300	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 341 ADHD offspring from 339 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12575642-?; SNPs: rs12575642; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [835,136]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
STIP1		21784300	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 341 ADHD offspring from 339 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11607165-?; SNPs: rs11607165; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [835,136]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
HLA-DPA1		21750111	TAS		Disease/Trait: Hepatitis B; Initial Sample Size: 458 Japanese ancestry cases, 2,056 Japanese ancestry controls; Replication Sample Size: 2,209 Japanese ancestry cases, 4,440 Japanese ancestry controls; Strongest SNP-Risk Allele: rs3077-G; SNPs: rs3077; Context: UTR-3; Risk Allele Frequency: 0.60; p-Value: 2E-61; OR or beta:    1.87; Platform [SNPs passing QC]: Illumina [423,627]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis B
HLA-DPB1		21750111	TAS		Disease/Trait: Hepatitis B; Initial Sample Size: 458 Japanese ancestry cases, 2,056 Japanese ancestry controls; Replication Sample Size: 2,209 Japanese ancestry cases, 4,440 Japanese ancestry controls; Strongest SNP-Risk Allele: rs9277535-G; SNPs: rs9277535; Context: UTR-3; Risk Allele Frequency: 0.57; p-Value: 3E-54; OR or beta:    1.77; Platform [SNPs passing QC]: Illumina [423,627]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis B
SLC14A1		21750109	TAS		Disease/Trait: Bladder cancer; Initial Sample Size: 2,234 European ancestry cases, 41,603 European ancestry controls; Replication Sample Size: 3,371 European ancestry cases, 10,261 European ancestry controls, 269 Iranian cases, 246 Iranian controls; Strongest SNP-Risk Allele: rs17674580-T; SNPs: rs17674580; Context: intron; Risk Allele Frequency: 0.33; p-Value: 8E-11; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina [5,340,737] (imputed)	0.00000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	urinary bladder cancer
KIF21B		21743469	TAS		Disease/Trait: Ankylosing spondylitis; Initial Sample Size: 3,023 European ancestry cases, 8,779 European ancestry controls; Replication Sample Size: 2,111 European ancestry cases, 4,483 European ancestry controls; Strongest SNP-Risk Allele: rs2297909-G; SNPs: rs2297909; Context: intron; Risk Allele Frequency: 0.68; p-Value: 5E-12; OR or beta: NR; Platform [SNPs passing QC]: Illumina [2,223,620] (imputed)	0.000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ankylosing spondylitis
IL23R		21743469	TAS		Disease/Trait: Ankylosing spondylitis; Initial Sample Size: 3,023 European ancestry cases, 8,779 European ancestry controls; Replication Sample Size: 2,111 European ancestry cases, 4,483 European ancestry controls; Strongest SNP-Risk Allele: rs11209026-G; SNPs: rs11209026; Context: missense; Risk Allele Frequency: 0.93; p-Value: 2E-17; OR or beta: NR; Platform [SNPs passing QC]: Illumina [2,223,620] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ankylosing spondylitis
CARD9		21743469	TAS		Disease/Trait: Ankylosing spondylitis; Initial Sample Size: 3,023 European ancestry cases, 8,779 European ancestry controls; Replication Sample Size: 2,111 European ancestry cases, 4,483 European ancestry controls; Strongest SNP-Risk Allele: rs10781500-T; SNPs: rs10781500; Context: nearGene-5; Risk Allele Frequency: 0.42; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [2,223,620] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ankylosing spondylitis
ANTXR2		21743469	TAS		Disease/Trait: Ankylosing spondylitis; Initial Sample Size: 3,023 European ancestry cases, 8,779 European ancestry controls; Replication Sample Size: 2,111 European ancestry cases, 4,483 European ancestry controls; Strongest SNP-Risk Allele: rs4389526-A; SNPs: rs4389526; Context: intron; Risk Allele Frequency: 0.63; p-Value: 9E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [2,223,620] (imputed)	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ankylosing spondylitis
ERAP1		21743469	TAS		Disease/Trait: Ankylosing spondylitis; Initial Sample Size: 3,023 European ancestry cases, 8,779 European ancestry controls; Replication Sample Size: 2,111 European ancestry cases, 4,483 European ancestry controls; Strongest SNP-Risk Allele: rs30187-T; SNPs: rs30187; Context: missense; Risk Allele Frequency: 0.33; p-Value: 2E-27; OR or beta: NR; Platform [SNPs passing QC]: Illumina [2,223,620] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ankylosing spondylitis
TERT		21743467	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 6,621 European ancestry cases, 6,939 European ancestry controls; Replication Sample Size: 22,957 European ancestry cases, 23,234 European ancestry controls, 285 Japanese cases, 298 Japanese controls, 135 Chinese cases, 135 Chinese controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls; Strongest SNP-Risk Allele: rs2242652-G; SNPs: rs2242652; Context: intron; Risk Allele Frequency: 0.81; p-Value: 3E-24; OR or beta:    1.15; Platform [SNPs passing QC]: NR [2.6 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
CCHCR1		21743467	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 6,621 European ancestry cases, 6,939 European ancestry controls; Replication Sample Size: 22,957 European ancestry cases, 23,234 European ancestry controls, 285 Japanese cases, 298 Japanese controls, 135 Chinese cases, 135 Chinese controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls; Strongest SNP-Risk Allele: rs130067-G; SNPs: rs130067; Context: missense; Risk Allele Frequency: 0.21; p-Value: 3E-8; OR or beta:    1.05; Platform [SNPs passing QC]: NR [2.6 million] (imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
FGF10		21743467	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 6,621 European ancestry cases, 6,939 European ancestry controls; Replication Sample Size: 22,957 European ancestry cases, 23,234 European ancestry controls, 285 Japanese cases, 298 Japanese controls, 135 Chinese cases, 135 Chinese controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls; Strongest SNP-Risk Allele: rs2121875-G; SNPs: rs2121875; Context: intron; Risk Allele Frequency: 0.34; p-Value: 4E-8; OR or beta:    1.05; Platform [SNPs passing QC]: NR [2.6 million] (imputed)	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
ZBTB38		21743467	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 6,621 European ancestry cases, 6,939 European ancestry controls; Replication Sample Size: 22,957 European ancestry cases, 23,234 European ancestry controls, 285 Japanese cases, 298 Japanese controls, 135 Chinese cases, 135 Chinese controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls; Strongest SNP-Risk Allele: rs6763931-T; SNPs: rs6763931; Context: intron; Risk Allele Frequency: 0.45; p-Value: 2E-8; OR or beta:    1.04; Platform [SNPs passing QC]: NR [2.6 million] (imputed)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
BIK		21743057	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 2,782 European ancestry cases, 4,458 European ancestry controls; Replication Sample Size: 8,217 European ancestry cases, 6,732 European ancestry controls; Strongest SNP-Risk Allele: rs742134-G; SNPs: rs742134; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [571,243]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
MLPH		21743057	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 2,782 European ancestry cases, 4,458 European ancestry controls; Replication Sample Size: 8,217 European ancestry cases, 6,732 European ancestry controls; Strongest SNP-Risk Allele: rs2292884-G; SNPs: rs2292884; Context: missense; Risk Allele Frequency: 0.25; p-Value: 4E-8; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [571,243]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
MSMB		21743057	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 2,782 European ancestry cases, 4,458 European ancestry controls; Replication Sample Size: 8,217 European ancestry cases, 6,732 European ancestry controls; Strongest SNP-Risk Allele: rs10993994-T; SNPs: rs10993994; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina [571,243]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
CD247		21750679	TAS		Disease/Trait: Systemic sclerosis; Initial Sample Size: 564 European ancestry cases, 1,776 European ancestry controls; Replication Sample Size: 1,682 European ancestry cases, 3,926 European ancestry controls; Strongest SNP-Risk Allele: rs2056626-T; SNPs: rs2056626; Context: intron; Risk Allele Frequency: 0.61; p-Value: 1E-6; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [489,814]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic scleroderma
STAT4		21750679	TAS		Disease/Trait: Systemic sclerosis; Initial Sample Size: 564 European ancestry cases, 1,776 European ancestry controls; Replication Sample Size: 1,682 European ancestry cases, 3,926 European ancestry controls; Strongest SNP-Risk Allele: rs7574865-T; SNPs: rs7574865; Context: intron; Risk Allele Frequency: 0.22; p-Value: 2E-13; OR or beta:    1.38; Platform [SNPs passing QC]: Illumina [489,814]	0.0000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic scleroderma
TNIP1		21750679	TAS		Disease/Trait: Systemic sclerosis; Initial Sample Size: 564 European ancestry cases, 1,776 European ancestry controls; Replication Sample Size: 1,682 European ancestry cases, 3,926 European ancestry controls; Strongest SNP-Risk Allele: rs2233287-A; SNPs: rs2233287; Context: intron; Risk Allele Frequency: 0.10; p-Value: 5E-9; OR or beta:    1.31; Platform [SNPs passing QC]: Illumina [489,814]	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic scleroderma
WNT2		21732829	TAS		Disease/Trait: Dupuytren's disease; Initial Sample Size: 856 European ancestry cases, 2,836 European ancestry controls; Replication Sample Size: 1,298 European ancestry cases, 7,136 European ancestry controls; Strongest SNP-Risk Allele: rs4730775-?; SNPs: rs4730775; Context: ncRNA; Risk Allele Frequency: 0.59; p-Value: 3E-8; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [234,939]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	plantar fascial fibromatosis
TERT		21725308	TAS		Disease/Trait: Lung cancer; Initial Sample Size: 2,331 Chinese ancestry cases, 3,077 Chinese ancestry controls; Replication Sample Size: 6,313 Chinese ancestry cases, 6,409 Chinese ancestry controls; Strongest SNP-Risk Allele: rs2736100-C; SNPs: rs2736100; Context: intron; Risk Allele Frequency: 0.41; p-Value: 1E-27; OR or beta:    1.27; Platform [SNPs passing QC]: Affymetrix [906,703]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer
TP63		21725308	TAS		Disease/Trait: Lung cancer; Initial Sample Size: 2,331 Chinese ancestry cases, 3,077 Chinese ancestry controls; Replication Sample Size: 6,313 Chinese ancestry cases, 6,409 Chinese ancestry controls; Strongest SNP-Risk Allele: rs4488809-C; SNPs: rs4488809; Context: intron; Risk Allele Frequency: 0.47; p-Value: 7E-26; OR or beta:    1.26; Platform [SNPs passing QC]: Affymetrix [906,703]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer
MTMR3		21725308	TAS		Disease/Trait: Lung cancer; Initial Sample Size: 2,331 Chinese ancestry cases, 3,077 Chinese ancestry controls; Replication Sample Size: 6,313 Chinese ancestry cases, 6,409 Chinese ancestry controls; Strongest SNP-Risk Allele: rs36600-A; SNPs: rs36600; Context: intron; Risk Allele Frequency: 0.09; p-Value: 6E-13; OR or beta:    1.29; Platform [SNPs passing QC]: Affymetrix [906,703]	0.0000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer
DEPDC5		21725309	TAS		Disease/Trait: Chronic Hepatitis C infection; Initial Sample Size: 212 Japanese ancestry cases, 765 Japanese ancestry controls; Replication Sample Size: 710 Japanses ancestry cases, 1,625 Japanese ancestry controls; Strongest SNP-Risk Allele: rs1012068-G; SNPs: rs1012068; Context: intron; Risk Allele Frequency: 0.12; p-Value: 1E-13; OR or beta:    1.75; Platform [SNPs passing QC]: Illumina [467,538]	0.0000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C
BAZ2B		21738491	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 1,283 European ancestry cases, ~20,000 European ancestry controls; Replication Sample Size: 3,119 European ancestry cases, 11,146 European ancestry controls; Strongest SNP-Risk Allele: rs4665058-A; SNPs: rs4665058; Context: intron; Risk Allele Frequency: 0.014; p-Value: 2E-10; OR or beta:    1.92; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
HNRNPC		21738484	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 2,191 European ancestry cases, 1,434 European ancestry controls; Replication Sample Size: 16,179 individuals; Strongest SNP-Risk Allele: rs17197037-A; SNPs: rs17197037; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    1.17; Platform [SNPs passing QC]: Affymetrix [703,019]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
SYNE1		21738484	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 2,191 European ancestry cases, 1,434 European ancestry controls; Replication Sample Size: 16,179 individuals; Strongest SNP-Risk Allele: rs7747960-A; SNPs: rs7747960; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-6; OR or beta:    1.23; Platform [SNPs passing QC]: Affymetrix [703,019]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
MGAT4A		21738484	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 2,191 European ancestry cases, 1,434 European ancestry controls; Replication Sample Size: 16,179 individuals; Strongest SNP-Risk Allele: rs12618769-T; SNPs: rs12618769; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix [703,019]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
KCNMA1		21708048	TAS		Disease/Trait: Obesity; Initial Sample Size: 164 morbidly obese European ancestry individuals, 163 lean European ancestry individuals; Replication Sample Size: 4,674 morbidly obese European ancestry individuals, 5,663 lean European ancestry individuals; Strongest SNP-Risk Allele: rs2116830-G; SNPs: rs2116830; Context: intron; Risk Allele Frequency: 0.80; p-Value: 3E-10; OR or beta:    1.26; Platform [SNPs passing QC]: Affymetrix [406,177]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity
SLC41A1		21738487	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 3,426 cases, 29,624 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs823156-A; SNPs: rs823156; Context: intron; Risk Allele Frequency: 0.82; p-Value: 1E-7; OR or beta:    1.21; Platform [SNPs passing QC]: Illumina [522,782]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
LRRK2		21738487	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 3,426 cases, 29,624 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs34637584-A; SNPs: rs34637584; Context: missense; Risk Allele Frequency: 0.002; p-Value: 2E-28; OR or beta:    9.62; Platform [SNPs passing QC]: Illumina [522,782]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
MC1R		21700618	TAS		Disease/Trait: Basal cell carcinoma ; Initial Sample Size: 2,045 European ancestry cases, 6,013 European ancestry controls; Replication Sample Size: 1,426 European ancestry cases, 4,845 European ancestry controls; Strongest SNP-Risk Allele: rs1805007-T; SNPs: rs1805007; Context: missense; Risk Allele Frequency: 0.07; p-Value: 4E-17; OR or beta:    1.55; Platform [SNPs passing QC]: Affymetrix & Illumina [2,318,094] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	basal cell carcinoma
PKNOX2		21703634	TAS		Disease/Trait: Alcohol dependence; Initial Sample Size: 1,283 European ancestry cases, 1,416 European ancestry controls; Replication Sample Size: 3,334 European ancestry individuals from 778 nuclear families; Strongest SNP-Risk Allele: rs750338-C; SNPs: rs750338; Context: intron; Risk Allele Frequency: 0.22; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [up to 818,773]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol dependence
CD8B		21685912	TAS		Disease/Trait: Progressive supranuclear palsy; Initial Sample Size: 1,114 cases, 3,287 controls; Replication Sample Size: 1,051 European ancestry cases, 3,560 European ancestry controls; Strongest SNP-Risk Allele: rs6547705-?; SNPs: rs6547705; Context: intron; Risk Allele Frequency: 0.23; p-Value: 1E-8; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [531,451]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	progressive supranuclear palsy
MAPT		21685912	TAS		Disease/Trait: Progressive supranuclear palsy; Initial Sample Size: 1,114 cases, 3,287 controls; Replication Sample Size: 1,051 European ancestry cases, 3,560 European ancestry controls; Strongest SNP-Risk Allele: rs242557-?; SNPs: rs242557; Context: intron; Risk Allele Frequency: 0.35; p-Value: 9E-18; OR or beta:    1.43; Platform [SNPs passing QC]: Illumina [531,451]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	progressive supranuclear palsy
IRF4		21685912	TAS		Disease/Trait: Progressive supranuclear palsy; Initial Sample Size: 1,114 cases, 3,287 controls; Replication Sample Size: 1,051 European ancestry cases, 3,560 European ancestry controls; Strongest SNP-Risk Allele: rs12203592-?; SNPs: rs12203592; Context: intron; Risk Allele Frequency: 0.19; p-Value: 6E-15; OR or beta:    1.48; Platform [SNPs passing QC]: Illumina [531,451]	0.000000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	progressive supranuclear palsy
STX6		21685912	TAS		Disease/Trait: Progressive supranuclear palsy; Initial Sample Size: 1,114 cases, 3,287 controls; Replication Sample Size: 1,051 European ancestry cases, 3,560 European ancestry controls; Strongest SNP-Risk Allele: rs1411478-?; SNPs: rs1411478; Context: intron; Risk Allele Frequency: 0.58; p-Value: 4E-11; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [531,451]	0.00000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	progressive supranuclear palsy
EIF2AK3		21685912	TAS		Disease/Trait: Progressive supranuclear palsy; Initial Sample Size: 1,114 cases, 3,287 controls; Replication Sample Size: 1,051 European ancestry cases, 3,560 European ancestry controls; Strongest SNP-Risk Allele: rs7571971-?; SNPs: rs7571971; Context: intron; Risk Allele Frequency: 0.74; p-Value: 4E-13; OR or beta:    1.33; Platform [SNPs passing QC]: Illumina [531,451]	0.0000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	progressive supranuclear palsy
SLCO1A2		21685912	TAS		Disease/Trait: Progressive supranuclear palsy; Initial Sample Size: 1,114 cases, 3,287 controls; Replication Sample Size: 1,051 European ancestry cases, 3,560 European ancestry controls; Strongest SNP-Risk Allele: rs11568563-?; SNPs: rs11568563; Context: missense; Risk Allele Frequency: 0.95; p-Value: 7E-8; OR or beta:    1.47; Platform [SNPs passing QC]: Illumina [531,451]	0.00000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	progressive supranuclear palsy
MAPT		21685912	TAS		Disease/Trait: Progressive supranuclear palsy; Initial Sample Size: 1,114 cases, 3,287 controls; Replication Sample Size: 1,051 European ancestry cases, 3,560 European ancestry controls; Strongest SNP-Risk Allele: rs8070723-?; SNPs: rs8070723; Context: intron; Risk Allele Frequency: 0.23; p-Value: 2E-118; OR or beta:    5.11; Platform [SNPs passing QC]: Illumina [531,451]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	progressive supranuclear palsy
MOBP		21685912	TAS		Disease/Trait: Progressive supranuclear palsy; Initial Sample Size: 1,114 cases, 3,287 controls; Replication Sample Size: 1,051 European ancestry cases, 3,560 European ancestry controls; Strongest SNP-Risk Allele: rs1768208-?; SNPs: rs1768208; Context: intron; Risk Allele Frequency: 0.71; p-Value: 5E-17; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [531,451]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	progressive supranuclear palsy
MSRA		21679298	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 98 Chinese ancestry cases, 60 Chinese ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7017212-?; SNPs: rs7017212; Context: intron; Risk Allele Frequency: .41; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [464,301]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
CDYL		21685187	TAS		Disease/Trait: Chronic obstructive pulmonary disease; Initial Sample Size: 3,441 European ancestry ever-smokers with COPD; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs73717741-G; SNPs: rs73717741; Context: intron; Risk Allele Frequency: 0.07; p-Value: 3E-7; OR or beta:   11.90; Platform [SNPs passing QC]: Illumina [~6.3 million] (imputed)	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
ANXA5		21685187	TAS		Disease/Trait: Chronic obstructive pulmonary disease; Initial Sample Size: 3,441 European ancestry ever-smokers with COPD; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs55645543-T; SNPs: rs55645543; Context: intron; Risk Allele Frequency: 0.98; p-Value: 5E-7; OR or beta:    4.39; Platform [SNPs passing QC]: Illumina [~6.3 million] (imputed)	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
PLCE1		21685187	TAS		Disease/Trait: Chronic obstructive pulmonary disease; Initial Sample Size: 3,441 Caucasian ever-smokers with COPD; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs117607728-G; SNPs: rs117607728; Context: intron; Risk Allele Frequency: 0.98; p-Value: 4E-7; OR or beta:    3.00; Platform [SNPs passing QC]: Illumina [~6.3 million] (imputed)	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
AGPHD1		21685187	TAS		Disease/Trait: Chronic obstructive pulmonary disease; Initial Sample Size: 3,441 Caucasian ever-smokers with COPD; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs28675338-T; SNPs: rs28675338; Context: intron; Risk Allele Frequency: 0.11; p-Value: 1E-7; OR or beta:    5.21; Platform [SNPs passing QC]: Illumina [~6.3 million] (imputed)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
MICA		21653640	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 2768 European ancestry cases, 4198 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1063635-?; SNPs: rs1063635; Context: missense; Risk Allele Frequency: NR; p-Value: 1E-17; OR or beta:    1.35; Platform [SNPs passing QC]: Affymetrix & Illumina [NR]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
PRDM16		21666692	TAS		Disease/Trait: Migraine; Initial Sample Size: 5,122 European ancestry cases, 18,108 European ancestry controls; Replication Sample Size: 3,831 European ancestry cases, 13,889 European ancestry controls; Strongest SNP-Risk Allele: rs2651899-C; SNPs: rs2651899; Context: intron; Risk Allele Frequency: 0.43; p-Value: 4E-9; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina and Affymetrix [2,608,509] (imputed)	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	migraine
LRP1		21666692	TAS		Disease/Trait: Migraine; Initial Sample Size: 5,122 European ancestry cases, 18,108 European ancestry controls; Replication Sample Size: 3,831 European ancestry cases, 13,889 European ancestry controls; Strongest SNP-Risk Allele: rs11172113-T; SNPs: rs11172113; Context: intron; Risk Allele Frequency: 0.59; p-Value: 4E-9; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina and Affymetrix [2,608,509] (imputed)	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	migraine
TRPM8		21666692	TAS		Disease/Trait: Migraine; Initial Sample Size: 5,122 European ancestry cases, 18,108 European ancestry controls; Replication Sample Size: 3,831 European ancestry cases, 13,889 European ancestry controls; Strongest SNP-Risk Allele: rs10166942-T; SNPs: rs10166942; Context: nearGene-5; Risk Allele Frequency: 0.81; p-Value: 6E-12; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina and Affymetrix [2,608,509] (imputed)	0.000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	migraine
ACYP2		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1559040-?; SNPs: rs1559040; Context: intron; Risk Allele Frequency: 0.11; p-Value: 4E-8; OR or beta:    1.54; Platform [SNPs passing QC]: Affymetrix [319,222]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
ZNF385B		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs16866933-?; SNPs: rs16866933; Context: intron; Risk Allele Frequency: 0.09; p-Value: 6E-14; OR or beta:    1.69; Platform [SNPs passing QC]: Affymetrix [319,222]	0.00000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
CLSTN2		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11708189-?; SNPs: rs11708189; Context: intron; Risk Allele Frequency: 0.65; p-Value: 2E-6; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix [319,222]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
OCM2		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13438327-?; SNPs: rs13438327; Context: nearGene-5; Risk Allele Frequency: 0.09; p-Value: 2E-6; OR or beta:    2.05; Platform [SNPs passing QC]: Affymetrix [319,222]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
TMEFF2		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13007495-?; SNPs: rs13007495; Context: intron; Risk Allele Frequency: 0.14; p-Value: 4E-6; OR or beta:    1.47; Platform [SNPs passing QC]: Affymetrix [319,222]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
KCTD1		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs16942421-?; SNPs: rs16942421; Context: ; Risk Allele Frequency: 0.08; p-Value: 8E-10; OR or beta:    1.68; Platform [SNPs passing QC]: Affymetrix [319,222]	0.0000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
GRIA1		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12189362-?; SNPs: rs12189362; Context: intron; Risk Allele Frequency: 0.12; p-Value: 3E-10; OR or beta:    1.50; Platform [SNPs passing QC]: Affymetrix [319,222]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
SIN3A		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs8028182-?; SNPs: rs8028182; Context: intron; Risk Allele Frequency: 0.18; p-Value: 3E-6; OR or beta:    1.36; Platform [SNPs passing QC]: Affymetrix [319,222]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
AP1G2		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2281680-?; SNPs: rs2281680; Context: intron; Risk Allele Frequency: 0.21; p-Value: 6E-8; OR or beta:    1.38; Platform [SNPs passing QC]: Affymetrix [319,222]	0.00000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
PARP4		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9581094-?; SNPs: rs9581094; Context: intron; Risk Allele Frequency: 0.15; p-Value: 7E-7; OR or beta:    1.70; Platform [SNPs passing QC]: Affymetrix [319,222]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
ATF1		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17291650-?; SNPs: rs17291650; Context: cds-synon; Risk Allele Frequency: 0.10; p-Value: 3E-7; OR or beta:    1.43; Platform [SNPs passing QC]: Affymetrix [319,222]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
PLCE1		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11187837-?; SNPs: rs11187837; Context: intron; Risk Allele Frequency: 0.12; p-Value: 4E-7; OR or beta:    1.79; Platform [SNPs passing QC]: Affymetrix [319,222]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
CHL1		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6764363-?; SNPs: rs6764363; Context: intron; Risk Allele Frequency: 0.36; p-Value: 6E-6; OR or beta:    1.19; Platform [SNPs passing QC]: Affymetrix [319,222]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
DEGS2		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7157599-?; SNPs: rs7157599; Context: missense; Risk Allele Frequency: 0.31; p-Value: 1E-7; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix [319,222]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
CHRNB4		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs950776-?; SNPs: rs950776; Context: intron; Risk Allele Frequency: 0.68; p-Value: 4E-7; OR or beta:    1.09; Platform [SNPs passing QC]: Affymetrix [319,222]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
CDH4		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs944260-?; SNPs: rs944260; Context: intron; Risk Allele Frequency: 0.24; p-Value: 2E-6; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix [319,222]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
ESR1		21658281	TAS		Disease/Trait: Sudden cardiac arrest; Initial Sample Size: 89 European ancestry cases, 520 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2982694-?; SNPs: rs2982694; Context: intron; Risk Allele Frequency: 0.14; p-Value: 7E-10; OR or beta:    1.43; Platform [SNPs passing QC]: Affymetrix [319,222]	0.0000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Sudden cardiac death
TF		21665994	TAS		Disease/Trait: Alcohol consumption; Initial Sample Size: 5,181 European ancestry individuals; Replication Sample Size: 2,284 European ancestry individauls; Strongest SNP-Risk Allele: rs3811647-A; SNPs: rs3811647; Context: intron; Risk Allele Frequency: 0.32; p-Value: 1E-35; OR or beta:     .36; Platform [SNPs passing QC]: Affymetrix [390,631] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
TF		21665994	TAS		Disease/Trait: Alcohol consumption; Initial Sample Size: 5,181 European ancestry individuals; Replication Sample Size: 2,284 European ancestry individauls; Strongest SNP-Risk Allele: rs1049296-T; SNPs: rs1049296; Context: missense; Risk Allele Frequency: 0.17; p-Value: 5E-43; OR or beta:     .29; Platform [SNPs passing QC]: Affymetrix [390,631] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
HFE		21665994	TAS		Disease/Trait: Alcohol consumption; Initial Sample Size: 5,181 European ancestry individuals; Replication Sample Size: 2,284 European ancestry individauls; Strongest SNP-Risk Allele: rs1800562-A; SNPs: rs1800562; Context: missense; Risk Allele Frequency: 0.045; p-Value: 2E-32; OR or beta:     .63; Platform [SNPs passing QC]: Affymetrix [390,631] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
SRPRB		21665994	TAS		Disease/Trait: Alcohol consumption; Initial Sample Size: 5,181 European ancestry individuals; Replication Sample Size: 2,284 European ancestry individauls; Strongest SNP-Risk Allele: rs1534166-A; SNPs: rs1534166; Context: intron; Risk Allele Frequency: 0.30; p-Value: 2E-17; OR or beta:     .29; Platform [SNPs passing QC]: Affymetrix [390,631] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
TF		21665994	TAS		Disease/Trait: Alcohol consumption; Initial Sample Size: 5,181 European ancestry individuals; Replication Sample Size: 2,284 European ancestry individauls; Strongest SNP-Risk Allele: rs1799899-A; SNPs: rs1799899; Context: missense; Risk Allele Frequency: 0.06; p-Value: 1E-9; OR or beta:     .40; Platform [SNPs passing QC]: Affymetrix [390,631] (imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
C2		21665990	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 2,594 European ancestry cases, 4,134 European ancestry controls; Replication Sample Size: 5,640 cases, 52,174 controls; Strongest SNP-Risk Allele: rs9332739-?; SNPs: rs9332739; Context: missense; Risk Allele Frequency: 0.96; p-Value: 2E-23; OR or beta:    2.17; Platform [SNPs passing QC]: Affymetrix [6,036,699] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
C3		21665990	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 2,594 European ancestry cases, 4,134 European ancestry controls; Replication Sample Size: 5,640 cases, 52,174 controls; Strongest SNP-Risk Allele: rs2230199-C; SNPs: rs2230199; Context: missense; Risk Allele Frequency: 0.19; p-Value: 5E-29; OR or beta:    1.53; Platform [SNPs passing QC]: Affymetrix [6,036,699] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
CFB		21665990	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 2,594 European ancestry cases, 4,134 European ancestry controls; Replication Sample Size: 5,640 cases, 52,174 controls; Strongest SNP-Risk Allele: rs641153-?; SNPs: rs641153; Context: missense; Risk Allele Frequency: 0.90; p-Value: 6E-31; OR or beta:    1.85; Platform [SNPs passing QC]: Affymetrix [6,036,699] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
CFH		21665990	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 2,594 European ancestry cases, 4,134 European ancestry controls; Replication Sample Size: 5,640 cases, 52,174 controls; Strongest SNP-Risk Allele: rs1061170-C; SNPs: rs1061170; Context: missense; Risk Allele Frequency: 0.37; p-Value: 1E-261; OR or beta:    2.41; Platform [SNPs passing QC]: Affymetrix [6,036,699] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
YWHAG		21654844	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 1,470 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17149161-A; SNPs: rs17149161; Context: intron; Risk Allele Frequency: 0.2; p-Value: 6E-6; OR or beta:    1.87; Platform [SNPs passing QC]: Affymetrix [2,110,417] (imputed)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
YWHAG		21654844	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 1,470 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7779014-T; SNPs: rs7779014; Context: intron; Risk Allele Frequency: 0.2; p-Value: 8E-6; OR or beta:     .48; Platform [SNPs passing QC]: Affymetrix [2,110,417] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
TRIM2		21654844	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 1,470 European ancestry cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12644284-?; SNPs: rs12644284; Context: intron; Risk Allele Frequency: 0.67; p-Value: 4E-6; OR or beta:    2.04; Platform [SNPs passing QC]: Affymetrix [2,110,417] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
ITPA		21659334	TAS		Disease/Trait: Response to hepatitis C treatment; Initial Sample Size: 303 Japanese ancestry cases; Replication Sample Size: 391 Japanese ancestry cases; Strongest SNP-Risk Allele: rs6139030-T; SNPs: rs6139030; Context: nearGene-5; Risk Allele Frequency: 0.83; p-Value: 2E-25; OR or beta:   25.00; Platform [SNPs passing QC]: Affymetrix [595,052]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C
DDRGK1		21659334	TAS		Disease/Trait: Response to hepatitis C treatment; Initial Sample Size: 303 Japanese ancestry cases; Replication Sample Size: 391 Japanese ancestry cases; Strongest SNP-Risk Allele: rs11697186-T; SNPs: rs11697186; Context: intron; Risk Allele Frequency: 0.15; p-Value: 5E-17; OR or beta:    4.50; Platform [SNPs passing QC]: Affymetrix [595,052]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C
ITPA		21659334	TAS		Disease/Trait: Response to hepatitis C treatment; Initial Sample Size: 303 Japanese ancestry cases; Replication Sample Size: 391 Japanese ancestry cases; Strongest SNP-Risk Allele: rs6139030-C; SNPs: rs6139030; Context: nearGene-5; Risk Allele Frequency: 0.17; p-Value: 1E-15; OR or beta:    3.90; Platform [SNPs passing QC]: Affymetrix [595,052]	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C
DDRGK1		21659334	TAS		Disease/Trait: Response to hepatitis C treatment; Initial Sample Size: 303 Japanese ancestry cases; Replication Sample Size: 391 Japanese ancestry cases; Strongest SNP-Risk Allele: rs11697186-A; SNPs: rs11697186; Context: intron; Risk Allele Frequency: 0.85; p-Value: 9E-25; OR or beta:   33.33; Platform [SNPs passing QC]: Affymetrix [595,052]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C
PTPRD		21647700	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 837 Mexican-American cases, 781 Mexican-American controls; Replication Sample Size: 967 Hispanic cases, 343 Hispanic controls; Strongest SNP-Risk Allele: rs649891-C; SNPs: rs649891; Context: intron; Risk Allele Frequency: 0.35; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [1,829,586] (imputed)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
PDE4D		21642993	TAS		Disease/Trait: Esophageal cancer; Initial Sample Size: 2,031 Han Chinese cases, 2,044 Han Chinese controls; Replication Sample Size: 3,986 Han Chinese cases, 4,157 Han Chinese controls; Strongest SNP-Risk Allele: rs10052657-C; SNPs: rs10052657; Context: intron; Risk Allele Frequency: 0.78; p-Value: 2E-19; OR or beta:    1.49; Platform [SNPs passing QC]: Affymetrix [666,141]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	esophageal cancer
ACAD10		21642993	TAS		Disease/Trait: Esophageal cancer; Initial Sample Size: 2,031 Han Chinese cases, 2,044 Han Chinese controls; Replication Sample Size: 3,986 Han Chinese cases, 4,157 Han Chinese controls; Strongest SNP-Risk Allele: rs11066015-A; SNPs: rs11066015; Context: intron; Risk Allele Frequency: 0.19; p-Value: 7E-21; OR or beta:    1.38; Platform [SNPs passing QC]: Affymetrix [666,141]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	esophageal cancer
RUNX1		21642993	TAS		Disease/Trait: Esophageal cancer; Initial Sample Size: 2,031 Han Chinese cases, 2,044 Han Chinese controls; Replication Sample Size: 3,986 Han Chinese cases, 4,157 Han Chinese controls; Strongest SNP-Risk Allele: rs2014300-G; SNPs: rs2014300; Context: intron; Risk Allele Frequency: 0.83; p-Value: 8E-22; OR or beta:    1.43; Platform [SNPs passing QC]: Affymetrix [666,141]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	esophageal cancer
CSNK1A1		21642993	TAS		Disease/Trait: Esophageal cancer; Initial Sample Size: 2,031 Han Chinese cases, 2,044 Han Chinese controls; Replication Sample Size: 3,986 Han Chinese cases, 4,157 Han Chinese controls; Strongest SNP-Risk Allele: rs10058728-T; SNPs: rs10058728; Context: intron; Risk Allele Frequency: 0.98; p-Value: 5E-9; OR or beta:    2.04; Platform [SNPs passing QC]: Affymetrix [666,141]	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	esophageal cancer
SEMA5B		21642993	TAS		Disease/Trait: Esophageal cancer; Initial Sample Size: 2,031 Han Chinese cases, 2,044 Han Chinese controls; Replication Sample Size: 3,986 Han Chinese cases, 4,157 Han Chinese controls; Strongest SNP-Risk Allele: rs9868873-G; SNPs: rs9868873; Context: intron; Risk Allele Frequency: 0.82; p-Value: 1E-7; OR or beta:    1.19; Platform [SNPs passing QC]: Affymetrix [666,141]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	esophageal cancer
PLCE1		21642993	TAS		Disease/Trait: Esophageal cancer; Initial Sample Size: 2,031 Han Chinese cases, 2,044 Han Chinese controls; Replication Sample Size: 3,986 Han Chinese cases, 4,157 Han Chinese controls; Strongest SNP-Risk Allele: rs2274223-G; SNPs: rs2274223; Context: missense; Risk Allele Frequency: 0.21; p-Value: 4E-20; OR or beta:    1.34; Platform [SNPs passing QC]: Affymetrix [666,141]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	esophageal cancer
RIN3		21623375	TAS		Disease/Trait: Paget's disease; Initial Sample Size: 741 European ancestry cases, 2,699 European ancestry controls; Replication Sample Size: 1,474 European descent cases, 1,671 European descent controls; Strongest SNP-Risk Allele: rs10498635-C; SNPs: rs10498635; Context: intron; Risk Allele Frequency: 0.82; p-Value: 3E-11; OR or beta:    1.44; Platform [SNPs passing QC]: Illumina [2,487,078] (imputed)	0.00000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	mammary Paget's disease
PRL		21623375	TAS		Disease/Trait: Paget's disease; Initial Sample Size: 741 European ancestry cases, 2,699 European ancestry controls; Replication Sample Size: 1,474 European descent cases, 1,671 European descent controls; Strongest SNP-Risk Allele: rs1341239-T; SNPs: rs1341239; Context: nearGene-5; Risk Allele Frequency: 0.38; p-Value: 4E-6; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [2,487,078] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	mammary Paget's disease
NUP205		21623375	TAS		Disease/Trait: Paget's disease; Initial Sample Size: 741 European ancestry cases, 2,699 European ancestry controls; Replication Sample Size: 1,474 European descent cases, 1,671 European descent controls; Strongest SNP-Risk Allele: rs4294134-G; SNPs: rs4294134; Context: intron; Risk Allele Frequency: 0.84; p-Value: 8E-10; OR or beta:    1.45; Platform [SNPs passing QC]: Illumina [2,487,078] (imputed)	0.0000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	mammary Paget's disease
SLC25A43		21623375	TAS		Disease/Trait: Paget's disease; Initial Sample Size: 741 European ancestry cases, 2,699 European ancestry controls; Replication Sample Size: 1,474 European descent cases, 1,671 European descent controls; Strongest SNP-Risk Allele: rs5910578-C; SNPs: rs5910578; Context: intron; Risk Allele Frequency: 0.74; p-Value: 1E-7; OR or beta:    1.34; Platform [SNPs passing QC]: Illumina [2,487,078] (imputed)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	mammary Paget's disease
OPTN		21623375	TAS		Disease/Trait: Paget's disease; Initial Sample Size: 741 European ancestry cases, 2,699 European ancestry controls; Replication Sample Size: 1,474 European descent cases, 1,671 European descent controls; Strongest SNP-Risk Allele: rs1561570-T; SNPs: rs1561570; Context: intron; Risk Allele Frequency: 0.53; p-Value: 4E-38; OR or beta:    1.67; Platform [SNPs passing QC]: Illumina [2,487,078] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	mammary Paget's disease
PML		21623375	TAS		Disease/Trait: Paget's disease; Initial Sample Size: 741 European ancestry cases, 2,699 European ancestry controls; Replication Sample Size: 1,474 European descent cases, 1,671 European descent controls; Strongest SNP-Risk Allele: rs5742915-C; SNPs: rs5742915; Context: missense; Risk Allele Frequency: 0.45; p-Value: 2E-14; OR or beta:    1.34; Platform [SNPs passing QC]: Illumina [2,487,078] (imputed)	0.00000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	mammary Paget's disease
SHC4		21621269	TAS		Disease/Trait: Major depressive disorder; Initial Sample Size: 1,726 cases, 1,630 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs8023445-?; SNPs: rs8023445; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Perlegen [433,556]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	major depressive disorder
PCLO		21621269	TAS		Disease/Trait: Major depressive disorder; Initial Sample Size: 1,726 cases, 1,630 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2715148-?; SNPs: rs2715148; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Perlegen [433,556]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	major depressive disorder
FNDC1		21606135	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 2,078 European descent cases, 2,953 European descent controls; Replication Sample Size: 19,350 European descent cases, 35,408 European descent controls; Strongest SNP-Risk Allele: rs365302-C; SNPs: rs365302; Context: intron; Risk Allele Frequency: 0.24; p-Value: 8E-7; OR or beta:    1.11; Platform [SNPs passing QC]: Affymetrix [608,247]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
LIPA		21606135	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 2,078 European descent cases, 2,953 European descent controls; Replication Sample Size: 19,350 European descent cases, 35,408 European descent controls; Strongest SNP-Risk Allele: rs1412444-T; SNPs: rs1412444; Context: intron; Risk Allele Frequency: 0.32; p-Value: 4E-8; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix [608,247]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
ZNF652		21602798	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 3,425 African American cases, 3,290 African American controls; Replication Sample Size: 1,275 African American cases, 1,695 African American controls, 86 Senegalese cases, 414 Senegalese controls, 271 Ghanaian cases, 968 Ghanaian controls, 246 Barbadian cases, 253 Barbadian controls; Strongest SNP-Risk Allele: rs7210100-?; SNPs: rs7210100; Context: intron; Risk Allele Frequency: 0.05; p-Value: 3E-13; OR or beta:    1.51; Platform [SNPs passing QC]: Illumina [1,047,1986]	0.0000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
AGTR2		21602797	TAS		Disease/Trait: Cystic fibrosis severity; Initial Sample Size: up to 2,494 individuals with cystic fibrosis; Replication Sample Size: up to 973 individuals with cystic fibrosis from sibling pairs; Strongest SNP-Risk Allele: rs1403543-A; SNPs: rs1403543; Context: intron; Risk Allele Frequency: 0.51; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~2,609,000] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cystic fibrosis
AHRR		21602797	TAS		Disease/Trait: Cystic fibrosis severity; Initial Sample Size: up to 2,494 individuals with cystic fibrosis; Replication Sample Size: up to 973 individuals with cystic fibrosis from sibling pairs; Strongest SNP-Risk Allele: rs12188164-A; SNPs: rs12188164; Context: intron; Risk Allele Frequency: 0.38; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~2,609,000] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cystic fibrosis
SLC8A3		21602797	TAS		Disease/Trait: Cystic fibrosis severity; Initial Sample Size: up to 2,494 individuals with cystic fibrosis; Replication Sample Size: up to 973 individuals with cystic fibrosis from sibling pairs; Strongest SNP-Risk Allele: rs12883884-T; SNPs: rs12883884; Context: intron; Risk Allele Frequency: 0.61; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~2,609,000] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cystic fibrosis
IGF2BP2		21573907	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,804 Hispanic ancestry cases, 780 Hispanic ancestry controls; Replication Sample Size: European ancestry individuals (NR); Strongest SNP-Risk Allele: rs1374910-T; SNPs: rs1374910; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta:    1.24; Platform [SNPs passing QC]: Affymetrix [315,658]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
KCNQ1		21573907	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,804 Hispanic ancestry cases, 780 Hispanic ancestry controls; Replication Sample Size: European ancestry individuals (NR); Strongest SNP-Risk Allele: rs2237892-C; SNPs: rs2237892; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix [315,658]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
DMRT1		21551455	TAS		Disease/Trait: Testicular cancer; Initial Sample Size: 349 cases, 919 controls; Replication Sample Size: 439 non-Hispanic White cases,960 non-Hispanic White controls; Strongest SNP-Risk Allele: rs7040024-A; SNPs: rs7040024; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-11; OR or beta:    1.70; Platform [SNPs passing QC]: Affymetrix [609,482]	0.00000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	testicular cancer
DMRT1		21551455	TAS		Disease/Trait: Testicular cancer; Initial Sample Size: 349 cases, 919 controls; Replication Sample Size: 439 non-Hispanic White cases,960 non-Hispanic White controls; Strongest SNP-Risk Allele: rs755383-T; SNPs: rs755383; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-10; OR or beta:    1.50; Platform [SNPs passing QC]: Affymetrix [609,482]	0.0000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	testicular cancer
CDKN2B-AS1		21532571	TAS		Disease/Trait: Glaucoma; Initial Sample Size: 590 European ancestry cases, 3,956 European ancestry controls; Replication Sample Size: 892 European ancestry cases, 4,582 European ancestry controls; Strongest SNP-Risk Allele: rs4977756-A; SNPs: rs4977756; Context: intron; Risk Allele Frequency: 0.60; p-Value: 1E-14; OR or beta:    1.39; Platform [SNPs passing QC]: Illumina [298,778]	0.00000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	glaucoma
DGKI		21502085	TAS		Disease/Trait: AIDS progression; Initial Sample Size: 755 European ancestry seroconverters; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6467710-?; SNPs: rs6467710; Context: intron; Risk Allele Frequency: 0.02; p-Value: 6E-7; OR or beta:    4.30; Platform [SNPs passing QC]: Affymetrix [700,022]	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	acquired immunodeficiency syndrome
PARD3B		21502085	TAS		Disease/Trait: AIDS progression; Initial Sample Size: 755 European ancestry seroconverters; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11884476-?; SNPs: rs11884476; Context: intron; Risk Allele Frequency: 0.94; p-Value: 3E-9; OR or beta:    3.32; Platform [SNPs passing QC]: Affymetrix [700,022]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	acquired immunodeficiency syndrome
TERT		21531791	TAS		Disease/Trait: Glioma; Initial Sample Size: 4,147 European ancestry cases, 7,435 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2736100-?; SNPs: rs2736100; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-14; OR or beta:    1.25; Platform [SNPs passing QC]: Illumina [424,460]	0.00000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	malignant glioma
EGFR		21531791	TAS		Disease/Trait: Glioma; Initial Sample Size: 4,147 European ancestry cases, 7,435 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11979158-A; SNPs: rs11979158; Context: intron; Risk Allele Frequency: 0.83; p-Value: 7E-8; OR or beta:    1.23; Platform [SNPs passing QC]: Illumina [424,460]	0.00000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	malignant glioma
PHLDB1		21531791	TAS		Disease/Trait: Glioma; Initial Sample Size: 4,147 European ancestry cases, 7,435 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs498872-?; SNPs: rs498872; Context: UTR-5; Risk Allele Frequency: NR; p-Value: 5E-11; OR or beta:    1.22; Platform [SNPs passing QC]: Illumina [424,460]	0.00000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	malignant glioma
WWOX		21552555	TAS		Disease/Trait: Obesity; Initial Sample Size: 520 European ancestry cases, 540 European ancestry controls; Replication Sample Size: 1,196 non-Hispanic Caucasian individuals; Strongest SNP-Risk Allele: rs9923451-?; SNPs: rs9923451; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~550,000]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity
NCAM2		21552555	TAS		Disease/Trait: Obesity; Initial Sample Size: 520 European ancestry cases, 540 European ancestry controls; Replication Sample Size: 1,196 non-Hispanic Caucasian individuals; Strongest SNP-Risk Allele: rs11088859-?; SNPs: rs11088859; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~550,000]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity
PCDH9		21552555	TAS		Disease/Trait: Obesity; Initial Sample Size: 520 European ancestry cases, 540 European ancestry controls; Replication Sample Size: 1,196 non-Hispanic Caucasian individuals; Strongest SNP-Risk Allele: rs17081231-?; SNPs: rs17081231; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~550,000]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity
FTO		21552555	TAS		Disease/Trait: Obesity; Initial Sample Size: 520 European ancestry cases, 540 European ancestry controls; Replication Sample Size: 1,196 non-Hispanic Caucasian individuals; Strongest SNP-Risk Allele: rs17817449-?; SNPs: rs17817449; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-12; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~550,000]	0.000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity
LHFPL3		21552555	TAS		Disease/Trait: Obesity; Initial Sample Size: 520 European ancestry cases, 540 European ancestry controls; Replication Sample Size: 1,196 non-Hispanic Caucasian individuals; Strongest SNP-Risk Allele: rs10953454-?; SNPs: rs10953454; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~550,000]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity
HIP1		21529783	TAS		Disease/Trait: Alcoholism (12-month weekly alcohol consumption); Initial Sample Size: 8,754 European ancestry family members; Replication Sample Size: 3,393 Australian individuals; Strongest SNP-Risk Allele: rs237238-A; SNPs: rs237238; Context: cds-synon; Risk Allele Frequency: 0.07; p-Value: 7E-6; OR or beta:     .16; Platform [SNPs passing QC]: Illumina [~300,000]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
MBNL2		21529783	TAS		Disease/Trait: Alcoholism (alcohol dependence factor score); Initial Sample Size: 8,754 European ancestry family members; Replication Sample Size: 3,393 Australian individuals; Strongest SNP-Risk Allele: rs9556711-G; SNPs: rs9556711; Context: intron; Risk Allele Frequency: 0.08; p-Value: 8E-7; OR or beta:     .17; Platform [SNPs passing QC]: Illumina [~300,000]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
MBNL2		21529783	TAS		Disease/Trait: Alcoholism (alcohol use disorder factor score); Initial Sample Size: 8,754 European ancestry family members; Replication Sample Size: 3,393 Australian individuals; Strongest SNP-Risk Allele: rs9556711-G; SNPs: rs9556711; Context: intron; Risk Allele Frequency: 0.08; p-Value: 2E-6; OR or beta:     .16; Platform [SNPs passing QC]: Illumina [~300,000]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
DCC		21529783	TAS		Disease/Trait: Alcoholism (alcohol use disorder factor score); Initial Sample Size: 8,754 European ancestry family members; Replication Sample Size: 3,393 Australian individuals; Strongest SNP-Risk Allele: rs768048-C; SNPs: rs768048; Context: intron; Risk Allele Frequency: 0.12; p-Value: 8E-6; OR or beta:     .11; Platform [SNPs passing QC]: Illumina [~300,000]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
C15orf32		21529783	TAS		Disease/Trait: Alcoholism (heaviness of drinking); Initial Sample Size: 8,754 European ancestry family members; Replication Sample Size: 3,393 Australian individuals; Strongest SNP-Risk Allele: rs8040009-T; SNPs: rs8040009; Context: UTR-3; Risk Allele Frequency: 0.21; p-Value: 3E-7; OR or beta:     .12; Platform [SNPs passing QC]: Illumina [~300,000]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
FTO		21544081	TAS		Disease/Trait: Obesity; Initial Sample Size: 5,429 Chinese anacestry individuals, 2,431 Malay ancestry individuals, 2,531 Asian Indian ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1558902-T; SNPs: rs1558902; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta:     .09; Platform [SNPs passing QC]: Illumina [1,283,957] (imputed)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity
PADI4		21505073	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 1,247 Japanese cases, 1,486 Japanese controls; Replication Sample Size: 4,168 Japanese cases, 5,003 Japanese controls; Strongest SNP-Risk Allele: rs2240335-?; SNPs: rs2240335; Context: cds-synon; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [241,523]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
MICA		21499248	TAS		Disease/Trait: Hepatocellular carcinoma; Initial Sample Size: 721 Japanese ancestry cases, 2,890 Japanese ancestry controls; Replication Sample Size: 673 Japanese ancestry cases, 2,596 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2596542-A; SNPs: rs2596542; Context: nearGene-5; Risk Allele Frequency: 0.33; p-Value: 4E-13; OR or beta:    1.39; Platform [SNPs passing QC]: Illumina [432,703]	0.0000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatocellular carcinoma
HNF1B		21499250	TAS		Disease/Trait: Endometrial cancer; Initial Sample Size: 1,265 European ancestry cases, 5,188 European ancestry controls; Replication Sample Size: 3,957 European ancestry cases, 6,886 European ancestry controls; Strongest SNP-Risk Allele: rs4430796-A; SNPs: rs4430796; Context: intron; Risk Allele Frequency: 0.52; p-Value: 7E-10; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [519,655]	0.0000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	endometrial cancer
CMKLR1		21483023	TAS		Disease/Trait: Response to platinum-based chemotherapy in non-small-cell lung cancer; Initial Sample Size: 327 European ancestry individuals; Replication Sample Size: 587 European ancestry individuals; Strongest SNP-Risk Allele: rs1878022-?; SNPs: rs1878022; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta:    1.33; Platform [SNPs passing QC]: Illumina [307,260]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	non-small cell lung carcinoma
CDC42BPB		21471979	TAS		Disease/Trait: Large B-cell lymphoma; Initial Sample Size: 74 Japanese ancestry cases, 934 Japanese ancestry controls; Replication Sample Size: 325 Japanese ancestry cases, 3,309 Japanese ancestry controls; Strongest SNP-Risk Allele: rs751837-?; SNPs: rs751837; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta:    3.51; Platform [SNPs passing QC]: Illumina [444,361]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	diffuse large B-cell lymphoma
ACHE		21490949	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,010 Chinese ancestry cases, 1,945 Chinese ancestry controls, 794 Malaysian ancestry cases, 1,240 Malyasian ancestry controls, 977 Asian Indian ancestry cases, 1,169 Asian Indian ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7636-A; SNPs: rs7636; Context: cds-synon; Risk Allele Frequency: 0.06; p-Value: 5E-6; OR or beta:    1.85; Platform [SNPs passing QC]: Illumina [~2,000,000] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCERG1L		21490949	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,010 Chinese ancestry cases, 1,945 Chinese ancestry controls, 794 Malaysian ancestry cases, 1,240 Malyasian ancestry controls, 977 Asian Indian ancestry cases, 1,169 Asian Indian ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10741243-G; SNPs: rs10741243; Context: intron; Risk Allele Frequency: 0.93; p-Value: 5E-6; OR or beta:    1.75; Platform [SNPs passing QC]: Illumina [~2,000,000] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
HMG20A		21490949	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,010 Chinese ancestry cases, 1,945 Chinese ancestry controls, 794 Malaysian ancestry cases, 1,240 Malyasian ancestry controls, 977 Asian Indian ancestry cases, 1,169 Asian Indian ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7119-T; SNPs: rs7119; Context: ; Risk Allele Frequency: 0.19; p-Value: 5E-7; OR or beta:    1.24; Platform [SNPs passing QC]: Illumina [~2,000,000] (imputed)	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
PCNXL2		21490949	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,010 Chinese ancestry cases, 1,945 Chinese ancestry controls, 794 Malaysian ancestry cases, 1,240 Malyasian ancestry controls, 977 Asian Indian ancestry cases, 1,169 Asian Indian ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12027542-A; SNPs: rs12027542; Context: intron; Risk Allele Frequency: 0.61; p-Value: 4E-7; OR or beta:    1.41; Platform [SNPs passing QC]: Illumina [~2,000,000] (imputed)	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
MARCH1		21490949	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,010 Chinese ancestry cases, 1,945 Chinese ancestry controls, 794 Malaysian ancestry cases, 1,240 Malyasian ancestry controls, 977 Asian Indian ancestry cases, 1,169 Asian Indian ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3792615-T; SNPs: rs3792615; Context: intron; Risk Allele Frequency: 0.95; p-Value: 9E-6; OR or beta:    1.93; Platform [SNPs passing QC]: Illumina [~2,000,000] (imputed)	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CDKAL1		21490949	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,010 Chinese ancestry cases, 1,945 Chinese ancestry controls, 794 Malaysian ancestry cases, 1,240 Malyasian ancestry controls, 977 Asian Indian ancestry cases, 1,169 Asian Indian ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9295474-G; SNPs: rs9295474; Context: intron; Risk Allele Frequency: 0.36; p-Value: 9E-6; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [~2,000,000] (imputed)	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
PLS1		21490949	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,010 Chinese ancestry cases, 1,945 Chinese ancestry controls, 794 Malaysian ancestry cases, 1,240 Malyasian ancestry controls, 977 Asian Indian ancestry cases, 1,169 Asian Indian ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3773506-C; SNPs: rs3773506; Context: UTR-3; Risk Allele Frequency: 0.06; p-Value: 9E-6; OR or beta:    1.81; Platform [SNPs passing QC]: Illumina [~2,000,000] (imputed)	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
C6orf57		21490949	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,010 Chinese ancestry cases, 1,945 Chinese ancestry controls, 794 Malaysian ancestry cases, 1,240 Malyasian ancestry controls, 977 Asian Indian ancestry cases, 1,169 Asian Indian ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1048886-G; SNPs: rs1048886; Context: missense; Risk Allele Frequency: 0.18; p-Value: 3E-8; OR or beta:    1.54; Platform [SNPs passing QC]: Illumina [~2,000,000] (imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
PEX5L		21490949	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,010 Chinese ancestry cases, 1,945 Chinese ancestry controls, 794 Malaysian ancestry cases, 1,240 Malyasian ancestry controls, 977 Asian Indian ancestry cases, 1,169 Asian Indian ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7630877-A; SNPs: rs7630877; Context: intron; Risk Allele Frequency: 0.17; p-Value: 7E-6; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [~2,000,000] (imputed)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CR2		21490949	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 2,010 Chinese ancestry cases, 1,945 Chinese ancestry controls, 794 Malaysian ancestry cases, 1,240 Malyasian ancestry controls, 977 Asian Indian ancestry cases, 1,169 Asian Indian ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17045328-G; SNPs: rs17045328; Context: intron; Risk Allele Frequency: 0.30; p-Value: 7E-6; OR or beta:    1.38; Platform [SNPs passing QC]: Illumina [~2,000,000] (imputed)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
AUTS2		21471458	TAS		Disease/Trait: Alcohol consumption; Initial Sample Size: 26,316 European ancestry individuals; Replication Sample Size: 21,185 European ancestry individuals; Strongest SNP-Risk Allele: rs6943555-A; SNPs: rs6943555; Context: intron; Risk Allele Frequency: 0.24; p-Value: 4E-8; OR or beta:     .01; Platform [SNPs passing QC]: Affymetrix, Illumina, and Perlegen [~2.5 million] (imputed)	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
TNRC6B		21460842	TAS		Disease/Trait: Uterine fibroids; Initial Sample Size: 1,607 Japanese ancestry cases, 1,428 Japanese ancestry controls; Replication Sample Size: 3,439 Japanese ancestry cases, 3,244 Japanese ancestry controls; Strongest SNP-Risk Allele: rs12484776-G; SNPs: rs12484776; Context: intron; Risk Allele Frequency: 0.36; p-Value: 3E-12; OR or beta:    1.23; Platform [SNPs passing QC]: Illumina [457,044]	0.000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	uterine fibroid
CR1		21460840	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 6,688 European ancestry cases, 13,685 European ancestry controls; Replication Sample Size: 13,182 European ancestry cases, 26,161 European ancestry controls; Strongest SNP-Risk Allele: rs3818361-?; SNPs: rs3818361; Context: intron; Risk Allele Frequency: 0.19; p-Value: 4E-14; OR or beta:    1.18; Platform [SNPs passing QC]: Affymetrix & Illumina [496,763]	0.00000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
ABCA7		21460840	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 6,688 European ancestry cases, 13,685 European ancestry controls; Replication Sample Size: 13,182 European ancestry cases, 26,161 European ancestry controls; Strongest SNP-Risk Allele: rs3764650-?; SNPs: rs3764650; Context: intron; Risk Allele Frequency: 0.10; p-Value: 5E-17; OR or beta:    1.23; Platform [SNPs passing QC]: Affymetrix & Illumina [496,763]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
CLU		21460841	TAS		Disease/Trait: Alzheimer's disease (late onset); Initial Sample Size: 8,309 European ancestry cases, 7,366 European ancestry controls; Replication Sample Size: 10,523 European ancestry cases, 28,231 European ancestry controls; Strongest SNP-Risk Allele: rs1532278-?; SNPs: rs1532278; Context: intron; Risk Allele Frequency: 0.64; p-Value: 8E-8; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix & Illumina [2,324,889] (imputed)	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
CR1		21460841	TAS		Disease/Trait: Alzheimer's disease (late onset); Initial Sample Size: 8,309 European ancestry cases, 7,366 European ancestry controls; Replication Sample Size: 10,523 European ancestry cases, 28,231 European ancestry controls; Strongest SNP-Risk Allele: rs6701713-A; SNPs: rs6701713; Context: intron; Risk Allele Frequency: 0.20; p-Value: 5E-10; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix & Illumina [2,324,889] (imputed)	0.0000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
ABCA7		21460841	TAS		Disease/Trait: Alzheimer's disease (late onset); Initial Sample Size: 8,309 European ancestry cases, 7,366 European ancestry controls; Replication Sample Size: 10,523 European ancestry cases, 28,231 European ancestry controls; Strongest SNP-Risk Allele: rs3752246-G; SNPs: rs3752246; Context: missense; Risk Allele Frequency: 0.19; p-Value: 6E-7; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix & Illumina [2,324,889] (imputed)	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
CD2AP		21460841	TAS		Disease/Trait: Alzheimer's disease (late onset); Initial Sample Size: 8,309 European ancestry cases, 7,366 European ancestry controls; Replication Sample Size: 10,523 European ancestry cases, 28,231 European ancestry controls; Strongest SNP-Risk Allele: rs9349407-C; SNPs: rs9349407; Context: intron; Risk Allele Frequency: 0.27; p-Value: 9E-9; OR or beta:    1.11; Platform [SNPs passing QC]: Affymetrix & Illumina [2,324,889] (imputed)	0.000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
CD33		21460841	TAS		Disease/Trait: Alzheimer's disease (late onset); Initial Sample Size: 8,309 European ancestry cases, 7,366 European ancestry controls; Replication Sample Size: 10,523 European ancestry cases, 28,231 European ancestry controls; Strongest SNP-Risk Allele: rs3865444-?; SNPs: rs3865444; Context: nearGene-5; Risk Allele Frequency: 0.70; p-Value: 2E-9; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix & Illumina [2,324,889] (imputed)	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
BLK		21452313	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 801 Korean ancestry cases, 757 Korean ancestry controls; Replication Sample Size: 718 Korean ancestry cases, 719 Korean ancestry controls; Strongest SNP-Risk Allele: rs1600249-?; SNPs: rs1600249; Context: intron; Risk Allele Frequency: 0.67; p-Value: 5E-6; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [441,398]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
ARHGEF3		21452313	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 801 Korean ancestry cases, 757 Korean ancestry controls; Replication Sample Size: 718 Korean ancestry cases, 719 Korean ancestry controls; Strongest SNP-Risk Allele: rs2062583-?; SNPs: rs2062583; Context: intron; Risk Allele Frequency: 0.90; p-Value: 2E-6; OR or beta:    1.59; Platform [SNPs passing QC]: Illumina [441,398]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
TRHDE		21452313	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 801 Korean ancestry cases, 757 Korean ancestry controls; Replication Sample Size: 718 Korean ancestry cases, 719 Korean ancestry controls; Strongest SNP-Risk Allele: rs12831974-?; SNPs: rs12831974; Context: intron; Risk Allele Frequency: 0.42; p-Value: 6E-6; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [441,398]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
BAG3		21459883	TAS		Disease/Trait: Dilated cardiomyopathy; Initial Sample Size: 1,179 European ancestry cases, 1,108 European ancestry controls; Replication Sample Size: 1,165 European ancestry cases, 1,302 European ancestry controls; Strongest SNP-Risk Allele: rs2234962-?; SNPs: rs2234962; Context: missense; Risk Allele Frequency: NR; p-Value: 4E-12; OR or beta:    1.52; Platform [SNPs passing QC]: Illumina [517,382](pooled)	0.000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dilated cardiomyopathy
ZBTB17		21459883	TAS		Disease/Trait: Dilated cardiomyopathy; Initial Sample Size: 1,179 European ancestry cases, 1,108 European ancestry controls; Replication Sample Size: 1,165 European ancestry cases, 1,302 European ancestry controls; Strongest SNP-Risk Allele: rs10927875-?; SNPs: rs10927875; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-9; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [517,382](pooled)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dilated cardiomyopathy
IGLL1		21448238	TAS		Disease/Trait: Migraine; Initial Sample Size: 2,446 European ancestry cases, 8,534 European ancestry controls; Replication Sample Size: 1,106 Dutch cases, 1,766 Dutch controls, 1,851 Australian cases, 4,008 Australian controls; Strongest SNP-Risk Allele: rs140174-G; SNPs: rs140174; Context: nearGene-5; Risk Allele Frequency: 0.26; p-Value: 8E-6; OR or beta:    1.08; Platform [SNPs passing QC]: Affymetrix, Illumina & Perlegen [~2.5 million] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	migraine
GPC5		21441931	TAS		Disease/Trait: Nephrotic syndrome (acquired); Initial Sample Size: 195 Japanese ancestry cases, 1,546 Japanese ancestry controls; Replication Sample Size: 662 Japanese ancestry cases, 4,919 Japanese ancestry controls; Strongest SNP-Risk Allele: rs16946160-A; SNPs: rs16946160; Context: intron; Risk Allele Frequency: 0.17; p-Value: 3E-7; OR or beta:    1.39; Platform [SNPs passing QC]: Perlegen [205,203]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	nephrotic syndrome
TMEM132C		21423239	TAS		Disease/Trait: Suicide attempts in bipolar disorder; Initial Sample Size: 1,201 European ancestry attempters, 1,497 European ancestry non-attempters; Replication Sample Size: 1,295 attempters, 1,822 non-attempters; Strongest SNP-Risk Allele: rs7296262-T; SNPs: rs7296262; Context: intron; Risk Allele Frequency: 0.51; p-Value: 1E-6; OR or beta:    1.22; Platform [SNPs passing QC]: Affymetrix & Illumina [2,408,051] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
ZNF577		21424380	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 302 European ancestry  cases, 321 European ancestry controls; Replication Sample Size: 1,153 cases, 1,215 controls; Strongest SNP-Risk Allele: rs10411161-T; SNPs: rs10411161; Context: intron; Risk Allele Frequency: 0.13; p-Value: 7E-6; OR or beta:    1.42; Platform [SNPs passing QC]: Affymetrix [782,838]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
SPIB		21399635	TAS		Disease/Trait: Primary biliary cirrhosis; Initial Sample Size: 2,774 European ancestry cases, 9,814 European ancestry controls; Replication Sample Size: 620 European ancestry cases, 2,514 European ancestry controls; Strongest SNP-Risk Allele: rs3745516-A; SNPs: rs3745516; Context: intron; Risk Allele Frequency: 0.23; p-Value: 2E-13; OR or beta:    1.38; Platform [SNPs passing QC]: Illumina [507,467]	0.0000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary biliary cirrhosis
PLCL2		21399635	TAS		Disease/Trait: Primary biliary cirrhosis; Initial Sample Size: 2,774 European ancestry cases, 9,814 European ancestry controls; Replication Sample Size: 620 European ancestry cases, 2,514 European ancestry controls; Strongest SNP-Risk Allele: rs1372072-A; SNPs: rs1372072; Context: intron; Risk Allele Frequency: 0.37; p-Value: 2E-8; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [507,467]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary biliary cirrhosis
RPS6KA4		21399635	TAS		Disease/Trait: Primary biliary cirrhosis; Initial Sample Size: 2,774 European ancestry cases, 9,814 European ancestry controls; Replication Sample Size: 620 European ancestry cases, 2,514 European ancestry controls; Strongest SNP-Risk Allele: rs538147-G; SNPs: rs538147; Context: intron; Risk Allele Frequency: 0.61; p-Value: 2E-10; OR or beta:    1.23; Platform [SNPs passing QC]: Illumina [507,467]	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary biliary cirrhosis
CLEC16A		21399635	TAS		Disease/Trait: Primary biliary cirrhosis; Initial Sample Size: 2,774 European ancestry cases, 9,814 European ancestry controls; Replication Sample Size: 620 European ancestry cases, 2,514 European ancestry controls; Strongest SNP-Risk Allele: rs12924729-G; SNPs: rs12924729; Context: intron; Risk Allele Frequency: 0.68; p-Value: 3E-12; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [507,467]	0.000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary biliary cirrhosis
TNFRSF1A		21399635	TAS		Disease/Trait: Primary biliary cirrhosis; Initial Sample Size: 2,774 European ancestry cases, 9,814 European ancestry controls; Replication Sample Size: 620 European ancestry cases, 2,514 European ancestry controls; Strongest SNP-Risk Allele: rs1800693-C; SNPs: rs1800693; Context: intron; Risk Allele Frequency: 0.40; p-Value: 2E-9; OR or beta:    1.22; Platform [SNPs passing QC]: Illumina [507,467]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary biliary cirrhosis
PNPLA3		21423719	TAS		Disease/Trait: Nonalcoholic fatty liver disease; Initial Sample Size: 7,176 European ancestry individuals; Replication Sample Size: 592 European ancestry cases, 1,405 European ancestry controls; Strongest SNP-Risk Allele: rs738409-G; SNPs: rs738409; Context: missense; Risk Allele Frequency: 0.23; p-Value: 4E-34; OR or beta:     .26; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.4 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
ZNF259		21386085	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 22,161 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2075290-C; SNPs: rs2075290; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-9; OR or beta:     .26; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
BUD13		21386085	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 22,161 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10790162-A; SNPs: rs10790162; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-9; OR or beta:     .25; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
LPL		21386085	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 22,161 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs295-A; SNPs: rs295; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-9; OR or beta:     .17; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
TFAP2B		21386085	TAS		Disease/Trait: Metabolic syndrome (bivariate traits); Initial Sample Size: 22,161 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2206277-A; SNPs: rs2206277; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta:     .17; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
BUD13		21386085	TAS		Disease/Trait: Metabolic syndrome (bivariate traits); Initial Sample Size: 22,161 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11820589-A; SNPs: rs11820589; Context: missense; Risk Allele Frequency: NR; p-Value: 6E-9; OR or beta:     .32; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
LPL		21386085	TAS		Disease/Trait: Metabolic syndrome (bivariate traits); Initial Sample Size: 22,161 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs301-C; SNPs: rs301; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-11; OR or beta:     .22; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.00000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
ABCB11		21386085	TAS		Disease/Trait: Metabolic syndrome (bivariate traits); Initial Sample Size: 22,161 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs569805-A; SNPs: rs569805; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-8; OR or beta:     .16; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
CETP		21386085	TAS		Disease/Trait: Metabolic syndrome (bivariate traits); Initial Sample Size: 22,161 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9939224-G; SNPs: rs9939224; Context: intron; Risk Allele Frequency: 0.46; p-Value: 7E-12; OR or beta:     .31; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.000000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
ZNF259		21386085	TAS		Disease/Trait: Metabolic syndrome (bivariate traits); Initial Sample Size: 22,161 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12286037-C; SNPs: rs12286037; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta:     .32; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
HHIPL1		21378990	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 22,233 European ancestry cases, 64,762 European ancestry controls; Replication Sample Size: 28,834 cases, 27,674 controls, 2,115 individuals.; Strongest SNP-Risk Allele: rs2895811-C; SNPs: rs2895811; Context: intron; Risk Allele Frequency: 0.43; p-Value: 1E-10; OR or beta:    1.07; Platform [SNPs passing QC]: Affymetrix & Illumina {~2.3 million] (imputed)	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
MRAS		21378990	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 22,233 European ancestry cases, 64,762 European ancestry controls; Replication Sample Size: 28,834 cases, 27,674 controls, 2,115 individuals.; Strongest SNP-Risk Allele: rs2306374-C; SNPs: rs2306374; Context: intron; Risk Allele Frequency: 0.18; p-Value: 3E-8; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix & Illumina {~2.3 million] (imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
ZC3HC1		21378990	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 22,233 European ancestry cases, 64,762 European ancestry controls; Replication Sample Size: 28,834 cases, 27,674 controls, 2,115 individuals.; Strongest SNP-Risk Allele: rs11556924-C; SNPs: rs11556924; Context: missense; Risk Allele Frequency: 0.62; p-Value: 9E-18; OR or beta:    1.09; Platform [SNPs passing QC]: Affymetrix & Illumina {~2.3 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
ADAMTS7		21378990	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 22,233 European ancestry cases, 64,762 European ancestry controls; Replication Sample Size: 28,834 cases, 27,674 controls, 2,115 individuals.; Strongest SNP-Risk Allele: rs3825807-A; SNPs: rs3825807; Context: missense; Risk Allele Frequency: 0.57; p-Value: 1E-12; OR or beta:    1.08; Platform [SNPs passing QC]: Affymetrix & Illumina {~2.3 million] (imputed)	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
ANKS1A		21378990	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 22,233 European ancestry cases, 64,762 European ancestry controls; Replication Sample Size: 28,834 cases, 27,674 controls, 2,115 individuals.; Strongest SNP-Risk Allele: rs17609940-G; SNPs: rs17609940; Context: intron; Risk Allele Frequency: 0.75; p-Value: 1E-8; OR or beta:    1.07; Platform [SNPs passing QC]: Affymetrix & Illumina {~2.3 million] (imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
WDR12		21378990	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 22,233 European ancestry cases, 64,762 European ancestry controls; Replication Sample Size: 28,834 cases, 27,674 controls, 2,115 individuals.; Strongest SNP-Risk Allele: rs6725887-C; SNPs: rs6725887; Context: intron; Risk Allele Frequency: 0.15; p-Value: 1E-9; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix & Illumina {~2.3 million] (imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
TCF21		21378990	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 22,233 European ancestry cases, 64,762 European ancestry controls; Replication Sample Size: 28,834 cases, 27,674 controls, 2,115 individuals.; Strongest SNP-Risk Allele: rs12190287-C; SNPs: rs12190287; Context: UTR-3; Risk Allele Frequency: 0.62; p-Value: 1E-12; OR or beta:    1.08; Platform [SNPs passing QC]: Affymetrix & Illumina {~2.3 million] (imputed)	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
PPAP2B		21378990	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 22,233 European ancestry cases, 64,762 European ancestry controls; Replication Sample Size: 28,834 cases, 27,674 controls, 2,115 individuals.; Strongest SNP-Risk Allele: rs17114036-A; SNPs: rs17114036; Context: intron; Risk Allele Frequency: 0.91; p-Value: 4E-19; OR or beta:    1.17; Platform [SNPs passing QC]: Affymetrix & Illumina {~2.3 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
PHACTR1		21378990	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 22,233 European ancestry cases, 64,762 European ancestry controls; Replication Sample Size: 28,834 cases, 27,674 controls, 2,115 individuals.; Strongest SNP-Risk Allele: rs12526453-C; SNPs: rs12526453; Context: intron; Risk Allele Frequency: 0.67; p-Value: 1E-9; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix & Illumina {~2.3 million] (imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
MIA3		21378990	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 22,233 European ancestry cases, 64,762 European ancestry controls; Replication Sample Size: 28,834 cases, 27,674 controls, 2,115 individuals.; Strongest SNP-Risk Allele: rs17465637-C; SNPs: rs17465637; Context: intron; Risk Allele Frequency: 0.74; p-Value: 1E-8; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix & Illumina {~2.3 million] (imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
LPA		21378990	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 22,233 European ancestry cases, 64,762 European ancestry controls; Replication Sample Size: 28,834 cases, 27,674 controls, 2,115 individuals.; Strongest SNP-Risk Allele: rs3798220-C; SNPs: rs3798220; Context: missense; Risk Allele Frequency: 0.02; p-Value: 3E-11; OR or beta:    1.51; Platform [SNPs passing QC]: Affymetrix & Illumina {~2.3 million] (imputed)	0.00000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
SH2B3		21378990	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 22,233 European ancestry cases, 64,762 European ancestry controls; Replication Sample Size: 28,834 cases, 27,674 controls, 2,115 individuals.; Strongest SNP-Risk Allele: rs3184504-T; SNPs: rs3184504; Context: missense; Risk Allele Frequency: 0.44; p-Value: 6E-6; OR or beta:    1.07; Platform [SNPs passing QC]: Affymetrix & Illumina {~2.3 million] (imputed)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
PPAP2B		21378988	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,424 European ancestry cases, 7,268 European ancestry controls, 6,996 South Asian cases, 7,794 South Asian controls; Replication Sample Size: 18,049 European ancestry cases, 16,357 European ancestry controls, 3,359 South Asian cases, 2,828 South Asian controls; Strongest SNP-Risk Allele: rs17114046-?; SNPs: rs17114046; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [574,919]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
PHACTR1		21378988	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,424 European ancestry cases, 7,268 European ancestry controls, 6,996 South Asian cases, 7,794 South Asian controls; Replication Sample Size: 18,049 European ancestry cases, 16,357 European ancestry controls, 3,359 South Asian cases, 2,828 South Asian controls; Strongest SNP-Risk Allele: rs1332844-T; SNPs: rs1332844; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-8; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina [574,919]	0.00000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
LIPA		21378988	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,424 European ancestry cases, 7,268 European ancestry controls, 6,996 South Asian cases, 7,794 South Asian controls; Replication Sample Size: 18,049 European ancestry cases, 16,357 European ancestry controls, 3,359 South Asian cases, 2,828 South Asian controls; Strongest SNP-Risk Allele: rs1412444-T; SNPs: rs1412444; Context: intron; Risk Allele Frequency: 0.42; p-Value: 3E-13; OR or beta:    1.09; Platform [SNPs passing QC]: Illumina [574,919]	0.0000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
PHACTR1		21378988	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,424 European ancestry cases, 7,268 European ancestry controls, 6,996 South Asian cases, 7,794 South Asian controls; Replication Sample Size: 18,049 European ancestry cases, 16,357 European ancestry controls, 3,359 South Asian cases, 2,828 South Asian controls; Strongest SNP-Risk Allele: rs9349379-?; SNPs: rs9349379; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-26; OR or beta: NR; Platform [SNPs passing QC]: Illumina [574,919]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
KIAA1462		21378988	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,424 European ancestry cases, 7,268 European ancestry controls, 6,996 South Asian cases, 7,794 South Asian controls; Replication Sample Size: 18,049 European ancestry cases, 16,357 European ancestry controls, 3,359 South Asian cases, 2,828 South Asian controls; Strongest SNP-Risk Allele: rs2505083-C; SNPs: rs2505083; Context: intron; Risk Allele Frequency: 0.38; p-Value: 4E-8; OR or beta:    1.07; Platform [SNPs passing QC]: Illumina [574,919]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
TMC2		21408207	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 811 anti-dsDNA positive European ancestry cases, 906 anti-dsDNA negative European ancestry cases, 4,813 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6049839-T; SNPs: rs6049839; Context: intron; Risk Allele Frequency: 0.40; p-Value: 8E-6; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [421,318] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
TNXB		21408207	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 811 anti-dsDNA positive European ancestry cases, 906 anti-dsDNA negative European ancestry cases, 4,813 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1150754-A; SNPs: rs1150754; Context: intron; Risk Allele Frequency: 0.13; p-Value: 6E-29; OR or beta:    2.21; Platform [SNPs passing QC]: Illumina [421,318] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
STAT4		21408207	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 811 anti-dsDNA positive European ancestry cases, 906 anti-dsDNA negative European ancestry cases, 4,813 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7574865-T; SNPs: rs7574865; Context: intron; Risk Allele Frequency: 0.23; p-Value: 2E-20; OR or beta:    1.77; Platform [SNPs passing QC]: Illumina [421,318] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
LAMC2		21408207	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 811 anti-dsDNA positive European ancestry cases, 906 anti-dsDNA negative European ancestry cases, 4,813 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs525410-?; SNPs: rs525410; Context: intron; Risk Allele Frequency: 0.49; p-Value: 6E-7; OR or beta:    1.33; Platform [SNPs passing QC]: Illumina [421,318] (imputed)	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
UBE2L3		21408207	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 811 anti-dsDNA positive European ancestry cases, 906 anti-dsDNA negative European ancestry cases, 4,813 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs5754217-T; SNPs: rs5754217; Context: intron; Risk Allele Frequency: 0.19; p-Value: 2E-6; OR or beta:    1.38; Platform [SNPs passing QC]: Illumina [421,318] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
OR4A15		21408207	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 811 anti-dsDNA positive European ancestry cases, 906 anti-dsDNA negative European ancestry cases, 4,813 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7927370-?; SNPs: rs7927370; Context: missense; Risk Allele Frequency: 0.94; p-Value: 7E-6; OR or beta:    1.92; Platform [SNPs passing QC]: Illumina [421,318] (imputed)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
ITGAM		21408207	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 811 anti-dsDNA positive European ancestry cases, 906 anti-dsDNA negative European ancestry cases, 4,813 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9888739-T; SNPs: rs9888739; Context: intron; Risk Allele Frequency: 0.13; p-Value: 1E-15; OR or beta:    1.80; Platform [SNPs passing QC]: Illumina [421,318] (imputed)	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
NAALADL2		21408207	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 811 anti-dsDNA positive European ancestry cases, 906 anti-dsDNA negative European ancestry cases, 4,813 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1463525-?; SNPs: rs1463525; Context: intron; Risk Allele Frequency: 0.43; p-Value: 8E-6; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [421,318] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
STAT4		21408207	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 811 anti-dsDNA positive European ancestry cases, 906 anti-dsDNA negative European ancestry cases, 4,813 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7574865-T; SNPs: rs7574865; Context: intron; Risk Allele Frequency: 0.28; p-Value: 8E-6; OR or beta:    1.41; Platform [SNPs passing QC]: Illumina [421,318] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
DYRK1A		21364930	TAS		Disease/Trait: HIV-1 replication; Initial Sample Size: 191 European ancestry individuals; Replication Sample Size: 31 individuals; Strongest SNP-Risk Allele: rs12483205-?; SNPs: rs12483205; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [494,656]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
STAT4		21383967	TAS		Disease/Trait: Celiac disease and Rheumatoid arthritis; Initial Sample Size: 4,533 European ancestry celiac disease cases, 5,539 European ancestry rheumatoid arthritis cases, 27,981 European ancestry controls; Replication Sample Size: 2,169 celiac disease cases, 2,845 rheumatoid arthritis cases, 7,199 controls; Strongest SNP-Risk Allele: rs7574865-T; SNPs: rs7574865; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-10; OR or beta: NR; Platform [SNPs passing QC]: Illumina [472,854]	0.0000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis;celiac disease
SPRED2		21383967	TAS		Disease/Trait: Celiac disease and Rheumatoid arthritis; Initial Sample Size: 4,533 European ancestry celiac disease cases, 5,539 European ancestry rheumatoid arthritis cases, 27,981 European ancestry controls; Replication Sample Size: 2,169 celiac disease cases, 2,845 rheumatoid arthritis cases, 7,199 controls; Strongest SNP-Risk Allele: rs1876518-?; SNPs: rs1876518; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [472,854]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis;celiac disease
PTPN2		21383967	TAS		Disease/Trait: Celiac disease and Rheumatoid arthritis; Initial Sample Size: 4,533 European ancestry celiac disease cases, 5,539 European ancestry rheumatoid arthritis cases, 27,981 European ancestry controls; Replication Sample Size: 2,169 celiac disease cases, 2,845 rheumatoid arthritis cases, 7,199 controls; Strongest SNP-Risk Allele: rs1893217-G; SNPs: rs1893217; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-12; OR or beta: NR; Platform [SNPs passing QC]: Illumina [472,854]	0.000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis;celiac disease
ELMO1		21383967	TAS		Disease/Trait: Celiac disease and Rheumatoid arthritis; Initial Sample Size: 4,533 European ancestry celiac disease cases, 5,539 European ancestry rheumatoid arthritis cases, 27,981 European ancestry controls; Replication Sample Size: 2,169 celiac disease cases, 2,845 rheumatoid arthritis cases, 7,199 controls; Strongest SNP-Risk Allele: rs11984075-G; SNPs: rs11984075; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [472,854]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis;celiac disease
CD247		21383967	TAS		Disease/Trait: Celiac disease and Rheumatoid arthritis; Initial Sample Size: 4,533 European ancestry celiac disease cases, 5,539 European ancestry rheumatoid arthritis cases, 27,981 European ancestry controls; Replication Sample Size: 2,169 celiac disease cases, 2,845 rheumatoid arthritis cases, 7,199 controls; Strongest SNP-Risk Allele: rs864537-?; SNPs: rs864537; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-11; OR or beta: NR; Platform [SNPs passing QC]: Illumina [472,854]	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis;celiac disease
UBASH3A		21383967	TAS		Disease/Trait: Celiac disease and Rheumatoid arthritis; Initial Sample Size: 4,533 European ancestry celiac disease cases, 5,539 European ancestry rheumatoid arthritis cases, 27,981 European ancestry controls; Replication Sample Size: 2,169 celiac disease cases, 2,845 rheumatoid arthritis cases, 7,199 controls; Strongest SNP-Risk Allele: rs11203203-A; SNPs: rs11203203; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [472,854]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis;celiac disease
IFI16		21383967	TAS		Disease/Trait: Celiac disease and Rheumatoid arthritis; Initial Sample Size: 4,533 European ancestry celiac disease cases, 5,539 European ancestry rheumatoid arthritis cases, 27,981 European ancestry controls; Replication Sample Size: 2,169 celiac disease cases, 2,845 rheumatoid arthritis cases, 7,199 controls; Strongest SNP-Risk Allele: rs1772408-?; SNPs: rs1772408; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [472,854]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis;celiac disease
NCAN		21353194	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 682 European ancestry cases, 1,300 European ancestry controls; Replication Sample Size: 7,759 European ancestry cases, 34,062 European ancestry controls; Strongest SNP-Risk Allele: rs1064395-A; SNPs: rs1064395; Context: UTR-3; Risk Allele Frequency: 0.16; p-Value: 2E-9; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina [511,978]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
HLA-DQA1		21323541	TAS		Disease/Trait: Nephropathy (idiopathic membranous); Initial Sample Size: 556 European ancestry cases, 2,338 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2187668-?; SNPs: rs2187668; Context: intron; Risk Allele Frequency: 0.13; p-Value: 8E-93; OR or beta:    4.32; Platform [SNPs passing QC]: Illumina [242,824]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	membranous glomerulonephritis
IGSF5		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs1735151-T; SNPs: rs1735151; Context: intron; Risk Allele Frequency: 0.58; p-Value: 9E-6; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
DTNB		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs11684202-A; SNPs: rs11684202; Context: intron; Risk Allele Frequency: 0.86; p-Value: 6E-6; OR or beta:     .09; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
PDGFD		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs10895547-T; SNPs: rs10895547; Context: intron; Risk Allele Frequency: 0.23; p-Value: 3E-6; OR or beta:     .07; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
PLEKHO2		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs12595292-A; SNPs: rs12595292; Context: cds-synon; Risk Allele Frequency: 0.12; p-Value: 9E-6; OR or beta:     .11; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
ZFHX3		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs16971384-A; SNPs: rs16971384; Context: intron; Risk Allele Frequency: 0.55; p-Value: 5E-6; OR or beta:     .07; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
DNM2		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs11671653-A; SNPs: rs11671653; Context: intron; Risk Allele Frequency: 0.11; p-Value: 9E-7; OR or beta:     .11; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
TCF7L2		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs7901695-?; SNPs: rs7901695; Context: intron; Risk Allele Frequency: 0.45; p-Value: 1E-6; OR or beta:    1.19; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
LAMC2		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs1028771-A; SNPs: rs1028771; Context: intron; Risk Allele Frequency: 0.97; p-Value: 4E-6; OR or beta:     .22; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
CSMD1		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs4875320-A; SNPs: rs4875320; Context: intron; Risk Allele Frequency: 0.82; p-Value: 6E-6; OR or beta:     .10; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
ABCA1		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs2515629-A; SNPs: rs2515629; Context: intron; Risk Allele Frequency: 0.78; p-Value: 5E-7; OR or beta:     .12; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
EDC4		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs8060686-T; SNPs: rs8060686; Context: cds-synon; Risk Allele Frequency: 0.38; p-Value: 8E-6; OR or beta:     .07; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
KLHL29		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs4665630-?; SNPs: rs4665630; Context: intron; Risk Allele Frequency: 0.49; p-Value: 1E-7; OR or beta:    1.21; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
OPRM1		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs675026-?; SNPs: rs675026; Context: cds-synon; Risk Allele Frequency: 0.72; p-Value: 5E-6; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
RNF130		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs13161895-T; SNPs: rs13161895; Context: intron; Risk Allele Frequency: 0.08; p-Value: 6E-7; OR or beta:     .15; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
SLC12A9		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs7801190-C; SNPs: rs7801190; Context: ; Risk Allele Frequency: 0.73; p-Value: 3E-8; OR or beta:    1.31; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
DOCK6		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs4804155-C; SNPs: rs4804155; Context: intron; Risk Allele Frequency: 0.69; p-Value: 5E-6; OR or beta:     .08; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
CELSR2		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs12740374-T; SNPs: rs12740374; Context: UTR-3; Risk Allele Frequency: 0.25; p-Value: 9E-29; OR or beta:     .18; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
TNIK		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs11920719-A; SNPs: rs11920719; Context: intron; Risk Allele Frequency: 0.77; p-Value: 4E-6; OR or beta:     .10; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
SMARCA4		21347282	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 8,090 African American individuals; Replication Sample Size: 8,849 African American or African-Caribbean individuals; Strongest SNP-Risk Allele: rs11669133-A; SNPs: rs11669133; Context: intron; Risk Allele Frequency: 0.06; p-Value: 1E-8; OR or beta:     .17; Platform [SNPs passing QC]: Affymetrix [~2.74 million] (imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
CGNL1		21305692	TAS		Disease/Trait: Bipolar disorder (age of onset and psychomotor symptoms); Initial Sample Size: 2,836 European Caucasian cases; 2,744 European Caucasian controls; Replication Sample Size: 3,916 European Caucasian cases; 5,112 controls; Strongest SNP-Risk Allele: rs2934442-?; SNPs: rs2934442; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.02; Platform [SNPs passing QC]: Affymetrix & Illumina [2,373,895] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
PRKAG2		21305692	TAS		Disease/Trait: Bipolar disorder (age of onset and psychomotor symptoms); Initial Sample Size: 2,836 European Caucasian cases; 2,744 European Caucasian controls; Replication Sample Size: 3,916 European Caucasian cases; 5,112 controls; Strongest SNP-Risk Allele: rs7795096-?; SNPs: rs7795096; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix & Illumina [2,373,895] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
ARHGAP22		21310492	TAS		Disease/Trait: Diabetic retinopathy ; Initial Sample Size: 174 Han Chinese Type 2 diabetics with diabetic retinopathy, 575 Han Chinese Type 2 diabetics w/o diabetic retinopathy, 100 Han Chinese controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4838605-C; SNPs: rs4838605; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-9; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~550,000]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	diabetic retinopathy
MYSM1		21310492	TAS		Disease/Trait: Diabetic retinopathy ; Initial Sample Size: 174 Han Chinese Type 2 diabetics with diabetic retinopathy, 575 Han Chinese Type 2 diabetics w/o diabetic retinopathy, 100 Han Chinese controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2811893-T; SNPs: rs2811893; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~550,000]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	diabetic retinopathy
HS6ST3		21310492	TAS		Disease/Trait: Diabetic retinopathy ; Initial Sample Size: 174 Han Chinese Type 2 diabetics with diabetic retinopathy, 575 Han Chinese Type 2 diabetics w/o diabetic retinopathy, 100 Han Chinese controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2038823-C; SNPs: rs2038823; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-11; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~550,000]	0.00000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	diabetic retinopathy
PLXDC2		21310492	TAS		Disease/Trait: Diabetic retinopathy ; Initial Sample Size: 174 Han Chinese Type 2 diabetics with diabetic retinopathy, 575 Han Chinese Type 2 diabetics w/o diabetic retinopathy, 100 Han Chinese controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1571942-C; SNPs: rs1571942; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~550,000]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	diabetic retinopathy
CCNY		21297633	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 6,687 European ancestry cases, 19,718 European ancestry controls; Replication Sample Size: 9,628 European ancestry cases, 12,917 European ancestry controls; Strongest SNP-Risk Allele: rs12261843-G; SNPs: rs12261843; Context: intron; Risk Allele Frequency: 0.29; p-Value: 7E-10; OR or beta:    1.07; Platform [SNPs passing QC]: Affymetrix & Illumina [~1.1 million] (imputed)	0.0000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
LSP1		21297633	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 6,687 European ancestry cases, 19,718 European ancestry controls; Replication Sample Size: 9,628 European ancestry cases, 12,917 European ancestry controls; Strongest SNP-Risk Allele: rs907611-A; SNPs: rs907611; Context: nearGene-5; Risk Allele Frequency: 0.32; p-Value: 1E-10; OR or beta:    1.08; Platform [SNPs passing QC]: Affymetrix & Illumina [~1.1 million] (imputed)	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
GNA12		21297633	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 6,687 European ancestry cases, 19,718 European ancestry controls; Replication Sample Size: 9,628 European ancestry cases, 12,917 European ancestry controls; Strongest SNP-Risk Allele: rs798502-A; SNPs: rs798502; Context: intron; Risk Allele Frequency: 0.71; p-Value: 3E-15; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix & Illumina [~1.1 million] (imputed)	0.000000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
IL23R		21297633	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 6,687 European ancestry cases, 19,718 European ancestry controls; Replication Sample Size: 9,628 European ancestry cases, 12,917 European ancestry controls; Strongest SNP-Risk Allele: rs11209026-G; SNPs: rs11209026; Context: missense; Risk Allele Frequency: 0.94; p-Value: 5E-28; OR or beta:    1.74; Platform [SNPs passing QC]: Affymetrix & Illumina [~1.1 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
C1orf106		21297633	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 6,687 European ancestry cases, 19,718 European ancestry controls; Replication Sample Size: 9,628 European ancestry cases, 12,917 European ancestry controls; Strongest SNP-Risk Allele: rs7554511-C; SNPs: rs7554511; Context: intron; Risk Allele Frequency: 0.72; p-Value: 2E-13; OR or beta:    1.19; Platform [SNPs passing QC]: Affymetrix & Illumina [~1.1 million] (imputed)	0.0000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
PUS10		21297633	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 6,687 European ancestry cases, 19,718 European ancestry controls; Replication Sample Size: 9,628 European ancestry cases, 12,917 European ancestry controls; Strongest SNP-Risk Allele: rs7608910-G; SNPs: rs7608910; Context: intron; Risk Allele Frequency: 0.39; p-Value: 2E-14; OR or beta:    1.19; Platform [SNPs passing QC]: Affymetrix & Illumina [~1.1 million] (imputed)	0.00000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
DAP		21297633	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 6,687 European ancestry cases, 19,718 European ancestry controls; Replication Sample Size: 9,628 European ancestry cases, 12,917 European ancestry controls; Strongest SNP-Risk Allele: rs267939-C; SNPs: rs267939; Context: intron; Risk Allele Frequency: 0.37; p-Value: 6E-12; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix & Illumina [~1.1 million] (imputed)	0.000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
IL7R		21297633	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 6,687 European ancestry cases, 19,718 European ancestry controls; Replication Sample Size: 9,628 European ancestry cases, 12,917 European ancestry controls; Strongest SNP-Risk Allele: rs3194051-G; SNPs: rs3194051; Context: missense; Risk Allele Frequency: 0.27; p-Value: 4E-8; OR or beta:    1.07; Platform [SNPs passing QC]: Affymetrix & Illumina [~1.1 million] (imputed)	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
BTBD1		21326860	TAS		Disease/Trait: Kawasaki disease; Initial Sample Size: 250 Han Chinese cases, 446 Han Chinese controls; Replication Sample Size: 208 Han Chinese cases, 366 Han Chinese controls; Strongest SNP-Risk Allele: rs1568657-G; SNPs: rs1568657; Context: intron; Risk Allele Frequency: 0.52; p-Value: 7E-6; OR or beta:    1.41; Platform [SNPs passing QC]: Affymetrix [723,638]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Kawasaki disease
LRRK2		21292315	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 5,333 European ancestry cases, 12,019 European ancestry controls; Replication Sample Size: 7,053 European ancestry cases, 9,007 European ancestry controls; Strongest SNP-Risk Allele: rs1491942-G; SNPs: rs1491942; Context: intron; Risk Allele Frequency: 0.08; p-Value: 6E-14; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [7,689,524] (imputed)	0.00000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
PHF11		21348951	TAS		Disease/Trait: Cardiac hypertrophy; Initial Sample Size: 851 Old Order Amish individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs2031532-?; SNPs: rs2031532; Context: cds-synon; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [361,034]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertrophic cardiomyopathy
ESRRG		21348951	TAS		Disease/Trait: Cardiac hypertrophy; Initial Sample Size: 851 Old Order Amish individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs12757165-?; SNPs: rs12757165; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [361,034]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertrophic cardiomyopathy
COL17A1		21348951	TAS		Disease/Trait: Cardiac hypertrophy; Initial Sample Size: 851 Old Order Amish individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs1320448-?; SNPs: rs1320448; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [361,034]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertrophic cardiomyopathy
RAF1		21348951	TAS		Disease/Trait: Cardiac hypertrophy; Initial Sample Size: 851 Old Order Amish individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs3729931-?; SNPs: rs3729931; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [361,034]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertrophic cardiomyopathy
FGF1		21348951	TAS		Disease/Trait: Cardiac hypertrophy; Initial Sample Size: 851 Old Order Amish individuals; Replication Sample Size: ; Strongest SNP-Risk Allele: rs152528-?; SNPs: rs152528; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [361,034]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertrophic cardiomyopathy
PKNOX2		21298047	TAS		Disease/Trait: Substance dependence; Initial Sample Size: 2,524 individuals of European ancestry, 1,103 individuals of African ancestry; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12284594-G; SNPs: rs12284594; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-8; OR or beta:    1.77; Platform [SNPs passing QC]: Illumina [830,696]	0.00000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	substance dependence
PUS10		21298027	TAS		Disease/Trait: Crohn's disease and celiac disease; Initial Sample Size: 3,230 European ancestry Crohn's disease cases, 4,829 European ancestry Crohn's disease controls, 768 European ancestry celiac disease cases, 1,422 European ancestry celiac disease controls; Replication Sample Size: 3,149 European ancestry Crohn's disease cases, 4,714 European ancestry Crohn's disease controls, 1,835 European ancestry celiac disease cases, 1,669 European ancestry celiac disease controls; Strongest SNP-Risk Allele: rs10188217-C; SNPs: rs10188217; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-11; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [471,504]	0.00000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease;celiac disease
CCDC63		21270382	TAS		Disease/Trait: Alcohol consumption; Initial Sample Size: 1,721 Korean male drinkers; Replication Sample Size: 1,113 Korean male drinkers; Strongest SNP-Risk Allele: rs10849915-G; SNPs: rs10849915; Context: intron; Risk Allele Frequency: 0.18; p-Value: 1E-23; OR or beta:     .55; Platform [SNPs passing QC]: Affymetrix [315,914]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
OAS3		21270382	TAS		Disease/Trait: Alcohol consumption; Initial Sample Size: 1,721 Korean male drinkers; Replication Sample Size: 1,113 Korean male drinkers; Strongest SNP-Risk Allele: rs2072134-A; SNPs: rs2072134; Context: UTR-3; Risk Allele Frequency: 0.11; p-Value: 6E-17; OR or beta:     .61; Platform [SNPs passing QC]: Affymetrix [315,914]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol abuse
SLC4A7		21263130	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 1,694 British cases, 2,365 British controls, 1,145 European ancestry cases, 1,142 European ancestry controls; Replication Sample Size: 7,317 British cases, 8,124 British controls; Strongest SNP-Risk Allele: rs4973768-C; SNPs: rs4973768; Context: UTR-3; Risk Allele Frequency: 0.49; p-Value: 2E-8; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [~296,114]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
FGFR2		21263130	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 1,694 British cases, 2,365 British controls, 1,145 European ancestry cases, 1,142 European ancestry controls; Replication Sample Size: 7,317 British cases, 8,124 British controls; Strongest SNP-Risk Allele: rs1219648-?; SNPs: rs1219648; Context: intron; Risk Allele Frequency: 0.42; p-Value: 1E-30; OR or beta:    1.31; Platform [SNPs passing QC]: Illumina [~296,114]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
SLC22A3		21242260	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 1,583 Japanese cases, 1,898 Japanese controls; Replication Sample Size: Up to 4,584 Japanese cases, 2,596 Japanese controls, 225 Korean cases, 377 Korean controls; Strongest SNP-Risk Allele: rs7758229-T; SNPs: rs7758229; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-9; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [391,749]	0.000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
ABO		21239051	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 1,808 European ancestry AngCAD cases, 915 European ancestry AngCAD controls, 4,572 European ancestry AngCAD with MI cases, 2,739 European ancestry AngCAD without MI controls; Replication Sample Size: 10,585 European ancestry AngCAD cases, 6,468 European ancestry AngCAD controls, 1,211 European ancestry AngCAD with MI cases, 905 European ancestry AngCAD without MI controls; Strongest SNP-Risk Allele: rs514659-C; SNPs: rs514659; Context: intron; Risk Allele Frequency: 0.37; p-Value: 8E-9; OR or beta:    1.21; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.4 million] (imputed)	0.000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
ADAMTS7		21239051	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 1,808 European ancestry AngCAD cases, 915 European ancestry AngCAD controls, 4,572 European ancestry AngCAD with MI cases, 2,739 European ancestry AngCAD without MI controls; Replication Sample Size: 10,585 European ancestry AngCAD cases, 6,468 European ancestry AngCAD controls, 1,211 European ancestry AngCAD with MI cases, 905 European ancestry AngCAD without MI controls; Strongest SNP-Risk Allele: rs1994016-C; SNPs: rs1994016; Context: intron; Risk Allele Frequency: 0.60; p-Value: 5E-13; OR or beta:    1.19; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.4 million] (imputed)	0.0000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
TRHDE		21452313	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 801 Korean cases, 757 Korean controls; Replication Sample Size: 718 Korean cases, 719 Korean controls; Strongest SNP-Risk Allele: rs12831974-?; SNPs: rs12831974; Context: intron; Risk Allele Frequency: 0.42; p-Value: 6E-6; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [441,398]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
BLK		21452313	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 801 Korean cases, 757 Korean controls; Replication Sample Size: 718 Korean cases, 719 Korean controls; Strongest SNP-Risk Allele: rs1600249-?; SNPs: rs1600249; Context: intron; Risk Allele Frequency: 0.67; p-Value: 5E-6; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [441,398]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
ARHGEF3		21452313	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 801 Korean cases, 757 Korean controls; Replication Sample Size: 718 Korean cases, 719 Korean controls; Strongest SNP-Risk Allele: rs2062583-?; SNPs: rs2062583; Context: intron; Risk Allele Frequency: 0.90; p-Value: 2E-6; OR or beta:    1.59; Platform [SNPs passing QC]: Illumina [441,398]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
PADI4		21452313	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 801 Korean cases, 757 Korean controls; Replication Sample Size: 718 Korean cases, 719 Korean controls; Strongest SNP-Risk Allele: rs2240335-?; SNPs: rs2240335; Context: cds-synon; Risk Allele Frequency: 0.40; p-Value: 2E-8; OR or beta:    1.50; Platform [SNPs passing QC]: Illumina [441,398]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
PELI1		21221998	TAS		Disease/Trait: Kawasaki disease; Initial Sample Size: 186 Korean child cases, 600 Korean adult controls; Replication Sample Size: 266 Korean child cases, 600 Korean adult controls, 248 Taiwanese cases,442 Taiwanese controls; Strongest SNP-Risk Allele: rs7604693-G; SNPs: rs7604693; Context: intron; Risk Allele Frequency: 0.05; p-Value: 2E-6; OR or beta:    2.70; Platform [SNPs passing QC]: Affymetrix [641,760]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Kawasaki disease
ZDHHC19		21160409	TAS		Disease/Trait: HIV-1 susceptibility; Initial Sample Size: 848 Malawian cases, 531 Malawian controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11924930-?; SNPs: rs11924930; Context: intron; Risk Allele Frequency: 0.40; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~800,000]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
FAM174B		21160409	TAS		Disease/Trait: HIV-1 susceptibility; Initial Sample Size: 848 Malawian cases, 531 Malawian controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs285757-?; SNPs: rs285757; Context: intron; Risk Allele Frequency: 0.15; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~800,000]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
DENND1A		21151128	TAS		Disease/Trait: Polycystic ovary syndrome; Initial Sample Size: 744 Han Chinese cases, 895 Han Chinese controls; Replication Sample Size: 2,840 northern Han Chinese cases, 5,012 northern Han Chinese controls, 498 southern and central Han Chinese cases, 780 southern and central Han Chinese controls; Strongest SNP-Risk Allele: rs2479106-G; SNPs: rs2479106; Context: intron; Risk Allele Frequency: 0.22; p-Value: 8E-19; OR or beta:    1.34; Platform [SNPs passing QC]: Affymetrix [611,633]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	polycystic ovary syndrome
DENND1A		21151128	TAS		Disease/Trait: Polycystic ovary syndrome; Initial Sample Size: 744 Han Chinese cases, 895 Han Chinese controls; Replication Sample Size: 2,840 northern Han Chinese cases, 5,012 northern Han Chinese controls, 498 southern and central Han Chinese cases, 780 southern and central Han Chinese controls; Strongest SNP-Risk Allele: rs10818854-A; SNPs: rs10818854; Context: intron; Risk Allele Frequency: 0.09; p-Value: 9E-18; OR or beta:    1.51; Platform [SNPs passing QC]: Affymetrix [611,633]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	polycystic ovary syndrome
MST1		21151127	TAS		Disease/Trait: Primary sclerosing cholangitis; Initial Sample Size: 332 Scandinavian cases, 262 Scandinavian controls, 383 German cases, 2,700 German controls; Replication Sample Size: 259 Scandinavian cases, 729 Scandinavian controls, 498 Central European cases, 554 Central European controls, 268 U.S. cases, 554 U.S. controls; Strongest SNP-Risk Allele: rs3197999-?; SNPs: rs3197999; Context: missense; Risk Allele Frequency: 0.28; p-Value: 1E-16; OR or beta:    1.39; Platform [SNPs passing QC]: Affymetrix [2,466,182] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	sclerosing cholangitis
LIMK2		21150874	TAS		Disease/Trait: Type 2 diabetes nephropathy; Initial Sample Size: 965 African American cases, 1,029 African American controls; Replication Sample Size: 709 African American cases, 690 African American controls; Strongest SNP-Risk Allele: rs2106294-T; SNPs: rs2106294; Context: intron; Risk Allele Frequency: 0.94; p-Value: 4E-6; OR or beta:    1.75; Platform [SNPs passing QC]: Affymetrix [832,357]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus;Nephropathy
SASH1		21150874	TAS		Disease/Trait: Type 2 diabetes nephropathy; Initial Sample Size: 965 African American cases, 1,029 African American controls; Replication Sample Size: 709 African American cases, 690 African American controls; Strongest SNP-Risk Allele: rs6930576-A; SNPs: rs6930576; Context: intron; Risk Allele Frequency: 0.28; p-Value: 7E-7; OR or beta:    1.31; Platform [SNPs passing QC]: Affymetrix [832,357]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus;Nephropathy
SLC12A2		21139019	TAS		Disease/Trait: Ileal carcinoids; Initial Sample Size: 239 Northern European ancestry cases, 107 Northern European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10089-?; SNPs: rs10089; Context: ncRNA; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    2.56; Platform [SNPs passing QC]: Illumina [308,330]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ileal neoplasm
KIF16B		21139019	TAS		Disease/Trait: Ileal carcinoids; Initial Sample Size: 239 Northern European ancestry cases, 107 Northern European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2208059-?; SNPs: rs2208059; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-7; OR or beta:    2.42; Platform [SNPs passing QC]: Illumina [308,330]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ileal neoplasm
CDKAL1		21139019	TAS		Disease/Trait: Ileal carcinoids; Initial Sample Size: 239 Northern European ancestry cases, 107 Northern European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2206734-?; SNPs: rs2206734; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    3.45; Platform [SNPs passing QC]: Illumina [308,330]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ileal neoplasm
FGF12		21139019	TAS		Disease/Trait: Ileal carcinoids; Initial Sample Size: 239 Northern European ancestry cases, 107 Northern European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs975121-?; SNPs: rs975121; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta:    2.17; Platform [SNPs passing QC]: Illumina [308,330]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ileal neoplasm
EPAS1		21131975	TAS		Disease/Trait: Renal cell carcinoma; Initial Sample Size: 3,772 European descent cases, 8,505 European descent controls; Replication Sample Size: 2,198 cases, 4,918 controls; Strongest SNP-Risk Allele: rs7579899-?; SNPs: rs7579899; Context: intron; Risk Allele Frequency: 0.40; p-Value: 2E-9; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [586,069]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	renal cell carcinoma
SCARB1		21131975	TAS		Disease/Trait: Renal cell carcinoma; Initial Sample Size: 3,772 European descent cases, 8,505 European descent controls; Replication Sample Size: 2,198 cases, 4,918 controls; Strongest SNP-Risk Allele: rs4765623-?; SNPs: rs4765623; Context: intron; Risk Allele Frequency: 0.34; p-Value: 3E-8; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [586,069]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	renal cell carcinoma
IRF8		21131588	TAS		Disease/Trait: Chronic lymphocytic leukemia; Initial Sample Size: 407 Caucasian cases, 296 Caucasian controls; Replication Sample Size: 252 Caucasian cases, 965 Caucasian controls; Strongest SNP-Risk Allele: rs391525-?; SNPs: rs391525; Context: intron; Risk Allele Frequency: 0.66; p-Value: 3E-9; OR or beta:    1.56; Platform [SNPs passing QC]: Affymetrix [827,777]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic lymphocytic leukemia
HLA-DQA1		21131588	TAS		Disease/Trait: Chronic lymphocytic leukemia; Initial Sample Size: 407 Caucasian cases, 296 Caucasian controls; Replication Sample Size: 252 Caucasian cases, 965 Caucasian controls; Strongest SNP-Risk Allele: rs9272535-A; SNPs: rs9272535; Context: intron; Risk Allele Frequency: 0.27; p-Value: 9E-8; OR or beta:    1.61; Platform [SNPs passing QC]: Affymetrix [827,777]	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic lymphocytic leukemia
C2		21105107	TAS		Disease/Trait: Hepatocellular carcinoma; Initial Sample Size: 180 Korean hepatocellular carcinoma cases, 271 Korean controls; Replication Sample Size: 206 Korean hepatocellular carcinoma cases, 316 Korean controls, 100 Chinese controls; Strongest SNP-Risk Allele: rs9267673-?; SNPs: rs9267673; Context: ; Risk Allele Frequency: 0.08; p-Value: 2E-6; OR or beta:    1.97; Platform [SNPs passing QC]: Affymetrix [658,897]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatocellular carcinoma
TOMM40		21123754	TAS		Disease/Trait: Alzheimer's disease biomarkers; Initial Sample Size: 374 non-Hispanic Caucasians; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs157580-?; SNPs: rs157580; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [322,557]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
CCDC134		21123754	TAS		Disease/Trait: Alzheimer's disease biomarkers; Initial Sample Size: 374 non-Hispanic Caucasians; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7364180-?; SNPs: rs7364180; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [322,557]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
APOE		21123754	TAS		Disease/Trait: Alzheimer's disease biomarkers; Initial Sample Size: 374 non-Hispanic Caucasians; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs429358-?; SNPs: rs429358; Context: missense; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [322,557]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
TOMM40		21123754	TAS		Disease/Trait: Alzheimer's disease biomarkers; Initial Sample Size: 374 non-Hispanic Caucasians; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2075650-?; SNPs: rs2075650; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [322,557]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
NTM		21182207	TAS		Disease/Trait: Asperger disorder; Initial Sample Size: 843 family members; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1550976-?; SNPs: rs1550976; Context: intron; Risk Allele Frequency: 0.33; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [439,282]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Asperger syndrome
FHIT		21182207	TAS		Disease/Trait: Asperger disorder; Initial Sample Size: 843 family members; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10510837-?; SNPs: rs10510837; Context: intron; Risk Allele Frequency: 0.12; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [439,282]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Asperger syndrome
LMO1		21124317	TAS		Disease/Trait: Neuroblastoma; Initial Sample Size: 1,627 European ancestry child cases, 3,254 European ancestry child controls; Replication Sample Size: 624 European ancestry child cases, 2,843 European ancestry child controls; Strongest SNP-Risk Allele: rs110419-A; SNPs: rs110419; Context: intron; Risk Allele Frequency: 0.49; p-Value: 5E-16; OR or beta:    1.34; Platform [SNPs passing QC]: Illumina [480,279]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	neuroblastoma
BARD1		21124317	TAS		Disease/Trait: Neuroblastoma; Initial Sample Size: 1,627 European ancestry child cases, 3,254 European ancestry child controls; Replication Sample Size: 624 European ancestry child cases, 2,843 European ancestry child controls; Strongest SNP-Risk Allele: rs3768716-C; SNPs: rs3768716; Context: intron; Risk Allele Frequency: 0.23; p-Value: 5E-13; OR or beta:    1.39; Platform [SNPs passing QC]: Illumina [480,279]	0.0000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	neuroblastoma
DGKK		21113153	TAS		Disease/Trait: Hypospadias; Initial Sample Size: 436 European descent cases, 494 European descent controls; Replication Sample Size: 133 Dutch families, 266 Swedish cases, 402 Swedish controls; Strongest SNP-Risk Allele: rs1934179-A; SNPs: rs1934179; Context: ; Risk Allele Frequency: 0.33; p-Value: 3E-21; OR or beta:    2.60; Platform [SNPs passing QC]: Affymetrix [574,400] (pooled)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypospadias
PTPN22		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs2476601-G; SNPs: rs2476601; Context: ; Risk Allele Frequency: 0.907; p-Value: 4E-9; OR or beta:    1.26; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
PTPN2		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs1893217-G; SNPs: rs1893217; Context: intron; Risk Allele Frequency: 0.153; p-Value: 1E-14; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0.00000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
NOD2		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs2076756-G; SNPs: rs2076756; Context: intron; Risk Allele Frequency: 0.26; p-Value: 4E-69; OR or beta:    1.53; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
ZMIZ1		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs1250550-G; SNPs: rs1250550; Context: intron; Risk Allele Frequency: 0.669; p-Value: 1E-30; OR or beta:    1.19; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
THADA		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs10495903-T; SNPs: rs10495903; Context: intron; Risk Allele Frequency: 0.129; p-Value: 2E-14; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0.00000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
PLCL1		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs6738825-A; SNPs: rs6738825; Context: intron; Risk Allele Frequency: 0.473; p-Value: 4E-9; OR or beta:    1.06; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
CDKAL1		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs6908425-C; SNPs: rs6908425; Context: intron; Risk Allele Frequency: 0.784; p-Value: 1E-8; OR or beta:    1.17; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
BACH2		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs1847472-G; SNPs: rs1847472; Context: intron; Risk Allele Frequency: 0.658; p-Value: 5E-9; OR or beta:    1.07; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
IL2RA		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs12722489-C; SNPs: rs12722489; Context: intron; Risk Allele Frequency: 0.852; p-Value: 3E-9; OR or beta:    1.11; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
IL23R		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs11209026-G; SNPs: rs11209026; Context: missense; Risk Allele Frequency: 0.932; p-Value: 1E-64; OR or beta:    2.66; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
GCKR		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs780093-T; SNPs: rs780093; Context: intron; Risk Allele Frequency: 0.418; p-Value: 5E-11; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0.00000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
DNMT3A		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs13428812-G; SNPs: rs13428812; Context: intron; Risk Allele Frequency: 0.326; p-Value: 9E-10; OR or beta:    1.06; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0.0000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
DENND1B		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs1998598-G; SNPs: rs1998598; Context: intron; Risk Allele Frequency: 0.302; p-Value: 9E-9; OR or beta:    1.04; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0.000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
SP140		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs7423615-T; SNPs: rs7423615; Context: intron; Risk Allele Frequency: 0.187; p-Value: 3E-13; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0.0000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
SMAD3		21102463	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 6,333 European ancestry cases, 15,056 European ancestry controls; Replication Sample Size: 15,694 European ancestry cases, 14,026 European ancestry controls, 414 European ancestry parent-offspring trios; Strongest SNP-Risk Allele: rs17293632-T; SNPs: rs17293632; Context: intron; Risk Allele Frequency: 0.233; p-Value: 3E-19; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix & Illumina [953,241] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
CTNND2		21095009	TAS		Disease/Trait: Myopia (pathological); Initial Sample Size: 65 Chinese child cases, 238 Chinese child controls, 222 Chinese adult cases, 455 Chinese adult cases; Replication Sample Size: 959 Japanese high myopia cases, 2,128 Japanese controls; Strongest SNP-Risk Allele: rs6885224-C; SNPs: rs6885224; Context: intron; Risk Allele Frequency: 0.26; p-Value: 8E-6; OR or beta:    1.24; Platform [SNPs passing QC]: Illumina [459,687]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myopia
KIAA1462		21088011	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 1,157 European cases, 1,748 European controls; Replication Sample Size: 7,887 European cases, 8,244 European controls; Strongest SNP-Risk Allele: rs3739998-C; SNPs: rs3739998; Context: missense; Risk Allele Frequency: 0.44; p-Value: 1E-11; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix [254,558]	0.00000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
AKAP6		21079607	TAS		Disease/Trait: Anorexia nervosa; Initial Sample Size: 1,033 European ancestry cases, 3,773 European ancestry pediatric controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2383378-?; SNPs: rs2383378; Context: intron; Risk Allele Frequency: 0.41; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~598,000]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	anorexia nervosa
VGLL4		21079607	TAS		Disease/Trait: Anorexia nervosa; Initial Sample Size: 1,033 European ancestry cases, 3,773 European ancestry pediatric controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6782029-?; SNPs: rs6782029; Context: intron; Risk Allele Frequency: 0.24; p-Value: 9E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~598,000]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	anorexia nervosa
ZNF804B		21079607	TAS		Disease/Trait: Anorexia nervosa; Initial Sample Size: 1,033 European ancestry cases, 3,773 European ancestry pediatric controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6959888-?; SNPs: rs6959888; Context: intron; Risk Allele Frequency: 0.11; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~598,000]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	anorexia nervosa
FAM155A		21079607	TAS		Disease/Trait: Anorexia nervosa; Initial Sample Size: 1,033 European ancestry cases, 3,773 European ancestry pediatric controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs957788-?; SNPs: rs957788; Context: intron; Risk Allele Frequency: 0.31; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~598,000]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	anorexia nervosa
LRP2		21079607	TAS		Disease/Trait: Anorexia nervosa; Initial Sample Size: 1,033 European ancestry cases, 3,773 European ancestry pediatric controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs830998-?; SNPs: rs830998; Context: intron; Risk Allele Frequency: 0.19; p-Value: 9E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~598,000]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	anorexia nervosa
NTNG1		21079607	TAS		Disease/Trait: Anorexia nervosa; Initial Sample Size: 1,033 European ancestry cases, 3,773 European ancestry pediatric controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10494067-?; SNPs: rs10494067; Context: intron; Risk Allele Frequency: 0.06; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~598,000]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	anorexia nervosa
DSCAM		21079520	TAS		Disease/Trait: Non-small cell lung cancer; Initial Sample Size: 105 individuals with non-small cell lung cancer; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9981861-G; SNPs: rs9981861; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.33; Platform [SNPs passing QC]: Illumina [~109,365]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	non-small cell lung carcinoma
EIF4E2		21079520	TAS		Disease/Trait: Non-small cell lung cancer; Initial Sample Size: 105 individuals with non-small cell lung cancer; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1656402-?; SNPs: rs1656402; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-8; OR or beta:    2.38; Platform [SNPs passing QC]: Illumina [~109,365]	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	non-small cell lung carcinoma
DUS4L		21068099	TAS		Disease/Trait: Osteoarthritis; Initial Sample Size: 2,371 European ancestry cases, 35,909 European ancestry controls; Replication Sample Size: 4,338 European ancestry cases, 8,530 European ancestry controls, 1,183 East Asian ancestry cases, 1,245 East Asian ancestry controls; Strongest SNP-Risk Allele: rs4730250-G; SNPs: rs4730250; Context: intron; Risk Allele Frequency: 0.17 (European); p-Value: 6E-8; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix & Illumina [2,335,627] (imputed)	0.00000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	osteoarthritis
PCSK6		21051773	TAS		Disease/Trait: Handedness in dyslexia; Initial Sample Size: 192 individuals; Replication Sample Size: 573 individuals; Strongest SNP-Risk Allele: rs11855415-A; SNPs: rs11855415; Context: intron; Risk Allele Frequency: 0.25; p-Value: 2E-8; OR or beta:     .35; Platform [SNPs passing QC]: Illumina [~2 million] (imputed)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	dyslexia
UCHL5		21668797	TAS		Disease/Trait: Cannabis dependence; Initial Sample Size: 708 cases, 2,346 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9427573-?; SNPs: rs9427573; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    2.56; Platform [SNPs passing QC]: Illumina [948,142]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cannabis dependence
ANKFN1		21668797	TAS		Disease/Trait: Cannabis dependence; Initial Sample Size: 708 cases, 2,346 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1019238-?; SNPs: rs1019238; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-7; OR or beta:    1.45; Platform [SNPs passing QC]: Illumina [948,142]	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cannabis dependence
CHST11		21668797	TAS		Disease/Trait: Cannabis dependence; Initial Sample Size: 708 cases, 2,346 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12811699-?; SNPs: rs12811699; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.74; Platform [SNPs passing QC]: Illumina [948,142]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cannabis dependence
ERC2		21057379	TAS		Disease/Trait: Bipolar disorder and schizophrenia; Initial Sample Size: 506 European bipolar 1 disorder cases, 523 European schizophrenia cases, 505 European controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1795648-?; SNPs: rs1795648; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [302,482]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder;schizophrenia
PHF8		21057379	TAS		Disease/Trait: Bipolar disorder and schizophrenia; Initial Sample Size: 506 European bipolar 1 disorder cases, 523 European schizophrenia cases, 505 European controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7065696-?; SNPs: rs7065696; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [302,482]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder;schizophrenia
PTPRN2		21057379	TAS		Disease/Trait: Bipolar disorder and schizophrenia; Initial Sample Size: 506 European bipolar 1 disorder cases, 523 European schizophrenia cases, 505 European controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6459804-?; SNPs: rs6459804; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [302,482]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder;schizophrenia
PSORS1C3		21051598	TAS		Disease/Trait: HIV-1 control; Initial Sample Size: 516 European cases, 1,196 European controls, 341 African American cases, 892 African American controls, 117 Hispanic controls, 560 Hispanic controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3131018-C; SNPs: rs3131018; Context: intron; Risk Allele Frequency: 0.625; p-Value: 4E-16; OR or beta:    2.10; Platform [SNPs passing QC]: Illumina [1,384,048] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
HLA-B		21051598	TAS		Disease/Trait: HIV-1 control; Initial Sample Size: 516 European cases, 1,196 European controls, 341 African American cases, 892 African American controls, 117 Hispanic controls, 560 Hispanic controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2523608-G; SNPs: rs2523608; Context: intron; Risk Allele Frequency: 0.326; p-Value: 9E-20; OR or beta:    2.60; Platform [SNPs passing QC]: Illumina [1,384,048] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
MAPT		21044948	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 1,705 UK cases, 5,175 UK controls; Replication Sample Size: 1,039 French cases, 1,984 French controls; Strongest SNP-Risk Allele: rs8070723-?; SNPs: rs8070723; Context: intron; Risk Allele Frequency: 0.76; p-Value: 7E-12; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [532,616]	0.000000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
ELF1		21044949	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 612 Chinese cases, 1,160 Chinese controls; Replication Sample Size: 2,090 Chinese cases, 462 Thai cases, 4482 Asian controls; Strongest SNP-Risk Allele: rs7329174-G; SNPs: rs7329174; Context: intron; Risk Allele Frequency: 0.22; p-Value: 1E-8; OR or beta:    1.26; Platform [SNPs passing QC]: Illumina [513,108]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
PVT1		21037568	TAS		Disease/Trait: Hodgkin's lymphoma; Initial Sample Size: 589 European ancestry cases, 5,199 European ancestry controls; Replication Sample Size: 2,057 European ancestry cases, 3,416 European ancestry controls; Strongest SNP-Risk Allele: rs2608053-G; SNPs: rs2608053; Context: intron; Risk Allele Frequency: 0.52; p-Value: 1E-7; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [504,374]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Hodgkin's lymphoma
FTO		21037115	TAS		Disease/Trait: Body mass in chronic obstructive pulmonary disease; Initial Sample Size: 2,272 Caucasian individuals, 933 Norwegian individuals; Replication Sample Size: 502 non-Hispanic whites; Strongest SNP-Risk Allele: rs8050136-A; SNPs: rs8050136; Context: intron; Risk Allele Frequency: 0.39; p-Value: 4E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~550,000]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
FGFR2		21060860	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 899 European ancestry affected BRCA2 carriers, 804 European ancestry unaffected BRCA2 carriers; Replication Sample Size: 1,264 cases, 1,222 controls; Strongest SNP-Risk Allele: rs2981575-?; SNPs: rs2981575; Context: intron; Risk Allele Frequency: 0.42; p-Value: 1E-8; OR or beta:    1.28; Platform [SNPs passing QC]: Affymetrix [592,163]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
UMOD		21082022	TAS		Disease/Trait: Hypertension; Initial Sample Size: 1,621 Swedish cases, 1,699 Swedish controls; Replication Sample Size: 19,845 European ancestry cases, 16,541 European ancestry controls; Strongest SNP-Risk Allele: rs13333226-A; SNPs: rs13333226; Context: nearGene-5; Risk Allele Frequency: 0.81; p-Value: 4E-11; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [521,220]	0.00000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertension
LAMA5		20972440	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 3,334 European ancestry cases, 4,628 European ancestry controls; Replication Sample Size: 14,851 European ancestry cases, 15,569 European ancestry controls; Strongest SNP-Risk Allele: rs4925386-C; SNPs: rs4925386; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-10; OR or beta:    1.08; Platform [SNPs passing QC]: Illumina [up to ~550,000] (imputed)	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
MYNN		20972440	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 3,334 European ancestry cases, 4,628 European ancestry controls; Replication Sample Size: 14,851 European ancestry cases, 15,569 European ancestry controls; Strongest SNP-Risk Allele: rs10936599-C; SNPs: rs10936599; Context: cds-synon; Risk Allele Frequency: NR; p-Value: 3E-8; OR or beta:    1.04; Platform [SNPs passing QC]: Illumina [up to ~550,000] (imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
PSCA		20972438	TAS		Disease/Trait: Bladder cancer; Initial Sample Size: 3,532 European descent cases, 5,120 European descent controls; Replication Sample Size: 8,382 cases, 48,275 controls; Strongest SNP-Risk Allele: rs2294008-T; SNPs: rs2294008; Context: intron; Risk Allele Frequency: 0.46; p-Value: 4E-11; OR or beta:    1.13; Platform [SNPs passing QC]: Illumina [591,637]	0.00000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	urinary bladder cancer
HLA-C		20953186	TAS		Disease/Trait: Psoriatic arthritis; Initial Sample Size: 572 German cases, 888 German controls; Replication Sample Size: Up to 1,761 European descent cases, 3,727 European descent controls; Strongest SNP-Risk Allele: rs13191343-T; SNPs: rs13191343; Context: nearGene-5; Risk Allele Frequency: 0.13; p-Value: 2E-72; OR or beta:    2.37; Platform [SNPs passing QC]: Affymetrix [1,585,307] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriatic arthritis
TYK2		20953190	TAS		Disease/Trait: Psoriasis; Initial Sample Size: 2,178 European ancestry cases, 5,175 European ancestry controls; Replication Sample Size: 3,174 European ancestry cases, 5,464 European ancestry controls; Strongest SNP-Risk Allele: rs12720356-A; SNPs: rs12720356; Context: missense; Risk Allele Frequency: 0.90; p-Value: 4E-11; OR or beta:    1.40; Platform [SNPs passing QC]: Illumina [535,475]	0.00000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriasis
IL12B		20953190	TAS		Disease/Trait: Psoriasis; Initial Sample Size: 2,178 European ancestry cases, 5,175 European ancestry controls; Replication Sample Size: 3,174 European ancestry cases, 5,464 European ancestry controls; Strongest SNP-Risk Allele: rs3213094-?; SNPs: rs3213094; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-11; OR or beta:    1.39; Platform [SNPs passing QC]: Illumina [535,475]	0.00000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriasis
TYK2		20953190	TAS		Disease/Trait: Psoriasis; Initial Sample Size: 2,178 European ancestry cases, 5,175 European ancestry controls; Replication Sample Size: 3,174 European ancestry cases, 5,464 European ancestry controls; Strongest SNP-Risk Allele: rs280519-A; SNPs: rs280519; Context: intron; Risk Allele Frequency: 0.47; p-Value: 4E-9; OR or beta:    1.13; Platform [SNPs passing QC]: Illumina [535,475]	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriasis
TNFAIP3		20953190	TAS		Disease/Trait: Psoriasis; Initial Sample Size: 2,178 European ancestry cases, 5,175 European ancestry controls; Replication Sample Size: 3,174 European ancestry cases, 5,464 European ancestry controls; Strongest SNP-Risk Allele: rs610604-?; SNPs: rs610604; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-7; OR or beta:    1.22; Platform [SNPs passing QC]: Illumina [535,475]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriasis
IL23R		20953190	TAS		Disease/Trait: Psoriasis; Initial Sample Size: 2,178 European ancestry cases, 5,175 European ancestry controls; Replication Sample Size: 3,174 European ancestry cases, 5,464 European ancestry controls; Strongest SNP-Risk Allele: rs11209026-?; SNPs: rs11209026; Context: missense; Risk Allele Frequency: NR; p-Value: 7E-7; OR or beta:    1.49; Platform [SNPs passing QC]: Illumina [535,475]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriasis
NOS2		20953189	TAS		Disease/Trait: Psoriasis; Initial Sample Size: Up to 1,831 cases, 2,546 controls; Replication Sample Size: Up to 4,064 cases, 4,685 controls; Strongest SNP-Risk Allele: rs4795067-G; SNPs: rs4795067; Context: intron; Risk Allele Frequency: 0.35; p-Value: 4E-11; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina & Perlegen [up to 7,456,344] (imputed)	0.00000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriasis
C9orf3		20932654	TAS		Disease/Trait: Erectile dysfunction and prostate cancer treatment; Initial Sample Size: 27 African American cases, 52 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3802458-?; SNPs: rs3802458; Context: intron; Risk Allele Frequency: 0.04; p-Value: 4E-6; OR or beta:   10.53; Platform [SNPs passing QC]: Affymetrix [512,497]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer;impotence 
GLI2		20932654	TAS		Disease/Trait: Erectile dysfunction and prostate cancer treatment; Initial Sample Size: 27 African American cases, 52 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11122834-?; SNPs: rs11122834; Context: intron; Risk Allele Frequency: 0.29; p-Value: 5E-6; OR or beta:    4.93; Platform [SNPs passing QC]: Affymetrix [512,497]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer;impotence 
TTC7A		20932654	TAS		Disease/Trait: Erectile dysfunction and prostate cancer treatment; Initial Sample Size: 27 African American cases, 52 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10194115-?; SNPs: rs10194115; Context: intron; Risk Allele Frequency: 0.07; p-Value: 5E-7; OR or beta:    9.00; Platform [SNPs passing QC]: Affymetrix [512,497]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer;impotence 
FSHR		20932654	TAS		Disease/Trait: Erectile dysfunction and prostate cancer treatment; Initial Sample Size: 27 African American cases, 52 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2268363-?; SNPs: rs2268363; Context: intron; Risk Allele Frequency: 0.18; p-Value: 5E-8; OR or beta:    7.03; Platform [SNPs passing QC]: Affymetrix [512,497]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer;impotence 
PTGFRN		20932654	TAS		Disease/Trait: Erectile dysfunction and prostate cancer treatment; Initial Sample Size: 27 African American cases, 52 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2806864-?; SNPs: rs2806864; Context: intron; Risk Allele Frequency: 0.15; p-Value: 6E-7; OR or beta:    6.42; Platform [SNPs passing QC]: Affymetrix [512,497]	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer;impotence 
LRP1B		20932654	TAS		Disease/Trait: Erectile dysfunction and prostate cancer treatment; Initial Sample Size: 27 African American cases, 52 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10210358-?; SNPs: rs10210358; Context: intron; Risk Allele Frequency: 0.31; p-Value: 2E-6; OR or beta:    5.34; Platform [SNPs passing QC]: Affymetrix [512,497]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer;impotence 
CNNM3		20932654	TAS		Disease/Trait: Erectile dysfunction and prostate cancer treatment; Initial Sample Size: 27 African American cases, 52 African American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9948-?; SNPs: rs9948; Context: UTR-3; Risk Allele Frequency: 0.31; p-Value: 6E-6; OR or beta:    4.90; Platform [SNPs passing QC]: Affymetrix [512,497]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer;impotence 
CNTNAP2		20889312	TAS		Disease/Trait: Bipolar disorder and schizophrenia; Initial Sample Size: 651 European American bipolar cases, 1,171 European American schizophrenia cases, 2,412 European American controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs802568-?; SNPs: rs802568; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-7; OR or beta:    2.03; Platform [SNPs passing QC]: Affymetrix [722,112]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder;schizophrenia
FGFR2		20872241	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 2,702 European ancestry women, 5,726 European ancestry controls; Replication Sample Size: Up to 7,386 European ancestry cases, 7,576 European ancestry controls; Strongest SNP-Risk Allele: rs1219648-G; SNPs: rs1219648; Context: intron; Risk Allele Frequency: 0.42; p-Value: 2E-13; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [285,984]	0.0000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
TERT		20871597	TAS		Disease/Trait: Lung adenocarcinoma; Initial Sample Size: 1,004 Japanese cases, 1,900 Japanese controls; Replication Sample Size: 525 Japanese cases, 7,678 Japanese controls, 569 Korean cases, 1,470 Korean controls; Strongest SNP-Risk Allele: rs2736100-C; SNPs: rs2736100; Context: intron; Risk Allele Frequency: 0.39; p-Value: 3E-11; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [432,024]	0.00000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung adenocarcinoma
TP63		20871597	TAS		Disease/Trait: Lung adenocarcinoma; Initial Sample Size: 1,004 Japanese cases, 1,900 Japanese controls; Replication Sample Size: 525 Japanese cases, 7,678 Japanese controls, 569 Korean cases, 1,470 Korean controls; Strongest SNP-Risk Allele: rs10937405-C; SNPs: rs10937405; Context: intron; Risk Allele Frequency: 0.67; p-Value: 7E-12; OR or beta:    1.31; Platform [SNPs passing QC]: Illumina [432,024]	0.000000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung adenocarcinoma
CFH		20861866	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 293 family members,  391 white non-Hispanic cases, 188 white non-Hispanic controls; Replication Sample Size: 1,241 white non-Hispanic cases, 622 white non-Hispanic conrols, 655 Northern European descent cases, 1,244 Northern European descent controls; Strongest SNP-Risk Allele: rs1329428-?; SNPs: rs1329428; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-64; OR or beta:    2.78; Platform [SNPs passing QC]: Affymetrix [>361,556] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
IL2RB		20860503	TAS		Disease/Trait: Asthma; Initial Sample Size: 10,365 cases, 16,110 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2284033-G; SNPs: rs2284033; Context: intron; Risk Allele Frequency: 0.56; p-Value: 1E-8; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [582,892]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
SLC22A5		20860503	TAS		Disease/Trait: Asthma; Initial Sample Size: 10,365 cases, 16,110 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2073643-T; SNPs: rs2073643; Context: intron; Risk Allele Frequency: 0.45; p-Value: 2E-7; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina [582,892]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
GSDMB		20860503	TAS		Disease/Trait: Asthma; Initial Sample Size: 10,365 cases, 16,110 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2305480-G; SNPs: rs2305480; Context: missense; Risk Allele Frequency: 0.55; p-Value: 1E-7; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina [582,892]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
SMAD3		20860503	TAS		Disease/Trait: Asthma; Initial Sample Size: 10,365 cases, 16,110 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs744910-G; SNPs: rs744910; Context: intron; Risk Allele Frequency: 0.49; p-Value: 4E-9; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [582,892]	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
GSDMA		20860503	TAS		Disease/Trait: Asthma; Initial Sample Size: 10,365 cases, 16,110 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3894194-A; SNPs: rs3894194; Context: missense; Risk Allele Frequency: 0.45; p-Value: 5E-9; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina [582,892]	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
IL18R1		20860503	TAS		Disease/Trait: Asthma; Initial Sample Size: 10,365 cases, 16,110 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3771166-G; SNPs: rs3771166; Context: intron; Risk Allele Frequency: 0.62; p-Value: 3E-9; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [582,892]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
IL13		20860503	TAS		Disease/Trait: Asthma; Initial Sample Size: 10,365 cases, 16,110 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1295686-T; SNPs: rs1295686; Context: intron; Risk Allele Frequency: 0.20; p-Value: 1E-7; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [582,892]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
RORA		20860503	TAS		Disease/Trait: Asthma; Initial Sample Size: 10,365 cases, 16,110 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11071559-C; SNPs: rs11071559; Context: intron; Risk Allele Frequency: 0.86; p-Value: 1E-7; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina [582,892]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
MTHFD1L		20885792	TAS		Disease/Trait: Alzheimer's disease (late onset); Initial Sample Size: 931 cases, 1,104 controls; Replication Sample Size: 1,338 cases, 2,003 controls; Strongest SNP-Risk Allele: rs11754661-A; SNPs: rs11754661; Context: intron; Risk Allele Frequency: 0.07; p-Value: 2E-10; OR or beta:    2.10; Platform [SNPs passing QC]: Illumina [483,399]	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
PVRL2		20885792	TAS		Disease/Trait: Alzheimer's disease (late onset); Initial Sample Size: 931 cases, 1,104 controls; Replication Sample Size: 1,338 cases, 2,003 controls; Strongest SNP-Risk Allele: rs6859-A; SNPs: rs6859; Context: intron; Risk Allele Frequency: 0.46; p-Value: 1E-7; OR or beta:    1.41; Platform [SNPs passing QC]: Illumina [483,399]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
ANKLE1		20852633	TAS		Disease/Trait: Ovarian cancer; Initial Sample Size: 1,768 European ancestry cases, 2,353 European ancestry controls; Replication Sample Size: 8,739 European ancestry cases, 10,831 European ancestry controls; Strongest SNP-Risk Allele: rs2363956-T; SNPs: rs2363956; Context: missense; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta:    1.10; Platform [SNPs passing QC]: Illumina [540,573]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ovarian cancer
TIPARP		20852632	TAS		Disease/Trait: Ovarian cancer; Initial Sample Size: 1,768 European ancestry cases, 2,354 European ancestry controls; Replication Sample Size: 8,709 European ancestry cases, 51,764 European ancestry controls; Strongest SNP-Risk Allele: rs2665390T-C; SNPs: rs2665390; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-7; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [2,056,878] (imputed)	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ovarian cancer
SKAP1		20852632	TAS		Disease/Trait: Ovarian cancer; Initial Sample Size: 1,768 European ancestry cases, 2,354 European ancestry controls; Replication Sample Size: 8,709 European ancestry cases, 51,764 European ancestry controls; Strongest SNP-Risk Allele: rs9303542-G; SNPs: rs9303542; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina [2,056,878] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ovarian cancer
PTPRG		20825314	TAS		Disease/Trait: Fuchs's corneal dystrophy; Initial Sample Size: 130 European descent cases, 260 European descent controls; Replication Sample Size: 150 European descent cases, 150 European descent controls; Strongest SNP-Risk Allele: rs10490775-A; SNPs: rs10490775; Context: intron; Risk Allele Frequency: 0.10; p-Value: 1E-6; OR or beta:    2.30; Platform [SNPs passing QC]: Illumina [~370,000]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Fuchs' endothelial dystrophy
TCF4		20825314	TAS		Disease/Trait: Fuchs's corneal dystrophy; Initial Sample Size: 130 European descent cases, 260 European descent controls; Replication Sample Size: 150 European descent cases, 150 European descent controls; Strongest SNP-Risk Allele: rs613872-G; SNPs: rs613872; Context: intron; Risk Allele Frequency: 0.15; p-Value: 1E-18; OR or beta:    5.47; Platform [SNPs passing QC]: Illumina [~370,000]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Fuchs' endothelial dystrophy
IL1RAPL1		20838585	TAS		Disease/Trait: Cardiovascular disease risk factors; Initial Sample Size: 525 European ancestry individuals; Replication Sample Size: 2,265 Finnish individuals; Strongest SNP-Risk Allele: rs7890572-G; SNPs: rs7890572; Context: intron; Risk Allele Frequency: 0.07; p-Value: 1E-7; OR or beta:     .97; Platform [SNPs passing QC]: Illumina [545,821]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cardiovascular system disease
SUMF1		20802204	TAS		Disease/Trait: Multiple sclerosis--Brain Glutamate Levels; Initial Sample Size: 372 individuals with multiple sclerosis; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs794185-?; SNPs: rs794185; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [~500,000]	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
RORA		20800221	TAS		Disease/Trait: Depression (quantitative trait); Initial Sample Size: 3,972 Italian individuals, 839 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12912233-T; SNPs: rs12912233; Context: intron; Risk Allele Frequency: 0.46; p-Value: 6E-7; OR or beta:     .15; Platform [SNPs passing QC]: Affymetrix & Illumina [up to 2.5 million] (imputed)	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	mental depression
EIF3F		20800221	TAS		Disease/Trait: Depression (quantitative trait); Initial Sample Size: 3,972 Italian individuals, 839 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12420464-T; SNPs: rs12420464; Context: intron; Risk Allele Frequency: 0.04; p-Value: 3E-6; OR or beta:     .38; Platform [SNPs passing QC]: Affymetrix & Illumina [up to 2.5 million] (imputed)	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	mental depression
CDH13		20800221	TAS		Disease/Trait: Depression (quantitative trait); Initial Sample Size: 3,972 Italian individuals, 839 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10514585-A; SNPs: rs10514585; Context: intron; Risk Allele Frequency: 0.31; p-Value: 5E-6; OR or beta:     .15; Platform [SNPs passing QC]: Affymetrix & Illumina [up to 2.5 million] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	mental depression
GRM8		20800221	TAS		Disease/Trait: Depression (quantitative trait); Initial Sample Size: 3,972 Italian individuals, 839 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17864092-T; SNPs: rs17864092; Context: intron; Risk Allele Frequency: 0.90; p-Value: 6E-6; OR or beta:     .17; Platform [SNPs passing QC]: Affymetrix & Illumina [up to 2.5 million] (imputed)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	mental depression
NPAS3		20713499	TAS		Disease/Trait: Schizophrenia, bipolar disorder and depression (combined); Initial Sample Size: 402 European ancestry schizophrenia cases, 1,021 European ancestry bipolar I cases, 493 European ancestry bipolar II cases, 1,210 European ancestry MDD cases, 1,060 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4982029-A; SNPs: rs4982029; Context: intron; Risk Allele Frequency: 0.02; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Perlegen [1,574,154] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder;schizophrenia;mental depression
IFT88		20713499	TAS		Disease/Trait: Schizophrenia, bipolar disorder and depression (combined); Initial Sample Size: 402 European ancestry schizophrenia cases, 1,021 European ancestry bipolar I cases, 493 European ancestry bipolar II cases, 1,210 European ancestry MDD cases, 1,060 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7326068-A; SNPs: rs7326068; Context: intron; Risk Allele Frequency: 0.19; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Perlegen [1,574,154] (imputed)	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder;schizophrenia;mental depression
MYO18B		20713499	TAS		Disease/Trait: Schizophrenia, bipolar disorder and depression (combined); Initial Sample Size: 402 European ancestry schizophrenia cases, 1,021 European ancestry bipolar I cases, 493 European ancestry bipolar II cases, 1,210 European ancestry MDD cases, 1,060 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1001021-A; SNPs: rs1001021; Context: intron; Risk Allele Frequency: 0.02; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Perlegen [1,574,154] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder;schizophrenia;mental depression
GAK		20711177	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 2,000 European ancestry cases, 1,986 European ancestry controls; Replication Sample Size: Up to 1,447 cases, 1,468 controls; Strongest SNP-Risk Allele: rs11248051-T; SNPs: rs11248051; Context: intron; Risk Allele Frequency: 0.09; p-Value: 3E-9; OR or beta:    1.46; Platform [SNPs passing QC]: Illumina [811,597]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
HLA-DRA		20711177	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 2,000 European ancestry cases, 1,986 European ancestry controls; Replication Sample Size: Up to 1,447 cases, 1,468 controls; Strongest SNP-Risk Allele: rs3129882-G; SNPs: rs3129882; Context: intron; Risk Allele Frequency: 0.40; p-Value: 2E-10; OR or beta:    1.26; Platform [SNPs passing QC]: Illumina [811,597]	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
TRA@		20711174	TAS		Disease/Trait: Narcolepsy; Initial Sample Size: 562 European cases, 954 European controls; Replication Sample Size: 370 European cases, 495 European controls; Strongest SNP-Risk Allele: rs1154155-G; SNPs: rs1154155; Context: ; Risk Allele Frequency: 0.15; p-Value: 5E-7; OR or beta:    1.54; Platform [SNPs passing QC]: Affymetrix [392,949]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	narcolepsy
NEDD4		20711176	TAS		Disease/Trait: Keloid; Initial Sample Size: 178 Japanese cases, 906 Japanese controls; Replication Sample Size: 621 Japanese cases, 2,271 Japanese controls; Strongest SNP-Risk Allele: rs8032158-C; SNPs: rs8032158; Context: intron; Risk Allele Frequency: 0.36; p-Value: 6E-13; OR or beta:    1.51; Platform [SNPs passing QC]: Illumina [452,038]	0.0000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Keloids
BICD1		20709820	TAS		Disease/Trait: Emphysema-related traits; Initial Sample Size: Up to 2,380 Caucasian individuals (including 1,455 Caucasian cases); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10844154-C; SNPs: rs10844154; Context: intron; Risk Allele Frequency: 0.58; p-Value: 6E-7; OR or beta:    1.46; Platform [SNPs passing QC]: Illumina [499,578]	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pulmonary emphysema
ADARB2		20709820	TAS		Disease/Trait: Emphysema-related traits; Initial Sample Size: Up to 2,380 Caucasian individuals (including 1,455 Caucasian cases); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2999399-T; SNPs: rs2999399; Context: intron; Risk Allele Frequency: 0.76; p-Value: 6E-6; OR or beta:    1.47; Platform [SNPs passing QC]: Illumina [499,578]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pulmonary emphysema
FDFT1		20708005	TAS		Disease/Trait: Non-alcoholic fatty liver disease histology (lobular); Initial Sample Size: 236 non-Hispanic Caucasian women; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2645424-A; SNPs: rs2645424; Context: intron; Risk Allele Frequency: 0.40; p-Value: 3E-6; OR or beta:     .30; Platform [SNPs passing QC]: Illumina [324,623]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
COL13A1		20708005	TAS		Disease/Trait: Non-alcoholic fatty liver disease histology (lobular); Initial Sample Size: 236 non-Hispanic Caucasian women; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1227756-G; SNPs: rs1227756; Context: intron; Risk Allele Frequency: 0.46; p-Value: 2E-7; OR or beta:     .57; Platform [SNPs passing QC]: Illumina [324,623]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
CACNA2D1		20708005	TAS		Disease/Trait: Non-alcoholic fatty liver disease histology (lobular); Initial Sample Size: 236 non-Hispanic Caucasian women; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10954668-A; SNPs: rs10954668; Context: intron; Risk Allele Frequency: 0.33; p-Value: 7E-6; OR or beta:     .32; Platform [SNPs passing QC]: Illumina [324,623]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
COL13A1		20708005	TAS		Disease/Trait: Non-alcoholic fatty liver disease histology (lobular); Initial Sample Size: 236 non-Hispanic Caucasian women; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7077164-A; SNPs: rs7077164; Context: intron; Risk Allele Frequency: 0.30; p-Value: 7E-6; OR or beta:     .67; Platform [SNPs passing QC]: Illumina [324,623]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
EFCAB4B		20708005	TAS		Disease/Trait: Non-alcoholic fatty liver disease histology (lobular); Initial Sample Size: 236 non-Hispanic Caucasian women; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs887304-A; SNPs: rs887304; Context: intron; Risk Allele Frequency: 0.31; p-Value: 8E-7; OR or beta:     .36; Platform [SNPs passing QC]: Illumina [324,623]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
FARP1		20708005	TAS		Disease/Trait: Non-alcoholic fatty liver disease histology (lobular); Initial Sample Size: 236 non-Hispanic Caucasian women; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9584805-G; SNPs: rs9584805; Context: intron; Risk Allele Frequency: 0.35; p-Value: 2E-6; OR or beta:     .44; Platform [SNPs passing QC]: Illumina [324,623]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
ST8SIA1		20708005	TAS		Disease/Trait: Non-alcoholic fatty liver disease histology (lobular); Initial Sample Size: 236 non-Hispanic Caucasian women; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2216228-G; SNPs: rs2216228; Context: intron; Risk Allele Frequency: 0.18; p-Value: 4E-6; OR or beta:     .45; Platform [SNPs passing QC]: Illumina [324,623]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
MACROD2		20708005	TAS		Disease/Trait: Non-alcoholic fatty liver disease histology (other); Initial Sample Size: 236 non-Hispanic Caucasian women; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6079395-A; SNPs: rs6079395; Context: intron; Risk Allele Frequency: 0.49; p-Value: 7E-6; OR or beta:     .92; Platform [SNPs passing QC]: Illumina [324,623]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
FDFT1		20708005	TAS		Disease/Trait: Non-alcoholic fatty liver disease histology (other); Initial Sample Size: 236 non-Hispanic Caucasian women; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2645424-A; SNPs: rs2645424; Context: intron; Risk Allele Frequency: 0.40; p-Value: 7E-7; OR or beta:     .77; Platform [SNPs passing QC]: Illumina [324,623]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
SLC9A9		20708005	TAS		Disease/Trait: Non-alcoholic fatty liver disease histology (other); Initial Sample Size: 236 non-Hispanic Caucasian women; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2800-G; SNPs: rs2800; Context: intron; Risk Allele Frequency: 0.34; p-Value: 3E-6; OR or beta:     .61; Platform [SNPs passing QC]: Illumina [324,623]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	fatty liver disease
CRTAC1		20694148	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,554 Indian Asian men; Replication Sample Size: 2,240 Indian Asian men; Strongest SNP-Risk Allele: rs531676-?; SNPs: rs531676; Context: intron; Risk Allele Frequency: 0.45; p-Value: 9E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [308,011]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
TCF7L2		20694148	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,554 Indian Asian men; Replication Sample Size: 2,240 Indian Asian men; Strongest SNP-Risk Allele: rs7903146-A; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.30; p-Value: 7E-7; OR or beta:    1.33; Platform [SNPs passing QC]: Illumina [308,011]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
HERPUD1		20694148	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,554 Indian Asian men; Replication Sample Size: 2,240 Indian Asian men; Strongest SNP-Risk Allele: rs2217332-?; SNPs: rs2217332; Context: missense; Risk Allele Frequency: 0.19; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [308,011]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
GIT2		20694148	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,554 Indian Asian men; Replication Sample Size: 2,240 Indian Asian men; Strongest SNP-Risk Allele: rs2292354-?; SNPs: rs2292354; Context: UTR-3; Risk Allele Frequency: 0.46; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [308,011]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
FADS2		20694148	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,554 Indian Asian men; Replication Sample Size: 2,240 Indian Asian men; Strongest SNP-Risk Allele: rs1535-G; SNPs: rs1535; Context: intron; Risk Allele Frequency: 0.18; p-Value: 4E-7; OR or beta:     .03; Platform [SNPs passing QC]: Illumina [308,011]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
FADS1		20694148	TAS		Disease/Trait: Metabolic syndrome; Initial Sample Size: 2,554 Indian Asian men; Replication Sample Size: 2,240 Indian Asian men; Strongest SNP-Risk Allele: rs174546-A; SNPs: rs174546; Context: UTR-3; Risk Allele Frequency: 0.18; p-Value: 6E-7; OR or beta:     .03; Platform [SNPs passing QC]: Illumina [308,011]	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	disease of metabolism
FOXP4		20676098	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,583 Japanese cases, 3,386 Japanese controls; Replication Sample Size: 3,001 cases, 5,415 controls; Strongest SNP-Risk Allele: rs1983891-T; SNPs: rs1983891; Context: intron; Risk Allele Frequency: 0.41; p-Value: 8E-8; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [510,687]	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
C2orf43		20676098	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,583 Japanese cases, 3,386 Japanese controls; Replication Sample Size: 3,001 cases, 5,415 controls; Strongest SNP-Risk Allele: rs13385191-G; SNPs: rs13385191; Context: intron; Risk Allele Frequency: 0.44; p-Value: 8E-8; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [510,687]	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
HNF1B		20676098	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,583 Japanese cases, 3,386 Japanese controls; Replication Sample Size: 3,001 cases, 5,415 controls; Strongest SNP-Risk Allele: rs7501939-?; SNPs: rs7501939; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-12; OR or beta: NR; Platform [SNPs passing QC]: Illumina [510,687]	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
MSMB		20676098	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,583 Japanese cases, 3,386 Japanese controls; Replication Sample Size: 3,001 cases, 5,415 controls; Strongest SNP-Risk Allele: rs10993994-?; SNPs: rs10993994; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 3E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [510,687]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
UMOD		20686651	TAS		Disease/Trait: Chronic kidney disease and serum creatinine levels; Initial Sample Size: 2,903 Icelandic CKD cases, 35,818 Icelandic controls, 22,256 Icelandic subjects with serum creatinine; Replication Sample Size: 300 Icelandic CKD cases, 2,964 Icelandic controls, 2,379 Icelandic subjects with serum creatinine, 1,819 Dutch subjects with serum creatinine; Strongest SNP-Risk Allele: rs4293393-T; SNPs: rs4293393; Context: nearGene-5; Risk Allele Frequency: 0.798; p-Value: 4E-10; OR or beta:    1.25; Platform [SNPs passing QC]: Illumina [~2.5 million] (imputed)	0.0000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	kidney disease;Abnormal circulating creatinine level
DPP6		20686608	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 991 Japanese cases, 5,209 Japanese controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6464375-A; SNPs: rs6464375; Context: ; Risk Allele Frequency: 0.10; p-Value: 4E-7; OR or beta:    3.73; Platform [SNPs passing QC]: Illumina [420,236]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
BICD1		20686608	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 991 Japanese cases, 5,209 Japanese controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs708224-A; SNPs: rs708224; Context: intron; Risk Allele Frequency: 0.66; p-Value: 3E-7; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [420,236]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
MYO1D		20686608	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 991 Japanese cases, 5,209 Japanese controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs225190-G; SNPs: rs225190; Context: ; Risk Allele Frequency: 0.36; p-Value: 6E-6; OR or beta:    1.26; Platform [SNPs passing QC]: Illumina [420,236]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
PARK2		20686608	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 991 Japanese cases, 5,209 Japanese controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3016539-A; SNPs: rs3016539; Context: intron; Risk Allele Frequency: 0.87; p-Value: 7E-6; OR or beta:    1.50; Platform [SNPs passing QC]: Illumina [420,236]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
RNF149		20686608	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 991 Japanese cases, 5,209 Japanese controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6711606-A; SNPs: rs6711606; Context: intron; Risk Allele Frequency: 0.12; p-Value: 4E-6; OR or beta:    2.81; Platform [SNPs passing QC]: Illumina [420,236]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
RNF43		20686608	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 991 Japanese cases, 5,209 Japanese controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2257205-A; SNPs: rs2257205; Context: missense; Risk Allele Frequency: 0.33; p-Value: 8E-6; OR or beta:    1.38; Platform [SNPs passing QC]: Illumina [420,236]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
PPP2R5C		20663923	TAS		Disease/Trait: Autism; Initial Sample Size: 1,385 affected children from 1,369 families; Replication Sample Size: 1,086 affected children from 595 families, 1,965 European, African American and other controls; Strongest SNP-Risk Allele: rs7142002-?; SNPs: rs7142002; Context: intron; Risk Allele Frequency: 0.94; p-Value: 3E-6; OR or beta:    1.56; Platform [SNPs passing QC]: Illumina [842,348]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	autistic disorder
MACROD2		20663923	TAS		Disease/Trait: Autism; Initial Sample Size: 1,385 affected children from 1,369 families; Replication Sample Size: 1,086 affected children from 595 families, 1,965 European, African American and other controls; Strongest SNP-Risk Allele: rs4141463-?; SNPs: rs4141463; Context: intron; Risk Allele Frequency: 0.57; p-Value: 4E-8; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [842,348]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	autistic disorder
GCKR		20657596	TAS		Disease/Trait: Hypertriglyceridemia; Initial Sample Size: 463 European ancestry cases, 1,197 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1260326-T; SNPs: rs1260326; Context: missense; Risk Allele Frequency: 0.41; p-Value: 7E-9; OR or beta:    1.75; Platform [SNPs passing QC]: Affymetrix [~2.1 million] (imputed)	0.000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	familial hypertriglyceridemia
IL12RB2		20639880	TAS		Disease/Trait: Primary biliary cirrhosis; Initial Sample Size: 453 Italian cases, 945 Italian controls,; Replication Sample Size: 481 Canadian cases, 3,706 Canadian controls; Strongest SNP-Risk Allele: rs3790567-A; SNPs: rs3790567; Context: intron; Risk Allele Frequency: 0.232; p-Value: 8E-12; OR or beta:    1.48; Platform [SNPs passing QC]: Illumina [276,459]	0.000000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary biliary cirrhosis
SPIB		20639880	TAS		Disease/Trait: Primary biliary cirrhosis; Initial Sample Size: 453 Italian cases, 945 Italian controls,; Replication Sample Size: 481 Canadian cases, 3,706 Canadian controls; Strongest SNP-Risk Allele: rs3745516-A; SNPs: rs3745516; Context: intron; Risk Allele Frequency: 0.23; p-Value: 8E-11; OR or beta:    1.46; Platform [SNPs passing QC]: Illumina [276,459]	0.00000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary biliary cirrhosis
DAB2IP		20622881	TAS		Disease/Trait: Abdominal aortic aneurysm; Initial Sample Size: 452 Icelandic cases, 27,712 Icelandic controls, 840 Dutch cases, 2,791 Dutch controls; Replication Sample Size: 7,451 European ancestry cases, 3,267 European ancestry controls; Strongest SNP-Risk Allele: rs7025486-A; SNPs: rs7025486; Context: intron; Risk Allele Frequency: 0.23; p-Value: 5E-10; OR or beta:    1.21; Platform [SNPs passing QC]: Illumina [293,677]	0.0000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	abdominal aortic aneurysm
IL10		20622879	TAS		Disease/Trait: Behcet's disease; Initial Sample Size: 611 Japanese cases, 737 Japanese controls; Replication Sample Size: 119 Korean cases, 140 Korean controls; Strongest SNP-Risk Allele: rs1800871-T; SNPs: rs1800871; Context: nearGene-5; Risk Allele Frequency: 0.31; p-Value: 1E-14; OR or beta:    1.45; Platform [SNPs passing QC]: Affymetrix [320,438]	0.00000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Behcet's disease
IL10		20622878	TAS		Disease/Trait: Behcet's disease; Initial Sample Size: 1,215 Turkish cases, 1,278 Turkish controls; Replication Sample Size: Up to 110 Turkish cases, 225 Turkish controls, 189 Middle Eastern Arab cases, 163 Middle Eastern Arab controls, 107 Greek cases, 84 Greek controls, 120 UK European descent cases, 119 UK European descent controls, 77 Korean cases, 54 Korean controls, 611 Japanese cases, 737 Japanese controls; Strongest SNP-Risk Allele: rs1518111-?; SNPs: rs1518111; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-18; OR or beta:    1.45; Platform [SNPs passing QC]: Illumina [311,459]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Behcet's disease
OSBPL10		20610895	TAS		Disease/Trait: Peripheral artery disease; Initial Sample Size: 195 Japanese cases, 1,358 Japanese controls; Replication Sample Size: 699 Japanese cases, 1,540 Japanese controls; Strongest SNP-Risk Allele: rs1902341-G; SNPs: rs1902341; Context: intron; Risk Allele Frequency: 0.397; p-Value: 5E-7; OR or beta:    1.31; Platform [SNPs passing QC]: Perlegen [222,285]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	peripheral vascular disease
STX17		20596022	TAS		Disease/Trait: Alopecia areata; Initial Sample Size: Up to 1,054 European ancestry cases, 3,278 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10760706-G; SNPs: rs10760706; Context: intron; Risk Allele Frequency: 0.31; p-Value: 4E-7; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [463,301]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alopecia areata
IL2RA		20596022	TAS		Disease/Trait: Alopecia areata; Initial Sample Size: Up to 1,054 European ancestry cases, 3,278 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3118470-G; SNPs: rs3118470; Context: intron; Risk Allele Frequency: 0.30; p-Value: 2E-12; OR or beta:    1.41; Platform [SNPs passing QC]: Illumina [463,301]	0.000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alopecia areata
ZNF433		20598377	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 590 Caucasian European descent cases, 825 Caucasian European descent controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3745672-?; SNPs: rs3745672; Context: UTR-5; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    7.39; Platform [SNPs passing QC]: Illumina [~300,000]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
VAV2		20598377	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 590 Caucasian European descent cases, 825 Caucasian European descent controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3780792-G; SNPs: rs3780792; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.60; Platform [SNPs passing QC]: Illumina [~300,000]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
ARHGAP22		20585324	TAS		Disease/Trait: Conduct disorder (case status); Initial Sample Size: 872 cases, 3,091 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10776612-?; SNPs: rs10776612; Context: intron; Risk Allele Frequency: 0.519; p-Value: 2E-6; OR or beta:    1.33; Platform [SNPs passing QC]: Illumina [948,658]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
ZNF330		20585324	TAS		Disease/Trait: Conduct disorder (case status); Initial Sample Size: 872 cases, 3,091 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17007017-?; SNPs: rs17007017; Context: intron; Risk Allele Frequency: 0.685; p-Value: 7E-6; OR or beta:    1.34; Platform [SNPs passing QC]: Illumina [948,658]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
C1QTNF7		20585324	TAS		Disease/Trait: Conduct disorder (case status); Initial Sample Size: 872 cases, 3,091 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1861046-?; SNPs: rs1861046; Context: intron; Risk Allele Frequency: 0.095; p-Value: 6E-8; OR or beta:    1.65; Platform [SNPs passing QC]: Illumina [948,658]	0.00000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
ERCC4		20585324	TAS		Disease/Trait: Conduct disorder (symptom count); Initial Sample Size: 872 cases, 3,091 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3136202-?; SNPs: rs3136202; Context: intron; Risk Allele Frequency: 0.429; p-Value: 6E-6; OR or beta:     .07; Platform [SNPs passing QC]: Illumina [948,658]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
TOX2		20585324	TAS		Disease/Trait: Conduct disorder (symptom count); Initial Sample Size: 872 cases, 3,091 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6031252-?; SNPs: rs6031252; Context: intron; Risk Allele Frequency: 0.142; p-Value: 6E-6; OR or beta:     .11; Platform [SNPs passing QC]: Illumina [948,658]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
PDE10A		20585324	TAS		Disease/Trait: Conduct disorder (symptom count); Initial Sample Size: 872 cases, 3,091 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7762160-?; SNPs: rs7762160; Context: intron; Risk Allele Frequency: 0.365; p-Value: 1E-6; OR or beta:     .07; Platform [SNPs passing QC]: Illumina [948,658]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
C1QTNF7		20585324	TAS		Disease/Trait: Conduct disorder (symptom count); Initial Sample Size: 872 cases, 3,091 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs16891867-?; SNPs: rs16891867; Context: intron; Risk Allele Frequency: 0.097; p-Value: 3E-9; OR or beta:     .15; Platform [SNPs passing QC]: Illumina [948,658]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
LOC343052		20585324	TAS		Disease/Trait: Conduct disorder (symptom count); Initial Sample Size: 872 cases, 3,091 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4434872-?; SNPs: rs4434872; Context: ; Risk Allele Frequency: 0.263; p-Value: 8E-6; OR or beta:     .08; Platform [SNPs passing QC]: Illumina [948,658]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
SELPLG		20585324	TAS		Disease/Trait: Conduct disorder (symptom count); Initial Sample Size: 872 cases, 3,091 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs8179116-?; SNPs: rs8179116; Context: intron; Risk Allele Frequency: 0.021; p-Value: 3E-6; OR or beta:     .23; Platform [SNPs passing QC]: Illumina [948,658]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
FTO		20581827	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 8,130 European ancestry cases, 38,987 European ancestry controls; Replication Sample Size: Up to 34,412 European ancestry cases, 59,925 European ancestry controls; Strongest SNP-Risk Allele: rs11642841-A; SNPs: rs11642841; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-8; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix & Illumina [2,426,886] (imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
JAZF1		20581827	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 8,130 European ancestry cases, 38,987 European ancestry controls; Replication Sample Size: Up to 34,412 European ancestry cases, 59,925 European ancestry controls; Strongest SNP-Risk Allele: rs849134-A; SNPs: rs849134; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-9; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix & Illumina [2,426,886] (imputed)	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
IGF2BP2		20581827	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 8,130 European ancestry cases, 38,987 European ancestry controls; Replication Sample Size: Up to 34,412 European ancestry cases, 59,925 European ancestry controls; Strongest SNP-Risk Allele: rs1470579-C; SNPs: rs1470579; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-9; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix & Illumina [2,426,886] (imputed)	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CDKAL1		20581827	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 8,130 European ancestry cases, 38,987 European ancestry controls; Replication Sample Size: Up to 34,412 European ancestry cases, 59,925 European ancestry controls; Strongest SNP-Risk Allele: rs10440833-A; SNPs: rs10440833; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-22; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix & Illumina [2,426,886] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
SLC30A8		20581827	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 8,130 European ancestry cases, 38,987 European ancestry controls; Replication Sample Size: Up to 34,412 European ancestry cases, 59,925 European ancestry controls; Strongest SNP-Risk Allele: rs3802177-G; SNPs: rs3802177; Context: UTR-3; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix & Illumina [2,426,886] (imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		20581827	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 8,130 European ancestry cases, 38,987 European ancestry controls; Replication Sample Size: Up to 34,412 European ancestry cases, 59,925 European ancestry controls; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-51; OR or beta:    1.40; Platform [SNPs passing QC]: Affymetrix & Illumina [2,426,886] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TP53INP1		20581827	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 8,130 European ancestry cases, 38,987 European ancestry controls; Replication Sample Size: Up to 34,412 European ancestry cases, 59,925 European ancestry controls; Strongest SNP-Risk Allele: rs896854-T; SNPs: rs896854; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-9; OR or beta:    1.06; Platform [SNPs passing QC]: Affymetrix & Illumina [2,426,886] (imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
WFS1		20581827	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 8,130 European ancestry cases, 38,987 European ancestry controls; Replication Sample Size: Up to 34,412 European ancestry cases, 59,925 European ancestry controls; Strongest SNP-Risk Allele: rs1801214-T; SNPs: rs1801214; Context: missense; Risk Allele Frequency: NR; p-Value: 3E-8; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix & Illumina [2,426,886] (imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
BNC2		20585627	TAS		Disease/Trait: Freckling; Initial Sample Size: 9,126 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2153271-C; SNPs: rs2153271; Context: intron; Risk Allele Frequency: 0.41; p-Value: 4E-10; OR or beta:     .40; Platform [SNPs passing QC]: Illumina [535,076]	0.0000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Freckling
IRF4		20585627	TAS		Disease/Trait: Freckling; Initial Sample Size: 9,126 European ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12203592-T; SNPs: rs12203592; Context: intron; Risk Allele Frequency: 0.18; p-Value: 2E-91; OR or beta:    1.61; Platform [SNPs passing QC]: Illumina [535,076]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Freckling
FUT2		20570966	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 896 European ancestry cases, 3,204 European ancestry controls; Replication Sample Size: 1,174 European ancestry cases, 357 European ancestry controls; Strongest SNP-Risk Allele: rs504963-A; SNPs: rs504963; Context: UTR-3; Risk Allele Frequency: 0.431; p-Value: 2E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [304,825]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
IL23R		20570966	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 896 European ancestry cases, 3,204 European ancestry controls; Replication Sample Size: 1,174 European ancestry cases, 357 European ancestry controls; Strongest SNP-Risk Allele: rs11465804-?; SNPs: rs11465804; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.89; Platform [SNPs passing QC]: Illumina [304,825]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
NOD2		20570966	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 896 European ancestry cases, 3,204 European ancestry controls; Replication Sample Size: 1,174 European ancestry cases, 357 European ancestry controls; Strongest SNP-Risk Allele: rs2066847-?; SNPs: rs2066847; Context: frameshift; Risk Allele Frequency: NR; p-Value: 2E-15; OR or beta:    1.62; Platform [SNPs passing QC]: Illumina [304,825]	0.000000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
DMRT1		20543847	TAS		Disease/Trait: Testicular germ cell cancer; Initial Sample Size: 979 European ancestry cases, 4,947 European ancestry controls; Replication Sample Size: 664 European ancestry cases, 3,456 European ancestry controls; Strongest SNP-Risk Allele: rs755383-T; SNPs: rs755383; Context: intron; Risk Allele Frequency: 0.62; p-Value: 1E-23; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [298,782]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	testicular germ cell cancer
TERT		20543847	TAS		Disease/Trait: Testicular germ cell cancer; Initial Sample Size: 979 European ancestry cases, 4,947 European ancestry controls; Replication Sample Size: 664 European ancestry cases, 3,456 European ancestry controls; Strongest SNP-Risk Allele: rs2736100-T; SNPs: rs2736100; Context: intron; Risk Allele Frequency: 0.49; p-Value: 8E-15; OR or beta:    1.33; Platform [SNPs passing QC]: Illumina [298,782]	0.000000000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	testicular germ cell cancer
KITLG		20543847	TAS		Disease/Trait: Testicular germ cell cancer; Initial Sample Size: 979 European ancestry cases, 4,947 European ancestry controls; Replication Sample Size: 664 European ancestry cases, 3,456 European ancestry controls; Strongest SNP-Risk Allele: rs3782181-?; SNPs: rs3782181; Context: intron; Risk Allele Frequency: 0.78; p-Value: 2E-26; OR or beta:    2.22; Platform [SNPs passing QC]: Illumina [298,782]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	testicular germ cell cancer
OSBPL1A		20548944	TAS		Disease/Trait: Osteoporosis; Initial Sample Size: 2,038 European ancestry women, 1,531 European ancestry  men; Replication Sample Size: 5,595 European ancestry women, 2,126 European ancestry men; Strongest SNP-Risk Allele: rs7227401-T; SNPs: rs7227401; Context: intron; Risk Allele Frequency: 0.39; p-Value: 4E-7; OR or beta:     .17; Platform [SNPs passing QC]: Affymetrix [433,510]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	osteoporosis
TBC1D8		20548944	TAS		Disease/Trait: Osteoporosis; Initial Sample Size: 2,038 European ancestry women, 1,531 European ancestry  men; Replication Sample Size: 5,595 European ancestry women, 2,126 European ancestry men; Strongest SNP-Risk Allele: rs2278729-A; SNPs: rs2278729; Context: intron; Risk Allele Frequency: 0.33; p-Value: 1E-7; OR or beta:     .19; Platform [SNPs passing QC]: Affymetrix [433,510]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	osteoporosis
DOK6		20548944	TAS		Disease/Trait: Osteoporosis; Initial Sample Size: 2,038 European ancestry women, 1,531 European ancestry  men; Replication Sample Size: 5,595 European ancestry women, 2,126 European ancestry men; Strongest SNP-Risk Allele: rs17184557-A; SNPs: rs17184557; Context: intron; Risk Allele Frequency: 0.23; p-Value: 9E-7; OR or beta:     .13; Platform [SNPs passing QC]: Affymetrix [433,510]	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	osteoporosis
RAP1A		20548944	TAS		Disease/Trait: Osteoporosis; Initial Sample Size: 2,038 European ancestry women, 1,531 European ancestry  men; Replication Sample Size: 5,595 European ancestry women, 2,126 European ancestry men; Strongest SNP-Risk Allele: rs494453-C; SNPs: rs494453; Context: intron; Risk Allele Frequency: 0.24; p-Value: 4E-8; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [433,510]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	osteoporosis
GC		20541252	TAS		Disease/Trait: Vitamin D insufficiency; Initial Sample Size: 16,125 European ancestry individuals; Replication Sample Size: 17,871 European ancestry individuals; Strongest SNP-Risk Allele: rs2282679-?; SNPs: rs2282679; Context: intron; Risk Allele Frequency: 0.29; p-Value: 2E-109; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [up to 2,548,976] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitamin metabolic disorder
CYP2R1		20541252	TAS		Disease/Trait: Vitamin D insufficiency; Initial Sample Size: 16,125 European ancestry individuals; Replication Sample Size: 17,871 European ancestry individuals; Strongest SNP-Risk Allele: rs10741657-?; SNPs: rs10741657; Context: nearGene-5; Risk Allele Frequency: 0.40; p-Value: 3E-20; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [up to 2,548,976] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitamin metabolic disorder
ZMIZ1		20526339	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 1,117 Chinese Han cases, 1,429 Chinese Han controls; Replication Sample Size: 5,910 Chinese Han cases, 9,916 Chinese Han controls, 713 Chinese Uygur cases, 824 Chinese Uygur controls; Strongest SNP-Risk Allele: rs11593576-?; SNPs: rs11593576; Context: intron; Risk Allele Frequency: 0.805; p-Value: 8E-7; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [493,909]	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
ZNF385D		20522523	TAS		Disease/Trait: Partial epilepsies; Initial Sample Size: Up to 3,445 European ancestry cases, 6,935 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1490157-?; SNPs: rs1490157; Context: intron; Risk Allele Frequency: 0.739; p-Value: 5E-6; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [528,745]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	focal epilepsy
PTPRD		20522523	TAS		Disease/Trait: Partial epilepsies; Initial Sample Size: Up to 3,445 European ancestry cases, 6,935 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2475335-?; SNPs: rs2475335; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [528,745]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	focal epilepsy
ADCY9		20522523	TAS		Disease/Trait: Partial epilepsies; Initial Sample Size: Up to 3,445 European ancestry cases, 6,935 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2601828-A; SNPs: rs2601828; Context: intron; Risk Allele Frequency: 0.222; p-Value: 1E-6; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [528,745]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	focal epilepsy
LPHN3		20522523	TAS		Disease/Trait: Partial epilepsies; Initial Sample Size: Up to 3,445 European ancestry cases, 6,935 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2172802-?; SNPs: rs2172802; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [528,745]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	focal epilepsy
TNFRSF19		20512145	TAS		Disease/Trait: Nasopharyngeal carcinoma; Initial Sample Size: 1,583 Southern Chinese descent cases, 972 Southern Chinese descent controls, 922 Singapore Chinese controls; Replication Sample Size: 3,507 Southern Chinese descent cases, 3,063 Southern Chinese descent controls, 284 Southern Chinese family trios; Strongest SNP-Risk Allele: rs9510787-G; SNPs: rs9510787; Context: intron; Risk Allele Frequency: 0.37; p-Value: 2E-9; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [464,328]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	nasopharynx carcinoma
ELOVL6		20732626	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 735 trios from 732 families; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10011926-?; SNPs: rs10011926; Context: intron; Risk Allele Frequency: 0.78; p-Value: 8E-6; OR or beta:    1.49; Platform [SNPs passing QC]: Illumina [835,136]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
EMP2		20732626	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 735 trios from 732 families; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11074889-A; SNPs: rs11074889; Context: intron; Risk Allele Frequency: 0.16; p-Value: 7E-7; OR or beta:    1.68; Platform [SNPs passing QC]: Illumina [835,136]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
BMPR1B		20732626	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 735 trios from 732 families; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1859156-?; SNPs: rs1859156; Context: intron; Risk Allele Frequency: 0.79; p-Value: 2E-6; OR or beta:    1.54; Platform [SNPs passing QC]: Illumina [835,136]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
CCR6		20453841	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 2,303 Japanese cases, 3,380 Japanese controls; Replication Sample Size: 4,768 Japanese cases, 17,359 Japanese controls; Strongest SNP-Risk Allele: rs3093024-T; SNPs: rs3093024; Context: intron; Risk Allele Frequency: 0.46; p-Value: 8E-19; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [393,217]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
STAT4		20453841	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 2,303 Japanese cases, 3,380 Japanese controls; Replication Sample Size: 4,768 Japanese cases, 17,359 Japanese controls; Strongest SNP-Risk Allele: rs7574865-T; SNPs: rs7574865; Context: intron; Risk Allele Frequency: 0.33; p-Value: 2E-6; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina [393,217]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
CBLB		20453840	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 882 Sardinian cases, 872 Sardinian controls; Replication Sample Size: 1,775 Sardinian cases, 2,005 Sardinian controls; Strongest SNP-Risk Allele: rs9657904-T; SNPs: rs9657904; Context: intron; Risk Allele Frequency: 0.826; p-Value: 2E-10; OR or beta:    1.40; Platform [SNPs passing QC]: Affymetrix [6,607,266] (imputed)	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
SH2B3		20453842	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 5,539 European ancestry cases, 20,169 European ancestry controls; Replication Sample Size: 6,768 European ancestry cases, 8,806 European ancestry controls; Strongest SNP-Risk Allele: rs3184504-T; SNPs: rs3184504; Context: missense; Risk Allele Frequency: 0.51; p-Value: 6E-6; OR or beta:    1.08; Platform [SNPs passing QC]: Affymetrix & Illumina [~2,716,259] (imputed)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
UBASH3A		20453842	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 5,539 European ancestry cases, 20,169 European ancestry controls; Replication Sample Size: 6,768 European ancestry cases, 8,806 European ancestry controls; Strongest SNP-Risk Allele: rs11203203-A; SNPs: rs11203203; Context: intron; Risk Allele Frequency: 0.37; p-Value: 4E-6; OR or beta:    1.11; Platform [SNPs passing QC]: Affymetrix & Illumina [~2,716,259] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
IL2RA		20453842	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 5,539 European ancestry cases, 20,169 European ancestry controls; Replication Sample Size: 6,768 European ancestry cases, 8,806 European ancestry controls; Strongest SNP-Risk Allele: rs706778-T; SNPs: rs706778; Context: intron; Risk Allele Frequency: 0.40; p-Value: 1E-11; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix & Illumina [~2,716,259] (imputed)	0.00000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
CCR6		20453842	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 5,539 European ancestry cases, 20,169 European ancestry controls; Replication Sample Size: 6,768 European ancestry cases, 8,806 European ancestry controls; Strongest SNP-Risk Allele: rs3093023-A; SNPs: rs3093023; Context: intron; Risk Allele Frequency: 0.43; p-Value: 2E-11; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix & Illumina [~2,716,259] (imputed)	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
SPRED2		20453842	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 5,539 European ancestry cases, 20,169 European ancestry controls; Replication Sample Size: 6,768 European ancestry cases, 8,806 European ancestry controls; Strongest SNP-Risk Allele: rs934734-G; SNPs: rs934734; Context: intron; Risk Allele Frequency: 0.49; p-Value: 5E-10; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix & Illumina [~2,716,259] (imputed)	0.0000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
CD247		20453842	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 5,539 European ancestry cases, 20,169 European ancestry controls; Replication Sample Size: 6,768 European ancestry cases, 8,806 European ancestry controls; Strongest SNP-Risk Allele: rs840016-C; SNPs: rs840016; Context: intron; Risk Allele Frequency: 0.58; p-Value: 2E-6; OR or beta:    1.11; Platform [SNPs passing QC]: Affymetrix & Illumina [~2,716,259] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
C5orf30		20453842	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 5,539 European ancestry cases, 20,169 European ancestry controls; Replication Sample Size: 6,768 European ancestry cases, 8,806 European ancestry controls; Strongest SNP-Risk Allele: rs26232-C; SNPs: rs26232; Context: intron; Risk Allele Frequency: 0.68; p-Value: 4E-8; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix & Illumina [~2,716,259] (imputed)	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
STAT4		20453842	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 5,539 European ancestry cases, 20,169 European ancestry controls; Replication Sample Size: 6,768 European ancestry cases, 8,806 European ancestry controls; Strongest SNP-Risk Allele: rs7574865-T; SNPs: rs7574865; Context: intron; Risk Allele Frequency: 0.22; p-Value: 3E-7; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix & Illumina [~2,716,259] (imputed)	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
PTPN22		20453842	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 5,539 European ancestry cases, 20,169 European ancestry controls; Replication Sample Size: 6,768 European ancestry cases, 8,806 European ancestry controls; Strongest SNP-Risk Allele: rs2476601-A; SNPs: rs2476601; Context: ; Risk Allele Frequency: 0.10; p-Value: 9E-74; OR or beta:    1.94; Platform [SNPs passing QC]: Affymetrix & Illumina [~2,716,259] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
REL		20453842	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 5,539 European ancestry cases, 20,169 European ancestry controls; Replication Sample Size: 6,768 European ancestry cases, 8,806 European ancestry controls; Strongest SNP-Risk Allele: rs13031237-T; SNPs: rs13031237; Context: intron; Risk Allele Frequency: 0.36; p-Value: 8E-7; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix & Illumina [~2,716,259] (imputed)	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
CTLA4		20453842	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 5,539 European ancestry cases, 20,169 European ancestry controls; Replication Sample Size: 6,768 European ancestry cases, 8,806 European ancestry controls; Strongest SNP-Risk Allele: rs3087243-G; SNPs: rs3087243; Context: nearGene-3; Risk Allele Frequency: 0.56; p-Value: 1E-8; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix & Illumina [~2,716,259] (imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
CD40		20453842	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 5,539 European ancestry cases, 20,169 European ancestry controls; Replication Sample Size: 6,768 European ancestry cases, 8,806 European ancestry controls; Strongest SNP-Risk Allele: rs4810485-T; SNPs: rs4810485; Context: intron; Risk Allele Frequency: 0.25; p-Value: 3E-9; OR or beta:    1.18; Platform [SNPs passing QC]: Affymetrix & Illumina [~2,716,259] (imputed)	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
ZNF365		20453838	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 3,659 UK cases, 4,897 UK controls; Replication Sample Size: 12,576 European cases, 12,223 European controls; Strongest SNP-Risk Allele: rs10995190-G; SNPs: rs10995190; Context: intron; Risk Allele Frequency: 0.85; p-Value: 5E-15; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [582,886]	0.000000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
FGFR2		20453838	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 3,659 UK cases, 4,897 UK controls; Replication Sample Size: 12,576 European cases, 12,223 European controls; Strongest SNP-Risk Allele: rs2981579-A; SNPs: rs2981579; Context: intron; Risk Allele Frequency: 0.42; p-Value: 4E-31; OR or beta:    1.43; Platform [SNPs passing QC]: Illumina [582,886]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
SLC4A7		20453838	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 3,659 UK cases, 4,897 UK controls; Replication Sample Size: 12,576 European cases, 12,223 European controls; Strongest SNP-Risk Allele: rs4973768-T; SNPs: rs4973768; Context: UTR-3; Risk Allele Frequency: 0.47; p-Value: 6E-7; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [582,886]	0.0000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
ZMIZ1		20453838	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 3,659 UK cases, 4,897 UK controls; Replication Sample Size: 12,576 European cases, 12,223 European controls; Strongest SNP-Risk Allele: rs704010-A; SNPs: rs704010; Context: intron; Risk Allele Frequency: 0.39; p-Value: 4E-9; OR or beta:    1.07; Platform [SNPs passing QC]: Illumina [582,886]	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
RELN		20452100	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 299 non-demented Caucasian individuals (low and heavy NFT burden); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4298437-A; SNPs: rs4298437; Context: intron; Risk Allele Frequency: 0.26; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [292,175]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
GNA15		20445134	TAS		Disease/Trait: Heart failure; Initial Sample Size: 20,926 European ancestry participants, 2,895 African ancestry participants; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11880198-?; SNPs: rs11880198; Context: intron; Risk Allele Frequency: 0.13; p-Value: 6E-6; OR or beta:    1.23; Platform [SNPs passing QC]: Affymetrix & Illumina [2,478,304] (imputed)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	congestive heart failure
OPTN		20436471	TAS		Disease/Trait: Paget's disease; Initial Sample Size: 692 European ancestry cases, 1,001 European ancestry controls; Replication Sample Size: 481 European ancestry cases, 520 European ancestry controls; Strongest SNP-Risk Allele: rs1561570-?; SNPs: rs1561570; Context: intron; Risk Allele Frequency: 0.55; p-Value: 6E-13; OR or beta:    1.54; Platform [SNPs passing QC]: Illumina [294,663]	0.0000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	mammary Paget's disease
FTO		20421936	TAS		Disease/Trait: Obesity (extreme); Initial Sample Size: 1,138 French and German extremely obese children, 1,120 French and German normal or underweight children; Replication Sample Size: 1,892 European ancestry obese or overweight children and adolescents, 3,763 European ancestry normal or underweight controls, 715 families with obese offspring; Strongest SNP-Risk Allele: rs1558902-A; SNPs: rs1558902; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-13; OR or beta:    1.37; Platform [SNPs passing QC]: Affymetrix & Illumina [1,596,878] (imputed)	0.0000000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	morbid obesity
LPP		20410501	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 1,392 European ancestry cases, 2,629 European ancestry controls; Replication Sample Size: 647 European ancestry cases, 1,056 European ancestry controls, 183 European ancestry trios, 332 European ancestry multiplex families; Strongest SNP-Risk Allele: rs1464510-T; SNPs: rs1464510; Context: intron; Risk Allele Frequency: 0.44; p-Value: 1E-11; OR or beta:    1.31; Platform [SNPs passing QC]: Illumina [520,460]	0.00000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
PTPN22		20410501	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 1,392 European ancestry cases, 2,629 European ancestry controls; Replication Sample Size: 647 European ancestry cases, 1,056 European ancestry controls, 183 European ancestry trios, 332 European ancestry multiplex families; Strongest SNP-Risk Allele: rs2476601-A; SNPs: rs2476601; Context: ; Risk Allele Frequency: 0.095; p-Value: 1E-7; OR or beta:    1.39; Platform [SNPs passing QC]: Illumina [520,460]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
GZMB		20410501	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 1,392 European ancestry cases, 2,629 European ancestry controls; Replication Sample Size: 647 European ancestry cases, 1,056 European ancestry controls, 183 European ancestry trios, 332 European ancestry multiplex families; Strongest SNP-Risk Allele: rs8192917-G; SNPs: rs8192917; Context: missense; Risk Allele Frequency: 0.236; p-Value: 3E-8; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [520,460]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
UBASH3A		20410501	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 1,392 European ancestry cases, 2,629 European ancestry controls; Replication Sample Size: 647 European ancestry cases, 1,056 European ancestry controls, 183 European ancestry trios, 332 European ancestry multiplex families; Strongest SNP-Risk Allele: rs11203203-A; SNPs: rs11203203; Context: intron; Risk Allele Frequency: 0.373; p-Value: 1E-9; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [520,460]	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
RERE		20410501	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 1,392 European ancestry cases, 2,629 European ancestry controls; Replication Sample Size: 647 European ancestry cases, 1,056 European ancestry controls, 183 European ancestry trios, 332 European ancestry multiplex families; Strongest SNP-Risk Allele: rs4908760-G; SNPs: rs4908760; Context: intron; Risk Allele Frequency: 0.37; p-Value: 7E-15; OR or beta:    1.36; Platform [SNPs passing QC]: Illumina [520,460]	0.000000000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
TYR		20410501	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 1,392 European ancestry cases, 2,629 European ancestry controls; Replication Sample Size: 647 European ancestry cases, 1,056 European ancestry controls, 183 European ancestry trios, 332 European ancestry multiplex families; Strongest SNP-Risk Allele: rs1393350-G; SNPs: rs1393350; Context: intron; Risk Allele Frequency: 0.733; p-Value: 2E-18; OR or beta:    1.53; Platform [SNPs passing QC]: Illumina [520,460]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
C1QTNF6		20410501	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 1,392 European ancestry cases, 2,629 European ancestry controls; Replication Sample Size: 647 European ancestry cases, 1,056 European ancestry controls, 183 European ancestry trios, 332 European ancestry multiplex families; Strongest SNP-Risk Allele: rs229527-T; SNPs: rs229527; Context: missense; Risk Allele Frequency: 0.419; p-Value: 2E-16; OR or beta:    1.38; Platform [SNPs passing QC]: Illumina [520,460]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
CMTM7		20400778	TAS		Disease/Trait: Mortality among heart failure patients; Initial Sample Size: 2,526 European ancestry individuals, 466 African ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12638540-G; SNPs: rs12638540; Context: intron; Risk Allele Frequency: 0.043; p-Value: 3E-7; OR or beta:    1.53; Platform [SNPs passing QC]: Affymetrix [~2.4 million] (imputed)	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	congestive heart failure
GPM6A		20400778	TAS		Disease/Trait: Mortality among heart failure patients; Initial Sample Size: 2,526 European ancestry individuals, 466 African ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7687921-T; SNPs: rs7687921; Context: intron; Risk Allele Frequency: 0.039; p-Value: 4E-6; OR or beta:    1.77; Platform [SNPs passing QC]: Affymetrix [~2.4 million] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	congestive heart failure
IFRD1		20400778	TAS		Disease/Trait: Mortality among heart failure patients; Initial Sample Size: 2,526 European ancestry individuals, 466 African ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17159640-T; SNPs: rs17159640; Context: intron; Risk Allele Frequency: 0.048; p-Value: 9E-6; OR or beta:    1.59; Platform [SNPs passing QC]: Affymetrix [~2.4 million] (imputed)	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	congestive heart failure
OTUD7A		20400778	TAS		Disease/Trait: Mortality among heart failure patients; Initial Sample Size: 2,526 European ancestry individuals, 466 African ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2125623-C; SNPs: rs2125623; Context: intron; Risk Allele Frequency: 0.71; p-Value: 1E-6; OR or beta:    1.23; Platform [SNPs passing QC]: Affymetrix [~2.4 million] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	congestive heart failure
PARVA		20400778	TAS		Disease/Trait: Mortality among heart failure patients; Initial Sample Size: 2,526 European ancestry individuals, 466 African ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7120489-A; SNPs: rs7120489; Context: intron; Risk Allele Frequency: 0.069; p-Value: 7E-6; OR or beta:    1.35; Platform [SNPs passing QC]: Affymetrix [~2.4 million] (imputed)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	congestive heart failure
ADAMTS12		20400778	TAS		Disease/Trait: Mortality among heart failure patients; Initial Sample Size: 2,526 European ancestry individuals, 466 African ancestry individuals; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6868223-A; SNPs: rs6868223; Context: intron; Risk Allele Frequency: 0.338; p-Value: 2E-6; OR or beta:    1.58; Platform [SNPs passing QC]: Affymetrix [~2.4 million] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	congestive heart failure
GPC5		20205591	TAS		Disease/Trait: HIV-1 control; Initial Sample Size: 515 African American cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1413191-?; SNPs: rs1413191; Context: intron; Risk Allele Frequency: 0.18; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [1,212,217]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
EVI5L		20205591	TAS		Disease/Trait: HIV-1 control; Initial Sample Size: 515 African American cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs558718-?; SNPs: rs558718; Context: intron; Risk Allele Frequency: 0.11; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [1,212,217]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
AOAH		20205591	TAS		Disease/Trait: HIV-1 control; Initial Sample Size: 515 African American cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6948404-?; SNPs: rs6948404; Context: ; Risk Allele Frequency: 0.07; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [1,212,217]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
HLA-B		20205591	TAS		Disease/Trait: HIV-1 control; Initial Sample Size: 515 African American cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2523608-?; SNPs: rs2523608; Context: intron; Risk Allele Frequency: 0.37; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [1,212,217]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
MCM8		20205591	TAS		Disease/Trait: HIV-1 control; Initial Sample Size: 515 African American cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs454422-?; SNPs: rs454422; Context: intron; Risk Allele Frequency: 0.26; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [1,212,217]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
CFH		20385819	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 2,978 European ancestry cases, 2,859 European ancestry controls; Replication Sample Size: 7,071 European ancestry cases, 678 Japanese cases, 4,289 European ancestry controls, 336 Japanese controls; Strongest SNP-Risk Allele: rs10737680-A; SNPs: rs10737680; Context: intron; Risk Allele Frequency: 0.566; p-Value: 2E-76; OR or beta:    3.11; Platform [SNPs passing QC]: Illumina [~2.5 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
C3		20385819	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 2,978 European ancestry cases, 2,859 European ancestry controls; Replication Sample Size: 7,071 European ancestry cases, 678 Japanese cases, 4,289 European ancestry controls, 336 Japanese controls; Strongest SNP-Risk Allele: rs2230199-C; SNPs: rs2230199; Context: missense; Risk Allele Frequency: 0.163; p-Value: 1E-10; OR or beta:    1.74; Platform [SNPs passing QC]: Illumina [~2.5 million] (imputed)	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
CFH		20385819	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 2,978 European ancestry cases, 2,859 European ancestry controls; Replication Sample Size: 7,071 European ancestry cases, 678 Japanese cases, 4,289 European ancestry controls, 336 Japanese controls; Strongest SNP-Risk Allele: rs1329424-T; SNPs: rs1329424; Context: intron; Risk Allele Frequency: 0.351; p-Value: 6E-16; OR or beta:    1.88; Platform [SNPs passing QC]: Illumina [~2.5 million] (imputed)	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
COL8A1		20385826	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 979 European ancestry cases, 1,709 European ancestry controls; Replication Sample Size: 5,789 Caucasian cases, 4,234 Caucasian controls; Strongest SNP-Risk Allele: rs13095226-C; SNPs: rs13095226; Context: intron; Risk Allele Frequency: 0.12; p-Value: 3E-6; OR or beta:    1.24; Platform [SNPs passing QC]: Affymetrix [632,932]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
RREB1		20385826	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 979 European ancestry cases, 1,709 European ancestry controls; Replication Sample Size: 5,789 Caucasian cases, 4,234 Caucasian controls; Strongest SNP-Risk Allele: rs11755724-G; SNPs: rs11755724; Context: intron; Risk Allele Frequency: 0.64; p-Value: 1E-6; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix [632,932]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
CFH		20385826	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 979 European ancestry cases, 1,709 European ancestry controls; Replication Sample Size: 5,789 Caucasian cases, 4,234 Caucasian controls; Strongest SNP-Risk Allele: rs1061170-?; SNPs: rs1061170; Context: missense; Risk Allele Frequency: NR; p-Value: 4E-117; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [632,932]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
CFH		20385826	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 979 European ancestry cases, 1,709 European ancestry controls; Replication Sample Size: 5,789 Caucasian cases, 4,234 Caucasian controls; Strongest SNP-Risk Allele: rs1410996-?; SNPs: rs1410996; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-111; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [632,932]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
C3		20385826	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 979 European ancestry cases, 1,709 European ancestry controls; Replication Sample Size: 5,789 Caucasian cases, 4,234 Caucasian controls; Strongest SNP-Risk Allele: rs2230199-?; SNPs: rs2230199; Context: missense; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [632,932]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
DACH1		20383146	TAS		Disease/Trait: Chronic kidney disease; Initial Sample Size: Up to 67,093 European ancestry individuals; Replication Sample Size: Up to 22,982 European ancestry individuals; Strongest SNP-Risk Allele: rs626277-C; SNPs: rs626277; Context: intron; Risk Allele Frequency: 0.40; p-Value: 3E-11; OR or beta:     .01; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.00000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	kidney disease
TFDP2		20383146	TAS		Disease/Trait: Chronic kidney disease; Initial Sample Size: Up to 67,093 European ancestry individuals; Replication Sample Size: Up to 22,982 European ancestry individuals; Strongest SNP-Risk Allele: rs347685-C; SNPs: rs347685; Context: intron; Risk Allele Frequency: 0.28; p-Value: 3E-11; OR or beta:    1.09; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.00000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	kidney disease
ATXN2		20383146	TAS		Disease/Trait: Chronic kidney disease; Initial Sample Size: Up to 67,093 European ancestry individuals; Replication Sample Size: Up to 22,982 European ancestry individuals; Strongest SNP-Risk Allele: rs653178-T; SNPs: rs653178; Context: intron; Risk Allele Frequency: 0.50; p-Value: 4E-11; OR or beta:     .01; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.00000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	kidney disease
CPS1		20383146	TAS		Disease/Trait: Chronic kidney disease; Initial Sample Size: Up to 67,093 European ancestry individuals; Replication Sample Size: Up to 22,982 European ancestry individuals; Strongest SNP-Risk Allele: rs7422339-A; SNPs: rs7422339; Context: missense; Risk Allele Frequency: 0.32; p-Value: 1E-15; OR or beta:     .01; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	kidney disease
WDR37		20383146	TAS		Disease/Trait: Chronic kidney disease; Initial Sample Size: Up to 67,093 European ancestry individuals; Replication Sample Size: Up to 22,982 European ancestry individuals; Strongest SNP-Risk Allele: rs10794720-T; SNPs: rs10794720; Context: intron; Risk Allele Frequency: 0.08; p-Value: 1E-8; OR or beta:     .01; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	kidney disease
WDR72		20383146	TAS		Disease/Trait: Chronic kidney disease; Initial Sample Size: Up to 67,093 European ancestry individuals; Replication Sample Size: Up to 22,982 European ancestry individuals; Strongest SNP-Risk Allele: rs491567-C; SNPs: rs491567; Context: intron; Risk Allele Frequency: 0.22; p-Value: 3E-13; OR or beta:     .01; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.0000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	kidney disease
PRKAG2		20383146	TAS		Disease/Trait: Chronic kidney disease; Initial Sample Size: Up to 67,093 European ancestry individuals; Replication Sample Size: Up to 22,982 European ancestry individuals; Strongest SNP-Risk Allele: rs7805747-A; SNPs: rs7805747; Context: intron; Risk Allele Frequency: 0.24; p-Value: 4E-12; OR or beta:    1.18; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	kidney disease
SLC22A2		20383146	TAS		Disease/Trait: Chronic kidney disease; Initial Sample Size: Up to 67,093 European ancestry individuals; Replication Sample Size: Up to 22,982 European ancestry individuals; Strongest SNP-Risk Allele: rs2279463-G; SNPs: rs2279463; Context: intron; Risk Allele Frequency: 0.12; p-Value: 6E-12; OR or beta:     .01; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	kidney disease
CD247		20383147	TAS		Disease/Trait: Systemic sclerosis; Initial Sample Size: 2,296 European ancestry cases, 5,171 European ancestry controls; Replication Sample Size: 2,753 European ancestry cases, 4,569 European ancestry controls; Strongest SNP-Risk Allele: rs2056626-?; SNPs: rs2056626; Context: intron; Risk Allele Frequency: 0.59; p-Value: 3E-9; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [279,621]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic scleroderma
STAT4		20383147	TAS		Disease/Trait: Systemic sclerosis; Initial Sample Size: 2,296 European ancestry cases, 5,171 European ancestry controls; Replication Sample Size: 2,753 European ancestry cases, 4,569 European ancestry controls; Strongest SNP-Risk Allele: rs3821236-A; SNPs: rs3821236; Context: intron; Risk Allele Frequency: 0.20; p-Value: 3E-9; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [279,621]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic scleroderma
CNNM2		20364137	TAS		Disease/Trait: Intracranial aneurysm; Initial Sample Size: 2,780 European cases, 12,515 European controls; Replication Sample Size: 3,111 Japanese cases, 1,666 Japanese controls; Strongest SNP-Risk Allele: rs12413409-G; SNPs: rs12413409; Context: intron; Risk Allele Frequency: 0.91; p-Value: 1E-9; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [831,534] (imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	intracranial aneurysm
STARD13		20364137	TAS		Disease/Trait: Intracranial aneurysm; Initial Sample Size: 2,780 European cases, 12,515 European controls; Replication Sample Size: 3,111 Japanese cases, 1,666 Japanese controls; Strongest SNP-Risk Allele: rs9315204-T; SNPs: rs9315204; Context: intron; Risk Allele Frequency: 0.21; p-Value: 3E-9; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [831,534] (imputed)	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	intracranial aneurysm
SRBD1		20363506	TAS		Disease/Trait: Glaucoma; Initial Sample Size: 305 Japanese cases, 355 Japanese controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3213787-A; SNPs: rs3213787; Context: intron; Risk Allele Frequency: 0.81; p-Value: 3E-9; OR or beta:    2.80; Platform [SNPs passing QC]: Affymetrix [325,947]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	glaucoma
FAT4		20351715	TAS		Disease/Trait: Bipolar disorder and major depressive disorder (combined); Initial Sample Size: 4,387 Caucasian bipolar cases, 6,209 Caucasian controls, 1,695 Dutch MDD cases, 1,761 Dutch controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1395241-G; SNPs: rs1395241; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Perlegen [1,472,580] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	major depressive disorder;bipolar disorder
SYNE1		20351715	TAS		Disease/Trait: Bipolar disorder and major depressive disorder (combined); Initial Sample Size: 4,387 Caucasian bipolar cases, 6,209 Caucasian controls, 1,695 Dutch MDD cases, 1,761 Dutch controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17082664-G; SNPs: rs17082664; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Perlegen [1,472,580] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	major depressive disorder;bipolar disorder
ANK3		20351715	TAS		Disease/Trait: Bipolar disorder and major depressive disorder (combined); Initial Sample Size: 4,387 Caucasian bipolar cases, 6,209 Caucasian controls, 1,695 Dutch MDD cases, 1,761 Dutch controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10994338-A; SNPs: rs10994338; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Perlegen [1,472,580] (imputed)	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	major depressive disorder;bipolar disorder
CACNA1C		20351715	TAS		Disease/Trait: Bipolar disorder and major depressive disorder (combined); Initial Sample Size: 4,387 Caucasian bipolar cases, 6,209 Caucasian controls, 1,695 Dutch MDD cases, 1,761 Dutch controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1006737-A; SNPs: rs1006737; Context: intron; Risk Allele Frequency: 0.36; p-Value: 3E-8; OR or beta:    1.18; Platform [SNPs passing QC]: Affymetrix & Perlegen [1,472,580] (imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	major depressive disorder;bipolar disorder
GPC5		20304703	TAS		Disease/Trait: Lung cancer; Initial Sample Size: 377 cases, 377 matched controls; Replication Sample Size: 511 cases, 1,007 controls; Strongest SNP-Risk Allele: rs2352028-A; SNPs: rs2352028; Context: intron; Risk Allele Frequency: 0.26; p-Value: 6E-6; OR or beta:    1.46; Platform [SNPs passing QC]: Illumina [331,918]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer
IL17REL		20228798	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 1,043 German cases, 1,703 German controls; Replication Sample Size: 2,539 European descent cases, 5,428 European descent controls; Strongest SNP-Risk Allele: rs5771069-G; SNPs: rs5771069; Context: missense; Risk Allele Frequency: 0.49; p-Value: 4E-8; OR or beta:    1.17; Platform [SNPs passing QC]: Affymetrix [1,897,764] (imputed)	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
IL10		20228798	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 1,043 German cases, 1,703 German controls; Replication Sample Size: 2,539 European descent cases, 5,428 European descent controls; Strongest SNP-Risk Allele: rs3024493-T; SNPs: rs3024493; Context: intron; Risk Allele Frequency: 0.16; p-Value: 1E-12; OR or beta:    1.35; Platform [SNPs passing QC]: Affymetrix [1,897,764] (imputed)	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
OTUD3		20228798	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 1,043 German cases, 1,703 German controls; Replication Sample Size: 2,539 European descent cases, 5,428 European descent controls; Strongest SNP-Risk Allele: rs4654925-G; SNPs: rs4654925; Context: intron; Risk Allele Frequency: 0.52; p-Value: 9E-22; OR or beta:    1.41; Platform [SNPs passing QC]: Affymetrix [1,897,764] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
CIITA		20228799	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 2,693 European descent cases, 6,791 European descent controls; Replication Sample Size: 2,009 European descent cases, 1,580 European descent controls; Strongest SNP-Risk Allele: rs4781011-T; SNPs: rs4781011; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix [266,047]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
NKX2-3		20228799	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 2,693 European descent cases, 6,791 European descent controls; Replication Sample Size: 2,009 European descent cases, 1,580 European descent controls; Strongest SNP-Risk Allele: rs11190140-T; SNPs: rs11190140; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix [266,047]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
MST1		20228799	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 2,693 European descent cases, 6,791 European descent controls; Replication Sample Size: 2,009 European descent cases, 1,580 European descent controls; Strongest SNP-Risk Allele: rs3197999-T; SNPs: rs3197999; Context: missense; Risk Allele Frequency: NR; p-Value: 4E-9; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix [266,047]	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
CARD9		20228799	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 2,693 European descent cases, 6,791 European descent controls; Replication Sample Size: 2,009 European descent cases, 1,580 European descent controls; Strongest SNP-Risk Allele: rs4077515-C; SNPs: rs4077515; Context: missense; Risk Allele Frequency: NR; p-Value: 5E-8; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix [266,047]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
IL23R		20228799	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 2,693 European descent cases, 6,791 European descent controls; Replication Sample Size: 2,009 European descent cases, 1,580 European descent controls; Strongest SNP-Risk Allele: rs2201841-A; SNPs: rs2201841; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-13; OR or beta:    1.27; Platform [SNPs passing QC]: Affymetrix [266,047]	0.0000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
SATB2		20228799	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 2,693 European descent cases, 6,791 European descent controls; Replication Sample Size: 2,009 European descent cases, 1,580 European descent controls; Strongest SNP-Risk Allele: rs1992950-A; SNPs: rs1992950; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix [266,047]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
DSG1		20208534	TAS		Disease/Trait: Eosinophilic esophagitis (pediatric); Initial Sample Size: 181 European descent adolescent cases, 1,974 European descent adolescent controls; Replication Sample Size: 170 European descent cases, 1,130 European descent controls; Strongest SNP-Risk Allele: rs7236477-G; SNPs: rs7236477; Context: intron; Risk Allele Frequency: 0.03; p-Value: 7E-6; OR or beta:    2.22; Platform [SNPs passing QC]: Illumina [~550,000]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	eosinophilic esophagitis
STAT6		20208534	TAS		Disease/Trait: Eosinophilic esophagitis (pediatric); Initial Sample Size: 181 European descent adolescent cases, 1,974 European descent adolescent controls; Replication Sample Size: 170 European descent cases, 1,130 European descent controls; Strongest SNP-Risk Allele: rs167769-T; SNPs: rs167769; Context: intron; Risk Allele Frequency: 0.37; p-Value: 2E-6; OR or beta:    1.36; Platform [SNPs passing QC]: Illumina [~550,000]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	eosinophilic esophagitis
ELMO1		20190752	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 4,533 European descent cases, 10,750 European descent controls; Replication Sample Size: 4,918 European descent cases, 5,684 European descent controls; Strongest SNP-Risk Allele: rs6974491-A; SNPs: rs6974491; Context: intron; Risk Allele Frequency: 0.17; p-Value: 2E-7; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [292,387]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
PLEK		20190752	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 4,533 European descent cases, 10,750 European descent controls; Replication Sample Size: 4,918 European descent cases, 5,684 European descent controls; Strongest SNP-Risk Allele: rs17035378-?; SNPs: rs17035378; Context: intron; Risk Allele Frequency: 0.72; p-Value: 8E-9; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [292,387]	0.000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
ZMIZ1		20190752	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 4,533 European descent cases, 10,750 European descent controls; Replication Sample Size: 4,918 European descent cases, 5,684 European descent controls; Strongest SNP-Risk Allele: rs1250552-?; SNPs: rs1250552; Context: intron; Risk Allele Frequency: 0.53; p-Value: 9E-10; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [292,387]	0.0000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
ETS1		20190752	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 4,533 European descent cases, 10,750 European descent controls; Replication Sample Size: 4,918 European descent cases, 5,684 European descent controls; Strongest SNP-Risk Allele: rs11221332-A; SNPs: rs11221332; Context: intron; Risk Allele Frequency: 0.24; p-Value: 5E-16; OR or beta:    1.21; Platform [SNPs passing QC]: Illumina [292,387]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
ICOSLG		20190752	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 4,533 European descent cases, 10,750 European descent controls; Replication Sample Size: 4,918 European descent cases, 5,684 European descent controls; Strongest SNP-Risk Allele: rs4819388-?; SNPs: rs4819388; Context: UTR-3; Risk Allele Frequency: 0.72; p-Value: 2E-9; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [292,387]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
FRMD4B		20190752	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 4,533 European descent cases, 10,750 European descent controls; Replication Sample Size: 4,918 European descent cases, 5,684 European descent controls; Strongest SNP-Risk Allele: rs6806528-A; SNPs: rs6806528; Context: intron; Risk Allele Frequency: 0.10; p-Value: 2E-7; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [292,387]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
PTPN2		20190752	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 4,533 European descent cases, 10,750 European descent controls; Replication Sample Size: 4,918 European descent cases, 5,684 European descent controls; Strongest SNP-Risk Allele: rs1893217-G; SNPs: rs1893217; Context: intron; Risk Allele Frequency: 0.17; p-Value: 3E-10; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina [292,387]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
CD247		20190752	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 4,533 European descent cases, 10,750 European descent controls; Replication Sample Size: 4,918 European descent cases, 5,684 European descent controls; Strongest SNP-Risk Allele: rs864537-?; SNPs: rs864537; Context: intron; Risk Allele Frequency: 0.61; p-Value: 4E-7; OR or beta:    1.10; Platform [SNPs passing QC]: Illumina [292,387]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
TAGAP		20190752	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 4,533 European descent cases, 10,750 European descent controls; Replication Sample Size: 4,918 European descent cases, 5,684 European descent controls; Strongest SNP-Risk Allele: rs1738074-A; SNPs: rs1738074; Context: UTR-5; Risk Allele Frequency: 0.43; p-Value: 3E-15; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [292,387]	0.000000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
LPP		20190752	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 4,533 European descent cases, 10,750 European descent controls; Replication Sample Size: 4,918 European descent cases, 5,684 European descent controls; Strongest SNP-Risk Allele: rs1464510-A; SNPs: rs1464510; Context: intron; Risk Allele Frequency: 0.49; p-Value: 3E-40; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [292,387]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
NFIA		20190752	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 4,533 European descent cases, 10,750 European descent controls; Replication Sample Size: 4,918 European descent cases, 5,684 European descent controls; Strongest SNP-Risk Allele: rs6691768-?; SNPs: rs6691768; Context: intron; Risk Allele Frequency: 0.62; p-Value: 1E-7; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina [292,387]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
ACSM1		20185149	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 201 Caucasian cases, 305 European controls; Replication Sample Size: 2,663 European cases, 13,780 European controls; Strongest SNP-Risk Allele: rs433598-T; SNPs: rs433598; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix [572,888]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
ANK3		20185149	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 201 Caucasian cases, 305 European controls; Replication Sample Size: 2,663 European cases, 13,780 European controls; Strongest SNP-Risk Allele: rs10761482-?; SNPs: rs10761482; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix [572,888]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
PLAA		20185149	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 201 Caucasian cases, 305 European controls; Replication Sample Size: 2,663 European cases, 13,780 European controls; Strongest SNP-Risk Allele: rs7045881-?; SNPs: rs7045881; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix [572,888]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
FAM13A		20173748	TAS		Disease/Trait: Chronic obstructive pulmonary disease; Initial Sample Size: 2,940 white cases, 1,380 white controls; Replication Sample Size: 502 non-Hispanic Caucasian cases, 504 non-Hispanic Caucasian controls, 1,100 probands, 2,698 relatives; Strongest SNP-Risk Allele: rs7671167-?; SNPs: rs7671167; Context: intron; Risk Allele Frequency: 0.48; p-Value: 1E-11; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [499,578]	0.00000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic obstructive pulmonary disease
KCNN3		20173747	TAS		Disease/Trait: Atrial fibrillation; Initial Sample Size: 1,335 European descent cases, 12,844 European descent controls; Replication Sample Size: 1,164 European descent cases, 3,607 European descent controls; Strongest SNP-Risk Allele: rs13376333-T; SNPs: rs13376333; Context: intron; Risk Allele Frequency: 0.30; p-Value: 2E-21; OR or beta:    1.52; Platform [SNPs passing QC]: Affymetrix and Illumina [~2.5 million] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	familial atrial fibrillation
ITPA		20173735	TAS		Disease/Trait: Chronic Hepatitis C infection; Initial Sample Size: 988 European-American cases, 198 African-American cases, 100 Hispanic cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7270101-C; SNPs: rs7270101; Context: intron; Risk Allele Frequency: 0.11; p-Value: 9E-76; OR or beta: NR; Platform [SNPs passing QC]: Illumina [565,759]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C
ITPA		20173735	TAS		Disease/Trait: Chronic Hepatitis C infection; Initial Sample Size: 988 European-American cases, 198 African-American cases, 100 Hispanic cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1127354-A; SNPs: rs1127354; Context: missense; Risk Allele Frequency: 0.069; p-Value: 2E-58; OR or beta: NR; Platform [SNPs passing QC]: Illumina [565,759]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis C
PTPRD		20174558	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 995 Han Chinese cases, 894 Han Chinese controls; Replication Sample Size: 1,803 Han Chinese cases, 1,473 Han Chinese controls; Strongest SNP-Risk Allele: rs17584499-T; SNPs: rs17584499; Context: intron; Risk Allele Frequency: 0.06; p-Value: 9E-10; OR or beta:    1.57; Platform [SNPs passing QC]: Illumina [516,737]	0.0000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
SRR		20174558	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 995 Han Chinese cases, 894 Han Chinese controls; Replication Sample Size: 1,803 Han Chinese cases, 1,473 Han Chinese controls; Strongest SNP-Risk Allele: rs391300-G; SNPs: rs391300; Context: intron; Risk Allele Frequency: 0.62; p-Value: 3E-9; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [516,737]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
KCNQ1		20174558	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 995 Han Chinese cases, 894 Han Chinese controls; Replication Sample Size: 1,803 Han Chinese cases, 1,473 Han Chinese controls; Strongest SNP-Risk Allele: rs2237895-C; SNPs: rs2237895; Context: intron; Risk Allele Frequency: 0.33; p-Value: 1E-9; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [516,737]	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
STAT3		20159113	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 68 Finnish cases, 136 Finnish controls; Replication Sample Size: 4,570 European cases, 10,143 Finnish controls; Strongest SNP-Risk Allele: rs744166-G; SNPs: rs744166; Context: intron; Risk Allele Frequency: 0.41; p-Value: 3E-10; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [297,343]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
WDFY4		20169177	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 314 Chinese cases, 1,500 Chinese controls; Replication Sample Size: 2,630 Chinese cases, 2,155 Chinese controls, 314 Thai cases, 519 Thai controls; Strongest SNP-Risk Allele: rs7097397-G; SNPs: rs7097397; Context: missense; Risk Allele Frequency: 0.28; p-Value: 8E-12; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [514,221]	0.000000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
ETS1		20169177	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 314 Chinese cases, 1,500 Chinese controls; Replication Sample Size: 2,630 Chinese cases, 2,155 Chinese controls, 314 Thai cases, 519 Thai controls; Strongest SNP-Risk Allele: rs1128334-A; SNPs: rs1128334; Context: UTR-3; Risk Allele Frequency: 0.35; p-Value: 2E-11; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [514,221]	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
SP4		20125088	TAS		Disease/Trait: Major depressive disorder; Initial Sample Size: 1,020 European cases, 1,636 European controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17144465-G; SNPs: rs17144465; Context: intron; Risk Allele Frequency: 0.04; p-Value: 6E-6; OR or beta:    1.82; Platform [SNPs passing QC]: Affymetrix [671,424]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	major depressive disorder
RAD50		20159242	TAS		Disease/Trait: Asthma; Initial Sample Size: 607 cases, 3,294 white controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2244012-C; SNPs: rs2244012; Context: intron; Risk Allele Frequency: 0.21; p-Value: 3E-7; OR or beta:    1.64; Platform [SNPs passing QC]: Illumina [292,443]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
NR5A2		20101243	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 3,851 cases, 3,934 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3790844-T; SNPs: rs3790844; Context: intron; Risk Allele Frequency: 0.76; p-Value: 2E-10; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina [551,766]	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
CLPTM1L		20101243	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 3,851 cases, 3,934 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs401681-T; SNPs: rs401681; Context: intron; Risk Allele Frequency: 0.45; p-Value: 7E-7; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [551,766]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
PBRM1		20081856	TAS		Disease/Trait: Major mood disorders; Initial Sample Size: 6,686 European cases, 9,068 European controls; Replication Sample Size: 1,930 European cases, 2,747 European controls; Strongest SNP-Risk Allele: rs2251219-?; SNPs: rs2251219; Context: cds-synon; Risk Allele Frequency: 0.59; p-Value: 2E-9; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix, Illumina and Perlegen [~2.1 million] (imputed)	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	mood disorder
DGKQ		20070850	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 1,752 Caucasian cases, 1,745 Caucasian controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11248060-?; SNPs: rs11248060; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [495,715] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
SNCA		20070850	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 1,752 Caucasian cases, 1,745 Caucasian controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2736990-?; SNPs: rs2736990; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-8; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [495,715] (imputed)	0.00000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
DBC1		20070850	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 1,752 Caucasian cases, 1,745 Caucasian controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4837628-A; SNPs: rs4837628; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [495,715] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
CPEB1		20062064	TAS		Disease/Trait: Chronic lymphocytic leukemia; Initial Sample Size: 505 European cases, 1,438 European controls; Replication Sample Size: 1,998 European cases, 4,351 European controls; Strongest SNP-Risk Allele: rs783540-G; SNPs: rs783540; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina [299,983]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic lymphocytic leukemia
FARP2		20062064	TAS		Disease/Trait: Chronic lymphocytic leukemia; Initial Sample Size: 505 European cases, 1,438 European controls; Replication Sample Size: 1,998 European cases, 4,351 European controls; Strongest SNP-Risk Allele: rs757978-A; SNPs: rs757978; Context: missense; Risk Allele Frequency: NR; p-Value: 2E-9; OR or beta:    1.38; Platform [SNPs passing QC]: Illumina [299,983]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic lymphocytic leukemia
ERAP1		20062062	TAS		Disease/Trait: Ankylosing spondylitis; Initial Sample Size: 2,053 European descent cases, 5,140 European descent controls; Replication Sample Size: 898 British cases, 1,518 British controls; Strongest SNP-Risk Allele: rs27434-A; SNPs: rs27434; Context: cds-synon; Risk Allele Frequency: 0.23; p-Value: 5E-12; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [288,662]	0.000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ankylosing spondylitis
IL23R		20062062	TAS		Disease/Trait: Ankylosing spondylitis; Initial Sample Size: 2,053 European descent cases, 5,140 European descent controls; Replication Sample Size: 898 British cases, 1,518 British controls; Strongest SNP-Risk Allele: rs11209026-?; SNPs: rs11209026; Context: missense; Risk Allele Frequency: 0.94; p-Value: 9E-14; OR or beta:    1.89; Platform [SNPs passing QC]: Illumina [288,662]	0.00000000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ankylosing spondylitis
ANTXR2		20062062	TAS		Disease/Trait: Ankylosing spondylitis; Initial Sample Size: 2,053 European descent cases, 5,140 European descent controls; Replication Sample Size: 898 British cases, 1,518 British controls; Strongest SNP-Risk Allele: rs4333130-?; SNPs: rs4333130; Context: intron; Risk Allele Frequency: 0.64; p-Value: 9E-8; OR or beta:    1.22; Platform [SNPs passing QC]: Illumina [288,662]	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ankylosing spondylitis
ALDH7A1		20072603	TAS		Disease/Trait: Osteoporosis; Initial Sample Size: 350 Han Chinese cases, 350 Han Chinese controls; Replication Sample Size: 390 Han Chinese cases, 516 Han Chinsese controls; Strongest SNP-Risk Allele: rs13182402-G; SNPs: rs13182402; Context: intron; Risk Allele Frequency: 0.05; p-Value: 2E-9; OR or beta:    2.25; Platform [SNPs passing QC]: Affymetrix [281,533]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	osteoporosis
COG5		20112360	TAS		Disease/Trait: Osteoarthritis; Initial Sample Size: 1,341 European cases, 3,496 European controls; Replication Sample Size: 13,597 European cases, up to 40,000 European controls; Strongest SNP-Risk Allele: rs3815148-C; SNPs: rs3815148; Context: intron; Risk Allele Frequency: 0.23; p-Value: 8E-8; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [500,510]	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	osteoarthritis
MAST4		20009918	TAS		Disease/Trait: Carotid atherosclerosis in HIV infection; Initial Sample Size: 177 Caucasian HIV-infected men; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1697137-C; SNPs: rs1697137; Context: intron; Risk Allele Frequency: 0.36; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [311,194]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atherosclerosis;Human immunodeficiency virus infectious disease
RYR3		20009918	TAS		Disease/Trait: Carotid atherosclerosis in HIV infection; Initial Sample Size: 177 Caucasian HIV-infected men; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2229116-G; SNPs: rs2229116; Context: missense; Risk Allele Frequency: 0.18; p-Value: 3E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [311,194]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atherosclerosis;Human immunodeficiency virus infectious disease
GRM8		20009918	TAS		Disease/Trait: Carotid atherosclerosis in HIV infection; Initial Sample Size: 177 Caucasian HIV-infected men; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17691394-G; SNPs: rs17691394; Context: intron; Risk Allele Frequency: 0.20; p-Value: 9E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [311,194]	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atherosclerosis;Human immunodeficiency virus infectious disease
GRM7		20038947	TAS		Disease/Trait: Major depressive disorder (broad); Initial Sample Size: 3,957 cases, 3,428 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9870680-T; SNPs: rs9870680; Context: intron; Risk Allele Frequency: 0.44; p-Value: 1E-6; OR or beta:    1.19; Platform [SNPs passing QC]: Affymetrix and Perlegen [2,391,203] (imputed)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	major depressive disorder
SP4		20038947	TAS		Disease/Trait: Major depressive disorder (broad); Initial Sample Size: 3,957 cases, 3,428 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17144465-G; SNPs: rs17144465; Context: intron; Risk Allele Frequency: 0.03; p-Value: 8E-7; OR or beta:    1.56; Platform [SNPs passing QC]: Affymetrix and Perlegen [2,391,203] (imputed)	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	major depressive disorder
TRIM10		20041166	TAS		Disease/Trait: HIV-1 control; Initial Sample Size: 2,362 Caucasian cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9468692-?; SNPs: rs9468692; Context: UTR-3; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
TNXB		20041166	TAS		Disease/Trait: HIV-1 control; Initial Sample Size: 2,362 Caucasian cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12198173-?; SNPs: rs12198173; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [NR]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Human immunodeficiency virus infectious disease
THADA		20023658	TAS		Disease/Trait: Orofacial clefts; Initial Sample Size: 399 European origin cases, 1,318 European origin controls; Replication Sample Size: 739 European origin triads; Strongest SNP-Risk Allele: rs7590268-G; SNPs: rs7590268; Context: intron; Risk Allele Frequency: 0.22; p-Value: 9E-8; OR or beta:    1.42; Platform [SNPs passing QC]: Illumina [521,288]	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	orofacial cleft
TNFSF15		20018961	TAS		Disease/Trait: Leprosy; Initial Sample Size: 706 Han Chinese cases, 1,225 Han Chinese controls; Replication Sample Size: 3,254 Chinese cases, 5,955 Chinese controls; Strongest SNP-Risk Allele: rs6478108-A; SNPs: rs6478108; Context: intron; Risk Allele Frequency: 0.46; p-Value: 3E-21; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [491,883]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	leprosy
RIPK2		20018961	TAS		Disease/Trait: Leprosy; Initial Sample Size: 706 Han Chinese cases, 1,225 Han Chinese controls; Replication Sample Size: 3,254 Chinese cases, 5,955 Chinese controls; Strongest SNP-Risk Allele: rs42490-G; SNPs: rs42490; Context: intron; Risk Allele Frequency: 0.58; p-Value: 1E-16; OR or beta:    1.32; Platform [SNPs passing QC]: Illumina [491,883]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	leprosy
TYK2		19966805	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 European ancestry cases, 9,045 European ancestry controls; Replication Sample Size: 4,840 European ancestry cases, 2,670 European ancestry controls, 4,152 European ancestry familial triads; Strongest SNP-Risk Allele: rs2304256-C; SNPs: rs2304256; Context: missense; Risk Allele Frequency: 0.71; p-Value: 4E-9; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.6 million](imputed)	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
BCL11A		20183929	TAS		Disease/Trait: Beta thalassemia/hemoglobin E disease; Initial Sample Size: 235 mild Thai-Chinese cases, 383 severe Thai-Chinese cases; Replication Sample Size: 52 mild Indonesian cases, 122 severe Indonesian cases; Strongest SNP-Risk Allele: rs766432-?; SNPs: rs766432; Context: intron; Risk Allele Frequency: 0.24; p-Value: 1E-10; OR or beta:    2.80; Platform [SNPs passing QC]: Illumina [548,094]	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hemoglobin E disease;beta thalassemia
FCGR2A		19915573	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 376 Japanese cases, 934 Japanese controls; Replication Sample Size: 376 Japanese cases, 1,097 Japanese controls; Strongest SNP-Risk Allele: rs1801274-?; SNPs: rs1801274; Context: missense; Risk Allele Frequency: 0.78; p-Value: 2E-12; OR or beta:    1.59; Platform [SNPs passing QC]: Illumina [513,923]	0.000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
BTNL2		19915573	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 376 Japanese cases, 934 Japanese controls; Replication Sample Size: 376 Japanese cases, 1,097 Japanese controls; Strongest SNP-Risk Allele: rs9268480-G; SNPs: rs9268480; Context: cds-synon; Risk Allele Frequency: 0.91; p-Value: 3E-6; OR or beta:    1.82; Platform [SNPs passing QC]: Illumina [513,923]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
CARD9		19915572	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 2,361 European ancestry cases, 5,417 European ancestry controls; Replication Sample Size: 2,321 European ancestry cases, 4,818 European ancestry controls; Strongest SNP-Risk Allele: rs10781500-?; SNPs: rs10781500; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [NR]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
IL23R		19915572	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 2,361 European ancestry cases, 5,417 European ancestry controls; Replication Sample Size: 2,321 European ancestry cases, 4,818 European ancestry controls; Strongest SNP-Risk Allele: rs11209026-?; SNPs: rs11209026; Context: missense; Risk Allele Frequency: NR; p-Value: 3E-10; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [NR]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
IL10		19915572	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 2,361 European ancestry cases, 5,417 European ancestry controls; Replication Sample Size: 2,321 European ancestry cases, 4,818 European ancestry controls; Strongest SNP-Risk Allele: rs3024493-?; SNPs: rs3024493; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-8; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [NR]	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
ZMIZ1		19915574	TAS		Disease/Trait: Inflammatory bowel disease (early onset); Initial Sample Size: 2,413 European ancestry cases, 6,158 European ancestry controls; Replication Sample Size: 1,013 European ancestry cases, 5,805 European ancestry controls; Strongest SNP-Risk Allele: rs1250550-?; SNPs: rs1250550; Context: intron; Risk Allele Frequency: 0.68; p-Value: 6E-9; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [~500,000]	0.000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
NSF		19915575	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 1,713 European ancestry cases, 3,978 European ancestry controls; Replication Sample Size: 3,361 European ancestry cases, 4,573 European ancestry controls; Strongest SNP-Risk Allele: rs199533-C; SNPs: rs199533; Context: cds-synon; Risk Allele Frequency: 0.83; p-Value: 1E-14; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [463,185]	0.00000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
ITGA8		19915575	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 1,713 European ancestry cases, 3,978 European ancestry controls; Replication Sample Size: 3,361 European ancestry cases, 4,573 European ancestry controls; Strongest SNP-Risk Allele: rs7077361-T; SNPs: rs7077361; Context: ; Risk Allele Frequency: 0.89; p-Value: 5E-6; OR or beta:    1.19; Platform [SNPs passing QC]: Illumina [463,185]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
SNCA		19915575	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 1,713 European ancestry cases, 3,978 European ancestry controls; Replication Sample Size: 3,361 European ancestry cases, 4,573 European ancestry controls; Strongest SNP-Risk Allele: rs2736990-C; SNPs: rs2736990; Context: intron; Risk Allele Frequency: 0.51; p-Value: 2E-16; OR or beta:    1.23; Platform [SNPs passing QC]: Illumina [463,185]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
GLT6D1		19897590	TAS		Disease/Trait: Periodontitis; Initial Sample Size: 283 German cases, 972 German controls; Replication Sample Size: 602 Dutch cases, 577 Dutch controls; Strongest SNP-Risk Allele: rs1537415-G; SNPs: rs1537415; Context: intron; Risk Allele Frequency: 0.38; p-Value: 6E-9; OR or beta:    1.59; Platform [SNPs passing QC]: Affymetrix [345,646]	0.000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	periodontitis
ATP8B1		19890347	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 32 Romanian cases, 44 Romanian controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10503019-?; SNPs: rs10503019; Context: intron; Risk Allele Frequency: 0.28; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [297,342]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
SMOC2		19890347	TAS		Disease/Trait: Vitiligo; Initial Sample Size: 32 Romanian cases, 44 Romanian controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs13208776-?; SNPs: rs13208776; Context: intron; Risk Allele Frequency: 0.38; p-Value: 9E-8; OR or beta: NR; Platform [SNPs passing QC]: Illumina [297,342]	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	vitiligo
RASGRP3		19838193	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,047 Chinese Han cases, 1,205 Chinese Han controls; Replication Sample Size: 3,152 Chinese Han cases, 7,050 Chinese Han controls; Strongest SNP-Risk Allele: rs13385731-A; SNPs: rs13385731; Context: intron; Risk Allele Frequency: 0.85; p-Value: 1E-15; OR or beta:    1.43; Platform [SNPs passing QC]: Illumina [493,955]	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
TNFAIP3		19838193	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,047 Chinese Han cases, 1,205 Chinese Han controls; Replication Sample Size: 3,152 Chinese Han cases, 7,050 Chinese Han controls; Strongest SNP-Risk Allele: rs2230926-C; SNPs: rs2230926; Context: missense; Risk Allele Frequency: 0.04; p-Value: 1E-17; OR or beta:    1.72; Platform [SNPs passing QC]: Illumina [493,955]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
SLC15A4		19838193	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,047 Chinese Han cases, 1,205 Chinese Han controls; Replication Sample Size: 3,152 Chinese Han cases, 7,050 Chinese Han controls; Strongest SNP-Risk Allele: rs1385374-A; SNPs: rs1385374; Context: intron; Risk Allele Frequency: 0.20; p-Value: 2E-11; OR or beta:    1.26; Platform [SNPs passing QC]: Illumina [493,955]	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
TNIP1		19838193	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,047 Chinese Han cases, 1,205 Chinese Han controls; Replication Sample Size: 3,152 Chinese Han cases, 7,050 Chinese Han controls; Strongest SNP-Risk Allele: rs10036748-A; SNPs: rs10036748; Context: intron; Risk Allele Frequency: 0.76; p-Value: 2E-9; OR or beta:    1.23; Platform [SNPs passing QC]: Illumina [493,955]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
STAT4		19838193	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,047 Chinese Han cases, 1,205 Chinese Han controls; Replication Sample Size: 3,152 Chinese Han cases, 7,050 Chinese Han controls; Strongest SNP-Risk Allele: rs7574865-A; SNPs: rs7574865; Context: intron; Risk Allele Frequency: 0.33; p-Value: 5E-42; OR or beta:    1.51; Platform [SNPs passing QC]: Illumina [493,955]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
CLPTM1L		19836008	TAS		Disease/Trait: Lung adenocarcinoma; Initial Sample Size: 5,739 European descent cases, 5,848 European descent controls; Replication Sample Size: 7,561 European descent cases, 13,818 European descent controls; Strongest SNP-Risk Allele: rs31489-C; SNPs: rs31489; Context: intron; Risk Allele Frequency: 0.59; p-Value: 2E-10; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [515,922]	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung adenocarcinoma
TERT		19836008	TAS		Disease/Trait: Lung adenocarcinoma; Initial Sample Size: 5,739 European descent cases, 5,848 European descent controls; Replication Sample Size: 7,561 European descent cases, 13,818 European descent controls; Strongest SNP-Risk Allele: rs2736100-G; SNPs: rs2736100; Context: intron; Risk Allele Frequency: 0.50; p-Value: 2E-10; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [515,922]	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung adenocarcinoma
ATF6		19772629	TAS		Disease/Trait: Parkinson's disease (age of onset); Initial Sample Size: 857 white familial cases, 440 white idiopathic cases; Replication Sample Size: 747 Italian idiopathic cases; Strongest SNP-Risk Allele: rs10918270-A; SNPs: rs10918270; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    2.26; Platform [SNPs passing QC]: Illumina and Perlegen [1,861,750] (imputed)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
AAK1		19772629	TAS		Disease/Trait: Parkinson's disease (age of onset); Initial Sample Size: 857 white familial cases, 440 white idiopathic cases; Replication Sample Size: 747 Italian idiopathic cases; Strongest SNP-Risk Allele: rs7577851-T; SNPs: rs7577851; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-6; OR or beta:    6.85; Platform [SNPs passing QC]: Illumina and Perlegen [1,861,750] (imputed)	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
DSG3		19772629	TAS		Disease/Trait: Parkinson's disease (age of onset); Initial Sample Size: 857 white familial cases, 440 white idiopathic cases; Replication Sample Size: 747 Italian idiopathic cases; Strongest SNP-Risk Allele: rs1941184-C; SNPs: rs1941184; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    2.28; Platform [SNPs passing QC]: Illumina and Perlegen [1,861,750] (imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
PDLIM5		19767753	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,854 European ancestry cases, 1,894 European ancestry controls; Replication Sample Size: 19,879 cases, 18,761 controls (European, Chinese, Japanese, African American, Latino, and Hawaiian ancestry); Strongest SNP-Risk Allele: rs12500426-A; SNPs: rs12500426; Context: intron; Risk Allele Frequency: 0.46; p-Value: 1E-11; OR or beta:    1.08; Platform [SNPs passing QC]: Illumina [541,129]	0.00000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
PDLIM5		19767753	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,854 European ancestry cases, 1,894 European ancestry controls; Replication Sample Size: 19,879 cases, 18,761 controls (European, Chinese, Japanese, African American, Latino, and Hawaiian ancestry); Strongest SNP-Risk Allele: rs17021918-C; SNPs: rs17021918; Context: intron; Risk Allele Frequency: 0.65; p-Value: 4E-15; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina [541,129]	0.000000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
THADA		19767753	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,854 European ancestry cases, 1,894 European ancestry controls; Replication Sample Size: 19,879 cases, 18,761 controls (European, Chinese, Japanese, African American, Latino, and Hawaiian ancestry); Strongest SNP-Risk Allele: rs1465618-A; SNPs: rs1465618; Context: intron; Risk Allele Frequency: 0.23; p-Value: 2E-8; OR or beta:    1.08; Platform [SNPs passing QC]: Illumina [541,129]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
ITGA6		19767753	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,854 European ancestry cases, 1,894 European ancestry controls; Replication Sample Size: 19,879 cases, 18,761 controls (European, Chinese, Japanese, African American, Latino, and Hawaiian ancestry); Strongest SNP-Risk Allele: rs12621278-A; SNPs: rs12621278; Context: intron; Risk Allele Frequency: 0.94; p-Value: 9E-23; OR or beta:    1.33; Platform [SNPs passing QC]: Illumina [541,129]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
RXRG		19754311	TAS		Disease/Trait: AIDS; Initial Sample Size: 85 French cases, 2,049 French controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10800098-A; SNPs: rs10800098; Context: intron; Risk Allele Frequency: 0.05; p-Value: 4E-6; OR or beta:    3.29; Platform [SNPs passing QC]: Illumina [291,119]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	acquired immunodeficiency syndrome
SOX5		19754311	TAS		Disease/Trait: AIDS; Initial Sample Size: 85 French cases, 2,049 French controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1522232-C; SNPs: rs1522232; Context: intron; Risk Allele Frequency: 0.52; p-Value: 2E-6; OR or beta:    2.22; Platform [SNPs passing QC]: Illumina [291,119]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	acquired immunodeficiency syndrome
TGFBRAP1		19754311	TAS		Disease/Trait: AIDS; Initial Sample Size: 85 French cases, 2,049 French controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1020064-G; SNPs: rs1020064; Context: intron; Risk Allele Frequency: 0.77; p-Value: 7E-6; OR or beta:    2.94; Platform [SNPs passing QC]: Illumina [291,119]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	acquired immunodeficiency syndrome
CLU		19734902	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 3,941 European ancestry cases, 7,848 European ancestry controls; Replication Sample Size: 2,023 European ancestry cases, 2,340 European ancestry controls; Strongest SNP-Risk Allele: rs11136000-?; SNPs: rs11136000; Context: intron; Risk Allele Frequency: 0.60; p-Value: 9E-10; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [529,205]	0.0000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
CDKAL1		19734900	TAS		Disease/Trait: Type 2 diabetes and other traits; Initial Sample Size: 679 French cases, 697 French controls; Replication Sample Size: 5,579 European cases, 7,096 European controls; Strongest SNP-Risk Allele: rs4712523-G; SNPs: rs4712523; Context: intron; Risk Allele Frequency: 0.32; p-Value: 2E-12; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [392,365]	0.000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		19734900	TAS		Disease/Trait: Type 2 diabetes and other traits; Initial Sample Size: 679 French cases, 697 French controls; Replication Sample Size: 5,579 European cases, 7,096 European controls; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.27; p-Value: 1E-30; OR or beta:    1.48; Platform [SNPs passing QC]: Illumina [392,365]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
SLC30A8		19734900	TAS		Disease/Trait: Type 2 diabetes and other traits; Initial Sample Size: 679 French cases, 697 French controls; Replication Sample Size: 5,579 European cases, 7,096 European controls; Strongest SNP-Risk Allele: rs13266634-C; SNPs: rs13266634; Context: missense; Risk Allele Frequency: 0.68; p-Value: 8E-8; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [392,365]	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
UNC13A		19734901	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 2,323 European descent cases, 9,013 European descent controls; Replication Sample Size: 2,532 European descent cases, 5,940 European descent controls; Strongest SNP-Risk Allele: rs12608932-?; SNPs: rs12608932; Context: intron; Risk Allele Frequency: 0.34; p-Value: 3E-14; OR or beta:    1.25; Platform [SNPs passing QC]: Illumina [292,768]	0.00000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
SOX6		19714249	TAS		Disease/Trait: Obesity and osteoporosis; Initial Sample Size: 499 Caucasian males, 501 Caucasian females; Replication Sample Size: 1,370 Caucasian males, 1,985 Caucasian females; Strongest SNP-Risk Allele: rs297325-C; SNPs: rs297325; Context: intron; Risk Allele Frequency: 0.23; p-Value: 4E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [379,319]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity;osteoporosis
SOX6		19714249	TAS		Disease/Trait: Obesity and osteoporosis; Initial Sample Size: 499 Caucasian males, 501 Caucasian females; Replication Sample Size: 1,370 Caucasian males, 1,985 Caucasian females; Strongest SNP-Risk Allele: rs4756846-C; SNPs: rs4756846; Context: intron; Risk Allele Frequency: 0.12; p-Value: 5E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [379,319]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity;osteoporosis
ARID5B		19684604	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 503 European ancestry pediatric cases, 1,438 European ancestry pediatric controls; Replication Sample Size: 404 European ancestry pediatric cases, 960 European ancestry pediatric controls; Strongest SNP-Risk Allele: rs7089424-C; SNPs: rs7089424; Context: intron; Risk Allele Frequency: 0.34; p-Value: 7E-19; OR or beta:    1.65; Platform [SNPs passing QC]: Illumina [291,473]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
CEBPE		19684604	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 503 European ancestry pediatric cases, 1,438 European ancestry pediatric controls; Replication Sample Size: 404 European ancestry pediatric cases, 960 European ancestry pediatric controls; Strongest SNP-Risk Allele: rs2239633-G; SNPs: rs2239633; Context: nearGene-5; Risk Allele Frequency: 0.52; p-Value: 3E-7; OR or beta:    1.34; Platform [SNPs passing QC]: Illumina [291,473]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
IKZF1		19684604	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 503 European ancestry pediatric cases, 1,438 European ancestry pediatric controls; Replication Sample Size: 404 European ancestry pediatric cases, 960 European ancestry pediatric controls; Strongest SNP-Risk Allele: rs4132601-C; SNPs: rs4132601; Context: UTR-3; Risk Allele Frequency: 0.28; p-Value: 1E-19; OR or beta:    1.69; Platform [SNPs passing QC]: Illumina [291,473]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
ARID5B		19684603	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 317 European descent cases, 17,958 European descent controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10821936-C; SNPs: rs10821936; Context: intron; Risk Allele Frequency: 0.34; p-Value: 1E-15; OR or beta:    1.91; Platform [SNPs passing QC]: Affymetrix [307,944]	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
ZNF230		19684603	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 317 European descent cases, 17,958 European descent controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2191566-G; SNPs: rs2191566; Context: intron; Risk Allele Frequency: 0.28; p-Value: 4E-7; OR or beta:    1.52; Platform [SNPs passing QC]: Affymetrix [307,944]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
KCNMB2		19684603	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 317 European descent cases, 17,958 European descent controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9290663-T; SNPs: rs9290663; Context: intron; Risk Allele Frequency: 0.13; p-Value: 6E-6; OR or beta:    1.58; Platform [SNPs passing QC]: Affymetrix [307,944]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
KCNE4		19684603	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 317 European descent cases, 17,958 European descent controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs12621643-T; SNPs: rs12621643; Context: missense; Risk Allele Frequency: 0.28; p-Value: 3E-6; OR or beta:    1.48; Platform [SNPs passing QC]: Affymetrix [307,944]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
PARD3		19684603	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 317 European descent cases, 17,958 European descent controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs563507-A; SNPs: rs563507; Context: intron; Risk Allele Frequency: 0.04; p-Value: 9E-6; OR or beta:    2.00; Platform [SNPs passing QC]: Affymetrix [307,944]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
RYR2		19684603	TAS		Disease/Trait: Acute lymphoblastic leukemia (childhood); Initial Sample Size: 317 European descent cases, 17,958 European descent controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7554607-A; SNPs: rs7554607; Context: intron; Risk Allele Frequency: 0.56; p-Value: 2E-6; OR or beta:    1.49; Platform [SNPs passing QC]: Affymetrix [307,944]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
TGM5		19654303	TAS		Disease/Trait: Lung cancer; Initial Sample Size: 1,952 European ancestry cases, 1,438 European ancestry controls; Replication Sample Size: 5,608 European ancestry cases, 6,767 European ancestry controls; Strongest SNP-Risk Allele: rs748404-?; SNPs: rs748404; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [511,919]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer
ABO		19648918	TAS		Disease/Trait: Pancreatic cancer; Initial Sample Size: 1,771 European ancestry cases, 1,805 European ancestry controls; Replication Sample Size: 2,120 European ancestry cases, 2,127 European ancestry controls; Strongest SNP-Risk Allele: rs505922-C; SNPs: rs505922; Context: intron; Risk Allele Frequency: 0.35; p-Value: 5E-8; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina [558,542]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	pancreatic cancer
PSCA		19648920	TAS		Disease/Trait: Bladder cancer; Initial Sample Size: 969 European ancestry cases, 957 European ancestry controls; Replication Sample Size: 5,698 European ancestry cases, 38,633 European ancestry controls; Strongest SNP-Risk Allele: rs2294008-T; SNPs: rs2294008; Context: intron; Risk Allele Frequency: 0.46; p-Value: 2E-10; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina [556,429]	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	urinary bladder cancer
ZFHX3		19597492	TAS		Disease/Trait: Atrial fibrillation; Initial Sample Size: 3,413 cases, 37,105 referents; Replication Sample Size: 2,145 cases, 4,073 controls; Strongest SNP-Risk Allele: rs2106261-T; SNPs: rs2106261; Context: intron; Risk Allele Frequency: 0.174; p-Value: 2E-15; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.000000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	familial atrial fibrillation
ZFHX3		19597491	TAS		Disease/Trait: Atrial fibrillation; Initial Sample Size: 2,385 European ancestry cases, 33,752 European ancestry controls; Replication Sample Size: up to 2,427 European ancestry cases, 3,379 European ancestry controls; Strongest SNP-Risk Allele: rs7193343-T; SNPs: rs7193343; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-10; OR or beta:    1.21; Platform [SNPs passing QC]: Illumina [303,136]	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	familial atrial fibrillation
TYR		19578364	TAS		Disease/Trait: Melanoma; Initial Sample Size: 1,539 European ancestry cases, 3,917 European ancestry controls; Replication Sample Size: 2,312 European ancestry cases, 1,867 European ancestry controls; Strongest SNP-Risk Allele: rs1393350-A; SNPs: rs1393350; Context: intron; Risk Allele Frequency: 0.27; p-Value: 2E-14; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [~317,000]	0.00000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	melanoma
PHLDB1		19578367	TAS		Disease/Trait: Glioma; Initial Sample Size: 1,878 cases, 3,670 controls; Replication Sample Size: 2,545 cases, 2,953 controls; Strongest SNP-Risk Allele: rs498872-T; SNPs: rs498872; Context: UTR-5; Risk Allele Frequency: 0.69; p-Value: 1E-8; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina [454,576]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	malignant glioma
TERT		19578367	TAS		Disease/Trait: Glioma; Initial Sample Size: 1,878 cases, 3,670 controls; Replication Sample Size: 2,545 cases, 2,953 controls; Strongest SNP-Risk Allele: rs2736100-G; SNPs: rs2736100; Context: intron; Risk Allele Frequency: 0.49; p-Value: 2E-17; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [454,576]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	malignant glioma
TERT		19578367	TAS		Disease/Trait: Glioma; Initial Sample Size: 1,878 cases, 3,670 controls; Replication Sample Size: 2,545 cases, 2,953 controls; Strongest SNP-Risk Allele: rs2853676-A; SNPs: rs2853676; Context: intron; Risk Allele Frequency: 0.73; p-Value: 4E-14; OR or beta:    1.26; Platform [SNPs passing QC]: Illumina [454,576]	0.00000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	malignant glioma
TCF4		19571811	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 3,322 European ancestry cases, 3,587 European ancestry controls; Replication Sample Size: 4,692 European ancestry cases, 15,493 European ancestry controls; Strongest SNP-Risk Allele: rs17594526-T; SNPs: rs17594526; Context: intron; Risk Allele Frequency: 0.03; p-Value: 1E-7; OR or beta:    1.44; Platform [SNPs passing QC]: Affymetrix [739,995]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
TCF4		19571808	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 2,663 European ancestry cases, 13,498 European ancestry controls; Replication Sample Size: 10,282 European ancestry cases, 21,093 European ancestry controls; Strongest SNP-Risk Allele: rs9960767-C; SNPs: rs9960767; Context: intron; Risk Allele Frequency: 0.06; p-Value: 4E-9; OR or beta:    1.23; Platform [SNPs passing QC]: Illumina [314,868]	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
ESR1		19581569	TAS		Disease/Trait: Alcohol dependence; Initial Sample Size: 476 European ancestry cases, 1,358 European ancestry controls; Replication Sample Size: 1,024 European ancestry cases, 996 European ancestry controls; Strongest SNP-Risk Allele: rs6902771-C; SNPs: rs6902771; Context: intron; Risk Allele Frequency: 0.51; p-Value: 8E-6; OR or beta:    1.24; Platform [SNPs passing QC]: Illumina [524,396]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol dependence
PPP2R2B		19581569	TAS		Disease/Trait: Alcohol dependence; Initial Sample Size: 476 European ancestry cases, 1,358 European ancestry controls; Replication Sample Size: 1,024 European ancestry cases, 996 European ancestry controls; Strongest SNP-Risk Allele: rs1864982-A; SNPs: rs1864982; Context: intron; Risk Allele Frequency: 0.13; p-Value: 3E-6; OR or beta:    1.36; Platform [SNPs passing QC]: Illumina [524,396]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	alcohol dependence
CLDN14		19561606	TAS		Disease/Trait: Kidney stones; Initial Sample Size: 1,507 European ancestry cases, 34,033 European ancestry controls; Replication Sample Size: 1,520 European ancestry cases, 4,726 European ancestry controls, 746 European ancestry cases, 3,751 European ancestry controls; Strongest SNP-Risk Allele: rs219780-C; SNPs: rs219780; Context: cds-synon; Risk Allele Frequency: 0.79; p-Value: 4E-12; OR or beta:    1.25; Platform [SNPs passing QC]: Illumina [303,120]	0.000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	nephrolithiasis
FBN2		19553259	TAS		Disease/Trait: Obesity (extreme); Initial Sample Size: 775 European ancestry cases, 3,197 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs374748-G; SNPs: rs374748; Context: intron; Risk Allele Frequency: 0.11; p-Value: 4E-6; OR or beta:    1.47; Platform [SNPs passing QC]: Illumina [457,251]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	morbid obesity
RARB		19553259	TAS		Disease/Trait: Obesity (extreme); Initial Sample Size: 775 European ancestry cases, 3,197 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1435703-T; SNPs: rs1435703; Context: intron; Risk Allele Frequency: 0.06; p-Value: 4E-6; OR or beta:    1.66; Platform [SNPs passing QC]: Illumina [457,251]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	morbid obesity
MLN		19553259	TAS		Disease/Trait: Obesity (extreme); Initial Sample Size: 775 European ancestry cases, 3,197 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2274459-A; SNPs: rs2274459; Context: nearGene-3; Risk Allele Frequency: 0.17; p-Value: 6E-6; OR or beta:    1.38; Platform [SNPs passing QC]: Illumina [457,251]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	morbid obesity
ITPR3		19553259	TAS		Disease/Trait: Obesity (extreme); Initial Sample Size: 775 European ancestry cases, 3,197 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs999943-T; SNPs: rs999943; Context: intron; Risk Allele Frequency: 0.72; p-Value: 1E-6; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina [457,251]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	morbid obesity
FTO		19553259	TAS		Disease/Trait: Obesity (extreme); Initial Sample Size: 775 European ancestry cases, 3,197 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9941349-T; SNPs: rs9941349; Context: intron; Risk Allele Frequency: 0.43; p-Value: 6E-12; OR or beta:    1.48; Platform [SNPs passing QC]: Illumina [457,251]	0.000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	morbid obesity
CD58		19525955	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 1,618 European ancestry cases, 3,413 European ancestry controls; Replication Sample Size: 2,256 European ancestry cases, 2,310 European ancestry controls; Strongest SNP-Risk Allele: rs1335532-A; SNPs: rs1335532; Context: intron; Risk Allele Frequency: 0.87; p-Value: 1E-7; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [302,098]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
IL2RA		19525955	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 1,618 European ancestry cases, 3,413 European ancestry controls; Replication Sample Size: 2,256 European ancestry cases, 2,310 European ancestry controls; Strongest SNP-Risk Allele: rs2104286-A; SNPs: rs2104286; Context: intron; Risk Allele Frequency: 0.73; p-Value: 7E-6; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [302,098]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
IL7R		19525953	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 2,624 cases, 7,220 controls; Replication Sample Size: 2,215 cases, 2,116 controls; Strongest SNP-Risk Allele: rs6897932-C; SNPs: rs6897932; Context: missense; Risk Allele Frequency: 0.75; p-Value: 2E-6; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.56 million] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
CD6		19525953	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 2,624 cases, 7,220 controls; Replication Sample Size: 2,215 cases, 2,116 controls; Strongest SNP-Risk Allele: rs17824933-G; SNPs: rs17824933; Context: intron; Risk Allele Frequency: 0.25; p-Value: 4E-9; OR or beta:    1.18; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.56 million] (imputed)	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
MPHOSPH9		19525953	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 2,624 cases, 7,220 controls; Replication Sample Size: 2,215 cases, 2,116 controls; Strongest SNP-Risk Allele: rs1790100-G; SNPs: rs1790100; Context: intron; Risk Allele Frequency: 0.24; p-Value: 7E-7; OR or beta:    1.11; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.56 million] (imputed)	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
CLEC16A		19525953	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 2,624 cases, 7,220 controls; Replication Sample Size: 2,215 cases, 2,116 controls; Strongest SNP-Risk Allele: rs11865121-C; SNPs: rs11865121; Context: intron; Risk Allele Frequency: 0.69; p-Value: 2E-7; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.56 million] (imputed)	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
ZMIZ1		19525953	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 2,624 cases, 7,220 controls; Replication Sample Size: 2,215 cases, 2,116 controls; Strongest SNP-Risk Allele: rs1250540-G; SNPs: rs1250540; Context: intron; Risk Allele Frequency: 0.35; p-Value: 2E-6; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.56 million] (imputed)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
TNFRSF1A		19525953	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 2,624 cases, 7,220 controls; Replication Sample Size: 2,215 cases, 2,116 controls; Strongest SNP-Risk Allele: rs1800693-C; SNPs: rs1800693; Context: intron; Risk Allele Frequency: 0.45; p-Value: 2E-11; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.56 million] (imputed)	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
IL2RA		19525953	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 2,624 cases, 7,220 controls; Replication Sample Size: 2,215 cases, 2,116 controls; Strongest SNP-Risk Allele: rs2104286-T; SNPs: rs2104286; Context: intron; Risk Allele Frequency: 0.76; p-Value: 9E-8; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.56 million] (imputed)	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
TNFRSF1A		19525953	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 2,624 cases, 7,220 controls; Replication Sample Size: 2,215 cases, 2,116 controls; Strongest SNP-Risk Allele: rs4149584-T; SNPs: rs4149584; Context: missense; Risk Allele Frequency: 0.022; p-Value: 5E-6; OR or beta:    1.58; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.56 million] (imputed)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
PTPN22		19503088	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 2,418 cases, 4,504 controls; Replication Sample Size: 2,604 cases, 2,882 controls; Strongest SNP-Risk Allele: rs2476601-?; SNPs: rs2476601; Context: ; Risk Allele Frequency: NR; p-Value: 2E-21; OR or beta: NR; Platform [SNPs passing QC]: Illumina [278,502]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
DPY19L3		19488044	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 1,001 European ancestry cases, 345 African American cases, 1,033 European ancestry controls, 670 African American controls; Replication Sample Size: 1,749 European ancestry family members, 1,263 European ancestry cases, 431 European ancestry controls; Strongest SNP-Risk Allele: rs2111504-T; SNPs: rs2111504; Context: intron; Risk Allele Frequency: 0.23; p-Value: 2E-6; OR or beta:    1.74; Platform [SNPs passing QC]: Affymetrix [702,044]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
MCTP2		19483685	TAS		Disease/Trait: Drug-induced liver injury (flucloxacillin); Initial Sample Size: 58 cases, 282 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4984390-?; SNPs: rs4984390; Context: intron; Risk Allele Frequency: 0.41; p-Value: 4E-6; OR or beta:    3.27; Platform [SNPs passing QC]: Illumina [866,399]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	drug-induced hepatitis
KITLG		19483682	TAS		Disease/Trait: Testicular cancer; Initial Sample Size: 277 European ancestry cases, 919 European ancestry controls; Replication Sample Size: 371 European ancestry  cases + 204 sets of parents, 860 European ancestry controls; Strongest SNP-Risk Allele: rs4474514-A; SNPs: rs4474514; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-15; OR or beta:    3.07; Platform [SNPs passing QC]: Affymetrix [611,254]	0.000000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	testicular cancer
ITGA9		19478819	TAS		Disease/Trait: Nasopharyngeal carcinoma; Initial Sample Size: 111 Chinese ancestry cases, 260 Chinese ancestry controls; Replication Sample Size: 168 Chinese ancestry cases, 252 Chinese ancestry controls; Strongest SNP-Risk Allele: rs189897-A; SNPs: rs189897; Context: intron; Risk Allele Frequency: 0.09; p-Value: 7E-8; OR or beta:    3.18; Platform [SNPs passing QC]: Illumina [533,048]	0.00000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	nasopharynx carcinoma
EFCAB4B		19478329	TAS		Disease/Trait: Male infertility; Initial Sample Size: 52 oligozoospermic European ancestry males, 40 non-obstructive azoospermic European ancestry males, 80 European ancestry male controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10848911-?; SNPs: rs10848911; Context: intron; Risk Allele Frequency: 0.11; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [314,776]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	male infertility
PDE3A		19478329	TAS		Disease/Trait: Male infertility; Initial Sample Size: 52 oligozoospermic European ancestry males, 40 non-obstructive azoospermic European ancestry males, 80 European ancestry male controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10841496-?; SNPs: rs10841496; Context: nearGene-5; Risk Allele Frequency: 0.58; p-Value: 5E-7; OR or beta: NR; Platform [SNPs passing QC]: Illumina [314,776]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	male infertility
DDC		19465909	TAS		Disease/Trait: Malaria; Initial Sample Size: 958 African ancestry cases, 1,382 African ancestry controls, all children; Replication Sample Size: 1,087 African ancestry cases, 2,376 African ancestry controls, all children; Strongest SNP-Risk Allele: rs1451375-?; SNPs: rs1451375; Context: intron; Risk Allele Frequency: 0.78; p-Value: 6E-6; OR or beta:    1.33; Platform [SNPs passing QC]: Affymetrix [402,814]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	malaria
IL12RB2		19458352	TAS		Disease/Trait: Primary biliary cirrhosis; Initial Sample Size: 505 cases, 1,507 controls; Replication Sample Size: up to 526 cases, 1,206 controls; Strongest SNP-Risk Allele: rs3790567-A; SNPs: rs3790567; Context: intron; Risk Allele Frequency: 0.24; p-Value: 3E-11; OR or beta:    1.51; Platform [SNPs passing QC]: Illumina [305,724]	0.00000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary biliary cirrhosis
IKZF3		19458352	TAS		Disease/Trait: Primary biliary cirrhosis; Initial Sample Size: 505 cases, 1,507 controls; Replication Sample Size: up to 526 cases, 1,206 controls; Strongest SNP-Risk Allele: rs907092-A; SNPs: rs907092; Context: cds-synon; Risk Allele Frequency: 0.45; p-Value: 8E-6; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [305,724]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	primary biliary cirrhosis
SELL		19451621	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 1,821 cases, 2,258 controls; Replication Sample Size: 538 cases, 556 controls; Strongest SNP-Risk Allele: rs3177980-G; SNPs: rs3177980; Context: missense; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:     .51; Platform [SNPs passing QC]: Illumina [288,357]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
CNTN4		19451621	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 1,821 cases, 2,258 controls; Replication Sample Size: 538 cases, 556 controls; Strongest SNP-Risk Allele: rs2619566-G; SNPs: rs2619566; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta:    3.03; Platform [SNPs passing QC]: Illumina [288,357]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
KIFAP3		19451621	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 1,821 cases, 2,258 controls; Replication Sample Size: 538 cases, 556 controls; Strongest SNP-Risk Allele: rs1541160-C; SNPs: rs1541160; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta:     .58; Platform [SNPs passing QC]: Illumina [288,357]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
NT5C1A		19451621	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 1,821 cases, 2,258 controls; Replication Sample Size: 538 cases, 556 controls; Strongest SNP-Risk Allele: rs873917-T; SNPs: rs873917; Context: intron; Risk Allele Frequency: 0.29; p-Value: 8E-6; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina [288,357]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
SLC39A11		19451621	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 1,821 cases, 2,258 controls; Replication Sample Size: 538 cases, 556 controls; Strongest SNP-Risk Allele: rs8066857-C; SNPs: rs8066857; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.48; Platform [SNPs passing QC]: Illumina [288,357]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
ATXN1		19451621	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 1,821 cases, 2,258 controls; Replication Sample Size: 538 cases, 556 controls; Strongest SNP-Risk Allele: rs697739-A; SNPs: rs697739; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    2.04; Platform [SNPs passing QC]: Illumina [288,357]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
BACH2		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs11755527-?; SNPs: rs11755527; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-8; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
CLEC16A		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs12708716-?; SNPs: rs12708716; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-16; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
GLIS3		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs7020673-?; SNPs: rs7020673; Context: intron; Risk Allele Frequency: 0.50; p-Value: 5E-12; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0.000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
PTPN22		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs2476601-?; SNPs: rs2476601; Context: ; Risk Allele Frequency: NR; p-Value: 9E-85; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
IFIH1		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs1990760-?; SNPs: rs1990760; Context: missense; Risk Allele Frequency: NR; p-Value: 7E-9; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0.000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
CTLA4		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs3087243-?; SNPs: rs3087243; Context: nearGene-3; Risk Allele Frequency: NR; p-Value: 1E-15; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
PRKCQ		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs11258747-?; SNPs: rs11258747; Context: cds-synon; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
ERBB3		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs2292239-?; SNPs: rs2292239; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-25; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
SH2B3		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs3184504-?; SNPs: rs3184504; Context: missense; Risk Allele Frequency: NR; p-Value: 3E-27; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
CTSH		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs3825932-?; SNPs: rs3825932; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-8; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
PTPN2		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs1893217-?; SNPs: rs1893217; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-15; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0.000000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
UBASH3A		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs11203203-?; SNPs: rs11203203; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-9; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
CD69		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs4763879-A; SNPs: rs4763879; Context: intron; Risk Allele Frequency: 0.37; p-Value: 2E-11; OR or beta:    1.09; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
PGM1		19430480	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 7,514 cases, 9,045 controls; Replication Sample Size: 4,267 cases, 4,670 controls, 4,342 trios; Strongest SNP-Risk Allele: rs2269241-G; SNPs: rs2269241; Context: intron; Risk Allele Frequency: 0.19; p-Value: 4E-7; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix & Illumina [841,622] (imputed)	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
SHROOM3		19430482	TAS		Disease/Trait: Renal function and chronic kidney disease; Initial Sample Size: 19,877 individuals, up to 2,388 cases; Replication Sample Size: 21,466 individuals, up to 1,932 cases; Strongest SNP-Risk Allele: rs17319721-A; SNPs: rs17319721; Context: intron; Risk Allele Frequency: 0.44; p-Value: 1E-12; OR or beta:     .01; Platform [SNPs passing QC]: Affymetrix & Illumina [~2.5 million] (imputed)	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	kidney disease
MSRA		19430479	TAS		Disease/Trait: Hypertension; Initial Sample Size: 29,136 individuals; Replication Sample Size: 34,433 individuals; Strongest SNP-Risk Allele: rs11775334-A; SNPs: rs11775334; Context: intron; Risk Allele Frequency: 0.32; p-Value: 4E-6; OR or beta:     .08; Platform [SNPs passing QC]: Affymetrix & Illumina [2,533,153](imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertension
ATP2B1		19430479	TAS		Disease/Trait: Hypertension; Initial Sample Size: 29,136 individuals; Replication Sample Size: 34,433 individuals; Strongest SNP-Risk Allele: rs2681472-A; SNPs: rs2681472; Context: intron; Risk Allele Frequency: 0.83; p-Value: 2E-11; OR or beta:     .15; Platform [SNPs passing QC]: Affymetrix & Illumina [2,533,153](imputed)	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertension
CACNB2		19430479	TAS		Disease/Trait: Hypertension; Initial Sample Size: 29,136 individuals; Replication Sample Size: 34,433 individuals; Strongest SNP-Risk Allele: rs11014166-A; SNPs: rs11014166; Context: intron; Risk Allele Frequency: 0.66; p-Value: 6E-8; OR or beta:     .09; Platform [SNPs passing QC]: Affymetrix & Illumina [2,533,153](imputed)	0.00000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hypertension
PDE4D		19426955	TAS		Disease/Trait: Asthma; Initial Sample Size: 422 cases, 1,533 controls; Replication Sample Size: 3,750 white cases, 13,365 white controls, 592 white trios, 1,903 black cases, 2,432 black controls, 929 black family members; Strongest SNP-Risk Allele: rs1588265-C; SNPs: rs1588265; Context: intron; Risk Allele Frequency: 0.29; p-Value: 3E-8; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina [518,230]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
MCTP1		19416921	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 3,683 cases, 14,507 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17418283-C; SNPs: rs17418283; Context: intron; Risk Allele Frequency: 0.28; p-Value: 1E-7; OR or beta:    1.21; Platform [SNPs passing QC]: Affymetrix and Illumina [2,366,197] (imputed)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
BARD1		19412175	TAS		Disease/Trait: Neuroblastoma (high-risk); Initial Sample Size: 397 cases, 2,043 controls; Replication Sample Size: 189 cases, 1,178 controls; Strongest SNP-Risk Allele: rs6435862-G; SNPs: rs6435862; Context: intron; Risk Allele Frequency: 0.29; p-Value: 9E-18; OR or beta:    1.68; Platform [SNPs passing QC]: Illumina [462,866]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	neuroblastoma
SLC30A8		19401414	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 519 Japanese ancestry cases, 503 Japanese ancestry controls; Replication Sample Size: 5,629 Japanese ancestry cases, 7,370 Japanese ancestry controls; Strongest SNP-Risk Allele: rs13266634-C; SNPs: rs13266634; Context: missense; Risk Allele Frequency: 0.57; p-Value: 2E-14; OR or beta:    1.22; Platform [SNPs passing QC]: Illumina [482,625]	0.00000000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		19401414	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 519 Japanese ancestry cases, 503 Japanese ancestry controls; Replication Sample Size: 5,629 Japanese ancestry cases, 7,370 Japanese ancestry controls; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.04; p-Value: 8E-12; OR or beta:    1.54; Platform [SNPs passing QC]: Illumina [482,625]	0.000000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
IGF2BP2		19401414	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 519 Japanese ancestry cases, 503 Japanese ancestry controls; Replication Sample Size: 5,629 Japanese ancestry cases, 7,370 Japanese ancestry controls; Strongest SNP-Risk Allele: rs4402960-T; SNPs: rs4402960; Context: intron; Risk Allele Frequency: 0.31; p-Value: 1E-6; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina [482,625]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CDKAL1		19401414	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 519 Japanese ancestry cases, 503 Japanese ancestry controls; Replication Sample Size: 5,629 Japanese ancestry cases, 7,370 Japanese ancestry controls; Strongest SNP-Risk Allele: rs4712523-G; SNPs: rs4712523; Context: intron; Risk Allele Frequency: 0.41; p-Value: 7E-20; OR or beta:    1.27; Platform [SNPs passing QC]: Illumina [482,625]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
KCNQ1		19401414	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 519 Japanese ancestry cases, 503 Japanese ancestry controls; Replication Sample Size: 5,629 Japanese ancestry cases, 7,370 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2237892-C; SNPs: rs2237892; Context: intron; Risk Allele Frequency: 0.59; p-Value: 1E-26; OR or beta:    1.33; Platform [SNPs passing QC]: Illumina [482,625]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
HLA-DPB1		19349983	TAS		Disease/Trait: Hepatitis B; Initial Sample Size: 179 Japanese ancestry cases, 934 Japanese ancestry controls; Replication Sample Size: 1,599 Japanese ancestry cases, 2,821 Japanese ancestry controls, 308 Thai ancestry cases, 546 Thai ancestry controls; Strongest SNP-Risk Allele: rs9277535-G; SNPs: rs9277535; Context: UTR-3; Risk Allele Frequency: NR; p-Value: 6E-39; OR or beta:    1.75; Platform [SNPs passing QC]: Illumina [499,544]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	hepatitis B
FGFR2		19330030	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 1,145 cases, 1,142 controls; Replication Sample Size: 8,625 cases, 9,657 controls; Strongest SNP-Risk Allele: rs2981579-T; SNPs: rs2981579; Context: intron; Risk Allele Frequency: 0.41; p-Value: 2E-10; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina [528,173]	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
JAK2		19287384	TAS		Disease/Trait: Myeloproliferative neoplasms; Initial Sample Size: 324 cases, 2,999 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10974944-?; SNPs: rs10974944; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-20; OR or beta:    3.10; Platform [SNPs passing QC]: Affymetrix [62,775]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myelodysplastic myeloproliferative cancer
ABO		19278955	TAS		Disease/Trait: Venous thromboembolism; Initial Sample Size: 419 cases, 1,228 controls; Replication Sample Size: 1,757 cases, 1,480 controls; Strongest SNP-Risk Allele: rs505922-C; SNPs: rs505922; Context: intron; Risk Allele Frequency: 0.35; p-Value: 4E-15; OR or beta:    1.81; Platform [SNPs passing QC]: Illumina [291,872]	0.000000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Thromboembolism
RELN		19230858	TAS		Disease/Trait: Otosclerosis; Initial Sample Size: 302 cases, 302 controls; Replication Sample Size: 847 cases, 872 controls; Strongest SNP-Risk Allele: rs3914132-?; SNPs: rs3914132; Context: intron; Risk Allele Frequency: 0.23; p-Value: 2E-8; OR or beta:    1.54; Platform [SNPs passing QC]: Illumina [~555,000] (pooled)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	otosclerosis
MRAS		19198612	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 6,990 cases, 8,955 controls; Replication Sample Size: 12,417 cases, 12,411 controls; Strongest SNP-Risk Allele: rs9818870-T; SNPs: rs9818870; Context: UTR-3; Risk Allele Frequency: 0.15; p-Value: 7E-13; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix [567,119]	0.0000000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
MIA3		19198609	TAS		Disease/Trait: Myocardial infarction (early onset); Initial Sample Size: 2,967 cases, 3,075 controls; Replication Sample Size: 9,746 cases, 9,746 controls; Strongest SNP-Risk Allele: rs17465637-C; SNPs: rs17465637; Context: intron; Risk Allele Frequency: 0.72; p-Value: 1E-9; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix [~2.5 million] (imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myocardial infarction
WDR12		19198609	TAS		Disease/Trait: Myocardial infarction (early onset); Initial Sample Size: 2,967 cases, 3,075 controls; Replication Sample Size: 9,746 cases, 9,746 controls; Strongest SNP-Risk Allele: rs6725887-C; SNPs: rs6725887; Context: intron; Risk Allele Frequency: 0.14; p-Value: 1E-8; OR or beta:    1.17; Platform [SNPs passing QC]: Affymetrix [~2.5 million] (imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myocardial infarction
PHACTR1		19198609	TAS		Disease/Trait: Myocardial infarction (early onset); Initial Sample Size: 2,967 cases, 3,075 controls; Replication Sample Size: 9,746 cases, 9,746 controls; Strongest SNP-Risk Allele: rs12526453-C; SNPs: rs12526453; Context: intron; Risk Allele Frequency: 0.65; p-Value: 1E-9; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix [~2.5 million] (imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	myocardial infarction
NRG1		19196962	TAS		Disease/Trait: Hirschsprung's disease; Initial Sample Size: 181 Chinese ancestry cases, 346 Chinese ancestry controls; Replication Sample Size: 190 Chinese ancestry cases, 510 Chinese ancestry controls; Strongest SNP-Risk Allele: rs16879552-G; SNPs: rs16879552; Context: intron; Risk Allele Frequency: 0.61; p-Value: 2E-8; OR or beta:    1.68; Platform [SNPs passing QC]: Affymetrix [293,836]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Hirschsprung's disease
CTNNA3		19187332	TAS		Disease/Trait: Asthma (toluene diisocyanate-induced); Initial Sample Size: 84 Korean ancestry cases, 263 Korean ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10762058-G; SNPs: rs10762058; Context: intron; Risk Allele Frequency: 0.25; p-Value: 6E-6; OR or beta:    5.00; Platform [SNPs passing QC]: Affymetrix [312,978]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	asthma
NCOA3		19176441	TAS		Disease/Trait: Response to treatment for acute lymphoblastic leukemia; Initial Sample Size: 487 children; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6125048-T; SNPs: rs6125048; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    2.73; Platform [SNPs passing QC]: Affymetrix [476,796]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
LMBRD2		19176441	TAS		Disease/Trait: Response to treatment for acute lymphoblastic leukemia; Initial Sample Size: 487 children; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs267759-A; SNPs: rs267759; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta:    3.23; Platform [SNPs passing QC]: Affymetrix [476,796]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
MAML2		19176441	TAS		Disease/Trait: Response to treatment for acute lymphoblastic leukemia; Initial Sample Size: 487 children; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7115578-A; SNPs: rs7115578; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.86; Platform [SNPs passing QC]: Affymetrix [476,796]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
ST8SIA6		19176441	TAS		Disease/Trait: Response to treatment for acute lymphoblastic leukemia; Initial Sample Size: 487 children; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs359312-T; SNPs: rs359312; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-8; OR or beta:    3.91; Platform [SNPs passing QC]: Affymetrix [476,796]	0.00000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
ELMO1		19176441	TAS		Disease/Trait: Response to treatment for acute lymphoblastic leukemia; Initial Sample Size: 487 children; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4723619-C; SNPs: rs4723619; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta:    3.01; Platform [SNPs passing QC]: Affymetrix [476,796]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
DGKB		19176441	TAS		Disease/Trait: Response to treatment for acute lymphoblastic leukemia; Initial Sample Size: 487 children; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6971925-T; SNPs: rs6971925; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta:   13.91; Platform [SNPs passing QC]: Affymetrix [476,796]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lymphoblastic leukemia
IL13		19169254	TAS		Disease/Trait: Psoriasis; Initial Sample Size: 1,359 cases, 1,400 controls; Replication Sample Size: 5,048 cases, 5,041 controls; Strongest SNP-Risk Allele: rs20541-G; SNPs: rs20541; Context: missense; Risk Allele Frequency: 0.79; p-Value: 5E-15; OR or beta:    1.27; Platform [SNPs passing QC]: Perlegen [~2.5 million] (imputed)	0.000000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriasis
TSC1		19169254	TAS		Disease/Trait: Psoriasis; Initial Sample Size: 1,359 cases, 1,400 controls; Replication Sample Size: 5,048 cases, 5,041 controls; Strongest SNP-Risk Allele: rs1076160-T; SNPs: rs1076160; Context: intron; Risk Allele Frequency: 0.48; p-Value: 6E-6; OR or beta:    1.09; Platform [SNPs passing QC]: Perlegen [~2.5 million] (imputed)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriasis
IL23R		19169254	TAS		Disease/Trait: Psoriasis; Initial Sample Size: 1,359 cases, 1,400 controls; Replication Sample Size: 5,048 cases, 5,041 controls; Strongest SNP-Risk Allele: rs2201841-G; SNPs: rs2201841; Context: intron; Risk Allele Frequency: 0.30; p-Value: 3E-8; OR or beta:    1.13; Platform [SNPs passing QC]: Perlegen [~2.5 million] (imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriasis
TNFAIP3		19169254	TAS		Disease/Trait: Psoriasis; Initial Sample Size: 1,359 cases, 1,400 controls; Replication Sample Size: 5,048 cases, 5,041 controls; Strongest SNP-Risk Allele: rs610604-G; SNPs: rs610604; Context: intron; Risk Allele Frequency: 0.32; p-Value: 9E-12; OR or beta:    1.19; Platform [SNPs passing QC]: Perlegen [~2.5 million] (imputed)	0.000000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriasis
IL12B		19169255	TAS		Disease/Trait: Psoriasis; Initial Sample Size: 1,139 Chinese ancestry cases, 1,132 Chinese ancestry controls; Replication Sample Size: 5,721 Chinese ancestry cases, 7,340 Chinese ancestry controls; Strongest SNP-Risk Allele: rs3213094-A; SNPs: rs3213094; Context: intron; Risk Allele Frequency: 0.45; p-Value: 3E-26; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [494,902]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriasis
TNFRSF21		19165232	TAS		Disease/Trait: Panic disorder; Initial Sample Size: 200 Japanese ancestry cases, 200 Japanese ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2103868-?; SNPs: rs2103868; Context: intron; Risk Allele Frequency: 0.26; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [253,903]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	panic disorder
GRM7		19165232	TAS		Disease/Trait: Panic disorder; Initial Sample Size: 200 Japanese ancestry cases, 200 Japanese ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3749380-?; SNPs: rs3749380; Context: cds-synon; Risk Allele Frequency: 0.25; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [253,903]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	panic disorder
CALCOCO1		19165232	TAS		Disease/Trait: Panic disorder; Initial Sample Size: 200 Japanese ancestry cases, 200 Japanese ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs941184-?; SNPs: rs941184; Context: intron; Risk Allele Frequency: 0.03; p-Value: 3E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [253,903]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	panic disorder
PKP1		19165232	TAS		Disease/Trait: Panic disorder; Initial Sample Size: 200 Japanese ancestry cases, 200 Japanese ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs860554-?; SNPs: rs860554; Context: intron; Risk Allele Frequency: 0.05; p-Value: 5E-8; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [253,903]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	panic disorder
SDK2		19165232	TAS		Disease/Trait: Panic disorder; Initial Sample Size: 200 Japanese ancestry cases, 200 Japanese ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3816995-?; SNPs: rs3816995; Context: intron; Risk Allele Frequency: 0.03; p-Value: 2E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [253,903]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	panic disorder
NPC1		19151714	TAS		Disease/Trait: Obesity; Initial Sample Size: 695 obese adults, 685 obese children, 731 lean adults, 685 lean children; Replication Sample Size: 1,171 obese adults, 896 obese children, 1,114 lean adults, 1,297 lean children, 4,417 adults, 5,291 children; Strongest SNP-Risk Allele: rs1805081-A; SNPs: rs1805081; Context: missense; Risk Allele Frequency: 0.56; p-Value: 3E-7; OR or beta:    1.33; Platform [SNPs passing QC]: Illumina [308,846]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity
FTO		19151714	TAS		Disease/Trait: Obesity; Initial Sample Size: 695 obese adults, 685 obese children, 731 lean adults, 685 lean children; Replication Sample Size: 1,171 obese adults, 896 obese children, 1,114 lean adults, 1,297 lean children, 4,417 adults, 5,291 children; Strongest SNP-Risk Allele: rs1421085-C; SNPs: rs1421085; Context: intron; Risk Allele Frequency: 0.40; p-Value: 1E-28; OR or beta:    1.39; Platform [SNPs passing QC]: Illumina [308,846]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity
PCDH11X		19136949	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 844 cases, 1,255 controls; Replication Sample Size: 1,547 cases, 1,209 controls; Strongest SNP-Risk Allele: rs2573905-?; SNPs: rs2573905; Context: intron; Risk Allele Frequency: 0.46; p-Value: 2E-7; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [313,504]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
NAALADL2		19132087	TAS		Disease/Trait: Kawasaki disease; Initial Sample Size: 107 cases, 134 controls; Replication Sample Size: 583 cases, 1,357 family members; Strongest SNP-Risk Allele: rs17531088-T; SNPs: rs17531088; Context: intron; Risk Allele Frequency: 0.44; p-Value: 1E-6; OR or beta:    1.43; Platform [SNPs passing QC]: Affymetrix [223,922]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Kawasaki disease
ZFHX3		19132087	TAS		Disease/Trait: Kawasaki disease; Initial Sample Size: 107 cases, 134 controls; Replication Sample Size: 583 cases, 1,357 family members; Strongest SNP-Risk Allele: rs7199343-T; SNPs: rs7199343; Context: intron; Risk Allele Frequency: 0.30; p-Value: 2E-6; OR or beta:    1.56; Platform [SNPs passing QC]: Affymetrix [223,922]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Kawasaki disease
IL23R		19122664	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 1,022 cases, 2,503 controls; Replication Sample Size: 1,387 cases, 1,115 controls; Strongest SNP-Risk Allele: rs11209026-?; SNPs: rs11209026; Context: missense; Risk Allele Frequency: 0.93; p-Value: 1E-8; OR or beta:    1.79; Platform [SNPs passing QC]: Illumina [280,748]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
RNF186		19122664	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 1,022 cases, 2,503 controls; Replication Sample Size: 1,387 cases, 1,115 controls; Strongest SNP-Risk Allele: rs3806308-?; SNPs: rs3806308; Context: nearGene-5; Risk Allele Frequency: 0.63; p-Value: 7E-9; OR or beta:    1.28; Platform [SNPs passing QC]: Illumina [280,748]	0.000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
IL23R		19122664	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 1,022 cases, 2,503 controls; Replication Sample Size: 1,387 cases, 1,115 controls; Strongest SNP-Risk Allele: rs10889677-A; SNPs: rs10889677; Context: UTR-3; Risk Allele Frequency: 0.30; p-Value: 1E-8; OR or beta:    1.29; Platform [SNPs passing QC]: Illumina [280,748]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
IL26		19122664	TAS		Disease/Trait: Ulcerative colitis; Initial Sample Size: 1,022 cases, 2,503 controls; Replication Sample Size: 1,387 cases, 1,115 controls; Strongest SNP-Risk Allele: rs2870946-G; SNPs: rs2870946; Context: intron; Risk Allele Frequency: 0.055; p-Value: 5E-7; OR or beta:    1.54; Platform [SNPs passing QC]: Illumina [280,748]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	ulcerative colitis
VTCN1		19116933	TAS		Disease/Trait: Arthritis (juvenile idiopathic); Initial Sample Size: 279 cases, 184 controls; Replication Sample Size: up to 654 cases, 1,847 controls; Strongest SNP-Risk Allele: rs12046117-?; SNPs: rs12046117; Context: intron; Risk Allele Frequency: 0.09; p-Value: 1E-6; OR or beta:    1.58; Platform [SNPs passing QC]: Affymetrix [88,862]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	juvenile rheumatoid arthritis
TNRC6B		19117981	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,235 aggressive cases, 1,599 controls; Replication Sample Size: 3,629 aggressive cases, 4,255 non-aggressive cases, 5,738 controls; Strongest SNP-Risk Allele: rs9623117-C; SNPs: rs9623117; Context: intron; Risk Allele Frequency: 0.21; p-Value: 5E-7; OR or beta:    1.18; Platform [SNPs passing QC]: Affymetrix and Illumina [~2 million] (imputed)	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
PRNP		19081515	TAS		Disease/Trait: Creutzfeldt-Jakob disease; Initial Sample Size: 117 CJD cases, 3,083 controls; Replication Sample Size: 506 sCJD cases, 28 iCJD cases, 151 Kuru cases, 125 Kuru-resistant cases, up to 1,137 controls; Strongest SNP-Risk Allele: rs1799990-A; SNPs: rs1799990; Context: missense; Risk Allele Frequency: NR; p-Value: 2E-21; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [288,908]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Creutzfeldt-Jakob syndrome
ZNF544		18821565	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 909 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs260461-?; SNPs: rs260461; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Perlegen [429,981]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
FHIT		18821565	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 909 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6791644-?; SNPs: rs6791644; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Perlegen [429,981]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
NAPRT1		18821565	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 909 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2290416-?; SNPs: rs2290416; Context: cds-synon; Risk Allele Frequency: NR; p-Value: 9E-6; OR or beta: NR; Platform [SNPs passing QC]: Perlegen [429,981]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
FOXP1		18821565	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 909 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17651978-?; SNPs: rs17651978; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Perlegen [429,981]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
SULF2		18937294	TAS		Disease/Trait: Attention deficit hyperactivity disorder (time to onset); Initial Sample Size: 930 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4810685-C; SNPs: rs4810685; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Perlegen [429,981]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
ADAMTS2		18937294	TAS		Disease/Trait: Attention deficit hyperactivity disorder (time to onset); Initial Sample Size: 930 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10039254-A; SNPs: rs10039254; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Perlegen [429,981]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
KCNJ11		19056611	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases, 2,938 controls; Replication Sample Size: 3,757 cases, 5,346 controls; Strongest SNP-Risk Allele: rs5219-?; SNPs: rs5219; Context: STOP-GAIN; Risk Allele Frequency: NR; p-Value: 1E-9; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix [393,453]	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
KCNJ11		19056611	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases, 2,938 controls; Replication Sample Size: 3,757 cases, 5,346 controls; Strongest SNP-Risk Allele: rs5219-?; SNPs: rs5219; Context: STOP-GAIN; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta:    1.19; Platform [SNPs passing QC]: Affymetrix [393,453]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		19056611	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases, 2,938 controls; Replication Sample Size: 3,757 cases, 5,346 controls; Strongest SNP-Risk Allele: rs7903146-?; SNPs: rs7903146; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-30; OR or beta:    1.49; Platform [SNPs passing QC]: Affymetrix [393,453]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
SLC30A8		19056611	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases, 2,938 controls; Replication Sample Size: 3,757 cases, 5,346 controls; Strongest SNP-Risk Allele: rs13266634-?; SNPs: rs13266634; Context: missense; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta:    1.18; Platform [SNPs passing QC]: Affymetrix [393,453]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		19056611	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases, 2,938 controls; Replication Sample Size: 3,757 cases, 5,346 controls; Strongest SNP-Risk Allele: rs7903146-?; SNPs: rs7903146; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-16; OR or beta:    1.31; Platform [SNPs passing QC]: Affymetrix [393,453]	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
FTO		19056611	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases, 2,938 controls; Replication Sample Size: 3,757 cases, 5,346 controls; Strongest SNP-Risk Allele: rs8050136-?; SNPs: rs8050136; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-17; OR or beta:    1.30; Platform [SNPs passing QC]: Affymetrix [393,453]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TRAF3		19023125	TAS		Disease/Trait: Brain imaging in schizophrenia (interaction); Initial Sample Size: 64 cases, 74 cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10133111-?; SNPs: rs10133111; Context: UTR-3; Risk Allele Frequency: 0.20; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [302,783]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
TNIK		19023125	TAS		Disease/Trait: Brain imaging in schizophrenia (interaction); Initial Sample Size: 64 cases, 74 cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2088885-?; SNPs: rs2088885; Context: intron; Risk Allele Frequency: 0.47; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina [302,783]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
RHPN2		19011631	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 1,902 cases,1,929 controls; Replication Sample Size: 4,878 cases,4,914 controls; Strongest SNP-Risk Allele: rs10411210-C; SNPs: rs10411210; Context: intron; Risk Allele Frequency: 0.90; p-Value: 5E-9; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina[up to 548,586]	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
CDH1		19011631	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 1,902 cases,1,929 controls; Replication Sample Size: 4,878 cases,4,914 controls; Strongest SNP-Risk Allele: rs9929218-G; SNPs: rs9929218; Context: intron; Risk Allele Frequency: 0.29; p-Value: 1E-8; OR or beta:    1.10; Platform [SNPs passing QC]: Illumina[up to 548,586]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
PDZRN4		19010793	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 978 cases,883 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1458175-?; SNPs: rs1458175; Context: intron; Risk Allele Frequency: 0.49; p-Value: 2E-6; OR or beta:    1.34; Platform [SNPs passing QC]: Illumina[551,642]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
GPC5		19010793	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 978 cases,883 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9523762-?; SNPs: rs9523762; Context: intron; Risk Allele Frequency: 0.35; p-Value: 1E-6; OR or beta:    1.36; Platform [SNPs passing QC]: Illumina[551,642]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
CSMD1		19010793	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 978 cases,883 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1529316-?; SNPs: rs1529316; Context: intron; Risk Allele Frequency: 0.47; p-Value: 2E-6; OR or beta:    1.36; Platform [SNPs passing QC]: Illumina[551,642]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
RELN		19010793	TAS		Disease/Trait: Multiple sclerosis (age of onset); Initial Sample Size: 978 cases,883 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17157903-?; SNPs: rs17157903; Context: intron; Risk Allele Frequency: 0.14; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina[551,642]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
NLRP11		19010793	TAS		Disease/Trait: Multiple sclerosis (severity); Initial Sample Size: 794 cases, 883 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs299175-?; SNPs: rs299175; Context: intron; Risk Allele Frequency: 0.46; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina[551,642]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
C1GALT1		19010793	TAS		Disease/Trait: Multiple sclerosis (severity); Initial Sample Size: 794 cases, 883 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10259085-?; SNPs: rs10259085; Context: intron; Risk Allele Frequency: 0.46; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina[551,642]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
MET		19010793	TAS		Disease/Trait: Multiple sclerosis (severity); Initial Sample Size: 794 cases, 883 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10243024-?; SNPs: rs10243024; Context: intron; Risk Allele Frequency: 0.23; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina[551,642]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
KIF1B		18997785	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 45 cases,195 controls; Replication Sample Size: 2,634 cases,2,930 controls; Strongest SNP-Risk Allele: rs10492972-C; SNPs: rs10492972; Context: intron; Risk Allele Frequency: 0.27; p-Value: 3E-10; OR or beta:    1.34; Platform [SNPs passing QC]: Affymetrix[~250,000]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
DPP6		18987618	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 958 cases,932 controls; Replication Sample Size: 309 cases,404 controls; Strongest SNP-Risk Allele: rs10260404-C; SNPs: rs10260404; Context: ; Risk Allele Frequency: 0.35; p-Value: 3E-6; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina[287,522]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
CLEC16A		18978792	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 3,561 cases,4,646 controls; Replication Sample Size: 6,225 cases,6,946 controls, 3,064 trios; Strongest SNP-Risk Allele: rs12708716-G; SNPs: rs12708716; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-13; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[up to 335,565]	0.0000000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
BACH2		18978792	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 3,561 cases,4,646 controls; Replication Sample Size: 6,225 cases,6,946 controls, 3,064 trios; Strongest SNP-Risk Allele: rs11755527-G; SNPs: rs11755527; Context: intron; Risk Allele Frequency: 0.47; p-Value: 5E-12; OR or beta:    1.13; Platform [SNPs passing QC]: Affymetrix[up to 335,565]	0.000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
CTSH		18978792	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 3,561 cases,4,646 controls; Replication Sample Size: 6,225 cases,6,946 controls, 3,064 trios; Strongest SNP-Risk Allele: rs3825932-T; SNPs: rs3825932; Context: intron; Risk Allele Frequency: 0.68; p-Value: 3E-15; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix[up to 335,565]	0.000000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
CTLA4		18978792	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 3,561 cases,4,646 controls; Replication Sample Size: 6,225 cases,6,946 controls, 3,064 trios; Strongest SNP-Risk Allele: rs3087243-A; SNPs: rs3087243; Context: nearGene-3; Risk Allele Frequency: NR; p-Value: 8E-11; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[up to 335,565]	0.00000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
ERBB3		18978792	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 3,561 cases,4,646 controls; Replication Sample Size: 6,225 cases,6,946 controls, 3,064 trios; Strongest SNP-Risk Allele: rs2292239-A; SNPs: rs2292239; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-16; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[up to 335,565]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
CLPTM1L		18978787	TAS		Disease/Trait: Lung cancer; Initial Sample Size: 1,952 cases,1,438 controls; Replication Sample Size: 7,579 cases,8,236 controls; Strongest SNP-Risk Allele: rs401681-G; SNPs: rs401681; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-9; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina[223,891]	0.000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer
CD33		18976728	TAS		Disease/Trait: Alzheimer's disease; Initial Sample Size: 941 affected individuals,404 unaffected individuals; Replication Sample Size: 1,767 affected individuals,838 unaffected individuals; Strongest SNP-Risk Allele: rs3826656-?; SNPs: rs3826656; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[484,522]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
KIRREL3		18951430	TAS		Disease/Trait: Attention deficit hyperactivity disorder and conduct disorder; Initial Sample Size: 938 affected trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1557488-T; SNPs: rs1557488; Context: intron; Risk Allele Frequency: 0.18; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Perlegen[378,332]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder;conduct disorder
ATP8B1		18951430	TAS		Disease/Trait: Attention deficit hyperactivity disorder and conduct disorder; Initial Sample Size: 938 affected trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7236632-A; SNPs: rs7236632; Context: intron; Risk Allele Frequency: 0.86; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Perlegen[378,332]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder;conduct disorder
PAWR		18951430	TAS		Disease/Trait: Attention deficit hyperactivity disorder and conduct disorder; Initial Sample Size: 938 affected trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7297018-A; SNPs: rs7297018; Context: intron; Risk Allele Frequency: 0.19; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Perlegen[378,332]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder;conduct disorder
BACH2		18840781	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 563 cases,1,146 controls,483 case-parents trios; Replication Sample Size: 636 families,3,303 cases,4,673 controls; Strongest SNP-Risk Allele: rs3757247-A; SNPs: rs3757247; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta:    1.13; Platform [SNPs passing QC]: Illumina[up to 1,000,000]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
RASGRP1		18840781	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 563 cases,1,146 controls,483 case-parents trios; Replication Sample Size: 636 families,3,303 cases,4,673 controls; Strongest SNP-Risk Allele: rs8035957-C; SNPs: rs8035957; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina[up to 1,000,000]	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
UBASH3A		18840781	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 563 cases,1,146 controls,483 case-parents trios; Replication Sample Size: 636 families,3,303 cases,4,673 controls; Strongest SNP-Risk Allele: rs9976767-C; SNPs: rs9976767; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-8; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina[up to 1,000,000]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
GLIS3		18840781	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 563 cases,1,146 controls,483 case-parents trios; Replication Sample Size: 636 families,3,303 cases,4,673 controls; Strongest SNP-Risk Allele: rs10758593-A; SNPs: rs10758593; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta:    1.13; Platform [SNPs passing QC]: Illumina[up to 1,000,000]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
UNC5B		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs16928529-?; SNPs: rs16928529; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
SUPT3H		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs3799977-?; SNPs: rs3799977; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
REEP5		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs469727-?; SNPs: rs469727; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
MMP24		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1555322-?; SNPs: rs1555322; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
ITGAE		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs220470-?; SNPs: rs220470; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
CSMD2		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2281597-?; SNPs: rs2281597; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
PPM1F		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs412050-?; SNPs: rs412050; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
MOBP		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs864643-?; SNPs: rs864643; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
MAN2A2		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2677744-?; SNPs: rs2677744; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
ASTN2		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10983238-?; SNPs: rs10983238; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
NT5DC3		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4964805-?; SNPs: rs4964805; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
ITGA11		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7164335-?; SNPs: rs7164335; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
GPC6		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7995215-?; SNPs: rs7995215; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
MYT1L		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2241685-?; SNPs: rs2241685; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
TLL2		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10786284-?; SNPs: rs10786284; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
CREB5		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2237349-?; SNPs: rs2237349; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
ATP2C2		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10514604-?; SNPs: rs10514604; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.0000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
CDH13		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11646411-?; SNPs: rs11646411; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
MAP1B		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2199161-?; SNPs: rs2199161; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
DNM1		18839057	TAS		Disease/Trait: Attention deficit hyperactivity disorder; Initial Sample Size: 343 cases, 304 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2502731-?; SNPs: rs2502731; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix [504,219](pooled)	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
PIWIL4		18846501	TAS		Disease/Trait: Attention deficit hyperactivity disorder symptoms (interaction); Initial Sample Size: 909 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2212361-C; SNPs: rs2212361; Context: intron; Risk Allele Frequency: 0.26; p-Value: 9E-7; OR or beta:     .97; Platform [SNPs passing QC]: Perlegen[429,981]	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
KIF6		18846501	TAS		Disease/Trait: Attention deficit hyperactivity disorder symptoms (interaction); Initial Sample Size: 909 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4714261-T; SNPs: rs4714261; Context: intron; Risk Allele Frequency: 0.17; p-Value: 2E-6; OR or beta:     .95; Platform [SNPs passing QC]: Perlegen[429,981]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	attention deficit hyperactivity disorder
MFHAS1		18846501	TAS		Disease/Trait: Conduct disorder (interaction); Initial Sample Size: 909 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs332034-A; SNPs: rs332034; Context: intron; Risk Allele Frequency: 0.85; p-Value: 6E-6; OR or beta:    1.05; Platform [SNPs passing QC]: Perlegen [429,901)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
ZBTB16		18846501	TAS		Disease/Trait: Conduct disorder (interaction); Initial Sample Size: 909 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs17116334-T; SNPs: rs17116334; Context: intron; Risk Allele Frequency: 0.16; p-Value: 9E-6; OR or beta:    1.30; Platform [SNPs passing QC]: Perlegen [429,901)	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
SLC6A1		18846501	TAS		Disease/Trait: Conduct disorder (interaction); Initial Sample Size: 909 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9990174-T; SNPs: rs9990174; Context: intron; Risk Allele Frequency: 0.33; p-Value: 6E-6; OR or beta:    2.52; Platform [SNPs passing QC]: Perlegen [429,901)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
RIT1		18846501	TAS		Disease/Trait: Conduct disorder (interaction); Initial Sample Size: 909 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2282301-A; SNPs: rs2282301; Context: UTR-3; Risk Allele Frequency: 0.23; p-Value: 7E-6; OR or beta:    2.88; Platform [SNPs passing QC]: Perlegen [429,901)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
PPM1K		18846501	TAS		Disease/Trait: Conduct disorder (interaction); Initial Sample Size: 909 trios; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs893971-T; SNPs: rs893971; Context: intron; Risk Allele Frequency: 0.60; p-Value: 7E-6; OR or beta:    1.15; Platform [SNPs passing QC]: Perlegen [429,901)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	conduct disorder
TERT		18835860	TAS		Disease/Trait: Idiopathic pulmonary fibrosis; Initial Sample Size: 159 Japanese ancestry cases,934 Japanese ancestry controls; Replication Sample Size: 83 Japanese ancestry cases,535 Japanese ancestry controls; Strongest SNP-Risk Allele: rs2736100-A; SNPs: rs2736100; Context: intron; Risk Allele Frequency: 0.41; p-Value: 3E-8; OR or beta:    2.11; Platform [SNPs passing QC]: Illumina [214,508]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	idiopathic pulmonary fibrosis;idiopathic pulmonary fibrosis
CD40		18794853	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 3,393 cases,12,460 controls; Replication Sample Size: 3,929 cases,5,807 controls; Strongest SNP-Risk Allele: rs4810485-G; SNPs: rs4810485; Context: intron; Risk Allele Frequency: 0.75; p-Value: 8E-9; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina[818,728]Affymetrix[~340,000](imputed)	0.000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
CDK6		18794853	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 3,393 cases,12,460 controls; Replication Sample Size: 3,929 cases,5,807 controls; Strongest SNP-Risk Allele: rs42041-G; SNPs: rs42041; Context: intron; Risk Allele Frequency: 0.24; p-Value: 4E-6; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina[818,728]Affymetrix[~340,000](imputed)	0.000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
CCL21		18794853	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 3,393 cases,12,460 controls; Replication Sample Size: 3,929 cases,5,807 controls; Strongest SNP-Risk Allele: rs2812378-G; SNPs: rs2812378; Context: nearGene-5; Risk Allele Frequency: 0.34; p-Value: 3E-8; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina[818,728]Affymetrix[~340,000](imputed)	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
IRF4		18758461	TAS		Disease/Trait: Chronic lymphocytic leukemia; Initial Sample Size: 505 cases, 1,438 controls; Replication Sample Size: 1,024 cases,1,677 controls; Strongest SNP-Risk Allele: rs872071-G; SNPs: rs872071; Context: ncRNA; Risk Allele Frequency: 0.54; p-Value: 2E-20; OR or beta:    1.54; Platform [SNPs passing QC]: Illumina[345,665]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	chronic lymphocytic leukemia
IL23R		18758464	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 1,011 cases,4,250 controls; Replication Sample Size: 1,922 cases,14,124 controls; Strongest SNP-Risk Allele: rs11209026-?; SNPs: rs11209026; Context: missense; Risk Allele Frequency: 0.94; p-Value: 7E-11; OR or beta:    2.56; Platform [SNPs passing QC]: Illumina[NR]	0.00000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
TNFSF15		18758464	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 1,011 cases,4,250 controls; Replication Sample Size: 1,922 cases,14,124 controls; Strongest SNP-Risk Allele: rs6478109-?; SNPs: rs6478109; Context: nearGene-5; Risk Allele Frequency: 0.69; p-Value: 3E-8; OR or beta:    1.36; Platform [SNPs passing QC]: Illumina[NR]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
NOD2		18758464	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 1,011 cases,4,250 controls; Replication Sample Size: 1,922 cases,14,124 controls; Strongest SNP-Risk Allele: rs5743289-T; SNPs: rs5743289; Context: intron; Risk Allele Frequency: 0.17; p-Value: 4E-10; OR or beta:    1.46; Platform [SNPs passing QC]: Illumina[NR]	0.0000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
CACNA1C		18711365	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 4,387 cases,6,209 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1006737-A; SNPs: rs1006737; Context: intron; Risk Allele Frequency: 0.32; p-Value: 7E-8; OR or beta:    1.18; Platform [SNPs passing QC]: Affymetrix[1,769,948]imputed	0.00000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
ANK3		18711365	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 4,387 cases,6,209 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10994336-T; SNPs: rs10994336; Context: intron; Risk Allele Frequency: 0.05; p-Value: 9E-9; OR or beta:    1.45; Platform [SNPs passing QC]: Affymetrix[1,769,948]imputed	0.000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
IGF2BP2		18711366	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 194 Japanese cases, 1,558 Japanese controls; Replication Sample Size: 4,924 cases, 2,618 controls (Japanese), 1433 cases, 1,735 controls (Singaporean), 3,891 cases, 4,888 controls (Danish); Strongest SNP-Risk Allele: rs6769511-C; SNPs: rs6769511; Context: intron; Risk Allele Frequency: 0.32; p-Value: 1E-9; OR or beta:    1.23; Platform [SNPs passing QC]: Affymetrix [207,097]	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
KCNQ1		18711366	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 194 Japanese cases, 1,558 Japanese controls; Replication Sample Size: 4,924 cases, 2,618 controls (Japanese), 1433 cases, 1,735 controls (Singaporean), 3,891 cases, 4,888 controls (Danish); Strongest SNP-Risk Allele: rs2237897-C; SNPs: rs2237897; Context: intron; Risk Allele Frequency: 0.34; p-Value: 1E-16; OR or beta:    1.33; Platform [SNPs passing QC]: Affymetrix [207,097]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CDKAL1		18711366	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 194 Japanese cases, 1,558 Japanese controls; Replication Sample Size: 4,924 cases, 2,618 controls (Japanese), 1433 cases, 1,735 controls (Singaporean), 3,891 cases, 4,888 controls (Danish); Strongest SNP-Risk Allele: rs4712524-G; SNPs: rs4712524; Context: intron; Risk Allele Frequency: 0.42; p-Value: 3E-10; OR or beta:    1.22; Platform [SNPs passing QC]: Affymetrix [207,097]	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
KCNQ1		18711367	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 187 Japanese cases, 1,504 Japanese controls; Replication Sample Size: 6,552 Asian cases, 6,621 Asian controls, 2,830 cases, 3,740 controls (Swedish); Strongest SNP-Risk Allele: rs2237892-C; SNPs: rs2237892; Context: intron; Risk Allele Frequency: 0.61; p-Value: 2E-42; OR or beta:    1.40; Platform [SNPs passing QC]: Invader [82,343]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
ITGAM		19165918	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 431 cases,2,155 controls; Replication Sample Size: 740 trios; Strongest SNP-Risk Allele: rs11150610-?; SNPs: rs11150610; Context: intron; Risk Allele Frequency: 0.42; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[313,238]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
STAT4		19165918	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 431 cases,2,155 controls; Replication Sample Size: 740 trios; Strongest SNP-Risk Allele: rs3821236-?; SNPs: rs3821236; Context: intron; Risk Allele Frequency: 0.19; p-Value: 8E-11; OR or beta:    1.49; Platform [SNPs passing QC]: Affymetrix[313,238]	0.00000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
BLK		19165918	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 431 cases,2,155 controls; Replication Sample Size: 740 trios; Strongest SNP-Risk Allele: rs2618476-?; SNPs: rs2618476; Context: intron; Risk Allele Frequency: 0.26; p-Value: 2E-8; OR or beta:    1.29; Platform [SNPs passing QC]: Affymetrix[313,238]	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
TNFAIP3		19165918	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 431 cases,2,155 controls; Replication Sample Size: 740 trios; Strongest SNP-Risk Allele: rs5029939-?; SNPs: rs5029939; Context: intron; Risk Allele Frequency: 0.03; p-Value: 3E-12; OR or beta:    2.28; Platform [SNPs passing QC]: Affymetrix[313,238]	0.000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
ZNF804A		18677311	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 479 cases,2,937 controls; Replication Sample Size: 6,666 cases,9,897 controls; Strongest SNP-Risk Allele: rs1344706-T; SNPs: rs1344706; Context: intron; Risk Allele Frequency: 0.59; p-Value: 2E-7; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix[362,532]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
PTPRD		18660810	TAS		Disease/Trait: Restless legs syndrome; Initial Sample Size: 628 cases,1,644 controls; Replication Sample Size: 1,835 cases,3,111 controls; Strongest SNP-Risk Allele: rs1975197-T; SNPs: rs1975197; Context: intron; Risk Allele Frequency: 0.16; p-Value: 6E-9; OR or beta:    1.31; Platform [SNPs passing QC]: Affymetrix[208,733]	0.000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	restless legs syndrome
PTPRD		18660810	TAS		Disease/Trait: Restless legs syndrome; Initial Sample Size: 628 cases,1,644 controls; Replication Sample Size: 1,835 cases,3,111 controls; Strongest SNP-Risk Allele: rs4626664-A; SNPs: rs4626664; Context: intron; Risk Allele Frequency: 0.12; p-Value: 6E-10; OR or beta:    1.44; Platform [SNPs passing QC]: Affymetrix[208,733]	0.0000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	restless legs syndrome
CYP2C8		18594024	TAS		Disease/Trait: Osteonecrosis of the jaw; Initial Sample Size: 21 cases,64 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1934951-T; SNPs: rs1934951; Context: intron; Risk Allele Frequency: 0.12; p-Value: 1E-6; OR or beta:   12.75; Platform [SNPs passing QC]: Affymetrix[339,972]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	osteonecrosis
ATG16L1		18587394	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 3,230 cases4,829 controls; Replication Sample Size: 1,339 trios, 2,325 cases, 1,809 controls; Strongest SNP-Risk Allele: rs3828309-G; SNPs: rs3828309; Context: intron; Risk Allele Frequency: 0.53; p-Value: 2E-32; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix and Illumina[635,547](imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
NKX2-3		18587394	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 3,230 cases4,829 controls; Replication Sample Size: 1,339 trios, 2,325 cases, 1,809 controls; Strongest SNP-Risk Allele: rs11190140-T; SNPs: rs11190140; Context: nearGene-5; Risk Allele Frequency: 0.48; p-Value: 3E-16; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix and Illumina[635,547](imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
TNFSF15		18587394	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 3,230 cases4,829 controls; Replication Sample Size: 1,339 trios, 2,325 cases, 1,809 controls; Strongest SNP-Risk Allele: rs4263839-G; SNPs: rs4263839; Context: intron; Risk Allele Frequency: 0.68; p-Value: 3E-10; OR or beta:    1.22; Platform [SNPs passing QC]: Affymetrix and Illumina[635,547](imputed)	0.0000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
STAT3		18587394	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 3,230 cases4,829 controls; Replication Sample Size: 1,339 trios, 2,325 cases, 1,809 controls; Strongest SNP-Risk Allele: rs744166-A; SNPs: rs744166; Context: intron; Risk Allele Frequency: 0.57; p-Value: 7E-12; OR or beta:    1.18; Platform [SNPs passing QC]: Affymetrix and Illumina[635,547](imputed)	0.000000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
ITLN1		18587394	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 3,230 cases4,829 controls; Replication Sample Size: 1,339 trios, 2,325 cases, 1,809 controls; Strongest SNP-Risk Allele: rs2274910-C; SNPs: rs2274910; Context: intron; Risk Allele Frequency: 0.68; p-Value: 1E-9; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix and Illumina[635,547](imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
MST1		18587394	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 3,230 cases4,829 controls; Replication Sample Size: 1,339 trios, 2,325 cases, 1,809 controls; Strongest SNP-Risk Allele: rs3197999-A; SNPs: rs3197999; Context: missense; Risk Allele Frequency: 0.27; p-Value: 1E-12; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix and Illumina[635,547](imputed)	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
NOD2		18587394	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 3,230 cases4,829 controls; Replication Sample Size: 1,339 trios, 2,325 cases, 1,809 controls; Strongest SNP-Risk Allele: rs2066847-C; SNPs: rs2066847; Context: frameshift; Risk Allele Frequency: 0.02; p-Value: 3E-24; OR or beta:    3.99; Platform [SNPs passing QC]: Affymetrix and Illumina[635,547](imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
CDKAL1		18587394	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 3,230 cases4,829 controls; Replication Sample Size: 1,339 trios, 2,325 cases, 1,809 controls; Strongest SNP-Risk Allele: rs6908425-C; SNPs: rs6908425; Context: intron; Risk Allele Frequency: 0.78; p-Value: 9E-10; OR or beta:    1.21; Platform [SNPs passing QC]: Affymetrix and Illumina[635,547](imputed)	0.0000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
PTPN22		18587394	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 3,230 cases4,829 controls; Replication Sample Size: 1,339 trios, 2,325 cases, 1,809 controls; Strongest SNP-Risk Allele: rs2476601-G; SNPs: rs2476601; Context: ; Risk Allele Frequency: 0.90; p-Value: 1E-8; OR or beta:    1.31; Platform [SNPs passing QC]: Affymetrix and Illumina[635,547](imputed)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
IL23R		18587394	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 3,230 cases4,829 controls; Replication Sample Size: 1,339 trios, 2,325 cases, 1,809 controls; Strongest SNP-Risk Allele: rs11465804-T; SNPs: rs11465804; Context: intron; Risk Allele Frequency: 0.93; p-Value: 7E-63; OR or beta:    2.50; Platform [SNPs passing QC]: Affymetrix and Illumina[635,547](imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
OCA2		18483556	TAS		Disease/Trait: Black vs. blond hair color; Initial Sample Size: 2,287 women; Replication Sample Size: up to 8,465 individuals; Strongest SNP-Risk Allele: rs11855019-G; SNPs: rs11855019; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-24; OR or beta:     .28; Platform [SNPs passing QC]: Illumina[528,173]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Fair hair
HERC2		18483556	TAS		Disease/Trait: Black vs. blond hair color; Initial Sample Size: 2,287 women; Replication Sample Size: up to 8,465 individuals; Strongest SNP-Risk Allele: rs12913832-A; SNPs: rs12913832; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-103; OR or beta:     .44; Platform [SNPs passing QC]: Illumina[528,173]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Fair hair
EXOC2		18483556	TAS		Disease/Trait: Black vs. blond hair color; Initial Sample Size: 2,287 women; Replication Sample Size: up to 8,465 individuals; Strongest SNP-Risk Allele: rs6918152-A; SNPs: rs6918152; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-8; OR or beta:     .11; Platform [SNPs passing QC]: Illumina[528,173]	0.00000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Fair hair
IRF4		18483556	TAS		Disease/Trait: Black vs. blond hair color; Initial Sample Size: 2,287 women; Replication Sample Size: up to 8,465 individuals; Strongest SNP-Risk Allele: rs12203592-T; SNPs: rs12203592; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-127; OR or beta:     .35; Platform [SNPs passing QC]: Illumina[528,173]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Fair hair
EXOC2		18483556	TAS		Disease/Trait: Black vs. red hair color; Initial Sample Size: 2,287 women; Replication Sample Size: up to 8,465 individuals; Strongest SNP-Risk Allele: rs6918152-A; SNPs: rs6918152; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-7; OR or beta:     .11; Platform [SNPs passing QC]: Illumina[528,173]	0.0000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Red hair
IRF4		18483556	TAS		Disease/Trait: Black vs. red hair color; Initial Sample Size: 2,287 women; Replication Sample Size: up to 8,465 individuals; Strongest SNP-Risk Allele: rs12203592-T; SNPs: rs12203592; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-28; OR or beta:     .31; Platform [SNPs passing QC]: Illumina[528,173]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Red hair
OCA2		18483556	TAS		Disease/Trait: Black vs. red hair color; Initial Sample Size: 2,287 women; Replication Sample Size: up to 8,465 individuals; Strongest SNP-Risk Allele: rs11855019-G; SNPs: rs11855019; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-20; OR or beta:     .29; Platform [SNPs passing QC]: Illumina[528,173]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Red hair
HERC2		18483556	TAS		Disease/Trait: Black vs. red hair color; Initial Sample Size: 2,287 women; Replication Sample Size: up to 8,465 individuals; Strongest SNP-Risk Allele: rs12913832-A; SNPs: rs12913832; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-77; OR or beta:     .44; Platform [SNPs passing QC]: Illumina[528,173]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Red hair
PARD3B		18471798	TAS		Disease/Trait: Knee osteoarthritis; Initial Sample Size: 357 cases,285 controls; Replication Sample Size: 1,177 cases,2,372 controls; Strongest SNP-Risk Allele: rs1207421-?; SNPs: rs1207421; Context: intron; Risk Allele Frequency: 0.09; p-Value: 6E-6; OR or beta:    1.46; Platform [SNPs passing QC]: Illumina[413,461]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	osteoarthritis
COG6		18369459	TAS		Disease/Trait: Psoriasis; Initial Sample Size: 218 cases,519 controls; Replication Sample Size: 1,153 cases,1,217 controls; Strongest SNP-Risk Allele: rs7993214-?; SNPs: rs7993214; Context: intron; Risk Allele Frequency: 0.65; p-Value: 2E-6; OR or beta:    1.41; Platform [SNPs passing QC]: Illumina[305,983]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriasis
IL1RAP		18385676	TAS		Disease/Trait: Lung cancer; Initial Sample Size: 1,154 cases,1,137 controls; Replication Sample Size: 2,724 cases,3,694 controls; Strongest SNP-Risk Allele: rs7626795-G; SNPs: rs7626795; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina[317,498]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	lung cancer
SMAD7		18372901	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 981 cases,1,002 controls; Replication Sample Size: 16,476 cases,15,351 controls; Strongest SNP-Risk Allele: rs4939827-T; SNPs: rs4939827; Context: intron; Risk Allele Frequency: 0.52; p-Value: 8E-28; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina[541,628]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
SMAD7		18372905	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 922 cases, 927 controls; Replication Sample Size: 17,872 cases,17,526 controls; Strongest SNP-Risk Allele: rs4939827-?; SNPs: rs4939827; Context: intron; Risk Allele Frequency: 0.53; p-Value: 2E-6; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina[547,647]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
JAZF1		18372903	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 4,549 cases,5,579 controls; Replication Sample Size: 24,194 cases,55,598 controls; Strongest SNP-Risk Allele: rs864745-T; SNPs: rs864745; Context: intron; Risk Allele Frequency: 0.50; p-Value: 5E-14; OR or beta:    1.10; Platform [SNPs passing QC]: Affymetrix and Illumina[2,202,892](imputed)	0.00000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		18372903	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 4,549 cases,5,579 controls; Replication Sample Size: 24,194 cases,55,598 controls; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-23; OR or beta:    1.37; Platform [SNPs passing QC]: Affymetrix and Illumina[2,202,892](imputed)	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
KCNJ11		18372903	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 4,549 cases,5,579 controls; Replication Sample Size: 24,194 cases,55,598 controls; Strongest SNP-Risk Allele: rs5215-C; SNPs: rs5215; Context: missense; Risk Allele Frequency: NR; p-Value: 4E-7; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix and Illumina[2,202,892](imputed)	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
THADA		18372903	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 4,549 cases,5,579 controls; Replication Sample Size: 24,194 cases,55,598 controls; Strongest SNP-Risk Allele: rs7578597-T; SNPs: rs7578597; Context: missense; Risk Allele Frequency: 0.90; p-Value: 1E-9; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix and Illumina[2,202,892](imputed)	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
IGF2BP2		18372903	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 4,549 cases,5,579 controls; Replication Sample Size: 24,194 cases,55,598 controls; Strongest SNP-Risk Allele: rs4402960-T; SNPs: rs4402960; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-8; OR or beta:    1.17; Platform [SNPs passing QC]: Affymetrix and Illumina[2,202,892](imputed)	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CDKAL1		18372903	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 4,549 cases,5,579 controls; Replication Sample Size: 24,194 cases,55,598 controls; Strongest SNP-Risk Allele: rs6931514-G; SNPs: rs6931514; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-11; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix and Illumina[2,202,892](imputed)	0.00000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
FTO		18372903	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 4,549 cases,5,579 controls; Replication Sample Size: 24,194 cases,55,598 controls; Strongest SNP-Risk Allele: rs8050136-A; SNPs: rs8050136; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix and Illumina[2,202,892](imputed)	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
SPATA2		18364390	TAS		Disease/Trait: Psoriasis; Initial Sample Size: 318 cases,288 controls; Replication Sample Size: 2,361 cases,1,927 controls; Strongest SNP-Risk Allele: rs495337-?; SNPs: rs495337; Context: cds-synon; Risk Allele Frequency: NR; p-Value: 1E-8; OR or beta:    1.25; Platform [SNPs passing QC]: Illumina[~408,000] (pooled)	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	psoriasis
AGBL1		18347602	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 738 cases,733 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs16977195-?; SNPs: rs16977195; Context: intron; Risk Allele Frequency: 0.03; p-Value: 2E-6; OR or beta:    6.01; Platform [SNPs passing QC]: Affymetrix[492,900]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
CCDC60		18332876	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 574 cases, 605 controls,1,148 parents of cases; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11064768-A; SNPs: rs11064768; Context: intron; Risk Allele Frequency: 0.91; p-Value: 1E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina[~550,000](pooled)	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
LPP		18311140	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 767 cases,1,422 controls; Replication Sample Size: 1,643 cases,3,406 controls; Strongest SNP-Risk Allele: rs1464510-A; SNPs: rs1464510; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-9; OR or beta:    1.23; Platform [SNPs passing QC]: Illumina[310,605]	0.000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
TAGAP		18311140	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 767 cases,1,422 controls; Replication Sample Size: 1,643 cases,3,406 controls; Strongest SNP-Risk Allele: rs1738074-A; SNPs: rs1738074; Context: UTR-5; Risk Allele Frequency: NR; p-Value: 7E-8; OR or beta:    1.21; Platform [SNPs passing QC]: Illumina[310,605]	0.00000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
RELN		18282107	TAS		Disease/Trait: Schizophrenia; Initial Sample Size: 660 cases,2,271 controls; Replication Sample Size: 2,274 cases,4,401 controls; Strongest SNP-Risk Allele: rs7341475-G; SNPs: rs7341475; Context: intron; Risk Allele Frequency: 0.62; p-Value: 9E-7; OR or beta:    1.58; Platform [SNPs passing QC]: Affymetrix [510,552]	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	schizophrenia
LMTK2		18264097	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,854 cases, 1,894 controls; Replication Sample Size: 3,268 cases, 3,366 controls; Strongest SNP-Risk Allele: rs6465657-C; SNPs: rs6465657; Context: intron; Risk Allele Frequency: 0.46; p-Value: 1E-9; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina [541,129]	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
SLC22A3		18264097	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,854 cases, 1,894 controls; Replication Sample Size: 3,268 cases, 3,366 controls; Strongest SNP-Risk Allele: rs9364554-T; SNPs: rs9364554; Context: intron; Risk Allele Frequency: 0.29; p-Value: 6E-10; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina [541,129]	0.0000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
MSMB		18264097	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,854 cases, 1,894 controls; Replication Sample Size: 3,268 cases, 3,366 controls; Strongest SNP-Risk Allele: rs10993994-T; SNPs: rs10993994; Context: nearGene-5; Risk Allele Frequency: 0.40; p-Value: 9E-29; OR or beta:    1.25; Platform [SNPs passing QC]: Illumina [541,129]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
HNF1B		18264097	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,854 cases, 1,894 controls; Replication Sample Size: 3,268 cases, 3,366 controls; Strongest SNP-Risk Allele: rs7501939-C; SNPs: rs7501939; Context: intron; Risk Allele Frequency: 0.57; p-Value: 9E-12; OR or beta:    1.41; Platform [SNPs passing QC]: Illumina [541,129]	0.000000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
EHBP1		18264098	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,854 cases,21,372 controls; Replication Sample Size: 8,239 cases,7,590 controls; Strongest SNP-Risk Allele: rs721048-A; SNPs: rs721048; Context: intron; Risk Allele Frequency: 0.19; p-Value: 8E-9; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina[310,520]	0.000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
CTBP2		18264096	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,172 cases,1,157 controls; Replication Sample Size: 3,941 cases,3,964 controls; Strongest SNP-Risk Allele: rs4962416-C; SNPs: rs4962416; Context: intron; Risk Allele Frequency: 0.27; p-Value: 2E-7; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina[527,869]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
JAZF1		18264096	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,172 cases,1,157 controls; Replication Sample Size: 3,941 cases,3,964 controls; Strongest SNP-Risk Allele: rs10486567-G; SNPs: rs10486567; Context: intron; Risk Allele Frequency: 0.77; p-Value: 2E-6; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina[527,869]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
HNF1B		18264096	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,172 cases,1,157 controls; Replication Sample Size: 3,941 cases,3,964 controls; Strongest SNP-Risk Allele: rs4430796-A; SNPs: rs4430796; Context: intron; Risk Allele Frequency: 0.54; p-Value: 1E-9; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina[527,869]	0.000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
MSMB		18264096	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,172 cases,1,157 controls; Replication Sample Size: 3,941 cases,3,964 controls; Strongest SNP-Risk Allele: rs10993994-T; SNPs: rs10993994; Context: nearGene-5; Risk Allele Frequency: 0.40; p-Value: 7E-13; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina[527,869]	0.0000000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
PXK		18204446	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 720 female cases,2,337 female controls; Replication Sample Size: 1,846 female cases,1,825 female controls; Strongest SNP-Risk Allele: rs6445975-C; SNPs: rs6445975; Context: intron; Risk Allele Frequency: 0.28; p-Value: 7E-9; OR or beta:    1.25; Platform [SNPs passing QC]: Illumina [317,501]	0.000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
ITGAM		18204446	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 720 female cases,2,337 female controls; Replication Sample Size: 1,846 female cases,1,825 female controls; Strongest SNP-Risk Allele: rs9888739-T; SNPs: rs9888739; Context: intron; Risk Allele Frequency: 0.13; p-Value: 2E-23; OR or beta:    1.62; Platform [SNPs passing QC]: Illumina [317,501]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
NTNG2		18204098	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,311 cases,3,340 controls; Replication Sample Size: 793 cases,857 controls; Strongest SNP-Risk Allele: rs11243676-A; SNPs: rs11243676; Context: intron; Risk Allele Frequency: 0.07; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Illumina[502,033]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
HLA-DQA1		18204098	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,311 cases,3,340 controls; Replication Sample Size: 793 cases,857 controls; Strongest SNP-Risk Allele: rs2187668-A; SNPs: rs2187668; Context: intron; Risk Allele Frequency: 0.11; p-Value: 3E-21; OR or beta: NR; Platform [SNPs passing QC]: Illumina[502,033]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
STAT4		18204098	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 1,311 cases,3,340 controls; Replication Sample Size: 793 cases,857 controls; Strongest SNP-Risk Allele: rs7574865-T; SNPs: rs7574865; Context: intron; Risk Allele Frequency: 0.23; p-Value: 9E-14; OR or beta: NR; Platform [SNPs passing QC]: Illumina[502,033]	0.00000000000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
BANK1		18204447	TAS		Disease/Trait: Systemic lupus erythematosus; Initial Sample Size: 279 cases,515 controls; Replication Sample Size: 1,757 cases,1,540 controls; Strongest SNP-Risk Allele: rs10516487-G; SNPs: rs10516487; Context: missense; Risk Allele Frequency: 0.77; p-Value: 4E-10; OR or beta:    1.38; Platform [SNPs passing QC]: Affymetrix[85,042]	0.0000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	systemic lupus erythematosus
FTO		18159244	TAS		Disease/Trait: Obesity (early onset extreme); Initial Sample Size: 487 young cases,442 controls; Replication Sample Size: 2,269 individuals in 644 families; Strongest SNP-Risk Allele: rs1121980-T; SNPs: rs1121980; Context: intron; Risk Allele Frequency: 0.41; p-Value: 1E-7; OR or beta:    1.66; Platform [SNPs passing QC]: Affymetrix[440,794]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	morbid obesity
DPP6		18084291	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 737 cases,721 controls; Replication Sample Size: 1,030 cases,1,195 controls; Strongest SNP-Risk Allele: rs10260404-C; SNPs: rs10260404; Context: ; Risk Allele Frequency: 0.35; p-Value: 5E-8; OR or beta:    1.30; Platform [SNPs passing QC]: Illumina[311,946]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
LIPC		18084291	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 737 cases,721 controls; Replication Sample Size: 1,030 cases,1,195 controls; Strongest SNP-Risk Allele: rs3825776-?; SNPs: rs3825776; Context: intron; Risk Allele Frequency: 0.29; p-Value: 9E-6; OR or beta:    1.34; Platform [SNPs passing QC]: Illumina[311,946]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
DPP6		18057069	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 221 cases,211 controls; Replication Sample Size: 737 cases,721 controls; Strongest SNP-Risk Allele: rs10260404-?; SNPs: rs10260404; Context: ; Risk Allele Frequency: 0.37; p-Value: 3E-6; OR or beta:    1.37; Platform [SNPs passing QC]: Illumina[497,917]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
TYR		17999355	TAS		Disease/Trait: Skin pigmentation; Initial Sample Size: 363 with maxL* < 56 and 374 with maxL* > 63; 20% tails of distribution; Replication Sample Size: 116 low maxL*, 115 high maxL* individuals; Strongest SNP-Risk Allele: rs1042602-C; SNPs: rs1042602; Context: missense; Risk Allele Frequency: 0.84; p-Value: 4E-10; OR or beta:    4.36; Platform [SNPs passing QC]: Perlegen [1,502,205] (pooled)	0.0000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Abnormality of skin pigmentation
SLC45A2		17999355	TAS		Disease/Trait: Skin pigmentation; Initial Sample Size: 363 with maxL* < 56 and 374 with maxL* > 63; 20% tails of distribution; Replication Sample Size: 116 low maxL*, 115 high maxL* individuals; Strongest SNP-Risk Allele: rs16891982-C; SNPs: rs16891982; Context: ; Risk Allele Frequency: 0.83; p-Value: 3E-11; OR or beta:    4.86; Platform [SNPs passing QC]: Perlegen [1,502,205] (pooled)	0.00000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Abnormality of skin pigmentation
SMAD7		17934461	TAS		Disease/Trait: Colorectal cancer; Initial Sample Size: 940 cases,965 controls; Replication Sample Size: 7,473 cases,5,984 controls; Strongest SNP-Risk Allele: rs4939827-T; SNPs: rs4939827; Context: intron; Risk Allele Frequency: 0.52; p-Value: 1E-12; OR or beta:    1.16; Platform [SNPs passing QC]: Illumina[547,647]	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	colorectal cancer
CNTN5		17903304	TAS		Disease/Trait: Atrial fibrillation; Initial Sample Size: 1,341-1,345  individuals, depending on measure(Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10501920-?; SNPs: rs10501920; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	familial atrial fibrillation
TMEFF2		17903298	TAS		Disease/Trait: Diabetes (incident); Initial Sample Size: 1,087 individuals(Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10497721-?; SNPs: rs10497721; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	diabetes mellitus
CPVL		17903298	TAS		Disease/Trait: Diabetes related insulin traits; Initial Sample Size: 1,087 individuals(Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10486607-?; SNPs: rs10486607; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	diabetes mellitus
GRIK1		17903305	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 1,345 individuals(Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs458685-?; SNPs: rs458685; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
COL1A1		17903305	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 1,345 individuals(Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2075555-?; SNPs: rs2075555; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-8; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.00000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
ABCC4		17903305	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 1,345 individuals(Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1926657-?; SNPs: rs1926657; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
FBN1		17903305	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 1,345 individuals(Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1876206-?; SNPs: rs1876206; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
CTDSPL		17903305	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,345 individuals(Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs9311171-?; SNPs: rs9311171; Context: intron; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
HAPLN1		17903305	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,345 individuals(Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4466137-?; SNPs: rs4466137; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
PKHD1		17903305	TAS		Disease/Trait: Prostate cancer; Initial Sample Size: 1,345 individuals(Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10498792-?; SNPs: rs10498792; Context: intron; Risk Allele Frequency: NR; p-Value: 3E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	prostate cancer
NUMB		17903303	TAS		Disease/Trait: Coronary artery calcification; Initial Sample Size: 673-984 individuals, depending on measure(Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10483853-?; SNPs: rs10483853; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary arteriosclerosis
DNAH5		17903303	TAS		Disease/Trait: Subclinical atherosclerosis traits (other); Initial Sample Size: 673-984 individuals, depending on measure (Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7715811-?; SNPs: rs7715811; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atherosclerosis
DNAH5		17903303	TAS		Disease/Trait: Subclinical atherosclerosis traits (other); Initial Sample Size: 673-984 individuals, depending on measure (Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2896103-?; SNPs: rs2896103; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atherosclerosis
ABI2		17903303	TAS		Disease/Trait: Subclinical atherosclerosis traits (other); Initial Sample Size: 673-984 individuals, depending on measure (Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1376877-?; SNPs: rs1376877; Context: intron; Risk Allele Frequency: NR; p-Value: 4E-7; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.0000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atherosclerosis
DNAH5		17903303	TAS		Disease/Trait: Subclinical atherosclerosis traits (other); Initial Sample Size: 673-984 individuals, depending on measure (Framingham); Replication Sample Size: NR; Strongest SNP-Risk Allele: rs1502050-?; SNPs: rs1502050; Context: intron; Risk Allele Frequency: NR; p-Value: 9E-6; OR or beta: NR; Platform [SNPs passing QC]: Affymetrix[70,897]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	atherosclerosis
ITPR2		17827064	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 737 cases,721 controls; Replication Sample Size: 1,030 cases,1,195 controls; Strongest SNP-Risk Allele: rs2306677-?; SNPs: rs2306677; Context: intron; Risk Allele Frequency: 0.07; p-Value: 3E-6; OR or beta:    1.58; Platform [SNPs passing QC]: Illumina[311,946]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
PTPN22		17804836	TAS		Disease/Trait: Rheumatoid arthritis; Initial Sample Size: 1,493 cases,1,831 controls; Replication Sample Size: 1,053 cases,1,858 controls; Strongest SNP-Risk Allele: rs2476601-?; SNPs: rs2476601; Context: ; Risk Allele Frequency: 0.10; p-Value: 2E-11; OR or beta:    1.72; Platform [SNPs passing QC]: Illumina [297,086]	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	rheumatoid arthritis
NOD2		17804789	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 382 trios; Replication Sample Size: 750 cases,828 controls,521 trios; Strongest SNP-Risk Allele: rs5743289-?; SNPs: rs5743289; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-17; OR or beta: NR; Platform [SNPs passing QC]: Perlegen [164,279]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
NELL1		17684544	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 393 cases,399 controls; Replication Sample Size: 1,248 trios, 2,920 cases, 1,961 controls; Strongest SNP-Risk Allele: rs1793004-?; SNPs: rs1793004; Context: intron; Risk Allele Frequency: 0.27; p-Value: 3E-6; OR or beta:    1.30; Platform [SNPs passing QC]: Affymetrix[92,387]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
ELMO1		17653210	TAS		Disease/Trait: Type 2 diabetes nephropathy; Initial Sample Size: 94 cases,94 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs741301-?; SNPs: rs741301; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    2.67; Platform [SNPs passing QC]: NR[~80,000]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus;Nephropathy
DBC1		17660530	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 931 trios, 2,431 controls; Replication Sample Size: 609 trios, 2,322 cases, 2,987 controls; Strongest SNP-Risk Allele: rs10984447-A; SNPs: rs10984447; Context: intron; Risk Allele Frequency: 0.77; p-Value: 8E-6; OR or beta:    1.17; Platform [SNPs passing QC]: Affymetrix[334,923]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
IL2RA		17660530	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 931 trios, 2,431 controls; Replication Sample Size: 609 trios, 2,322 cases, 2,987 controls; Strongest SNP-Risk Allele: rs12722489-C; SNPs: rs12722489; Context: intron; Risk Allele Frequency: 0.85; p-Value: 3E-8; OR or beta:    1.25; Platform [SNPs passing QC]: Affymetrix[334,923]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
HLA-DRA		17660530	TAS		Disease/Trait: Multiple sclerosis; Initial Sample Size: 931 trios, 2,431 controls; Replication Sample Size: 609 trios, 2,322 cases, 2,987 controls; Strongest SNP-Risk Allele: rs3135388-A; SNPs: rs3135388; Context: nearGene-3; Risk Allele Frequency: 0.23; p-Value: 9E-81; OR or beta:    1.99; Platform [SNPs passing QC]: Affymetrix[334,923]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	multiple sclerosis
FTO		17658951	TAS		Disease/Trait: Obesity-related traits; Initial Sample Size: 4,741 individuals; Replication Sample Size: 3,205 individuals; Strongest SNP-Risk Allele: rs9930506-A; SNPs: rs9930506; Context: intron; Risk Allele Frequency: 0.54; p-Value: 9E-7; OR or beta:     .13; Platform [SNPs passing QC]: Affymetrix[362,129]	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity
FTO		17658951	TAS		Disease/Trait: Obesity-related traits; Initial Sample Size: 4,741 individuals; Replication Sample Size: 3,205 individuals; Strongest SNP-Risk Allele: rs9930506-A; SNPs: rs9930506; Context: intron; Risk Allele Frequency: 0.54; p-Value: 3E-8; OR or beta:     .16; Platform [SNPs passing QC]: Affymetrix[362,129]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity
FTO		17658951	TAS		Disease/Trait: Obesity-related traits; Initial Sample Size: 4,741 individuals; Replication Sample Size: 3,205 individuals; Strongest SNP-Risk Allele: rs9930506-A; SNPs: rs9930506; Context: intron; Risk Allele Frequency: 0.54; p-Value: 9E-7; OR or beta:     .12; Platform [SNPs passing QC]: Affymetrix[362,129]	0.0000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	obesity
BTBD9		17634447	TAS		Disease/Trait: Restless legs syndrome; Initial Sample Size: 306 cases,15,664 controls; Replication Sample Size: 311 cases,1,895 controls; Strongest SNP-Risk Allele: rs3923809-A; SNPs: rs3923809; Context: intron; Risk Allele Frequency: 0.66; p-Value: 1E-17; OR or beta:    1.90; Platform [SNPs passing QC]: Illumina[306,937]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	restless legs syndrome
SMAD3		17634449	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 1,926 cases,2,938 controls; Replication Sample Size: 875 cases,1,644 controls; Strongest SNP-Risk Allele: rs17228212-C; SNPs: rs17228212; Context: intron; Risk Allele Frequency: 0.30; p-Value: 2E-7; OR or beta:    1.21; Platform [SNPs passing QC]: Affymetrix [377,857]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
PSRC1		17634449	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 1,926 cases,2,938 controls; Replication Sample Size: 875 cases,1,644 controls; Strongest SNP-Risk Allele: rs599839-A; SNPs: rs599839; Context: nearGene-3; Risk Allele Frequency: 0.77; p-Value: 4E-9; OR or beta:    1.29; Platform [SNPs passing QC]: Affymetrix [377,857]	0.000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
MTHFD1L		17634449	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 1,926 cases,2,938 controls; Replication Sample Size: 875 cases,1,644 controls; Strongest SNP-Risk Allele: rs6922269-A; SNPs: rs6922269; Context: intron; Risk Allele Frequency: 0.25; p-Value: 3E-8; OR or beta:    1.23; Platform [SNPs passing QC]: Affymetrix [377,857]	0.00000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
MIA3		17634449	TAS		Disease/Trait: Coronary heart disease; Initial Sample Size: 1,926 cases,2,938 controls; Replication Sample Size: 875 cases,1,644 controls; Strongest SNP-Risk Allele: rs17465637-C; SNPs: rs17465637; Context: intron; Risk Allele Frequency: 0.71; p-Value: 1E-6; OR or beta:    1.20; Platform [SNPs passing QC]: Affymetrix [377,857]	0.000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	coronary heart disease
MEIS1		17637780	TAS		Disease/Trait: Restless legs syndrome; Initial Sample Size: 401 cases,1,644 controls; Replication Sample Size: 1,158 cases,1,178 controls; Strongest SNP-Risk Allele: rs2300478-G; SNPs: rs2300478; Context: intron; Risk Allele Frequency: 0.24; p-Value: 3E-28; OR or beta:    1.74; Platform [SNPs passing QC]: Affymetrix[236,758]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	restless legs syndrome
BTBD9		17637780	TAS		Disease/Trait: Restless legs syndrome; Initial Sample Size: 401 cases,1,644 controls; Replication Sample Size: 1,158 cases,1,178 controls; Strongest SNP-Risk Allele: rs9296249-T; SNPs: rs9296249; Context: intron; Risk Allele Frequency: 0.76; p-Value: 4E-18; OR or beta:    1.67; Platform [SNPs passing QC]: Affymetrix[236,758]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	restless legs syndrome
PTPN22		17632545	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 467 trios, 561 cases,1,143 controls; Replication Sample Size: 2,350 individuals in 549 families; 390 trios; Strongest SNP-Risk Allele: rs2476601-A; SNPs: rs2476601; Context: ; Risk Allele Frequency: 0.09; p-Value: 1E-7; OR or beta:    1.80; Platform [SNPs passing QC]: Illumina[543,071]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
TCF7L2		17668382	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 500 cases,497 controls; Replication Sample Size: 2,573 cases,2,776 controls; Strongest SNP-Risk Allele: rs7903146-A; SNPs: rs7903146; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-8; OR or beta:    1.71; Platform [SNPs passing QC]: Illumina  [315,917]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
HLA-DQA1		17558408	TAS		Disease/Trait: Celiac disease; Initial Sample Size: 778 cases,1,422 controls; Replication Sample Size: 991 cases,1,489 controls; Strongest SNP-Risk Allele: rs2187668-A; SNPs: rs2187668; Context: intron; Risk Allele Frequency: 0.14; p-Value: 1E-19; OR or beta:    7.04; Platform [SNPs passing QC]: Illumina[310,605]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	celiac disease
GAB2		17553421	TAS		Disease/Trait: Alzheimer's disease (late onset); Initial Sample Size: 446 cases,290 controls; Replication Sample Size: 415 cases,260 controls; Strongest SNP-Risk Allele: rs2373115-G; SNPs: rs2373115; Context: intron; Risk Allele Frequency: 0.70; p-Value: 1E-10; OR or beta:    4.06; Platform [SNPs passing QC]: Affymetrix[312,316]	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Alzheimer's disease
NOD2		17554300	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 1,748 cases,2,938 controls; Replication Sample Size: (see Parkes 2007); Strongest SNP-Risk Allele: rs17221417-G; SNPs: rs17221417; Context: intron; Risk Allele Frequency: 0.29; p-Value: 4E-11; OR or beta:    1.29; Platform [SNPs passing QC]: Affymetrix[469,557]	0.00000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
ATG16L1		17554300	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 1,748 cases,2,938 controls; Replication Sample Size: (see Parkes 2007); Strongest SNP-Risk Allele: rs10210302-T; SNPs: rs10210302; Context: nearGene-5; Risk Allele Frequency: 0.48; p-Value: 5E-14; OR or beta:    1.19; Platform [SNPs passing QC]: Affymetrix[469,557]	0.00000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
IL23R		17554300	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 1,748 cases,2,938 controls; Replication Sample Size: (see Parkes 2007); Strongest SNP-Risk Allele: rs11805303-T; SNPs: rs11805303; Context: intron; Risk Allele Frequency: 0.32; p-Value: 6E-12; OR or beta:    1.39; Platform [SNPs passing QC]: Affymetrix[469,557]	0.000000000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
FTO		17554300	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases,2,938 controls; Replication Sample Size: (see Zeggini 2007); Strongest SNP-Risk Allele: rs9939609-A; SNPs: rs9939609; Context: intron; Risk Allele Frequency: 0.40; p-Value: 2E-7; OR or beta:    1.34; Platform [SNPs passing QC]: Affymetrix[469,557]	0.0000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		17554300	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases,2,938 controls; Replication Sample Size: (see Zeggini 2007); Strongest SNP-Risk Allele: rs4506565-T; SNPs: rs4506565; Context: intron; Risk Allele Frequency: 0.32; p-Value: 5E-12; OR or beta:    1.36; Platform [SNPs passing QC]: Affymetrix[469,557]	0.000000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CDKAL1		17554300	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases,2,938 controls; Replication Sample Size: (see Zeggini 2007); Strongest SNP-Risk Allele: rs9465871-C; SNPs: rs9465871; Context: intron; Risk Allele Frequency: 0.18; p-Value: 3E-7; OR or beta:    1.18; Platform [SNPs passing QC]: Affymetrix[469,557]	0.0000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
ERBB3		17554260	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 1,963 cases,2,938 controls; Replication Sample Size: 2997 trios, 4,000 cases, 5,000 controls; Strongest SNP-Risk Allele: rs2292239-A; SNPs: rs2292239; Context: intron; Risk Allele Frequency: 0.34; p-Value: 2E-20; OR or beta:    1.28; Platform [SNPs passing QC]: see WTCCC	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
CD226		17554260	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 1,963 cases,2,938 controls; Replication Sample Size: 2997 trios, 4,000 cases, 5,000 controls; Strongest SNP-Risk Allele: rs763361-A; SNPs: rs763361; Context: missense; Risk Allele Frequency: 0.47; p-Value: 1E-8; OR or beta:    1.16; Platform [SNPs passing QC]: see WTCCC	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
IL7R		17554260	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 1,963 cases,2,938 controls; Replication Sample Size: 2997 trios, 4,000 cases, 5,000 controls; Strongest SNP-Risk Allele: rs6897932-G; SNPs: rs6897932; Context: missense; Risk Allele Frequency: 0.71; p-Value: 8E-6; OR or beta:    1.12; Platform [SNPs passing QC]: see WTCCC	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
IFIH1		17554260	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 1,963 cases,2,938 controls; Replication Sample Size: 2997 trios, 4,000 cases, 5,000 controls; Strongest SNP-Risk Allele: rs1990760-A; SNPs: rs1990760; Context: missense; Risk Allele Frequency: 0.60; p-Value: 2E-11; OR or beta:    1.18; Platform [SNPs passing QC]: see WTCCC	0.00000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
CAPSL		17554260	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 1,963 cases,2,938 controls; Replication Sample Size: 2997 trios, 4,000 cases, 5,000 controls; Strongest SNP-Risk Allele: rs1445898-G; SNPs: rs1445898; Context: missense; Risk Allele Frequency: 0.55; p-Value: 8E-6; OR or beta:    1.12; Platform [SNPs passing QC]: see WTCCC	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
PTPN22		17554260	TAS		Disease/Trait: Type 1 diabetes; Initial Sample Size: 1,963 cases,2,938 controls; Replication Sample Size: 2997 trios, 4,000 cases, 5,000 controls; Strongest SNP-Risk Allele: rs2476601-T; SNPs: rs2476601; Context: ; Risk Allele Frequency: 0.09; p-Value: 2E-80; OR or beta:    1.98; Platform [SNPs passing QC]: see WTCCC	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 1 diabetes mellitus
FGFR2		17529967	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 390 cases,364 controls; Replication Sample Size: 26,646 cases,24,889 controls; Strongest SNP-Risk Allele: rs2981582-A; SNPs: rs2981582; Context: intron; Risk Allele Frequency: 0.38; p-Value: 2E-76; OR or beta:    1.26; Platform [SNPs passing QC]: Perlegen[205,586]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
LSP1		17529967	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 390 cases,364 controls; Replication Sample Size: 26,646 cases,24,889 controls; Strongest SNP-Risk Allele: rs3817198-C; SNPs: rs3817198; Context: intron; Risk Allele Frequency: 0.30; p-Value: 3E-9; OR or beta:    1.07; Platform [SNPs passing QC]: Perlegen[205,586]	0.000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
FGFR2		17529973	TAS		Disease/Trait: Breast cancer; Initial Sample Size: 1,145 cases,1,142 controls; Replication Sample Size: 1,176 cases,2,072 controls; Strongest SNP-Risk Allele: rs1219648-G; SNPs: rs1219648; Context: intron; Risk Allele Frequency: 0.40; p-Value: 1E-10; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina[528,173]	0.0000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	breast cancer
DGKH		17486107	TAS		Disease/Trait: Bipolar disorder; Initial Sample Size: 461 cases,563 controls; Replication Sample Size: 772 cases,876 controls; Strongest SNP-Risk Allele: rs1012053-A; SNPs: rs1012053; Context: intron; Risk Allele Frequency: 0.84; p-Value: 2E-8; OR or beta:    1.59; Platform [SNPs passing QC]: Illumina [555,235](pooled)	0.00000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	bipolar disorder
IMPA2		17434096	TAS		Disease/Trait: Stroke; Initial Sample Size: 259 cases,269 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs7506045-?; SNPs: rs7506045; Context: intron; Risk Allele Frequency: 0.10; p-Value: 7E-7; OR or beta:    5.39; Platform [SNPs passing QC]: Illumina[408,803]	0.0000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cerebrovascular accident
AIM1		17434096	TAS		Disease/Trait: Stroke; Initial Sample Size: 259 cases,269 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs783396-?; SNPs: rs783396; Context: ; Risk Allele Frequency: 0.90; p-Value: 9E-6; OR or beta:    2.17; Platform [SNPs passing QC]: Illumina[408,803]	0.000009	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	cerebrovascular accident
SLC30A8		17463246	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,464 cases,1,467 controls; Replication Sample Size: 5,065 cases,5,785 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs13266634-C; SNPs: rs13266634; Context: missense; Risk Allele Frequency: 0.65; p-Value: 5E-8; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix[386,731]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		17463246	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,464 cases,1,467 controls; Replication Sample Size: 5,065 cases,5,785 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.26; p-Value: 2E-31; OR or beta:    1.38; Platform [SNPs passing QC]: Affymetrix[386,731]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
IGF2BP2		17463246	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,464 cases,1,467 controls; Replication Sample Size: 5,065 cases,5,785 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs4402960-T; SNPs: rs4402960; Context: intron; Risk Allele Frequency: 0.29; p-Value: 2E-9; OR or beta:    1.17; Platform [SNPs passing QC]: Affymetrix[386,731]	0.000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CDKAL1		17463246	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,464 cases,1,467 controls; Replication Sample Size: 5,065 cases,5,785 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs7754840-C; SNPs: rs7754840; Context: intron; Risk Allele Frequency: 0.31; p-Value: 4E-11; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix[386,731]	0.00000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
KCNJ11		17463246	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,464 cases,1,467 controls; Replication Sample Size: 5,065 cases,5,785 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs5219-T; SNPs: rs5219; Context: STOP-GAIN; Risk Allele Frequency: 0.47; p-Value: 1E-7; OR or beta:    1.15; Platform [SNPs passing QC]: Affymetrix[386,731]	0.0000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
PPARG		17463246	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,464 cases,1,467 controls; Replication Sample Size: 5,065 cases,5,785 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs1801282-C; SNPs: rs1801282; Context: missense; Risk Allele Frequency: 0.86; p-Value: 2E-6; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix[386,731]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
KCNJ11		17463248	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,161 cases,1,174 controls; Replication Sample Size: 1,215 cases,1,258 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs5219-T; SNPs: rs5219; Context: STOP-GAIN; Risk Allele Frequency: 0.46; p-Value: 7E-11; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina[315,635]	0.00000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
SLC30A8		17463248	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,161 cases,1,174 controls; Replication Sample Size: 1,215 cases,1,258 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs13266634-C; SNPs: rs13266634; Context: missense; Risk Allele Frequency: 0.61; p-Value: 5E-8; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina[315,635]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
FTO		17463248	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,161 cases,1,174 controls; Replication Sample Size: 1,215 cases,1,258 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs8050136-A; SNPs: rs8050136; Context: intron; Risk Allele Frequency: 0.38; p-Value: 1E-12; OR or beta:    1.17; Platform [SNPs passing QC]: Illumina[315,635]	0.000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		17463248	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,161 cases,1,174 controls; Replication Sample Size: 1,215 cases,1,258 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.18; p-Value: 1E-8; OR or beta:    1.34; Platform [SNPs passing QC]: Illumina[315,635]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CDKAL1		17463248	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,161 cases,1,174 controls; Replication Sample Size: 1,215 cases,1,258 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs7754840-C; SNPs: rs7754840; Context: intron; Risk Allele Frequency: 0.36; p-Value: 4E-11; OR or beta:    1.12; Platform [SNPs passing QC]: Illumina[315,635]	0.00000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
IGF2BP2		17463248	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,161 cases,1,174 controls; Replication Sample Size: 1,215 cases,1,258 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs4402960-T; SNPs: rs4402960; Context: intron; Risk Allele Frequency: 0.30; p-Value: 9E-16; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina[315,635]	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
PPARG		17463248	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,161 cases,1,174 controls; Replication Sample Size: 1,215 cases,1,258 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs1801282-C; SNPs: rs1801282; Context: missense; Risk Allele Frequency: 0.82; p-Value: 2E-6; OR or beta:    1.14; Platform [SNPs passing QC]: Illumina[315,635]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CDKAL1		17460697	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,399 EA cases,5,275 EA controls; Replication Sample Size: 2,437 EA cases,7,287 EA controls; Strongest SNP-Risk Allele: rs7756992-G; SNPs: rs7756992; Context: intron; Risk Allele Frequency: 0.26; p-Value: 8E-9; OR or beta:    1.20; Platform [SNPs passing QC]: Illumina[313,179 SNPs; 339,846 2-SNP haplotypes]	0.000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		17460697	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,399 EA cases,5,275 EA controls; Replication Sample Size: 2,437 EA cases,7,287 EA controls; Strongest SNP-Risk Allele: rs7903146-?; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.30; p-Value: 2E-10; OR or beta:    1.38; Platform [SNPs passing QC]: Illumina[313,179 SNPs; 339,846 2-SNP haplotypes]	0.0000000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
SLC30A8		17460697	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,399 EA cases,5,275 EA controls; Replication Sample Size: 2,437 EA cases,7,287 EA controls; Strongest SNP-Risk Allele: rs13266634-C; SNPs: rs13266634; Context: missense; Risk Allele Frequency: 0.67; p-Value: 3E-6; OR or beta:    1.15; Platform [SNPs passing QC]: Illumina[313,179 SNPs; 339,846 2-SNP haplotypes]	0.000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
TCF7L2		17463249	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases,2,938 controls; Replication Sample Size: 3,757 cases,5,346 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs7901695-C; SNPs: rs7901695; Context: intron; Risk Allele Frequency: NR; p-Value: 1E-48; OR or beta:    1.37; Platform [SNPs passing QC]: Affymetrix[393,453]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
FTO		17463249	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases,2,938 controls; Replication Sample Size: 3,757 cases,5,346 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs8050136-A; SNPs: rs8050136; Context: intron; Risk Allele Frequency: 0.40; p-Value: 7E-14; OR or beta:    1.23; Platform [SNPs passing QC]: Affymetrix[393,453]	0.00000000000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CDKAL1		17463249	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases,2,938 controls; Replication Sample Size: 3,757 cases,5,346 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs10946398-C; SNPs: rs10946398; Context: intron; Risk Allele Frequency: 0.32; p-Value: 1E-8; OR or beta:    1.16; Platform [SNPs passing QC]: Affymetrix[393,453]	0.00000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
PPARG		17463249	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases,2,938 controls; Replication Sample Size: 3,757 cases,5,346 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs1801282-C; SNPs: rs1801282; Context: missense; Risk Allele Frequency: NR; p-Value: 2E-6; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix[393,453]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
KCNJ11		17463249	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases,2,938 controls; Replication Sample Size: 3,757 cases,5,346 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs5215-C; SNPs: rs5215; Context: missense; Risk Allele Frequency: NR; p-Value: 5E-11; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix[393,453]	0.00000000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
SLC30A8		17463249	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases,2,938 controls; Replication Sample Size: 3,757 cases,5,346 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs13266634-C; SNPs: rs13266634; Context: missense; Risk Allele Frequency: 0.69; p-Value: 5E-8; OR or beta:    1.12; Platform [SNPs passing QC]: Affymetrix[393,453]	0.00000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
IGF2BP2		17463249	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 1,924 cases,2,938 controls; Replication Sample Size: 3,757 cases,5,346 controls (also includes meta-analysis from DGI+FUSION+WTCCC); Strongest SNP-Risk Allele: rs4402960-T; SNPs: rs4402960; Context: intron; Risk Allele Frequency: 0.32; p-Value: 9E-16; OR or beta:    1.14; Platform [SNPs passing QC]: Affymetrix[393,453]	0.000000000000001	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
IL23R		17435756	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 946 cases,977 controls; Replication Sample Size: 530 trios,353 cases,207 controls; Strongest SNP-Risk Allele: rs7517847-?; SNPs: rs7517847; Context: intron; Risk Allele Frequency: 0.40; p-Value: 3E-12; OR or beta: NR; Platform [SNPs passing QC]: Illumina[304,413]	0.000000000003	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
PVT1		17395743	TAS		Disease/Trait: End-stage renal disease; Initial Sample Size: 105 cases,102 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2648875-A; SNPs: rs2648875; Context: intron; Risk Allele Frequency: 0.53; p-Value: 2E-6; OR or beta:    2.97; Platform [SNPs passing QC]: Affymetrix[115,352]	0.000002	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	kidney disease
IL23R		17447842	TAS		Disease/Trait: Crohn's disease; Initial Sample Size: 547 cases,928 controls; Replication Sample Size: 1,266 cases,559 controls,428 trios; Strongest SNP-Risk Allele: rs11209026-?; SNPs: rs11209026; Context: missense; Risk Allele Frequency: 0.92; p-Value: 2E-18; OR or beta:    2.92; Platform [SNPs passing QC]: Illumina[302,451]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Crohn's disease
ZFP64		17362836	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 276 cases,276 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs6013382-?; SNPs: rs6013382; Context: intron; Risk Allele Frequency: NR; p-Value: 5E-6; OR or beta:    1.43; Platform [SNPs passing QC]: Illumina[549,062]	0.000005	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
SUSD1		17362836	TAS		Disease/Trait: Amyotrophic lateral sclerosis; Initial Sample Size: 276 cases,276 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs2782931-?; SNPs: rs2782931; Context: intron; Risk Allele Frequency: NR; p-Value: 6E-6; OR or beta:    1.11; Platform [SNPs passing QC]: Illumina[549,062]	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	amyotrophic lateral sclerosis
TCF7L2		17293876	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 661 cases,614 controls; Replication Sample Size: 2,617 cases,2,894 controls; Strongest SNP-Risk Allele: rs7903146-T; SNPs: rs7903146; Context: intron; Risk Allele Frequency: 0.30; p-Value: 2E-34; OR or beta:    1.65; Platform [SNPs passing QC]: Illumina [392,935]	0	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
SLC30A8		17293876	TAS		Disease/Trait: Type 2 diabetes; Initial Sample Size: 661 cases,614 controls; Replication Sample Size: 2,617 cases,2,894 controls; Strongest SNP-Risk Allele: rs13266634-C; SNPs: rs13266634; Context: missense; Risk Allele Frequency: 0.70; p-Value: 6E-8; OR or beta:    1.18; Platform [SNPs passing QC]: Illumina [392,935]	0.00000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	type 2 diabetes mellitus
CTNNA3		17158188	TAS		Disease/Trait: Nicotine dependence; Initial Sample Size: 1,050 cases,879 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs4142041-G; SNPs: rs4142041; Context: intron; Risk Allele Frequency: 0.34; p-Value: 6E-6; OR or beta:    1.14; Platform [SNPs passing QC]: Perlegen[2.4 million] (pooled)	0.000006	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	nicotine dependence
IL23R		17068223	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 547 cases,548 controls; Replication Sample Size: 401 cases,433 controls,883 families,1,119 affected offspring; Strongest SNP-Risk Allele: rs7517847-C; SNPs: rs7517847; Context: intron; Risk Allele Frequency: 0.56; p-Value: 4E-13; OR or beta:    1.61; Platform [SNPs passing QC]: Illumina[308,332]	0.0000000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
IL23R		17068223	TAS		Disease/Trait: Inflammatory bowel disease; Initial Sample Size: 547 cases,548 controls; Replication Sample Size: 401 cases,433 controls,883 families,1,119 affected offspring; Strongest SNP-Risk Allele: rs11209026-G; SNPs: rs11209026; Context: missense; Risk Allele Frequency: 0.93; p-Value: 4E-11; OR or beta:    3.84; Platform [SNPs passing QC]: Illumina[308,332]	0.00000000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	inflammatory bowel disease
HTRA1		17053108	TAS		Disease/Trait: Age-related macular degeneration (wet); Initial Sample Size: 96 Southeast Asian cases,130 Southeast Asian controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs11200638-A; SNPs: rs11200638; Context: nearGene-5; Risk Allele Frequency: NR; p-Value: 8E-12; OR or beta:    1.60; Platform [SNPs passing QC]: Affymetrix[97,824]	0.000000000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration
DLG2		17052657	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 267 cases,270 controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs10501570-?; SNPs: rs10501570; Context: intron; Risk Allele Frequency: NR; p-Value: 7E-6; OR or beta:    5.00; Platform [SNPs passing QC]: Illumina[408,803]	0.000007	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
SEMA5A		16252231	TAS		Disease/Trait: Parkinson's disease; Initial Sample Size: 443 sib pairs; Replication Sample Size: 332 cases,332 controls; Strongest SNP-Risk Allele: rs7702187-?; SNPs: rs7702187; Context: intron; Risk Allele Frequency: NR; p-Value: 8E-6; OR or beta:    1.74; Platform [SNPs passing QC]: Perlegen [198,345]	0.000008	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	Parkinson's disease
CFH		15761122	TAS		Disease/Trait: Age-related macular degeneration; Initial Sample Size: 96 European ancestry cases,50 European ancestry controls; Replication Sample Size: NR; Strongest SNP-Risk Allele: rs380390-C; SNPs: rs380390; Context: intron; Risk Allele Frequency: 0.70 (HapMap CEU); p-Value: 4E-8; OR or beta:    4.60; Platform [SNPs passing QC]: Affymetrix[103,611]	0.00000004	0.4	P-value	GWAS_Catalog	http://www.genome.gov/gwastudies/index.cfm	age related macular degeneration